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Abstract  
Women with epilepsy (WWE) are frequently presented with information when 
preparing for pregnancy, much of this includes statements of risk either concerning the 
health of the woman or her future child. Little is known about how women consider, 
use, are influenced by, trust and either act on or disregard information provided prior to 
conception, how they make decisions about conception, and what might influence their 
pregnancy planning. Studies have told us the numbers of women not receiving advice 
prior to getting pregnant, but these studies do not help us understand why this occurs 
and little is known of the potential to influence the involvement of women in 
preconception counselling. The rationale for this project was to develop understanding 
of the views of WWE, their beliefs, attitudes and perceptions of future pregnancy.  
 
Qualitative methods were applied to investigate the processes of WWE preparing for 
pregnancy. Purposive recruitment was undertaken for women aged 16 years to 45 
years with a confirmed diagnosis of epilepsy of at least three months who have 
experience of being prescribed antiepileptic drugs for management of epilepsy. 
Women were recruited from regional epilepsy clinics across the NW of England, and 
invited to take part in either a focus group or clinic observation and follow-up 
interview. All interviews and focus groups were recorded and transcribed verbatim. All 
transcript data was managed using NVIVO 7 computer-assisted qualitative analysis 
software and analysis was informed by interpretative phenomenological analysis.  
 
A total of 85 women participated within this study, and 12 clinicians provided consent 
for clinic observation. The results highlight the value of examining the subjective 
experiences of reproductive aged WWE, and contribute important insights into the part 
played by women within the decision-making process, and in the broader context of 
their personal experience, relationships, family and social life. The most significant 
finding from analysis was the inconsistent use of the term ‘planning’ both by women 
and their clinicians. Women frequently defined planning as the intention to conceive, 
implying activities to improve epilepsy management occurred before the planning 
stage. For those women who defined planning as involving more complex activities 
and commitment to improve preconception health, many also longed for a more 
natural approach to pregnancy of simply trying to conceive. Barriers to planning 
included misunderstandings about what interventions were required and the timing of 
implementation, in addition to the influence of significant others and past pregnancy 
experience including experience of miscarriage, pregnancy termination or abortion, 
and the likelihood of engaging in preconception interventions. 
 
The presentation of risk information to women during their childbearing years presents 
a challenge requiring a careful balance between delivery of risk information and 
promotion of self-efficacy to successfully achieve planned pregnancy. It is contended 
that current practice fails to acknowledge women’s active role in preconception 
decision-making. Risk information emphasises risks of harm to the unborn child 
heightening fear and worry and for some women perceptions of blame and selfishness 
when considering their needs above a future child. Future research is required to 
acknowledge the interconnectedness of factors likely to contribute or inhibit pregnancy 
planning, and the perceptions of risk, all of which were likely to act both independently 
and interdependently within the social context of the lives of WWE during their 
childbearing years. 
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Chapter 1 – Introduction:   
Women with epilepsy preparing for pregnancy  
“Epilepsy and pregnancy. The shock of waking every morning to such a grim 
problem of life” (Evans, 1952, p.125)1   
 
Introduction 
This thesis focuses upon how women with epilepsy (WWE) experience the 
communication of risk information and its influence upon their involvement in 
preconception care and decision-making during the stages of preparation for 
pregnancy. WWE are presented with risk information throughout their childbearing 
years through interactions between healthcare professionals, family, friends and the 
social media. National and International guidelines recommend the provision of 
preconceptual information and counselling (Crawford, 2005; Stokes et al., 2004; 
Delgado-Escueta and Janz, 1992; Centre for Maternal and Child Enquiries, 2011; 
National Clinical Guideline Centre, 2012), however little is known of how women use 
and interpret risk information, what factors influence their utilization of services and 
whether these factors influence changes in behaviour during the stages of preparation 
for pregnancy.     
 
Epilepsy is a common neurological disorder affecting individuals who show a 
tendency to experience recurrent unprovoked seizures as a result of abnormal and 
excessive neuronal discharge (Sanders and Shorvon, 1996). The prevalence rate of 
epilepsy in the UK is approximately 0.97% based on 2010 population estimates (Joint 
Epilepsy Council, 2011). The incidence of epilepsy in the general population is 
estimated at 50 cases per 100 000 per year (MacDonald et al., 2002), with an age 
specific prevalence rate in women of between 6.9 and 7.9 per 1000 (12-50 years) 
(Purcell et al., 2002). This represents a population of 139, 000 women of childbearing 
age in the UK and more than 1,000,000 women in the United States (Vazquez et al., 
2007; Joint Epilepsy Council, 2011). It has been estimated that twenty-three percent of 
                                                 
1
 Quotation by Margiad Evans’ an Anglo-Welsh author within her autobiographical book `A ray of 
darkness´ describing her journey into motherhood and her initial joy discovering her pregnancy, as 
fulfilling her role as a woman with epilepsy (p.120), tainted by her experience of seizures during 
pregnancy which led her to consider her own mortality (p.125). Evans, M. (1952) A Ray of Darkness, 
London, John Calder. 
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patients with epilepsy are women of reproductive age and 0.3% to 0.7% of all births 
are to mothers with epilepsy, most of whom require continuation of antiepileptic drugs 
(AEDs) during pregnancy because uncontrolled seizures might harm the mother and 
fetus (Lunardi et al., 2011; Tomson et al., 2011; Joint Epilepsy Council, 2011). This 
represents an estimated 22,800 children born each year following in utero AED 
exposure in the US (Meador and Zupanc, 2004); and in the UK, 2400 children born to 
mothers with epilepsy are exposed to AEDs in utero per annum (Kinney, 2011). The 
challenges facing WWE ‘and their supporters’ highlight the importance of adequate 
risk information prior to conception to inform reproductive decision-making and 
reduce risks including maternal mortality (Centre for Maternal and Child Enquiries 
(CMACE), 2011).  
  
Whilst the outcome of pregnancy for the majority of WWE is normal, there is a two- to 
threefold increased risk of adverse pregnancy outcomes; these include risks of 
maternal mortality and morbidity, together with fetal risks of death, major congenital 
malformations, dysmorphism and long-term cognitive delay (Barrett and Richens, 
2003; Yerby, 1997). The population frequency of newborn babies with one or more 
malformations secondary to in utero AED exposure has been calculated as 20/100 000. 
This falls within a similar range as the prevalence of phenyketonuria or congenital 
hypothyroidism, disorders at birth which are targeted by national screening 
programmes (Barrett and Richens, 2003). This comparison has been used by Barrett 
and Richens (2003) to highlight the inequitable service and research investment for 
WWE.  
 
1.1 Preconception counselling principles 
One of the principal goals of preconception care is the identification of and 
reduction in (modifiable) risk factors before conception in order to improve 
obstetric outcome. Therefore, the primary prevention of drug-induced teratogenic2 
exposure should be an important part of this new type of health care (Steegers, 
2005, p.278). 
 
                                                 
2
 A teratogen is defined as an ‘agent or factor that can cause abnormalities of form, function (physically 
resulting in birth defect and altered central nervous system performance resulting in neurological 
dysfunction, behavioural and cognitive abnormalities) or both in an exposed fetus’ (Hanson, J.W. (1997) 
Human Teratology. In Rimoin, D. L., Connor, J. M., Pyeritz, R. E. & Emery, A. E. H. (Eds.) Emery and 
Rimoin's principles and practice of medical genetics (pp.697-700). 3rd Ed. New York: Churchill 
Livingstone.p.697) 
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Preconception care is based on the principle that “healthy mothers produce healthy 
babies who become healthy children and adults” (Department of Health, 2004). 
Preconception counselling has been defined by Chamberlain (1986) as a process of 
preparing for pregnancy through which physical, mental and emotional health is 
optimised before pregnancy. Preconception counselling offers women contemplating 
pregnancy the opportunity to avoid exposure to potential teratogens with the goal of 
improving the chances of a better outcome both for themselves and their child 
(Chamberlain, 1986; Steegers, 2005). Improvements in preconception health to 
increase awareness of modifiable risk factors has been identified by the Center for 
Disease Control and Prevention (2006) as a primary means of preventing major 
congenital malformations, thereby reducing societal costs. The provision of health 
information, including promoting folic acid supplementation, is reported to ‘reduce the 
occurrence of spina bifida and other nervous system defects by at least 50%’ (Koonin 
et al., 2001). The Centre for Maternal and Child Enquiries (2011) has extended this to 
include reduction in preventable indirect maternal deaths. The impact of substandard 
care received by WWE in the UK, was highlighted as being instrumental in the 
epilepsy-related deaths reported (de Swiet et al., 2011). Deaths to WWE during 2006-
2008 represented a rate of 0.61 per 100, 000 mothers, many of whom did not receive 
preconception counselling. As a result, these women and their carers were unaware 
that closer surveillance or changes to medication during pregnancy were appropriate 
(Lewis, 2011, p.43; de Swiet et al., 2011). Promoting the benefits of preconception 
care of WWE, Kinney (2011) reports the potential cost reduction of preventing 31 
children each year born to mothers with epilepsy being affected by major congenital 
malformations (MCMs) (from changes in prescribing practices). He identifies that 
avoidance of sodium valproate would reduce the economic burden by preventing 5 
cases of spina bifida per year at an estimated cost saving of £1,746,000 (Kinney, 
2011)3. Unplanned pregnancy represents a missed opportunity to prevent teratogen 
exposure. Improvements in pregnancy planning has been estimated to represent an 
unadjusted relative risk reduction of 3.0 (95% CI 2.0-4.5) for first trimester exposure to 
potential teratogenic medications (Han et al., 2005).  
 
                                                 
3
 Poster presented at the ILAE UK Chapter Annual Scientific Meeting, York 2011by Dr Michael Kinney 
on behalf of the UK Epilepsy and Pregnancy Register. Slides made available by personal communication 
with Dr James Morrow on behalf of the UK Epilepsy and Pregnancy Register (correspondence date 28-
11-11).    
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Preconception care includes risk assessment, health promotion (involving screening 
and health education) and interventions to modify or eliminate risk factors in order to 
minimise the risk of adverse outcome (De Weerd and Steegers, 2002; Jack and 
Culpepper, 1990). Preconception interventions for WWE target the appropriate use of 
contraception to delay pregnancy until optimal health is achieved and improved 
adherence of preconception supplementation with folic acid (Pack et al., 2009; De 
Weerd et al., 2002). Risk assessment components of preconception counselling for 
WWE target review of diagnosis and AED regimen to ensure appropriate treatment 
prior to conception, focusing on drug choice and, for women experiencing frequent 
seizures, reduction of drug burden from polytherapy to monotherapy (Winterbottom et 
al., 2009; Bánhidy et al., 2011). The improvement of seizure control prior to 
conception is a primary objective of preconception epilepsy review. This requires a 
balanced discussion of both treatment and seizure-related risks, cautioning women of 
the risks of worsening seizures during pregnancy associated with abrupt withdrawal of 
AEDs (National Clinical Guideline Centre, 2012; de Swiet et al., 2011). The health 
promotion activities for WWE target improving health knowledge and awareness of 
the benefits of planned pregnancy, early booking into antenatal care, and use of 
individual risk information for the birth, neonatal period, breastfeeding, and care of 
infants (Winterbottom et al., 2009; Commission on Genetics et al., 1993). 
 
1.2 The history and development of preconception counselling 
Advice to women contemplating pregnancy to improve their ‘wellness’ and ‘avoid 
hazardous substances’ can be traced back to early civilisations, for example, within the 
Old Testament advising on women’s nutrition and the need to avoid alcohol prior to 
conception (Freda et al., 2006). The earliest reports of preconception care within a 
Medline search4 date back to 1957 (Bourquin and Bennum, 1957). The history of 
preconception counselling in the UK dates from 1978 with the establishment of clinics 
providing ‘specific medical advice concerning specific problems which might concern 
women and their partners before embarking in pregnancy’ (Chamberlain, 1980; 
Chamberlain, 1986; Bradley and Bennett, 1995; Lumley et al., 1980). The 
development of preconception counselling for women with chronic diseases including 
epilepsy was the primary intention of service developments in response to the first 
                                                 
4
 Medline search completed January 2012. 
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reports of the teratogenic properties of AEDs (Meadow, 1968; Müeller-Kueppers, 
1963). However, Chamberlain reported that women with prior medical problems 
represented only 17% of the referrals to the clinic (Chamberlain, 1986, p.5-8). The 
importance of targeting preconception care at women at higher risk of adverse 
pregnancy outcomes was the intention of the House of Commons Health Committee 
reporting on the inclusion of preconception care into maternity services (Health 
Committee (Fourth Report), 1990-1991). Improvements in treatment for WWE 
highlighted the need for medical advice prior to conception and modification of drug 
treatment, placing responsibility on the woman to inform her doctor of her plans for a 
family before trying to conceive (Health Committee (Fourth Report), 1990-1991, p.xi 
and Volume II Minutes of Evidence p.163, para 3.28).  
 
The first report on preconception counselling for WWE, entitled ‘Problems counseling 
the epileptic mother’, was published in 1979 by Char and colleagues, and reflected 
increased concern for the outcomes of pregnancy in women treated with phenytoin and 
phenobarbitone and the prevention of fetal hydantoin-barbiturate syndrome (Char et 
al., 1979). This was followed by the Advances in Epileptology Symposium in 1981, 
highlighting the importance of starting counselling early in the course of the disease 
and extending to include the patient’s future as she contemplates decisions concerning 
marriage and parenthood (Andermann et al., 1981, p.219). This symposium focused on 
reducing the two-threefold increased risk of major congenital malformation by 
maintaining the lowest possible plasma levels of anticonvulsants compatible with good 
seizure control, avoiding polytherapy with three or more agents, changing to 
monotherapy whenever possible, and avoiding drugs known to be highly teratogenic 
(Andermann et al., 1981, p.225). The importance of preconception counselling was 
recognised by the International League Against Epilepsy (ILAE), which recommended 
the format for provision of information, care and treatment of WWE relating to 
contraception, pregnancy, prenatal counselling and treatment, birth, the neonatal 
period, breastfeeding and infancy (Anonymous, 1993a; Anonymous, 1989).  
 
Preconception counselling developments have emphasised the complex and 
multifaceted health needs of reproductive-age WWE (Report of the Quality Standards 
Subcommittee of the American Academy of Neurology, 1998), together with the 
importance of missed opportunities for women to access counselling, or take folic acid 
                                                                        Introduction: Women with epilepsy preparing for pregnancy 
 17 
in the correct dose and at the appropriate time. WWE have been found to frequently 
experience unplanned pregnancy, forgetting preconception advice and information 
concerning malformation risks, and failing to recognise the benefits of preconception 
review of AEDs, improvements in seizure control and commencement of folic acid 
(Scottish Intercollegiate Guidelines Network, 2003 (Updated October 2005); 
Fairgrieve et al., 2000).    
 
The benefits of preconception counselling are achieved by timely identification of risk, 
life-style modifications, informed decisions about pregnancy and the opportunity to 
plan pregnancy (Cefalo et al., 1995). The context of preconception counselling for 
WWE emphasises the chronic nature of epilepsy, in which women require an ongoing 
process of preparation and review of epilepsy management, to ensure they conceive 
with a minimum of risk factors, fully aware of any risks and benefits of treatment, and 
able to make informed decisions about future pregnancies (Crawford, 2005). The 
Health Committee’s report on preconception counselling recommended that the Chief 
Medical Officer draw to the attention of GPs the need to advise people with existing 
medical problems (including epilepsy) of the implications of their illness for future 
pregnancies (Health Committee (Fourth Report), 1990-1991 v1 para 123, p.xxvii). The 
slow progress developing preconception services for WWE has been criticised (Pack et 
al., 2009), including in relation to contraceptive knowledge deficits as a method of 
preventing unplanned pregnancy for WWE (Davis et al., 2008). 
 
The progress of history is reflected in the updated NICE clinical guidelines (2012) 
which place responsibility upon healthcare professionals to be knowledgeable about 
potential interactions between AEDs and contraception, to offer all women and girls 
taking AEDs the opportunity to commence folic acid 5mg/day before any possibility of 
pregnancy, and to provide accurate and tailored information and counselling, in 
advance of sexual activity, about the risk of AEDs causing malformations and possible 
neurodevelopmental delay to an unborn child (National Clinical Guideline Centre, 
2012). The requirement for healthcare professionals be aware of the latest data on risks 
to the unborn child, and to assess the risks and benefits of treatment with individual 
AEDs is emphasised, with specific focus on the risk of continued use of sodium 
valproate, particularly at higher doses, and of polytherapy, particularly including 
sodium valproate (NICE, 2012).  
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1.3 Introduction to this thesis 
1.3.1 Research question 
How do WWE interpret risk information when presented within consultation? What 
factors influence their decision-making? Do women use risk information when making 
decisions, and following consultation, are women prepared to make a risk-benefit 
assessment and potential modifications to their epilepsy management and or health 
behaviour? What are women’s perceptions of the influence of communication of risk 
upon decisions made?  
 
These general questions inform the specific research question addressed here of how 
WWE perceive and communicate risk information, which in turn structures the aims 
and objectives of this study.   
 
1.3.2 Aims and objectives 
The main aims of the study were two-fold: 
1. To explore in-depth the perceptions of risk and probability of adverse 
pregnancy outcomes for WWE in the context of their preparations for 
pregnancy, and 
2. To explore how WWE interpret information about risk when making 
preconception decisions? 
 
Specific objectives were to explore:  
i. What factors influence risk behaviour and perception of risk in reproductive-
age WWE.  
ii. How risks and uncertainties are perceived and their potential influence on 
preconception decision-making. 
iii. The experiences of risk benefit assessment. 
iv. Women’s involvement in shared decision-making with their clinicians. 
 
1.3.3 Research context 
This study was influenced by my undergraduate and postgraduate studies in nursing 
and ethics; and, my employment within the NHS as an Epilepsy Nurse Specialist since 
1995, working alongside medical staff and psychologists to develop services for WWE 
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across Merseyside and Cheshire. This context influenced my approach to research, 
valuing evidence from randomised control trials, and the humanistic approach valued 
from my nursing perspective.  
 
The research presented in this thesis was developed from my clinical practice with 
WWE during their reproductive years. My experiential knowledge gained from 
practice reveals the routine presentation of information, in which some women actively 
requested additional risk information from their GP, neurologist or epilepsy nurse 
specialist; while others did not take up the offer of information and presented during 
pregnancy unaware of potential risks. Focusing on the experience of WWE, there was 
acknowledgement of a number of factors influencing reproductive decisions, including 
the role played by a partner. The primary focus of this study is to explore how women 
consider, use, are influenced by, trust and either act on or disregard the information 
provided during preconception clinic attendance.  
 
The study was also developed alongside the authorship of a Cochrane systematic 
review of the evidence of effectiveness of preconception counselling to reduce adverse 
pregnancy outcomes. Preconception counselling and care interventions can be 
characterised as complex interventions with no high quality evidence of effectiveness 
and, to-date, no theoretical underpinning (see Chapter 2.4). The study reported within 
this thesis was designed to gain insight into the experience of women receiving risk 
information as part of their preconception care; and to identify what factors influence 
decision-making with the goal of developing a theoretical understanding of how 
preconception interventions might bring about changes with preconception planning 
and decision-making.   
 
1.4 Outline of thesis 
In Chapter 2, the literature reviewing the gender-specific challenges experienced by 
WWE is outlined, highlighting how the experience of seizures and requirement for 
AEDs during their reproductive years is further challenged by knowledge deficits. The 
management of these reproductive challenges will be presented alongside the results of 
a Cochrane Systematic Review of the effectiveness of preconception counselling to 
reduce adverse pregnancy outcomes for WWE.  
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Chapter 3 examines the psychosocial impact of epilepsy and influences upon women’s 
perceptions of risk and personal judgements concerning preconception decisions. In 
Chapter 4 the methodological issues concerning research in this field are discussed, 
prior to describing the application of qualitative methods to explore the experiences of 
women preparing for pregnancy.    
 
Chapters 5 to 9 detail the findings of qualitative analysis. Chapter 5 introduces the 
women contributing their experiences of preparing for pregnancy. Chapters 6 to 9 
explore the substantive themes of ‘pregnancy planning’, the ‘communication of risk 
and uncertainty’, and ‘decision-making in preparation for pregnancy’ as experiential 
accounts utilized in the development of a model of preconception care for WWE. The 
contribution of these findings to the extant literature is discussed in Chapter 10.  
 
Chapter 11 presents the study conclusions within the context of the original research 
questions to critically review the strengths and weaknesses of the findings and their 
contribution to practice. Recommendations for preconception care are discussed in 
relation to the findings of the Cochrane Systematic Review into the effectiveness of 
preconception counselling to reduce adverse pregnancy outcome and the future 
research requirements in this area. 
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Chapter 2 Preconception counselling: A literature review   
Introduction 
WWE planning pregnancy can generally expect an uneventful pregnancy, resulting in 
a ‘normal child’ (Tomson and Battino, 2009). However, WWE face additional 
challenges as they consider the possibility of pregnancy, namely, potential changes in 
menstrual function and reduced fertility, potential interactions of AEDs with hormonal 
contraception, the risks of adverse pregnancy outcomes including maternal and fetal 
mortality, congenital malformations, dysmorphism, developmental delay and the risks 
of inheritance (Yerby, 1997). A review of the evidence of the impact of preconception 
care upon the reduction of adverse pregnancy outcomes for WWE and their children is 
the focus of this chapter.  
 
2.1 Gender-specific challenges 
For WWE, the experience of pregnancy takes on additional dimensions in which their 
own illness may compromise the health of the unborn baby and further reduce their 
ability to cope with the everyday work of motherhood (Thompson et al., 2008). This 
requires women who want to improve their chances of having a positive pregnancy 
outcome to take action to control their environment and minimise the associated risks 
(Corbin, 1987). Thompson et al (2008) referred to these requirements as ‘moral work’: 
to take action to avoid unplanned pregnancy; and, to both seek and comply with 
complex medical advice when considering pregnancy. The reproductive journey for 
WWE is ‘strewn with social barriers of an attitudinal, ideological and material’ nature 
(Thomas, 1997; Dansky et al., 1980), resulting in the lives of WWE being associated 
with psychosocial sequelae which can have major implications for overall quality of 
life (QOL) (Jacoby and Baker, 2008).  
 
Yue and colleagues (2011) identified the strongest predictors of QOL for women as 
perceived AED side effects and the numbers of AEDs taken; suggesting fertile WWE 
may worry about the increased risks of treatment in three important areas: fetal health, 
reproductive health including endocrine disorders and fertility, and the impact on 
appearance due to weight gain or hair loss. All these place a great burden on the social 
lives of women (Yue et al., 2011). Aspects of QOL for reproductive-age WWE relate 
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to the regulation of fertility, and attempts to normalise lifestyle through reliable 
contraception, including oral contraceptives as the most effective and commonly used 
contraceptive method (Lader, 2009; Boon et al., 2004). Effective contraception for 
WWE is seen as important because of the increased risks of pregnancy, which are 
compounded for some women by interactions between AEDs and hormonal 
contraception (Weisberg, 2010).  
 
Contraceptive interactions result in reduced contraceptive efficacy, accidental 
pregnancy and/or increased seizure activity (Gaffield et al., 2011). The most notable 
AED interactions are between hormonal contraception used concomitantly with 
enzyme-inducing AEDs: phenobarbital, primidone, phenytoin, carbamazepine, 
topiramate (mainly at higher dose), eslicarbazepine, rufinamide and oxcarbazepine 
(Joint Formulary Committee, 2011; Gaffield et al., 2011). The choice of contraception 
for some women is, therefore, influenced by AED selection, thus increasing their need 
for information and counselling to support informed reproductive health choices 
(Gaffield et al., 2011). For women taking the non enzyme-inducing AED, lamotrigine, 
recent evidence suggests a clinically significant risk of interaction with the combined 
oral contraceptive pill, lowering lamotrigine serum levels and increasing the risk of 
seizures (Sabers and Petrenaite, 2009; Gaffield et al., 2011). Women taking sodium 
valproate, or polytherapy regimens including sodium valproate, are advised of the 
importance of establishing ‘highly effective contraception’ to avoid unplanned 
pregnancy, due to the additional risks of adverse pregnancy outcomes (Stokes et al., 
2004; Harden et al., 2009; National Clinical Guideline Centre, 2012). The importance 
of WWE controlling their fertility is emphasised by recommendations – to plan 
pregnancy which for some women may require changes of AEDs or involve additional 
risks of contraceptive failure (Aylward, 2008; Thompson et al., 2008; Crawford, 
2005). The significance of unintended pregnancy for the health, economic, and social 
status of women and their families is a global challenge reflected within the United 
Nations Millennium Development Goals to reduce child mortality and improve 
maternal health (Singh et al., 2010).  
 
Further, the reproductive health of WWE is influenced by gender-specific side effects 
of AEDs, in addition to endocrine and menstrual dysfunctions (Herzog, 2006; Morrell, 
1998; Isojarvi, 2003; Taubøll et al., 2009). Isojarvi (2003) reported prevalence of 
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polycystic ovarian syndrome as higher among untreated WWE, while menstrual 
disorders are more common in women taking carbamazepine long-term. Those gaining 
weight with valproate are more likely to experience polycystic ovaries, 
hyperandrogenism, and menstrual disorders (Isojarvi, 2003). Menstrual disorders in 
WWE have been associated with an increased risk for infertility, migraine, emotional 
disorders, female cancers, and are neurologically important because they are associated 
with greater seizure frequency (Herzog, 2006).  
 
Infertility in WWE is likely due to social as well as medical reasons –  the ‘likelihood 
of women marrying and having children’ is ‘dependent on the nature, severity, and 
duration of the disease’ and the extent to which ‘existing medical, social, and legal 
conditions impede marriage’ - resulting in married WWE having fewer live-born 
offspring than expected for the general population (Dansky et al., 1980; Aylward, 
2008). Women with active epilepsy requiring continued AEDs into adulthood have 
been shown to have lower than average numbers of deliveries, pregnancies, and 
spontaneous and induced abortions, compared with women who achieve remission 
before the age of 20 years (Löfgren et al., 2009). Further, the Kerala Registry of 
Epilepsy and Pregnancy prospectively evaluated fertility in WWE, finding 61.6% of 
registrants conceived within 12 months; 38.4% were classed infertile, with exposure to 
AEDs increasing the risk of infertility, and polytherapy carrying a seven-fold risk 
(Sukumaran et al., 2010). It is estimated one in 200 pregnancies are exposed to AEDs 
(Fairgrieve et al., 2000; Barrett and Richens, 2003). 
 
2.2 Preparing for pregnancy: 
The risk of adverse pregnancy outcomes for women with epilepsy 
Most women with epilepsy today can conceive and bear normal, healthy children, 
but their pregnancies present an increased risk for complications. Pregnancy can 
exacerbate seizure frequency in some women with epilepsy, and both maternal 
epilepsy and in utero exposure to antiepileptic drugs can increase the risk of 
adverse outcomes in children born to women with epilepsy (Yerby et al., 2004). 
 
2.2.1 Major congenital malformation and birth defects  
In utero exposure to AEDs is associated with greater risk of MCMs. The size of risk is 
influenced not only by the type of AED, but also by dose and other variables, all of 
which need to be taken into account in the management of epilepsy in women of 
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childbearing potential (Tomson et al., 2011). AEDs taken as monotherapy are 
associated with a two- to three-fold increased risk of MCMs raising the background 
malformation risk within the UK population from 1-2% to 4-9% (Morrow et al., 2006). 
Earlier publications quote even higher AED-related risks, suggesting up to a sevenfold 
increased risk of MCMs (Oguni and Osawa, 2004). The variance between MCM risk 
estimates reflects a number of factors. These include drug-specific factors, such as, the 
nature of the drug, the dose, concomitant drugs (polytherapy AEDs are associated with 
increased MCM risk), timing of exposure, and the nature of MCMs (presenting as 
isolated defects or defects affecting several organ systems), together with 
methodological factors, such as, inclusion criteria and reporting of confounding factors 
of maternal age and parity (Czeizel et al., 1992). The hypotheses proposed to explain 
AED teratogenicity include: folate deficiency, interactions between AEDs, the effect 
of tonic clonic seizures, genetic factors, and other factors including alcohol, smoking, 
age and gestational age (Oguni and Osawa, 2004). The association of MCMs with in 
utero exposure to AEDs is the best known example of an irreversible side effect of 
AEDs (Perucca et al., 2000). 
 
The spectrum of MCMs associated with the older AEDs includes neural tube defects 
associated with exposure to sodium valproate and carbamazepine; congenital heart 
defects and facial clefts associated with exposures to phenobarbital, primidone and 
phenytoin; and urogenital and skeletal abnormalities associated with all older AEDs 
(Morrow et al., 2006). The rapid extension of newer AEDs into the treatment armoury 
for WWE has added to the uncertainty of teratogenic potential for all but the most 
commonly used ones, due to the time required from initial licensure to establish 
common use in women of reproductive potential (Tomson et al., 2007). AED use by 
registrants within the UK Epilepsy and Pregnancy Register illustrates this point, with 
reporting of monotherapy outcomes for the four most commonly used AEDs in the UK 
(1996-2005) carbamazepine, sodium valproate, lamotrigine and phenytoin (Morrow et 
al., 2006) (table 2.1). 
 
MCM risk information for the newer AEDs remains limited. For example, for 
topiramate licensed for use in the UK in 1995, only 35 pregnancy exposures were 
reported by Morrow et al (2006). A Danish cohort has contributed data on the newer 
AEDs, with reporting of pregnancy outcomes following in utero exposure to 
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topiramate (5 MCMs in 108 pregnancies, 4.6%), oxcarbazepine (11 MCMs in 393 
pregnancies, 2.8%), gabapentin (1 MCM in 59 pregnancies, 1.7%) and levetiracetam 
(0 MCM in 58 pregnancies) (Mølgaard-Nielsen and Hviid, 2011). The UK Epilepsy 
and Pregnancy Register has reported further on the MCM risks of levetiracetam, an 
AED licensed for use in the UK in 2000, and widely used in clinical practice to 
manage both generalised and partial seizure disorders. The Register reported three 
MCMs in 117 pregnancies exposed to levetiracetam in combination with other AEDs 
(2.7%; 95% CI 0.9% to 7.7%) (Hunt et al., 2006).  
 
   Type of malformation 
Drug/ date of 1
st
 use in 
practice (Shorvon, 1995) 
Number of MCMs / 
Informative Outcome* 
MCM rate  
       (95% CI) 
NTD Facial 
cleft 
Cardiac 
Carbamazepine (1962) 20 / 900 2.2% (1.4 to 3.4) 0.2%  0.4% 0.7% 
Sodium Valproate (1961) 44 / 715 6.2% (4.6 to 8.2) 1.0% 1.5% 0.7% 
Lamotrigine (1992) 21 / 647 3.2% (2.1 to 4.9) 0.2% 0.2% 0.6% 
Phenytoin (1938) 3 / 82 3.7% (1.3 to 10.2) 0.0% 1.2% 1.2% 
* Pregnancy losses with no MCM excluded; NTD, neural tube defect 
Table 2.1 Malformation risk of monotherapy AEDs (Morrow et al., 2006).  
 
Polytherapy regimens have been found to represent a greater risk of MCMs compared 
to monotherapy, particularly for regimens including sodium valproate, associated with 
MCM rates as great as 16.7% (Mawer et al., 2010). The challenge for reporting 
polytherapy MCM risk information was illustrated by Morrow and colleagues (2006) 
who reported 126 different combinations among 770 registrants into the UK Epilepsy 
and Pregnancy Register, the most commonly used polytherapy combinations being 
carbamazepine and sodium valproate (62 pregnancies, 8.8% MCM rate) and sodium 
valproate and lamotrigine (141 pregnancies, 9.6% MCM rate).  
 
The influence of maternal tonic-clonic seizures as a causal factor for MCMs has been 
proposed. However, the evidence is refuted by claims that the fetus is ‘remarkably 
resistant’ to the influence of metabolic acidosis secondary to isolated seizures, 
although seizures are likely to influence the adverse outcome of pregnancies already 
complicated by pre-existing conditions (such as, placental insufficiency or chronic 
fetal hypoxia) (Barrett and Richens, 2003). The increased risk of MCMs in untreated 
WWE has led to suggestions of epilepsy itself as a causal factor (Czeizel et al., 1992; 
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Shapiro et al., 1976). Whilst the increased rates of major malformations, minor 
anomalies, intrauterine growth restriction and impaired psychomotor development 
among children exposed to AEDs is felt to be multifactorial, evidence of the 
pathogenesis of these adverse outcomes strongly suggests AEDs as the dominant cause 
at least for major congenital malformations (Perucca et al., 2000). The main focus of 
research has been to quantify the risks of WWE delivering a baby affected by MCMs, 
to categorise exposed infants by specific AED exposure into specific malformation 
syndromes and, to identify the frequency of specific congenital malformations and/or 
association with neuro-developmental delay into drug-specific syndromes. To a lesser 
extent research has focused on strategies to ameliorate the risks of adverse pregnancy 
outcome through preconception interventions. Strategies identified to reduce 
malformation risks within the general population, such as, preconception 
supplementation with folic acid, reduction of smoking, alcohol consumption, and 
obesity have been considered, albeit as confounding factors, within studies into the 
pregnancy outcomes of WWE. 
 
The opportunity to influence the outcome of pregnancy and reduce MCMs for WWE is 
addressed by the recommendation for preconception folic acid supplementation, 
commencing prior to conception and continuing for a minimum of twelve weeks 
gestation (National Clinical Guideline Centre, 2012). Evidence of the effectiveness of 
folic acid in reducing the rate of AED-related MCMs, and specifically spina bifida, 
remains limited and is confounded by the variable uptake of folic acid either at the 
recommended doses or timings (Fairgrieve et al., 2000; Czeizel and Bánhidy, 2011). In 
the general population folic acid supplementation has been identified as having a 
primary preventive role for neural tube defects and other congenital defects (MRC 
Vitamin Study Research Group, 1991; De Weerd and Steegers, 2002). However, the 
ability to extrapolate this finding to treated WWE is unclear, with only limited 
evidence of its influence on reducing risks of spina bifida amongst sodium valproate 
exposed pregnancies (Craig et al., 1999; Morrow et al., 2009). WWE continue to be 
recommended folic acid supplementation, with benefit reported for reduction of 
congenital malformations in children unexposed to AEDs and those exposed in utero 
to carbamazepine, primidone, phenobarbital and phenytoin (Morrow et al., 2009; 
Jentink et al., 2010; National Clinical Guideline Centre, 2012; Kjær et al., 2008).  
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The potential teratogenic risks of all AEDs have been established, resulting in all older 
generation AEDs being classed as harmful to fetal health, and the majority of the 
newer AEDs classed as potentially harmful (Holmes, 2011). Assuming the effect of 
AEDs is important, then changes to newer AEDs may lead to changes in the risks of 
adverse pregnancy outcomes (Borthen et al., 2011). However, whatever reduction in 
specific MCMs changes to AEDs may afford, the ability to reduce the rate of MCMs is 
reliant on comprehensive changes in the medical care of preconceptual and pregnant 
women with epilepsy (Bánhidy et al., 2011). The value of research to inform on the 
MCM risks of AEDs is to assist both treating clinicians and individual women 
planning pregnancy, where ‘the goal for all concerned is a healthy, seizure-free mother 
and an undamaged child’ (Lander, 2008). MCM risk information serves to support 
epilepsy management decision-making, where the issues of maternal and fetal need 
require concurrent consideration, and a balance is likely required between acceptable 
MCM risk for a specific treatment regimen and the dosage required to establish 
effective seizure control (Lander, 2008). Data from the European Epilepsy and 
Pregnancy Register and UK Register have identified dose-dependent risks, supporting 
the recommendation to aim for lowest dose of an AED associated with optimum 
seizure control (Tomson et al., 2011; Morrow et al., 2006; Hauser, 2011).  
 
2.2.2 Neuro-developmental delay 
The longer-term implications for children born to mothers with epilepsy requiring 
AEDs throughout pregnancy is the influence upon their neurodevelopment and 
behaviour; early case reports indicate a relatively high incidence of ‘mental 
retardation’, intrauterine growth restriction and multiple minor anomalies as a marker 
for impairment (Barrett and Richens, 2003). Controversy exists pertaining to the 
existence of drug-specific risk and the frequency of neurodevelopmental effects 
associated with AED exposures, largely as a result of methodological concerns 
including study design, study size, control of confounding variables and duration of 
follow-up (Naghme Adab et al., 2004; Bromley et al., 2011). The Cochrane Systematic 
Review by Naghme Adab et al (2004) established the poor quality of evidence, 
revealing little evidence to guide drug selection, and caution interpreting the results. At 
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the time of completing the systematic review5, few studies reported outcomes for 
children exposed to sodium valproate, finding polytherapy to be associated with poorer 
neurodevelopmental outcomes (Naghme Adab et al., 2004).  
 
Investigation to classify the neuro-cognitive effects of in utero AED exposure has been 
the focus of several national and international study groups including the 
Neurodevelopment Effects of Antiepileptic Drugs (NEAD) Study Group (Meador et 
al., 2009; Meador et al., 2011; Cohen et al., 2011), the Australian Pregnancy Register 
for Women with Epilepsy and Allied Disorders (Nadebaum et al., 2011) and the UK 
Epilepsy and Pregnancy Register (Cummings et al., 2011). The Manchester and 
Liverpool Neurodevelopmental Study Group has extended the phenotype of sodium 
valproate exposed infants to include specific verbal deficits and autism spectrum 
disorder (Shallcross et al., 2011; N. Adab et al., 2004; Bromley et al., 2008; Adab et 
al., 2001; Bromley et al., 2010; Vinten et al., 2009; Kini et al., 2006). Drug-specific 
risks have been established, reporting a dose-dependent influence of valproate for both 
lower verbal and non-verbal abilities, and the dose of carbamazepine influencing lower 
verbal performance. These findings have led to the hypothesis that fetal drug exposure 
may alter normal cerebral lateralization of language (Meador et al., 2011). Attempts at 
prolonged follow-up of neuro-cognitive adverse effects of in utero exposure to AEDs 
into adolescence and adulthood have revealed an increased risk of cognitive delay 
following polytherapy exposure and a crude recurrence risk of 29% (Dean et al., 2002; 
Titze et al., 2008).  
 
The Liverpool and Manchester Neurodevelopment Group have added to 
methodological refinement in their prospective study of long-term risks following in 
utero AED exposure, confirming the overall development of children exposed to 
AEDS in monotherapy was statistically poorer than control children; and children 
exposed to valproate at doses >900mgs/day assessed younger than 24 months had a 
relative risk of 3.6 for below average developmental scores on the Griffiths Mental 
Development Scale [Confidence interval 1.760-7.571, p<0.001] (Bromley et al., 2010). 
A significant dose-related decline in motor functioning is reported for valproate and 
                                                 
5 The review revealed 31 studies meeting the inclusion criteria reporting on 18 independent cohorts. The 
recruitment for these studies spanned from 1959 through to 1999 reflecting the variable AED prescribing 
practices.  
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carbamazepine, with a significant dose-related performance decline in parental ratings 
for adaptive functioning following valproate exposure. In addition, based on parental 
ratings for attention span and hyperactivity, children exposed in utero to valproate 
were at significantly greater risk for a future diagnosis of attention-deficit/hyperactivity 
disorder (Cohen et al., 2011). These findings are in keeping with others reporting on 
the additional educational needs of children exposed to sodium valproate (Adab et al., 
2001) and valproate-specific language delay requiring speech therapy interventions (N. 
Adab et al., 2004). The odds ratio for detrimental effect of valproate upon 
neurodevelopment is reported as OR 26.1 (95% CI: 4.9-139) p>0.001 by Cummings et 
al. (2011).    
 
The identification of long-term developmental effects of in utero exposure to the newer 
AEDs is limited by the latent period from drug licence to adoption in practice and 
prescription within the childbearing population, as well as limitations in post-
marketing surveillance. Bromley et al (2010) reported delayed development following 
exposure to less commonly used AEDs in a sub-group of 13 children exposed to 
phenytoin (7), topiramate (2), gabapentin (2), vigabatrin (1) and oxcarbazepine (1). 
They found no statistical significance compared with control children and were unable 
to draw conclusions due to the small size of this group (Bromley et al., 2010). 
Shallcross and colleagues (2011), on behalf of the Liverpool and Manchester 
Neurodevelopment Study Group and UK Epilepsy and Pregnancy Register 
prospectively investigated one of the newer AEDs, levetiracetam, finding exposed 
children did differ significantly from controls and had higher scores for overall 
development quotient when compared to children exposed in utero to valproate. 
 
Alternative non-AED mechanisms influencing neurodevelopment of children born to 
WWE have been proposed, including a detrimental effect of maternal tonic clonic 
seizures during pregnancy (Titze et al., 2008). Adab et al (2004a) identified women 
experiencing five or more tonic clonic seizures in pregnancy as having a similar size 
effect upon child verbal IQ as exposure to sodium valproate. The potential 
mechanisms for convulsive seizures to influence neurodevelopment include fetal 
hypoxia and prolonged exposure to acidosis (N. Adab et al., 2004). Consistent with the 
majority opinion, Bromley et al (2010) and others have found no statistically 
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significant difference between children exposed to seizures and those not (Thomas et 
al., 2007; Meador et al., 2009; Titze et al., 2008).  
 
The opportunity to influence neurodevelopmental outcomes has been proposed by 
Meador and colleagues (2011) who report preconception folate as positively associated 
with higher verbal outcomes in AED-exposed children. This finding is supported by 
the general population prospective observational Norwegian Mother and Child Cohort, 
which identified maternal use of folic acid supplements in early pregnancy as 
associated with a reduced risk of severe language delay in children at age 3 years (Roth 
et al., 2011). Meador et al (2011) support the need for additional research to both 
confirm the findings of drug-specific dose-dependent risks for neurodevelopmental 
delay and understand the underlying mechanisms associated with the effect of AEDs 
on the immature brain. In addition, the potential influence of environmental factors 
upon neurodevelopment also requires attention, to examine the implications of 
maternal stress secondary to worries concerning the risk of malformations, as potential 
confounders (Van den Bergh et al., 2005; Turner et al., 2008; Nicolai et al., 2008). 
 
2.2.3 Adverse neonatal outcomes 
Adverse outcomes of neonates were reported by Lin and colleagues (2009), suggesting 
WWE have a greater tendency to have low birth weight, preterm and small for 
gestational age babies, which is counteracted by AED therapy. These results were 
contested by the Liverpool and Manchester Neurodevelopment Study Group. Their 
controlled observational study found no significant differences in the frequency of 
preterm birth or low birth weight babies between WWE receiving treatment and 
controls, whilst babies of untreated WWE did not differ from those of the control 
group in relation to gestational age at birth or birth weight (Mawer et al., 2010).  
 
2.2.4 Adverse antenatal outcomes  
Adverse antenatal outcomes include changes to seizure frequency. The Australian 
Register of Antiepileptic Drugs in Pregnancy suggest the risk of seizures during 
pregnancy is 50-70% less if WWE are seizure free one year before pregnancy (Vajda 
et al., 2008). Seizure-related risks in pregnancy have been reported in the literature, 
ranging from no changes in seizure frequency and improvements in control reported in 
83% of women with active epilepsy (Viinikainen et al., 2006), to infrequent seizure-
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related injuries reported by the Liverpool and Manchester Neurodevelopmental Study 
Group (Mawer et al., 2010). The implications of a single breakthrough seizure during 
pregnancy as posing serious consequences for everyday social life are considered by 
Sabers (2009). Findings from a UK prospective study of the care of WWE in 
pregnancy found 71% of women experiencing ongoing seizures at the time of 
pregnancy, while incomplete adherence with medication was reported in 62.3% of 
women, a factor likely to have influenced the continued experience of seizures during 
pregnancy (Fairgrieve et al., 2000). Women who abruptly withdraw AEDs within 
pregnancy have been found to be at increased risk of worsening seizure control and a 
ten fold increased risk of maternal mortality, the latter felt to be preventable in the 
majority of cases through adequate preconception and pregnancy patient and carer 
education (de Swiet et al., 2011; Barrett and Richens, 2003). Maternal mortality 
includes cases of sudden unexpected death in epilepsy (SUDEP), and other preventable 
causes such as drowning (de Swiet et al., 2011). Status epilepticus as a complication of 
pregnancy accounted for 1.8% of all pregnancies monitored within the European 
register, which concluded that the outcomes of status epilepticus were not associated 
with maternal mortality or miscarriage (though there was one case of stillbirth in a 
woman experiencing status epilepticus) (The EURAP Study Group, 2009).  
 
Obstetric complications associated with pregnancies in WWE taking AEDs throughout 
pregnancy include an increased risk of severe pre-eclampsia, early bleeding in 
pregnancy, induction of labour and caesarean delivery, and the increased risks of 
complications associated with AED use, the epilepsy itself being less influential 
(Borthen et al., 2011). Further, women with active epilepsy (seizures <5 years before 
conception) experienced planned caesarean sections more frequently. Rates of pre-
eclampsia, early bleeding, induction and caesarean were not different between women 
with active or inactive epilepsies, and women not using AEDs had no increased risk of 
pregnancy complications (Borthen et al., 2011). The Kerala Registry of Epilepsy and 
Pregnancy prospectively followed WWE from preconception/first trimester throughout 
pregnancy, confirming no excess in intrapartum complications (severe bleeding and 
prolonged labour) or postpartum problems (postpartum haemorrhage and puerperal 
infections) compared to a matched control group of women without epilepsy 
(Saramma et al., 2011). 
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2.3 Preparing for pregnancy: Information needs  
WWE require information concerning the increased risks associated with the 
management of epilepsy and its treatment throughout their reproductive years. This 
information is crucial to support their involvement in making informed reproductive 
decisions (Crawford and Lee, 1999). A number of studies have surveyed the 
information needs of WWE, identifying the extent of knowledge deficiency 
experienced by women and their poor satisfaction with service provision (Bell et al., 
2002; Crawford and Hudson, 2003; Crawford and Lee, 1999; Wallace and Solomon, 
1999; Fairgrieve et al., 2000). The significance of knowledge deficits were for 
women’s inability to avoid accidental pregnancy and their lack of awareness of the 
potential risks associated with their treatment (Madden, 1999). Accidental or 
unplanned pregnancy secondary to contraceptive failure has the potential to create 
continued anxiety about the risks of AEDs, and to result in women seeking information 
from other less creditable sources because of conflicting medical advice (Wallace and 
Solomon, 1999).  
 
The disparity between women’s concerns about pregnancy and their awareness of 
effective contraception were the focus of the cross-sectional survey sampling WWE 
attending routine epilepsy care within the Columbia Comprehensive Epilepsy Centre 
(Davis et al., 2008; Pack et al., 2009). Of women who reported being sexually active, 
only 53% used effective methods of contraception (defined as contraception ≤10% 
experience of pregnancy in the first year of typical use) and 17% relied on unorthodox 
methods and the unsafe method of ‘withdrawal’. Of those women who had been 
pregnant, 61% reported at least one unplanned pregnancy (Davis et al., 2008). 
Women’s knowledge of AED-related risks was found to be limited and inaccurate for 
the majority, with some women reporting AEDs as either having no effect on fetal 
development or a ‘good effect’. For those women reliant on older AEDs (phenytoin, 
phenobarbitone, primidone, carbamazepine and sodium valproate) 40% were unaware 
of the potential teratogenic potential of their treatment, and 50% of women reliant on 
enzyme-inducing AEDs were incorrect about the potential for their treatment to reduce 
the effectiveness of oral contraceptives (Pack et al., 2009). History of pregnancy was 
not found to be associated with increased knowledge of AED-oral contraceptive 
interactions, leading to the authors to underscore the significance of knowledge deficits 
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for WWE as resulting in preventable morbidity including unplanned pregnancy, fetal 
exposure to teratogenic AEDs, and maternal stress (Pack et al., 2009). 
 
The standard of care of WWE aged 14-55 years was examined as part of the 
Department of Health Clinical Standards Advisory Group (CSAG) questioning the 
information received on preconception and pregnancy topics. They found 40% of 
women recalled being advised of the need for pregnancy planning, 38% recalled being 
advised to commence folic acid prior to pregnancy and 48% of women recalled being 
advised of teratogenic risks (Bell et al., 2002). The results of the ‘Ideal World’ survey 
of female member of the UK charity Epilepsy Action, reinforced the value of written 
information about the effects of epilepsy on pregnancy and the risks to the unborn 
child being provided to support decision-making about adjusting AEDs when 
considering pregnancy (Crawford and Hudson, 2003). The potential improvements in 
epilepsy services for WWE were the focus of qualitative enquiry by Vazquez and 
colleagues (2007) who identified the level of dialogue between women and their 
physicians as insufficient to alleviate concerns. 
 
Bagshaw et al (2008) reviewed women’s information needs concerning childcare and 
the potential seizure-related risks of accidents and injury to their infant. These authors 
found only 50% of women recalled being provided with information about caring and 
managing childcare risks. The implications of maternal knowledge deficits for the 
psychomotor development of children have been raised, with both the childcare 
environment and maternal abilities identified as important determinants. These studies 
highlighted mothers’ anxiety about their ‘mothering’ skills and lack of confidence in 
their abilities to protect their baby from harms (Hirano et al., 2004; Saramma et al., 
2006; Bagshaw et al., 2008). The Kerala Registry of Epilepsy and Pregnancy group 
found a significant association between childrearing knowledge and practices, with 
WWE having significantly lower scores for childrearing knowledge, childcare 
monitoring and specific impairments of infant stimulation than women without 
epilepsy. The hesitations of WWE to actively involve themselves in cleaning and 
bathing their baby were felt to be due to the perceived fears both of the women 
themselves and family/carers concerning the risks of dropping the baby or causing 
injury (Saramma et al., 2011).  
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Improvement in women’s knowledge is contingent on the availability of information 
services and knowledgeable healthcare professionals. However, healthcare 
professionals have been found to lack the skills necessary to advise women of  
teratogenic risks (Hancock et al., 2007). Morrell and colleagues (2000) surveyed 3535 
healthcare professionals across a wide range of specialities, finding 50% of 
respondents uncertain about the frequency of birth defects of children born to WWE, 
and most not knowing the recommended minimum dose of folic acid supplementation. 
Around three-quarters of pharmacists were aware of enzyme-inducing AEDs reducing 
the efficacy of contraceptives; but neurologists were found to have significant 
knowledge gaps. Only 33% correctly identified the increased risks associated with 
sodium valproate, and even fewer responded correctly about the older AEDs (Roberts 
et al., 2011; McAuley et al., 2009). The majority of neurologists recognised the 
potential benefit of folic acid supplementation, despite lack of awareness of the 
additional risks for neurodevelopmental deficits in children exposed to AEDs (Roberts 
et al., 2011). These findings are significant for the care of WWE, given their reliance 
on healthcare professionals as first contact when considering pregnancy (Vazquez et 
al., 2007). This is reflected within NICE clinical guidance (2012), which requires those 
responsible for prescribing AEDs to be aware of the ‘latest data’ concerning risks to 
the unborn child when prescribing to any women or girl with current or future 
childbearing potential (National Clinical Guideline Centre, 2012).  
 
The need to reduce the health inequalities that result in an increased risk of adverse 
pregnancy outcome for WWE served as rationale for a formal systematic review to 
evaluate the evidence of effectiveness of preconception counselling for WWE, as part 
of The Cochrane Library series (JB Winterbottom et al., 2008). 
 
2.4 Preconception counselling for women with epilepsy  
– A Cochrane Review  
The objectives of completing this systematic review were two-fold; to establish the 
effectiveness of preconception counselling interventions for WWE, measured by a 
reduction of adverse pregnancy outcomes for both mother and child, increased 
knowledge of preconception issues and increased intentions to plan pregnancy; and to 
determine the level of evidence and primary research in the area (JB Winterbottom et 
al., 2008). The review has been completed in three stages:  
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1) Review protocol (first published in the Cochrane Library Issue 3 2007) 
2) Complete review (first published in the Cochrane Library Issue 3 2008) 
3) Update of review  
 
The review methods6 complied with The Cochrane Library and involved a systematic 
search and appraisal of all published and unpublished work in the field. The types of 
studies included: randomised control trials - including quasi-randomised and cluster 
randomised trials; prospective cohort studies; controlled before and after studies and 
interrupted time series studies. Participants of interest were women of childbearing 
potential aged 12-50 years, with a confirmed diagnosis of epilepsy, experiencing two 
or more seizures in the last two years, on or off treatment. Preconception counselling 
interventions included any educational and/or counselling interventions targeting 
WWE before conception with the intention of improving pregnancy outcomes. 
Preconception defines the time leading up to a pregnancy, starting from the decision to 
have a baby up until becoming pregnant, with interventions involving assessment of 
lifestyle, health and fitness by a healthcare professional (NHS Direct, 2009). Studies 
were considered relevant if they compared usual care (defined as no targeted 
intervention) with any combination of the recommended components of preconception 
care.  
 
Outcomes of interest included, as primary maternal outcomes, increased knowledge of 
pregnancy and treatment-related risks; and as secondary outcomes, reduction in 
maternal mortality and morbidity, reduction in unplanned pregnancy, improvement in 
rates of commencement of folic acid, increased uptake of breastfeeding, increased 
satisfaction with care, and increased concordance with treatment/intervention 
regimens. Primary fetal outcomes included reduced incidence of major malformations 
(minor anomaly) and developmental delay, while secondary outcomes included 
reduced infant mortality and morbidity (reduced admission into Special Care Baby 
Unit, reductions in preterm births and reductions in baby born small for gestational 
age). An essential component of evaluating the effectiveness of health promotion 
interventions is the measurement of cost effectiveness, requiring both immediate and 
                                                 
6
 Winterbottom, J.B., Smyth, R.M., Jacoby, A. & Baker, G.A. (2008) Preconception counselling for 
women with epilepsy to reduce adverse pregnancy outcome. Cochrane Database of Systematic Reviews 
Issue 3, Art.No.: CD006645.doi: 10.1002/14651858. CD006645.pub2. Review methods and results are 
presented acknowledging my contribution as main author. 
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long-term measurement of direct and indirect costs. Economic measures of cost-
effectiveness and cost-utility analysis were included in the review protocol as essential 
measures to estimate the likely benefits, harms or costs to reduce adverse pregnancy 
outcomes in WWE and their children (JB Winterbottom et al., 2008).          
 
2.4.1 Complete review results – Description of studies  
The search strategy7 identified 225 citations of which 211 were excluded (65 were 
guidelines or narrative reviews, and the remainder included non-interventional surveys 
of information needs). No study met the eligibility criteria for inclusion in the review 
(see 'Characteristics of excluded studies' table, within JB Winterbottom et al., 2008). 
The review identified several studies that attempted to provide evidence of the 
effectiveness of preconception counselling and reported positive outcomes, but caution 
is required interpreting these study findings due to their methodological weakness and 
failure to meet the predetermined inclusion criteria. Four studies identified improved 
fetal outcomes, reporting reduced incidence of MCMs (Betts and Fox, 1999; Oguni et 
al., 1992); reduced perinatal deaths (Martin and Millac, 1993); and one study8 reported 
improvements in live birth rate (Cox et al., 1992; Smith et al., 1987). Betts and Fox 
(1999) identified no cases of MCM in the preconception intervention group who had 
benefited from epilepsy review resulting in changes in AEDs, notably withdrawing or 
switching from valproate, and switching to monotherapy. Data were unavailable to 
ascertain the effectiveness of counselling to promote preconception folic acid 
supplementation, although no MCMs were recorded for WWE taking folic acid before 
conception (Betts and Fox, 1999). 
  
2.4.2 Updated review results – Description of studies 
The present literature review updates the previously published one in The Cochrane 
Database of Systematic Reviews (Issue 3, 2008) on ‘Preconception counselling for 
women with epilepsy to reduce adverse pregnancy outcome’, using the same search 
methods for identifying studies for inclusion and the same assessments of 
methodological quality (see JB Winterbottom et al., 2008, Methods & Appendix 1 
Search Strategy). Three studies awaiting classification at the time of the original 
                                                 
7
 A search of electronic databases included Medline (OVID) (1950-February 2008); Scopus (1966-
March 2008); CINAHL (1982-March 2008); PsycINFO (1806-March 2008); and ASSIA (1987-March 
2008)(Winterbottom et al., 2008). 
8
 One study reported findings in two papers. 
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review have now had their status updated. Contact was made with one author (Nguyen, 
2007) and retrieval of full text articles by Shafer and Santilli (1996) and Beffa Negrini, 
et al.(1998) confirmed them as opinion papers only describing service developments. 
Assessment of a paper by Beffa Negrini and colleagues (1998) identified a further 
publication describing a non-intervention retrospective study reporting pregnancy 
outcomes following development of an outpatient service for pregnant women with 
epilepsy (Franza et al., 1998). In addition, the update includes appraisal of two studies, 
updating their status following assessment of the complete published data. The study 
by Mawer and colleagues recruited women into a prospective pregnancy cohort 
evaluating pregnancy outcomes. Communication with the author revealed that 
preconception interventions were not included within analysis of outcomes, and 
recruitment occurred during the index pregnancy (Mawer et al., 2010). The study by 
Miškov and colleagues (2009) was included for assessment of quality.  
 
The updated electronic and hand searches were re-run including dates between March 
2008 and February 2012, with 73 new citations identified including one from the 
Cochrane Pregnancy and Childbirth Group. Sixty-eight papers were discounted as not 
relevant, of which 37 were guideline documents and narrative review articles. From 
those discounted; five surveyed information needs (three of professionals; two of 
WWE); one reviewed a midwife intervention in a non-epilepsy population; four were 
non-interventional, surveying genetic risk perceptions and fears concerning 
childbearing; two reported fertility rates. Three studies (four papers) were discounted 
due to study design, including the Hungarian case-control study which concluded that 
preconception folic acid supplementation reduced, but did not eliminate, the increased 
MCM risk for children exposed to AEDs (Kjær et al., 2008; Bánhidy et al., 2011); and 
the qualitative papers by Thompson and colleagues (2008) and Pashley and 
O’Donoghue (2009). Of note, Thompson et al (2008) provided an additional 
perspective on women’s experience of the ‘hard work’ coping with the uncertainties of 
reproduction, which result in few seeking specialist advice in advance of planning 
pregnancy; and on the dissonance between specialist advice and women’s 
internalization of health messages advising against drug use in pregnancy as a barrier 
when considering engaging in preconception counselling. In the study by Pashley and 
O’Donoghue (2009), women experiencing unplanned pregnancy were found to be less 
likely to worry about AED-related risks and to judge their ability to influence 
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pregnancy outcomes with a degree of fatalism. These qualitative papers provide insight 
into the problems faced by WWE, and provide rationale for the undertaking of a 
systematic review of the effectiveness of preconception interventions to influence 
pregnancy outcome.  
 
Assessment of selection of studies was completed with the search results classified as 
relevant, possible or rejected. One study met the inclusion criteria (Miškov et al., 
2009)(see table 2.2 Risk of Bias); the rationale for exclusions are shown in table 2.3 
Characteristics of excluded studies.  
 
2.4.3 Included studies 
The prospective cohort study by Miškov, et al. (2009) reported on the outcomes of 23 
women taking lamotrigine (mean age 27.14±3.15) recruited at Sestre milosrdnice 
University Hospital, Zagreb (May 2003- May 2008) and followed prospectively 
throughout pregnancy, including outcomes for their infants up to one year of life. The 
problem of incomplete reporting on the outcomes of interest has been resolved by 
writing to the study author.  
 
Bias Authors' judgement Support for judgement 
Random sequence generation 
(selection bias) 
 High risk All women enrolled in first trimester, "most of 
them had been surveyed at the same hospital 
before their index pregnancies occurred". 
Allocation concealment 
(selection bias) 
 High risk One third of participants presented for first time 
in the Centre for counselling during pregnancy. 
No evidence of concealment. 
Blinding of participants and 
personnel (performance bias) 
 High risk 
No evidence of blinding 
Blinding of outcome 
assessment (detection bias) 
 High risk 
No evidence of blinding 
Incomplete outcome data 
(attrition bias) 
 High risk Ascertainment of exposure to the preconception 
interventions restricted due to pooled data. 
Selective reporting (reporting 
bias) 
 High risk The published description of the methods and 
results prevented complete assessment of 
methodological quality, since no description 
was provided of the derivation of the 
intervention and control groups. 
Other bias  High risk Reported results of preconception counselling 
for only a subset of the main sample of women 
(those who had attended the hospital before 
their index pregnancy). 
Table 2.2 Risk of bias (non-randomised studies)  
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Eleven women were reported to have planned pregnancy (defined as deciding to 
achieve pregnancy and considering changing dietary habits prior to conception); 16 
women took folic acid at least four weeks before pregnancy and continued throughout 
pregnancy. The higher intake of folic acid was attributed to the ‘proper preconception 
counselling’ and repeated recommendations. However, the lack of baseline data means 
this conclusion is unsupported. Preconception switch of AEDs was completed by 17 
women, seven switching between 10 days and 1 month before pregnancy, of whom 
four planned pregnancy, and two experienced deterioration in seizure control during 
pregnancy. Adverse outcomes were reported in six pregnancies, no MCMs: there was 
one intrauterine death (without evidence of MCM), two spontaneous abortions (one 
excluded due to diagnosis of toxoplasmosis), and one elective termination (reasons not 
related to epilepsy or AEDs). Eight women experienced seizures during pregnancy, 
and two experienced preterm deliveries (Miškov et al., 2009). 
 
Study ID Reason for exclusion 
De Santis 
et al 2010 
Study design: Prospective cohort of callers to the Teratology Information Service. 
Participant: 344 non-pregnant women taking AEDs (10% of calls to TIS were doctors, 7% 
relatives), 3733 non-pregnant women taking non-AED therapeutic chemicals.  
Intervention: risk information concerning drug exposure in pregnancy.   
Main findings: 54% of all women callers had folic acid, compared to 12% of WWE.    
Reason for exclusion: Unable to differentiate AED use for WWE or other indications. 
Kazandi 
et al 
(2010) 
Study design: Retrospective cohort  
Participant: 66 pregnant WWE.  
Intervention: Provision of preconception counselling. 
Main findings: No MCMs or minor anomalies; 57% counselled WWE commenced 
preconception folic acid. All counselled women remained on prescribed AEDs throughout 
pregnancy compared to 60.71% of non-counselled women. 
Reason for exclusion: Retrospective study design. 
Mawer  
et al 
(2010) 
Study design: Controlled observational study 
Participant: 277 WWE, 315 controlled matched for age and parity. 
Intervention: Prospective review of pregnancy outcomes, no preconception intervention. 
Main findings: No association between MCM and dose of preconception folic acid. 
Reason for exclusion: Non-interventional. 
Rück & 
Bauer 
(2008) 
Study design: Retrospective cohort of patients referred into the Epileptology Clinic.  
Participant: 118 WWE attended for ‘special pregnancy planning advice’. 
Intervention: Preconception advice and changes to AEDs, commencement of folic acid. 
Main findings: 31.2% of counselled women took preconception folic acid. 35.5% planned 
pregnancy. 35.5% counselled WWE had increased seizure frequency. 
Reason for exclusion: Retrospective study design. 
Sabers  
et al 2009 
Study design: Retrospective chart review. 
Participant: 99 Pregnant WWE registered in European Epilepsy and Pregnancy Register. 
Group 1- 46 WWE receiving preconception review, Group 2- 44 WWE referred pregnant.  
Intervention: Preconception counselling delivered as routine care for all women. 
Main findings: 78% of counselled women versus 41% pregnant women took preconception 
folic acid. Counselled women were less likely to be seizure free prior to pregnancy.  
Reason for exclusion: Retrospective study design. 
Table 2.3 Characteristics of excluded studies  
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2.4.4 Discussion of review findings 
Caution is required when interpreting the results for the included study, due to the high 
risk of bias. There was little evidence to confirm the effectiveness of preconception 
counselling interventions to improve pregnancy outcomes in WWE. Several studies 
attempted to show evidence of effect. However, due to methodological weaknesses, no 
firm conclusions or implication for practice can be drawn. 
 
The study by Miškov and colleagues (2009) identified the ‘continuous processes of 
planning and preparing for pregnancy’ as reliant on a multidisciplinary approach. Their 
findings were supported by Sabers (2009), in that not all women referred to the 
epilepsy clinic before conception experienced a planned pregnancy (48%) or 
commenced folic acid (70%) (Miškov et al., 2009). This highlights the potential 
influence of other factors affecting pregnancy outcomes such as socioeconomic status, 
educational attainment and preconception knowledge deficits. Of note, from those 
studies excluded, Sabers (2009) described systematic delivery of preconception 
counselling information including about ‘adequate contraception’, and evaluation 
and/or adjustment of AEDs ‘aimed at therapeutic low-dose monotherapy regimens’, 
and reported counselled women as less likely to experience an increased seizure 
frequency during pregnancy. Sabers (2009) suggested preconception folic acid intake 
was not an accurate marker for receipt of preconception counselling, as not all 
counselled women commenced supplementation prior to conception. Sabers proposed 
preconception commencement of folic acid as more predictive of intention to conceive, 
as not all women followed medical advice. The goals of preconception counselling 
were extended by Kazandi and colleagues to include alleviation of pregnancy-related 
stress by improving folic acid supplementation, coordinating pregnancy care, 
providing ultrasound scans and information about the risks of seizure in pregnancy. 
Kazandi et al (2010) found preconception counselling was associated with complete 
adherence to treatment advice and women maintaining AEDs throughout pregnancy, 
when compared to non-counselled women who were at increased likelihood of 
discontinuing AEDs during the first trimester and of experiencing seizures during 
pregnancy. 
  
The methodological challenges raised by the results of this systematic review, 
alongside concerns about methodological quality of studies identified highlight the 
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need for caution interpreting the results. Others investigating the potential to recruit 
and retain women participating in preconception interventional studies, have 
demonstrated the ability to achieve an adequate rate of study completion and 
representative sample posing few threats to study validity (Brown et al., 1997). These 
authors highlight the potential barriers to recruitment included the tentative nature of 
pregnancy plans requiring adjustments of the data collection protocols and the 
importance of maintaining contact with participants throughout the study  (Brown et 
al., 1997). The Cochrane Effective Practice and Organisation of Care Group; in their 
work to review the effectiveness of complex interventions that involve both patients 
and professionals and organisational change, highlight the importance of a control 
group and pre-intervention data collection (Ballini et al., 2011). Evaluation of 
preconception counselling interventions represented a challenge, due to the complex 
nature of interventions involving several interconnected components; both 
pharmacological and educational, and the interdependence of interventional 
components dependent on organisational structures, personnel and service delivery; in 
addition to patient variables. Evaluation of the effectiveness of preconception 
counselling interventions is reliant on appropriately powered studies designed to 
eliminate the risk of confounding. 
  
The implication for practice is that there are major limitations to available evidence of 
the effectiveness of preconception interventions, and a need to evaluate the cost-
effectiveness of service developments. NHS maternity care for WWE is associated 
with additional care requirements, resulting in antenatal costs estimated at £660 higher 
per woman than for women overall (Mistry et al., 2007). However, no study reviewed 
included cost analysis of preconception care. In addition, uncertainty surrounds the 
effectiveness of one of the most commonly and widely applied primary preventive 
strategies: preconception folic acid supplementation (Kjær et al., 2008); and 
preconception health education to increase appropriate use of folic acid (Czeizel and 
Bánhidy, 2011). Preconception care aims to increase awareness of WWE of the 
importance of seizure control, together with knowledge of role AEDs play in 
maintaining optimal control both prior to and during pregnancy (Kalviainen and 
Tomson, 2006). Achieving this requires improvements in shared information 
concerning all aspects of reproduction (NICE, 2012).  
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The driver for future research is the need to understand the unique challenges faced by 
WWE throughout their childbearing years. Prospective investigation of factors that 
influence pregnancy planning, and sufficient long-term follow-up of WWE who have 
received preconception interventions are required so that the influence of risk 
information on risk framing and decision-making, and clarification of the meanings of 
risk for WWE and their likely motives for taking action, can be evaluated 
(Winterbottom et al., 2009).  
 
2.5 Summary 
Women with epilepsy preparing for pregnancy are required to manage a range of 
gender-specific challenges, including contraception, fertility, and the need for AEDs 
during their childbearing years. Whilst the majority of women achieve a desired 
pregnancy and good outcome, some face additional risks of congenital malformation 
and neuro-cognitive delay affecting their offspring. Clinical practice has addressed 
these challenges through provision of preconception counselling. However, current 
literature reveals limitations in the evidence of the effectiveness of preconception 
interventions. Future research should include prospective evaluation of primary and 
secondary outcomes of preconception counselling with pre-intervention measures of 
knowledge and health behaviours of WWE to reduce the potential bias reported by 
observational studies. To achieve this goal, research is first required to investigate the 
women’s perceptions of pregnancy-related risks and the influence upon reproductive 
decision-making and pregnancy planning. This thesis presents research that addresses 
this goal.    
 
In the next chapter, the contribution of social-cognitive theories and the psychosocial 
literature to understand reproductive health behaviour is considered. 
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Chapter 3 Reproductive health behaviours  
Introduction 
Preconception care is the physical and mental preparation for childbearing of both 
parents before pregnancy. It has a large component of health education, one facet 
of the total education of living, and a smaller medical component specifically for 
identifiable problems. Pregnancy is a load and probably is better coped with if 
preparations have been made (Chamberlain, 1986, p.1). 
 
WWE preparing for pregnancy face two sets of challenges: those common to any 
woman (deciding to have a child including negotiation with a partner, and setting time 
aside to prepare and optimise health prior to conception), and those specific to their 
condition. Managing pregnancy-related risks for WWE includes: the importance of 
optimising seizure control and the need for AEDs throughout childbearing years, non-
drug concerns about epilepsy inheritance, and epilepsy-specific knowledge deficits. 
WWE may experience additional psychosocial challenges, reflecting the additional 
responsibilities they face during their reproductive years. The challenges faced by 
WWE negotiating preconception decisions are highlighted, acknowledging the 
influence of a partner as implied by Chamberlain’s quote, in addition to external social 
factors all likely to influence pregnancy planning. In this chapter, I will examine the 
determinants of reproductive decision-making and risk perceptions considered by 
WWE, reviewing the literature both from the perspective of social cognitive theories 
and the wider psychosocial literature. 
 
3.1 Social cognitive theory 
Social cognitive theories and models have emerged to help explain and predict health 
behaviours and thereby assist the development of interventions to produce 
improvements in individual and populations’ health (Conner and Norman, 1995, 
p.1,7). Health behaviours are assumed to be the end result of rational decision-making, 
based upon elaborate subjective cost-benefit analyses of the likely outcomes, valued 
and associated with the highest expected utility (Conner and Norman, 1995, p.7). A 
literature search reveals the application of social cognitive theories across a wide range 
of health conditions, describing how the preparedness of an individual to action 
behaviour change is a consequence of a complex of variables and/or stages (Marks, 
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2008). This literature review will focus on application of social cognitive theories in 
the fields of preconception and epilepsy-related healthcare illustrated in table 3.1. 
 
Preconception Intervention Social Cognitive Theory Evidence of application 
Epilepsy management review 
 
Seeking preconception review 
Self-efficacy, self-
management. 
Extended Health Belief 
Model 
General epilepsy population (DiIorio 
et al., 2003). 
Teenagers with diabetes (Charron-
Prochownik et al., 2001)  
Improved contraception use 
 
 
Condom use consistency 
Composite model (perceived 
barriers, cues to action, self-
efficacy). 
Theory of planned behaviour  
Preconception diabetic population 
(Wang et al., 2006). 
 
Teenage non-epilepsy population 
(Abraham et al., 2011) 
Planned pregnancy Theory of planned 
behaviour. 
Locus of control 
Preconception non-epilepsy population 
(Lifflander et al., 2007).  
Preconception diabetic population 
(Holing et al., 1998) 
Adherence to intervention 
(switch to alternative 
treatment, withdrawal, dose 
reduction) 
Self-efficacy and self-
management of medications. 
Theory of planned 
behaviour. 
Maternal & fetal health locus 
of control  
General epilepsy population (DiIorio 
et al., 2004; Kobau and DiIorio, 2003). 
General epilepsy population (Kilinç 
and Campbell, 2008). 
Pregnant women with diabetes 
(Spirito et al., 1990) 
Initiation of folic acid Health belief model. 
 
Health belief model & ‘Fetal 
Health Locus of Control 
Scale’. 
Transtheoretical model 
Non-epilepsy pregnant population 
(Kloeblen and Batish, 1999). 
Non-epilepsy population 17-50 year 
olds (Quillin et al., 2000). 
 
Non-epilepsy population (Milan and 
White, 2010)  
General preconception health 
improvements. 
Stopping smoking. 
 
Locus of control & self-
efficacy. 
Transtheoretical model. 
 
Preconception non-epilepsy population 
(Bastani et al., 2010). 
Pregnant non-epilepsy population  
(Haslam and Draper, 2000). 
Table 3.1 Application of social cognitive theory 
 
3.1.1 Health Belief Model  
The health belief model (HBM) assumes that individual beliefs concerning personal 
susceptibility to, and severity of, a health concern (e.g. unplanned pregnancy) serve to 
motivate actions to reduce the threat through a person’s desire to avoid the area of 
concern and maintain wellness (Stretcher and Rosenstock, 1997, p.43). An individual’s 
level of readiness to respond to health concerns is motivated by their ability to take the 
necessary action and their perceptions of benefits weighed against perceived barriers. 
Barriers are seen to direct an individual’s decisions and course of action, whilst ‘cues 
for action’ serve as triggers to prompt an individual to feel ready to address the health 
concern (Stretcher and Rosenstock, 1997, p.45-6; Rutter and Quine, 2002, p.10).  
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Kloeblen and Batish (1999) tested the utility of the HBM to predict low income 
pregnant women’s intentions to follow a high folate diet, finding the perceived benefits 
of supplementing their diet were the strongest predictor of this outcome. Quillin et al 
(2000) identified four potential health belief variables predicting adherence to 
preconception folic acid intake, including, perceived susceptibility of having a baby 
affected by NTD if not complying with folic acid supplementation; perceived 
seriousness of NTDs; perceived benefits of supplementation to prevent occurrence of 
NTD; and, perceived barriers to compliance with folic acid supplementation (Quillin et 
al., 2000).  
 
Investigating reproductive health attitudes and behaviours of adolescent females with 
type 1 diabetes, Wang et al (2006) found perceived susceptibility to becoming 
pregnant had a significant positive relationship with perceived barriers and cues to use 
of birth control. Further, perceived benefits of birth control were significantly related 
to positive personal attitudes towards using birth control, and ‘cues to action’ were 
significantly related to intentions to perform reproductive health behaviours. Charron-
Prochownik et al (2001) applied an Extended Health Belief Model, and found a strong 
association between teenagers with diabetes’ initial awareness of preconception care 
and their later utilization of services, suggesting the timing of health messages and 
motivational cues by healthcare professionals played an important role triggering 
action and promoting positive reproductive health behaviours. 
 
3.1.2 Self-Efficacy Theory  
Perceived self-efficacy refers to beliefs in one’s capabilities to organize and 
execute the courses of action required to produce given attainments. The events 
over which personal influence is exercised vary, and influence may entail 
regulating one’s own motivation, thought processes, affective states, and actions, 
or it may involve changing environmental conditions, depending on what one 
seeks to manage (Bandura, 1997, p.3). 
 
Perceived self-efficacy is a good predictor of adherence to self-management regimens; 
predicting how well a person might stick to a particular health behaviour and manage 
their own health (Bandura, 1997, p.288). Bandura suggests chronic disease 
management requires the person not only to ‘alleviate symptoms that are more or less 
personally controllable but also exercise personal control over medical care and 
treatment that are prescribed for them’ (p.299). Schwarzer and Fuchs (1995, p.165) 
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propose that adoption of health promotion recommendations relies on three sets of 
cognitions, (adapted here to reflect the needs of WWE):  
1. an expectancy that one is at risk (‘my epilepsy might deteriorate in 
pregnancy’ or ‘my baby might be affected by my drugs’);   
2. an expectancy of reducing the threat by behaviour changes (‘if I seek 
epilepsy review to optimise my epilepsy control, I will reduce the risks to 
me and my future baby’); and 
3. the expectancy that one is sufficiently capable of making positive changes 
or avoiding risky habits (‘I can avoid accidental pregnancy and access 
preconception review’)   
 
Epilepsy self-management is achieved by the individual taking steps to control seizures 
and manage the consequences or effects of having a seizure disorder, finding 
‘perceived’ self-efficacy and patient satisfaction directly influencing perceived self-
management of medications and abilities to manage epilepsy and optimise seizure 
control (DiIorio et al., 2004). Those confident to manage their medications were more 
likely to believe the benefits associated with taking treatment and practice self-
management strategies. Further, the development and maintenance of self-management 
practices emphasises the importance of social support (DiIorio et al., 2004). Self-
efficacy beliefs are behaviour specific, with high levels of self-efficacy associated with 
confidence in performing behaviours prescribed to control seizures (Dilorio et al., 
1992). Amir et al (1999) found the level of perceived control to achieve mastery in 
dealing with epilepsy encouraged an individual’s coping, medication taking, and 
performance in self-management actions. Self-efficacy and its influence upon epilepsy 
self-management, in addition to social support and locus of control, were found to 
impact quality of life (Amir et al., 1999). 
 
3.1.3 Health Locus of Control 
Health locus of control (HLC) emphasises perceptions of control, mastery and self-
efficacy beliefs, focusing on expectancies that one’s actions are instrumental in goals 
attained (Norman and Bennett, 1995, p.63). Individuals with an internal locus of 
control are identified as assuming responsibility for their health, and more likely to 
engage in health-promoting activities than those with an external locus of control, who 
believe events occur outside their control, by chance, or the control of powerful others 
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(Norman and Bennett, 1995, p.63). The HLC model has been applied to epilepsy self-
management programmes. It suggests locus of control is a useful measure of an 
individual’s perceptions of their ability to change or control their lives, and is a 
predictor of a person’s willingness to comply with medical treatment. The HLC model 
supports interventions to empower people to better deal with the ramifications of living 
with a seizure disorder (Dechman, 1992). In a study by Asadi-Pooya, et al (2007) 
patients with good seizure control were found to have higher internal health locus of 
control scores on the multidimensional health locus of control scale compared with 
patients with uncontrolled seizures. Patients with epilepsy held stronger beliefs in 
powerful others influencing their health (external HLC), and tended to believe internal 
factors were unimportant for health control. They found significant interrelationships 
between HLC and health attitudes, behaviours, coping styles and outcomes, 
highlighting the strong role to be played by healthcare professionals influencing the 
health-related beliefs of patients accessing their care (Asadi-Pooya et al., 2007). 
Specific features of coping behaviours found among WWE were greater reliance on 
religion/faith, and fewer problem-solving strategies to help them overcome the 
problems they faced in daily life compared with pregnant healthy controls (Sachin et 
al., 2008).  
 
Assessment of HLC in pregnant women found those abstaining from smoking during 
pregnancy held significantly higher perceived internal control scores, and believed 
themselves responsible for the health of their unborn child, compared to women with 
external locus of control, who believed health professionals or chance factors 
determined their newborns’ health (Labs and Wurtele, 1986). Spirito et al (1990) found 
women with diabetes were more likely than non-diabetic women to believe the health 
of their unborn baby was under the control of powerful others such as healthcare 
professionals. Perceived internal control in relation to birth outcomes has been strongly 
associated with socio-demographic variables and physical health status; women 
perceiving greater control over future birth outcomes were older, more highly 
educated, married or living with a partner, and in better physical health (Weisman et 
al., 2008). Women with diabetes attributing their health outcomes to the control of 
powerful others were more likely to experience unplanned pregnancy (Holing et al., 
1998). Preconception interventions aimed at empowering women by increasing their 
awareness of the risks of unhealthy lifestyles and the benefits of health improvements 
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upon pregnancy outcomes; and at influencing beliefs of personal health as less 
dependent on influential others, were likely to improve health decisions and increase 
preferences for information seeking (Bastani et al., 2010).      
 
3.1.4 Theory of Planned Behaviour 
The theory of planned behaviour (TPB) assumes an individual holds beliefs which 
influence their intentions to perform particular behaviours (Ajzen, 1988, p.132-3). In 
this model three independent determinants influence a person’s intention to perform a 
particular behaviour; subjective norms, attitudes towards the behaviour, and the 
individual’s perceived control to be able to perform the behaviour (Ajzen, 1988). 
Perceived behavioural control is an important extension of the TPB, reflecting 
theoretical developments from the theory of reasoned actions (TRA), concerning the 
influence of behaviours not entirely under volitional control, and proposing a direct 
causal effect of perceived control on intentions and behavioural goals (Ajzen, 1988, 
p.136-7). The TRA was the basis for the analysis by Austin (1989), which showed that 
subjective norms predicted parental adherence to AED regimens, and influenced by 
negative beliefs based on inaccurate information. In relation to contraceptive practices, 
perceived behavioural control predicts intentions to use condoms and actual condom 
use (Conner and Sparks, 1995, p.129).  The impact of social structures, such as 
socioeconomic status (SES), gender and aspirations pertaining to lifestyle, employment 
and education, upon condom use has been explored. Mother’s SES and aspirations 
were found to have independent unmediated effects on consistent condom use, and 
educational aspirations and gender affecting condom specific cognitions and 
consistency of use (Abraham et al., 2011).  
 
Describing women’s motives and behaviours surrounding pregnancy planning, 
Lifflander et al (2007) identified three different dimensions: the decision to have a 
child; taking steps to increase the likelihood of conception; and making plans for 
childcare. Conflicting desires for pregnancy introduced uncertainty about the timing of 
conception, in which women wanting a child at a younger age, despite also wanting to 
complete their education or establish their career, were found to be less motivated to 
plan and more willing to leave the outcome of childbearing to chance (Lifflander et al., 
2007).  
 
                                                                                                                       Reproductive health behaviours 
 49 
Perceived behavioural control has been associated with the uncertainty of predicting 
the benefits of withdrawing AEDs weighed against the risks of seizure relapse, with 
planning behaviours influenced by normative beliefs and social pressures including the 
embarrassment associated with a diagnosis of epilepsy, problems associated with 
medication taking, timing of the decision to withdraw medication and perceived 
support (Kilinç and Campbell, 2008).  Motivations to withdraw AEDs were found to 
reflect personal experience and a wider awareness of others successfully achieving the 
planned outcome (Jacoby et al., 1992). In addition, decision-making processes unique 
to women were found to be influenced by subjective norms about achieving pregnancy 
off medications (Kilinç and Campbell, 2008).  
 
3.1.5 Stage theories of health behaviour change 
A number of differing stage theories have been developed to predict and explain health 
behaviour change, emphasizing the dynamic and temporal perspective of behaviour 
change reliant upon different cognitions at the different stages of change (Norman and 
Conner, 1995, p.213). The ‘contemplation ladder’ was developed by Biener and 
Adams (1991) as a single item self-report measure of a person’s motivation stage, and 
applied to measure readiness to take action to stop smoking, identifying a person in the 
‘precontemplative stage’ with ‘no thought of quitting’ at stage 0-1. It is assumed a 
level of threat must exist before a person contemplates the benefits of taking action, 
and ruminates about their competence to perform the behaviour (Schwarzer and Fuchs, 
1995, p.177). The Transtheoretical Model (TTM) was developed to include the stages 
of precontemplation and contemplation to help explain an individual’s readiness to 
plan a specific behaviour change (Prochaska and DiClemente, 1983). The stages of 
change are defined by the time between thinking about change and taking action. The 
preparation stage is the time immediately before taking action, and the action stage is 
the time immediately after having made the overt change of behaviour (Prochaska et 
al., 1994).  
 
Milan and White (2010) evaluated a web-based folic acid intervention based on the 
TTM, establishing that the majority of participants were not taking folic acid 
supplements at baseline, with greatest improvements following completion of the 
tailored intervention, based on self-efficacy and weighing the pros and cons for 
adopting a change in behaviour. ‘Precontemplative’ individuals experienced the 
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greatest impact, as they had no motivation to change prior to the intervention (Milan 
and White, 2010). In contrast, the health risk assessment of pregnant smokers was 
explored by Haslam and Draper (2000), identifying precontemplative women less 
convinced of the health risks associated with smoking compared to women in the 
contemplative, preparation or action phases. The importance of stage-specific 
interventions were highlighted, suggesting that women in the ‘contemplative’ and 
‘preparation’ stages held more conviction and, therefore, would benefit more from 
skills training, whilst those in the ‘precontemplative’ stage required consciousness-
raising health information to convince them of the risks of smoking in pregnancy 
(Haslam and Draper, 2000).  
 
3.1.6 The role of social cognition to explain preconception health behaviours 
The health behaviours associated with preparations for pregnancy are assumed in-part 
under volitional control (securing effective contraception, taking AEDs as prescribed, 
accessing the epilepsy clinic and requesting information). Other aspects of 
psychosocial experience, for example, life with epilepsy, risk perceptions, and 
outcome expectancies are assumed as under incomplete personal control, representing 
internal issues such as limited knowledge, uncertainty, emotional factors and 
dependence on others. Additionally, the influences of socioeconomic factors need 
recognition. All of these factors may act to constrain implementation of intended 
behaviours (Ajzen, 1988, p.127-133), and may help explain poor adherence by WWE 
to preconception recommendations. There is increasingly acknowledgement of the 
importance of assessing risk as a socially constructed phenomenon (Slovic, 2000b), an 
issue relevant for reproductive aged WWE due to the complexity of preconception 
interventions – a point extended in the following section.  
 
3.2 Psychosocial influences upon reproductive health behaviour 
The psychosocial burden to women during childbearing can be substantial, with 
mixed messages from different physicians, nurses, family, and friends, about the 
risk that she is “placing” on her unborn child by exposure to known teratogens. 
Although there are increased maternal and fetal risks compared to the general 
population, these risks are often over-exaggerated and are not presented in the 
context of the risk of recurrent and uncontrolled seizures  
(Pennell and Thompson, 2009, p.S21) 
 
                                                                                                                       Reproductive health behaviours 
 51 
Pennell and Thompson (2009) identify four types of ‘psychological burden’ facing 
WWE preparing for pregnancy: the first concerns their childbearing status and 
decisions to plan pregnancy; the second relates to their perception of pregnancy-related 
risk; the third concerns the influence of risk communication; the fourth, to women’s 
preference for involvement in decisions concerning their treatment.   
 
3.2.1 Pregnancy planning 
The challenge facing WWE making pregnancy decisions is the extent to which their 
decisions extend beyond the duration of pregnancy to influence pre-pregnancy 
decisions (Thomas, 1997), and motivate them to seek preconception review and secure 
highly effective contraception until completion of the recommended interventions. The 
decision to plan pregnancy has been proposed as a process moving from underlying 
motivations, attitudes and beliefs to desires and the active formation of reproductive 
intentions, through to the implementation of a decision and the resultant behaviours 
(Miller, 1994). In this process WWE must also respond to the specific-to-epilepsy risks 
of unplanned pregnancy and the benefits of planning (Pashley and O'Donoghue, 2009). 
 
The affective and psychological dimensions influencing ambivalence towards 
contraceptive use have been used to explain happiness or dismay about the discovery 
of pregnancy as stages along a continuum of planning (Bachrach and Newcomer, 
1999). From a sociological persective, becoming a mother has been constructed in 
terms of a life ‘transition’, in which motives for having children may not have been 
considered or discussed, and the questions of whether pregnancy was planned are 
complex, tapping into a ‘minefield of unexplored or half-explored motives and 
reasons’ (Oakley, 1979, p.33). These can be framed broadly as: expectations; the 
results of a ‘long process of critical self-examination’; the weighing up advantages and 
disadvantages; and the influence of images of family life (Oakley, 1979, p.30-35). 
Earle and Letherby (2002) identify the medical and lay discourses around women 
intentionally trying to conceive as creating an illusion of control, which fails to match 
the reality of the ability to conceive when desired, occurring earlier or later than 
anticipated, if at all. The experience of an earlier than planned pregnancy has been 
described within patient groups of WWE; with pregnancy in teenage years or when not 
ready, as a result of inadequate advice leading to contraceptive choices being 
ineffective (Wallace and Solomon, 1999).  
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Barrett and Wellings (2002) emphasise the importance of women’s definitions of 
pregnancy planning. They suggest that the term ‘unplanned pregnancy’ may fail to 
capture the positive pregnancy intentions expressed by some women. Earle (2004) 
presented a typology of pregnancy intentions identifying four categories: the planned 
pregnancy, the ‘laissez-faire pregnancy’, the ‘recalcitrant pregnancy’, and the 
accidental pregnancy. Earle (2004) considers the planned and accidental categories as 
unambiguous, describing women as either ‘following advocated health professional’ 
recommendations, or describing an ‘unexpected pregnancy due to contraceptive 
failure’. The categories of ‘Laissez-faire’ and ‘recalcitrant’ are seen as ambiguous: the 
former describing women’s experience of stopping contraception and adopting a more 
relaxed approach to pregnancy, the latter describing the experience of women who 
want to be pregnant but for whom planned pregnancy would be socially unacceptable 
(Earle, 2004). For others, ambivalence towards pregnancy has been linked to 
inconsistent contraceptive use and proposed as an alternate explanation for the poor 
predictive power of ‘pregnancy timing intentions’ (Zabin, 1999). Poor utilisation of 
contraception methods has been proposed as an important factor in the experience of 
unplanned pregnancy among WWE (Pennell and Thompson, 2009). A lack of 
planning surrounding contraception may be reflective of personality traits and a 
general disinclination to plan ahead on wide variety of issues in daily life (Brown and 
Eisenberg, 1995, p.170). The term ‘recalcitrant pregnancy’ highlights the affective 
dimensions of pregnancy desires, where past experiences can create barriers to seeking 
preconception care (Earle, 2004). Barriers to discussing pregnancy intentions with 
either a partner or healthcare professional are associated with WWE experiencing 
unplanned pregnancy, highlighting misunderstandings about fertility (Pashley and 
O'Donoghue, 2009).  
 
Analysis of women’s pregnancy intentions distinguishes a subset of women who 
knowingly take chances through ineffective contraceptive practices. These women in 
effect adopt a tactic of ‘contraceptive roulette’, in which ‘non-decisions’ are seen as 
valid alternatives to deliberate reproductive or contraceptive choices (Lippman-Hand 
and Fraser, 1979c, p.81; Pashley and O'Donoghue, 2009). Holing et al (1998) 
questioned why women with diabetes chose not to plan pregnancy, identifying 
unplanned pregnancy as often not due to contraceptive failure, but more closely 
classified as conscious or subconsciously intended. These authors highlighted the 
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complex ‘web of circumstances associated with poor pregnancy planning’, including 
poorer SES and, significantly poorer relationships with healthcare professionals and 
perceptions of discouragement (Holing et al., 1998). Extending the analysis within a 
General Practice population Hosli et al (2008) identified factors deterring women from 
participating in preconception counselling including: perceptions of having sufficient 
knowledge to make the necessary preconception health improvements, perceptions of 
low risk of adverse pregnancy outcome, and misunderstandings about the aim of 
preconception counselling. An important finding from these authors related to the 
influence of risk perception upon reproductive decision-making, suggesting women 
who felt they had already achieved a healthy lifestyle and perceived low personal and 
familial risks of congenital malformations were less likely to decide to participate in 
preconception counselling (Hosli et al., 2008).   
 
3.2.2 Perception of pregnancy-related risk 
The term ‘risk’ is often used to denote a phenomenon that has the potential to 
deliver substantial harm, whether or not the probability of this harm eventuating is 
estimable (Lupton, 1999, p.9).  
 
Lupton (1999) suggests pregnancy exemplifies the impact of the advance in risk-
related knowledge and technology, with advice constructed to regulate a woman’s 
body from the time she may be considering the idea of childbearing. The aim is to 
ensure she is at a peak state of health at the time of conception, and able to care for the 
fetus, which is portrayed as highly fragile and susceptible to risk throughout 
development (Lupton, 1999, p.89). For many women, the presentation of risk 
information as part of their medical care and communication with specialists defines 
their risk status as their individual responsibility (Parsons and Atkinson, 1992, p.438). 
 
Pregnancy risk perceptions have been judged major influences upon the lives of 
women with disability and chronic health conditions such as epilepsy (Lyerly et al., 
2009; Thomas, 1997; Douglas, 1990). In these circumstances women are seen to adopt 
‘protective governing’ strategies in order to exert some control over the potential 
harms threatening their pregnancy (Corbin, 1987). Corbin (1987) identified a number 
of strategies used by pregnant women to assess their level of risk in response to 
information, to balance available management options in terms of potential benefits 
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and risks, and to control risks through adoption of shared management processes in 
which management actions were taken by women alongside their clinician.  
 
Since the thalidomide disaster in the 1960s, fears about medicine use in pregnancy 
persist. Differing sources of risk information (social media, friends, family, healthcare 
professionals etc) may provide women with misleading information, further provoking 
anxieties and fears (Hancock et al., 2007). Assessment of therapeutic risk has been 
explored by Slovic (2000a), finding public perceptions of the likelihood of harm and 
seriousness of harm due to taking therapeutic drugs was highly correlated to perceived 
risk. Within patient groups, those experiencing adverse drug reactions were more 
likely to blame a lack of information about the drug as the cause of the reaction, in 
addition to inadequate monitoring by the doctor (Slovic, 2000a, p.261).  
 
3.2.3 The influence of risk communication 
Pennell and Thompson (2009) suggest the psychosocial issues facing WWE require 
attention by clinicians when counselling and considering treatment, as the content of 
risk information has far reaching consequences for the range of decisions made by 
women concerning pregnancy and life-style, before, during and after pregnancy. The 
potential influence of framing risk information is significant, a point explored by 
Parsons and Atkinson (1992) in their research of women receiving genetic counselling. 
Exploring the meanings of risk, these authors found that whilst some women retained 
mathematical risk information (such as percentage risk), others translated their risk into 
descriptive categories (such as, ‘high’ or ‘low’) and in doing so, shifted from the 
delicacy of ‘risk values’ originally communicated by the clinician into a binary 
statement of something that was either going to happen or not (Parsons and Atkinson, 
1992). Being offered treatment options in addition to the level of descriptions of 
potential drug side-effects (including negative descriptions) has been presented as a 
desirable approach to assisting medication/intervention decision-making (Toerien et 
al., 2011; Berry et al., 1997). Recent research shows that use of the internet to search 
for information about teratogenic risks of AEDs has resulted in many women 
remaining uncertain, confused and experiencing increased anxiety (De Santis et al., 
2010). De Santis and colleague’s (2010) highlight the importance of ‘health 
professionals directing women towards high quality websites’, and recommend women 
are ‘provided instruction about how to locate information, how to check its credibility, 
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and the need to discuss the information during consultation’ (p.157). The potential for 
women to benefit from a tailored internet intervention was reported by Milan and 
White (2010). These authors found female college students were receptive to an 
internet based intervention, tailored to their stage of change and able to promote self-
efficacy and perceived pros for commencing folic acid supplementation.  
 
The importance of frank discussion about drug risks regardless of whether health 
professional or patient feel comfortable has been identified as a crucial characteristic of 
satisfactory teratogenic risk counselling (Santucci et al., 2010). May et al (2009) 
identified WWE held differing perceptions of risks which were influenced by past 
experiences of pregnancy, and associated with expressions of ‘great worry during 
pregnancy about risks to their newborn child’. Perceived drug risks influenced 
women’s decisions about whether to have children or not, finding the potential risks of 
malformations caused by their treatment as instrumental in their conscious abstaining 
from having their own children (May et al., 2009). Perceptions of genetic risks were 
investigated by Helbig and colleagues (2010) who found perceived risks of epilepsy 
affecting the child to be overestimated, with a four-fold increase in risk estimated by 
parents with epilepsy. The implications of such overestimation were apparent in 
women’s perceptions of the abilities to care for a child and resulted in decisions to 
have fewer children (Helbig et al., 2010). Further, patients undergoing genetic 
investigations experienced intensified fears about the possibilities of their child 
developing epilepsy, with the potential for both positive and negative emotional impact 
upon the family (Hammond et al., 2010).  
 
Turner et al (2008) investigated prevalence of fears in pregnant WWE, and found 
women with higher seizure frequency during pregnancy were more fearful of 
childbirth; WWE were significantly more fearful about possible fetal malformations 
than were healthy controls, but less fearful of pain during delivery. May and colleagues 
(2009) identified fears during pregnancy as contributing to a fifth of women stopping 
or reducing AEDs during pregnancy without consulting their physician. The 
consequences of fear resulted in a third of women having great reservations about 
becoming pregnant because of their epilepsy (May et al., 2009; Helbig et al., 2010). 
This last point is exemplified by a sociological analysis of the medical discourse 
around ‘Fetal Alcohol Syndrome’ by Armstrong (2003). Armstrong notes the ‘tragedy’ 
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of birth defects associated with teratogen exposure and women’s ‘weighty’ 
responsibility towards the fetus has defined the woman as a ‘fetal vessel’ requiring 
careful risk management (p.117, 137,195). This may, in turn, lead to extensions of the 
‘ritual prohibitions’ of pregnancy to women who are no more than potentially pregnant 
(Armstrong, 2003, p.197).  
 
The unpredictability of patient responses to risk information has been reported either as 
emphasising ‘chance’ and ‘opportunity’, or accentuating ‘uncertainty’ and ‘danger’ 
(Wilkinson, 2010; Heyman and Henriksen, 1998). The disparity between lay and 
professional interpretations of perceived risks of seizure relapse have been studied in 
families and clinicians caring for children with epilepsy (Gordon, 1994), with the 
finding that clinicians are often unable to predict a family’s response to risk 
information (Gordon et al., 1996). Individual variance in views about acceptable 
seizure relapse risks have also been shown for adolescents with epilepsy when 
compared to their parents (Pogančev, 2011), and in the context of women’s 
perceptions of teratogenic risks in relation to their requirement for medical treatment 
during pregnancy (Jasper et al., 2001). Examining women callers to the Motherisk 
teratogen information service, Jasper et al (2001) found teratogenic risk information 
presented as the probability of giving birth to a normal child lowered perceptions of 
risk and influenced decisions to use a drug in pregnancy. Negative presentation of drug 
risk (e.g. “there is a 1-3% chance of having a child who has a major birth defect”) 
influenced women’s perceptions of higher teratogenic risks when compared to 
positively framed messages (e.g. “97-99% chance of having a normal child”), resulting 
in negative framing reducing the likelihood of wanting to take the medication (Jasper 
et al., 2001). Even among women counselled with positively framed information, more 
than 65% chose not to take their medication (Jasper et al., 2001). An alternate 
explanation of risk framing was presented by Jacoby’s et al (1993) analysis of 
counselling patients about AED withdrawal, identifying negative framing of risk 
information was more likely to influence decisions to remain on treatment in patients 
initially uncertain of their treatment preference. The clinician’s neutrality was felt to 
inadvertently ‘reflect a high magnitude of risk’ (Jacoby et al., 1993). That patients with 
epilepsy are more susceptible to framing bias places them at risk of making uniformed 
decisions and emphasises the decisions they face as complicated by the uncertainties 
involved in differing drug choices and their short- and long-term risks and benefits 
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(Choi et al., 2011). Wallace and Solomon (1999) identified WWE as concerned by 
conflicting advice which, they felt, left women unclear of exactly what risks they 
might face, anxious about the risks of AEDs in pregnancy, and philosophical about 
achieving a balance of seizures and side-effects that least interfered with their lives. 
The potential for ‘risky’ decisions about stopping treatment on discovery of pregnancy, 
and issues of women’s ability to perform their ‘moral work of avoiding unplanned 
pregnancy’ as being highly contingent upon their receipt of accurate and timely 
information, remains a concern in practice (Thompson et al., 2008, p.59). 
 
The experience of pregnancy for women with chronic illness requires effort and focus, 
keeping the condition closely monitored and under control, not only to maintain their 
own health ‘but for the safety of her developing fetus’ (Corbin and Strauss, 1987, 
p.266), and emphasising the probability of an abnormal process and the need for 
women to be dependent on medical care (Oakley, 1980, p.21 & p.215). The overall 
experience of pregnancy represents a transition period reflecting changes in biological, 
social and psychological makeup (Pennell and Thompson, 2009; Turner et al., 2008). 
This can, for WWE who interpret pregnancy as a stressor, result in additional worry 
and lack of control over their bodies (Lunardi et al., 2011). Knowledge as a 
prerequisite for psychosocial wellbeing for persons with epilepsy has been reviewed by 
Collings (1999), who positioned knowledge as central in the reduction of uncertainty. 
Psychosocial well-being is best achieved by the combination of effective AEDs and 
the provision of as much information as possible regarding epilepsy and its treatment 
(Collings, 1990). Collings (1990) proposed that a lack of information places the person 
with epilepsy unable to make realistic adjustments in their lifestyle, and more likely to 
fall victim to myths and other inaccurate information, in turn resulting in increased 
health worries and less fulfilment. Meeting women’s information needs requires their 
current beliefs, ideas and knowledge to be explored, challenging professionals not 
simply to dismiss erroneous beliefs, but to offer convincing alternative explanations 
(Wallace and Solomon, 1999). Having adequate knowledge and a stock of 
management strategies helps women to manage pregnancy risks; the greater the 
knowledge about their condition and about the purpose and implications of treatment 
plans in contrast to normal pregnancy, the better able WWE will be to accurately 
assess risk levels and adopt a position of control in making use of available support 
(Corbin, 1987).  
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3.2.4 Involvement in treatment decisions 
The challenge for WWE making reproductive decisions is their concerns about the 
continuation of medication during pregnancy. The importance of establishing ‘the right 
drug for their seizures’ was revealed in women’s accounts of a frustrating ‘trial and 
error’ process, in which they accepted lengthy and laborious changes in medication in 
the hope of gaining seizure control (Wallace and Solomon, 1999). The study of patient 
involvement in the AED decision-making reveals a widespread ‘paternalistic’ 
approach, in which patients attending routine epilepsy clinic consultations relinquish 
control of treatment options being presented, in favour of the clinician’s expertise 
(McCorry et al., 2009). In contrast to the literature in other fields of medicine elevating 
the patient as expert (Tuckett et al., 1985; Lowe, 2005), few patients held specific 
treatment preferences. Whilst the majority had ‘hopes and expectations’, including a 
keenness to try new treatments if recommended by their doctor, few expressed 
concerns about potential adverse side effects (McCorry et al., 2009). The case of a 
reproductive aged woman was exemplified by McCorry et al (2009), where the 
patient’s ‘risky decision’ to withdraw sodium valproate, had failed to take account of 
her personal risks, if her actions had resulted in worsening seizures. The patient’s 
account was  influenced by her perceived ‘high chance’ if she had experienced 
pregnancy of causing ‘damage’ to her child (McCorry et al., 2009).  
 
An alternative approach to women’s role in AED decision-making was presented by 
Pashley and O’Donoghue (2009). They identified women who planned pregnancy as 
more articulate and determined, taking a central role in the decision-making process, 
both in relation to instigating referral for counselling, and in asserting their opinions 
upon the available treatment options. The epilepsy-specific factors influencing 
treatment decisions have been found to include the potential loss of driving licence, 
‘fears of seizures because of past seizures and their after-effects’, and the gender 
specific factor of the ‘implications of continued AED treatment for contraception and 
pregnancy’ (Jacoby et al., 1993). Offering women the opportunity to withdraw AEDs 
may be controversial, highlighting that in the context of pregnancy, WWE need to be 
cautioned about the importance of weighing up the uncertain teratogenic risks of AEDs 
against the physical risks to them of experiencing a seizure, and the social penalties 
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such as loss of driving or employment (Williams et al., 2002). In this sense, Thomas 
(1997) proposes that women’s pregnancy decisions take into account their concerns 
about the implications of disability and/or treatment upon perceptions of themselves as 
‘good enough mothers’. Thomas (1997) highlighted the responsibilities placed on 
medication decisions for WWE and their needs to avoid the potential outcome of 
having a disabled child, based on their perception of being seen by others as 
‘irresponsible’ and ‘unfair’ to the child. 
  
3.3 Summary  
In this chapter, social cognitive theories have been shown to offer the potential to 
predict health behaviours, such as epilepsy self-management and AED adherence, and 
health promoting behaviours, such as securing effective contraception, commencement 
and maintenance of folic acid supplementation, and seeking preconception 
counselling. The psychosocial literature has illuminated many of the challenges facing 
WWE. These include the need to plan pregnancy and manage the risks associated with 
taking medication during pregnancy, and managing a seizure disorder, in which 
decisions made, could have far reaching consequences. The potential for ‘risky’ 
decisions to be influenced by misperceptions, the influence of framing bias, and the 
added influences of perceived judgements of others have been explored within the 
literature. 
 
Review of the literature reveals limited application of both social cognitive theories 
and psychosocial literature to account for the experiences unique to the population of 
WWE. A number of unanswered questions have been raised, including the continued 
struggle faced by WWE to adequately prepare for pregnancy, which can result in 
women experiencing pregnancy unaware of potential risks and resorting to stopping 
AEDs without discussion with their clinician. In Chapter 4, I will present the methods 
employed to address this thesis research question. 
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Chapter 4 Methodology and methods 
Introduction  
This chapter will outline the research methodology and methods used within this 
qualitative study to answer the research question of how WWE perceive and 
communicate risk information during preparation for pregnancy. I will describe the 
development of the approach taken within this study, and the rationale for selecting a   
qualitative approach. The final section of this chapter will describe the practical 
application of the study methods; detailing the recruitment of research participants, 
methods of data collection, and the processes of analysis.  
 
The author, Janine Winterbottom was responsible for the design and execution of this 
study, and was awarded The Sir Desmond Pond Fellowship from Epilepsy Research 
UK in 2006 to conduct it. 
 
4.1 The methodological approach 
This section will highlight the importance of methodology within health research, 
bringing together ‘two ways of knowing’ in which both medical and social science 
have influence (Oakley, 2000, p.20). 
 
4.1.1 Developing the methodological approach 
The primary focus of this study was to explore the context of women’s experience of 
preparing for pregnancy, and to develop a theoretical understanding of how 
preconception interventions might bring about changes in pregnancy planning and 
decision-making. The study protocol was written alongside a detailed literature review 
of the subject area, including a review of the effectiveness of preconception 
interventions to reduce the risk of adverse pregnancy outcome for WWE. The review 
was published within the Cochrane Library of Systematic Reviews and the results 
presented in Chapter 2. The review identifies the limitations of existing evidence, both 
to describe what constitutes preconception care and what factors were likely to 
influence its effectiveness. These factors influenced decisions concerning the research 
question and study design, and required choices to be made between a qualitative 
and/or quantitative methodology. The key characteristics of quantitative and 
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qualitative research are presented in table 4.1. My prior experiences working with 
WWE created a tension between selecting a quantitative objective approach, as against 
a qualitative paradigm which valued experiential knowledge. These competing 
interests were recognised during the process of study design, and highlighted the 
importance of selecting a ‘reflexive’ approach which acknowledged my prior 
knowledge of the subject and position within the research process.  
 
Referring to table 4.1 the following account is presented to situate this study within the 
broader health research paradigm, and to highlight the selection of research approach. 
 
 Quantitative  Qualitative  
Dominant 
Paradigm:  
Positivist, Empirical-analytical 
Epidemiology 
Interpretivist, Constructivist 
Humanistic or Naturalistic 
Research aim / 
stance: 
‘Outsider’ - Testing hypotheses / 
generalizing. Reductionist / inferential / 
hypothetico-deductive / outcome 
orientated.  
‘Insider’ - Generating hypotheses / 
describing. Exploratory / inductive / 
process-oriented / oriented to 
understanding. 
Question: 
Contextual: 
 
Explanatory: 
 
Evaluative: 
Generative: 
How many Xs? (enumeration) 
Extent of difference & characteristics of 
phenomena.  
Causal analysis & statistical 
associations.  
Extent of outcome achieved. Prediction. 
What, Why and How? 
Classifying difference, meanings of 
phenomena or experience.  
Examining reasoning descriptions & 
interpretations.  
How? Appraisal of interventions.  
Develop theory, policy solutions. 
Research 
relationship: 
Distance between researcher & subject. 
Relation between theory & research - 
confirming theory. 
Closeness between researcher & subject. 
Relation between theory & research - 
emergent theory. 
Sampling 
method: 
Respondent, participant. Random, 
statistical or probabilistic sampling.  
Frame fixed before start. 
Participant, informant. Theoretical or 
purposive sampling. Sampling units 
flexible before & during.  
Data collection: Experiment, survey, structured 
interview, questionnaire. 
Observation, semi-structured/in-depth 
interview, focus group 
Analysis: Specified in advance. Worked out during the study. 
Ethics: Appropriateness of standardized 
techniques.  
Intrusion, sensitivity or intimacy of 
subject 
Quality 
criterion: 
Rigour, proof, evidence, statistical 
significance. 
Relevance, plausibility, illustrativeness/ 
responsiveness to subject’s experience. 
Adapted from the following sources:  
Bryman (1988); Oakley (2000); Pope and Mays (1995); Ritchie (2003) 
Table 4.1 Key distinctions between quantitative and qualitative study design 
 
4.1.2 Dominant Paradigm 
Research in the field of epilepsy has been dominated by an empirical quantitative 
research paradigm, focusing upon questions of causality, statistical associations, 
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predictions and frequencies. This approach has resulted in an expediential increase of 
antiepileptic drug development, confirmation of the influence of genetics, and an 
emphasis on quantitative measurement of ‘quality of life’ as a determinant of treatment 
success (Baker et al., 1993; Baker et al., 1998). Qualitative research has supported 
extending understandings to achieve substantive and formal theoretical advancement, 
such as, the advancement of a model for ‘epileptic stigma’ (Scambler and Hopkins, 
1990; Jacoby et al., 1996; Jacoby et al., 2004). The value of conducting qualitative 
health research is its ability to bridge the gap between scientific evidence and clinical 
practice through a commitment to understanding health behaviours in everyday context 
and acknowledgement that subjective meanings are crucial (Green and Britten, 1998; 
Atkinson, 1995). 
 
4.1.3 Research Aim / Stance 
The focus of interest was to seek to understand the meaning of experiencing preparing 
for pregnancy from the perspective of the women themselves (Chapter 1). Review of 
the literature (Chapter 2) reveals few studies have sought to understand the beliefs and 
perceptions of women concerning their preconception care needs during their 
reproductive life, and therefore have failed to answer why many WWE do not utilise 
available services. The study objectives were to expand understanding and have direct 
applicability to the development and evaluation of preconception interventions to 
reduce the risks of adverse pregnancy outcomes for WWE.  
 
The researcher stance requires an interaction between the ‘researcher and participant’ 
with the intention of increasing understandings and generating theoretical concepts 
(Holloway and Wheeler, 2010). From a quantitative paradigm, deductive approaches 
are used by the researcher to test existing theory or hypotheses, with the findings either 
supporting or negating the hypothesis leading to extrapolation to larger populations 
(Broom and Willis, 2007). In contrast, the qualitative research paradigm acknowledges 
the limitations of striving for objectivity. Snape and Spencer (2003) acknowledge that 
the qualitative research process is interactive, with a dynamic relationship between the 
‘researcher’ and the ‘participant’ jointly creating understandings of the phenomena of 
interest.  
While one attempts to get close to the participant’s personal world, one cannot do 
this directly or completely. Access is both dependent on, and complicated by, the 
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researcher’s own conceptions which are required in order to make sense of the 
other personal world through a process of interpretative activity (Smith, 1996:264). 
 
4.1.4 Research Question 
The present study questioned the experience of WWE preparing for pregnancy. Punch 
(1998) judges the research question as giving direction to the research context, 
identifying the boundaries of investigation and the type of data to be collected, and 
finally, maintaining the researcher’s focus and providing a framework for writing. The 
research question was developed within clinical practice in response to the need to gain 
understanding of women’s experience of preparing for pregnancy, perception of risk 
information and decision-making within the context of epilepsy review, and more 
specifically preconception counselling, all of which might shape reproductive 
behaviour, information seeking and access to epilepsy review.   
 
4.1.5 Research relationship 
In setting out to examine the problems faced by women preparing for pregnancy, my 
concern was essentially with capturing the ‘essence’ of their reproductive experience 
as part of their wider social existence and concerns of everyday life. This approach is 
in sharp contrast to a positivist/quantitative approach, where the goal of research is to 
gather objective knowledge gained through impartial and ‘outsider’ observation. 
Oakley (2000) is critical of quantitative approaches which attempt to ‘imitate’ the 
natural sciences by creating the illusion of barriers between the researcher and the 
researched leading to a ‘dangerous disengagement’ positioning the researcher as 
expert: 
The idea of a world to be known about implies a knower; the knower is the expert, 
and the known are the objects of someone else’s knowledge, rather than their own. 
This is where power comes in. The notion of expertise, intrinsic to the 
‘quantitative’ model of how research is done, means a hierarchy of power 
relations; where there are the powerful, there are also the powerless (Oakley, 
2000:36). 
 
Oakley reveals an important issue concerning the relationship between my position as 
a female researcher and clinician researching the experience of WWE, and the moral 
obligation ‘to treat others as one would oneself wish to be treated’ by avoiding the 
imposition of ‘the theorist’s’ (my) own views upon the female subject (Oakley, 2000, 
p.36). Holloway and Wheeler (2010) acknowledge the potential for the qualitative 
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researcher to influence the process of the research and the findings, requiring explicit 
scrutiny of the research process, including both the interactional and interpersonal 
aspects of the research.  
 
In recognition of these methodological assertions, decisions were made to situate this 
research within an interpretivist paradigm. The essential quality of the relationship 
between the ‘interpretivist’ researcher and participant is its ability to get close to ‘view 
the world as a participant in that setting’ to gather rich and detailed data (Bryman, 
1988), which in turn supports analysis, theorising and inference. The relationship of 
the qualitative researcher to theory relates to its purpose as a framework for ‘critically 
understanding’ the data, with existing theories illuminating the findings, which in turn 
might be modified through the findings (Holloway and Wheeler, 2010). The 
relationship to theory has also been suggested as an ‘orientating or theoretical lens’ 
guiding the researcher ‘as to what issues are important to examine, and the people who 
should be studied’ (Creswell, 2009).  
 
This opening section has outlined the nature of the debate surrounding the qualitative-
quantitative divide. My relationship to the participants and the research questions being 
asked led to my decisions to take an interpretative phenomenological analytic 
approach. The decisions concerning analysis will be presented in the following section. 
 
 4. 2 Qualitative research methods 
A good qualitative research study design is one which has a clearly defined 
purpose, in which there is coherence between the research questions and the 
methods or approach proposed, and which generates data which is valid and 
reliable. (Lewis, 2003:47) 
 
4.2.1 Sampling methods / study population 
Holloway and Wheeler (2010) suggest the identification of the study population and 
the context and settings of the research refer both to the environment and conditions in 
which the study takes place, and to the culture of the participants and location of the 
research. Sampling methods were required to be purposeful as a means of recruiting 
individuals able to grant access to a particular perspective on the experience at the 
heart of the investigation (Langdridge, 2007). The study sample for an interpretive 
phenomenological analysis is most frequently limited in size and calls for a 
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homogenous sample. Homogeneity requires definition, as its use in interpretative 
phenomenological analysis refers to the selection of participants ‘for whom the 
research question is meaningful’ (Smith et al., 2009, p.49). Therefore, in relation to the 
current study, a homogeneous sample would select women of childbearing age (see 
inclusion criteria).  
 
The size of the study population was judged adequate by the participants being able to 
‘represent a particular perspective on the phenomenon of interest’ (Smith et al., 2009, 
p.49)(see Appendix 3 Stages of Analysis). The term representativeness within 
phenomenology refers to:  
…not seeking the human common differences, but seeking the differences that 
make us common, that make us human. (Morse, 1992:92)  
 
The importance placed on maximising opportunities for transfer of the findings to the 
wider population of reproductive age WWE preparing for pregnancy was a reflection 
of the commitment to the funding organisation and was addressed through careful 
selection of the recruitment site.  
 
4.2.2 Data collection techniques 
Qualitative data collection techniques have been divided into two approaches: those 
that allow investigation of the phenomena in their natural settings, and those that 
generate data through the interventions of the researcher (Ritchie, 2003). The selection 
of naturally occurring data (observation of clinic consultation) and generated data 
(focus groups and in-depth interview) were felt to reflect the descriptive and 
interpretative experiences surrounding preparation for pregnancy.    
 
Data that reflected the reproductive careers of WWE and invited women to offer a rich 
and detailed ‘first-person’ account of their experience was required to gain an 
understanding of the personal context of the reproductive decisions faced by women 
(Lewis, 2003). Focus groups represented the opportunity to collect data reflecting the 
normative influences, self-identity and shared meanings which likely shape 
perceptions of experience and understandings in the social world of WWE (Finch and 
Lewis, 2003). WWE rarely have opportunities to meet each other; and as no naturally 
occurring groups were available, the focus groups were convened specifically with the 
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purpose of the research project. Qualitative research can rely on a single source of data, 
however, the opportunity for a ‘mixed method’ approach to data collection can benefit 
a study, with each method bringing a particular insight to the phenomena of interest 
(Ritchie, 2003). The choice of ‘mixed methods’ or triangulation in relation to this 
study refers to the processes by which several methods (focus group methods, in-depth 
interviews and non-participant observation) and sources of data have been used to 
study the phenomenon in order to ensure validity (Holloway and Wheeler, 2010)(see 
also section 4.2.5 Quality Criteria).  
 
4.2.3 Qualitative analysis 
There are many ways of analysing qualitative data … what links all the approaches 
is a central concern with transforming and interpreting the qualitative data – in a 
rigorous and scholarly way – in order to capture the complexities of the social 
world we seek to understand. (Coffey and Atkinson, 1996:3) 
 
Decisions concerning the selection of analytic approach were made in collaboration 
with my academic supervisors and through formal research training which widened my 
appreciation of alternative approaches9. The selection of analytic approach resulted in a 
comparison between discourse analysis and interpretative phenomenological analysis 
(Table 4.2). Although discourse analysis has relevance to the epilepsy clinic 
consultation, and could be used to explore the discursive context of women attending 
the epilepsy clinic, it was felt to limit the scope of exploring experience and focus 
attention on the act of communication rather than the processes and products of the 
communication of risk and its influence upon decisions made by woman preparing for 
pregnancy, the majority of which lie outside of the influence of the consultation.  
 
Interpretative phenomenological analysis requires further distinction, as a number of 
approaches have been developed within health and social research (Smith et al., 2009; 
Benner, 1994; Van Manen, 1990). The approach selected recognised the necessity to 
value the social-cognitive paradigms, to explore the content of particular individuals’ 
beliefs and responses, and draw attention to the process operating between cognitions 
and behaviour consistent with the research objectives (Smith, 1996; Smith et al., 
1997). The main assumptions of interpretative phenomenological analysis place 
                                                 
9
 Research training ‘The design, conduct and analysis of qualitative research using depth interviews’ (4-
8
th
 July 2005) was provided by the National Centre for Social Research in London (NATCEN) and was 
invaluable in informing the writing of the study protocol and selection of methodology and methods.  
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interest in learning something about the participant’s psychological world in the form 
of beliefs and constructs; placing ‘meaning’ as the central aim of analysis – to try and 
understand the content and complexity of those meanings (Smith and Osborn, 2008). 
This quality was the main attraction, and was seen to offer a unique insight into the 
research subject: 
…the participant, like me, is a unique individual worthy of an idiographic, holistic 
analysis. At the same time, however, there is the possibility of bridging the divide 
between selves because we are all at the same time part of a larger whole, a 
collectivity that allows the possibility of mutual understanding. (Smith, 2007:5)   
 
Key features Discourse Analysis Interpretative Phenomenological 
Analysis 
Philosophy Knowledge and meaning produced 
through interaction with multiple 
discourses. 
People as psychological entities, able to 
reflect on actions which have existential 
consequences. 
Goal Understand how people use language to 
create and enact identities and activities.  
Exploring, describing, interpreting and 
situating the means by which individuals 
make sense of their experience. 
Data Observation of participants in 
conversation in their natural 
environment. Participant and researcher 
engage in dialogue, interviewer probes 
for inter-textual meaning. 
Observation of participants in the 
context where the phenomenon is 
experienced. Participants describe their 
experiences; interviewer probes for 
detail and clarity. 
Analytic 
methods 
Examine how understanding is produced 
through a close look at the words. 
Interested in how the story is told, what 
identities, activities, relationships, and 
shared meaning are created through 
language. 
Examine personal perceptions of the 
phenomenon to understand the 
participant’s point of view (the 
particular) with focus on personal 
meaning-making in particular contexts 
(an interpretative activity).  
Analytic 
Relationship  
Examine own place in the discourse(s). ‘Bracket’ or distance background beliefs 
and preconceptions, becoming open to 
the ‘insider perspective’. 
Product Description of language-in-use; identify 
how different discourses shape how 
identities, relationships, and social goods 
are negotiated and produced. 
Commitment to the person as a 
cognitive, linguistic, affective and 
physical being and assumes a chain of 
connection between people’s talk and 
their thinking and emotional state. 
Application Broad application within the discourses 
of doctor-patient communication 
(Silverman, 1987; Mishler, 1984). In 
epilepsy research; focusing on the 
epilepsy clinic consultation (McCorry et 
al., 2009), and as a method to analyses 
the discursive terms of epilepsy 
(Valachovic et al., 1999).  
Applied use: risk perception and chronic 
illness (Senior et al., 2002); risk 
perception and decision-making in 
genetic counselling (Smith et al., 2002). 
Epilepsy research: experience of stigma 
(Kilinç and Campbell, 2009); patient 
involvement informing the epilepsy 
research agenda (Thomas et al., 2010). 
(Adapted from the following sources: Starks and Trinidad, 2007; Smith and Osborn, 2008) 
Table 4.2 Comparison of analytic approaches 
 
4.2.3.1 Consideration of ‘fit’ between data collection techniques and analysis 
In-depth interviews provide a detailed account of personal disclosures made within a 
closed setting. In contrast, the more public forum of focus group discussions results in 
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data reflecting debate between group members and disclosures between participants 
(Flowers et al., 2000). The potential value of multiple data sources, was balanced 
against the requirements for additional analytic commitment directed towards group 
process (Smith et al., 2009). My selection of approaches draws influence from the 
application of interpretative phenomenological analysis applied to focus group data 
(Flowers et al., 2000; Dunne and Quayle, 2001) and observation data (Larkin and 
Griffiths, 2002) (discussed further in Section 4.3.4 Methods of Analysis).   
 
4.2.3.2 Selection of computer-assisted qualitative analysis methods 
A number of different computer-assisted qualitative data analysis software packages 
are available, and their application is guided by pragmatic concerns surrounding data 
management and storage (Flowers et al., 2000). The adoption of computer-assisted 
methods here was based on their ability to support my analysis, by allowing different 
levels of investigation to be achieved, such as, coding and connecting ideas using 
memos and annotations, and data management supporting storage and retrieval of data 
(Spencer et al., 2003). NVivo 7 software was selected following formal training and 
discussions with my academic supervisors10.  
    
4.2.4 Ethical considerations 
Attention was focused on the central ethical issues of respect for the research 
participant. These included respect for autonomy, the provision for informed consent, 
anonymity and confidentiality, and protection from harm. These principles ensured the 
study process and outputs reflected the codes of both professional practice and the 
research governance framework (Department of Health, 2005), and met the 
requirements of the relevant Multi-Centre Ethics Committee as directed by the Central 
Office of Research Ethic Committees11.  
 
4.2.4.1 Informed Consent 
The provision of informed consent is central to the ethical conduct of all research and 
respects participant autonomy to make informed decisions whether to take part, 
whether to withhold or whether to later withdraw consent from participation within a 
                                                 
10
 NVivo 7 training via The University of Liverpool Deanery & Departmental Postgraduate training 
providing the opportunity for regular updates (23-24
th
 Nov 2006; 29-30
th
 Nov 2007; 9-10
th
 June 2008).
   
11
 CORECs were replaced by the National Research Ethics Service in the 2
nd
 year of study reporting.  
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study. Study documentation packs12, including participant/clinician information sheets, 
letters of invitation to participate and consent forms were developed conforming to the 
recommendations within the COREC Guidelines for Researcher’s Version 2.0 
November 2005 (Davies, 2005). 
 
The approach of potential recruits was by invitation letter from their treating clinician. 
A returned reply slip was taken as implying agreement for contact to be made. 
Informed consent was supported by encouraging women read the study documentation 
in their own time. Stamp-addressed reply envelopes were provided with each study 
documentation pack and women could both indicate interest and provide consent 
during clinic attendance or by returning the reply slip on the invitation letter/consent 
form. The approved research protocol placed responsibility on the recruiting clinicians 
to identify and approach patients who met the inclusion criteria; this restricted my 
direct contact with potential recruits. Study documentation was distributed by clinical 
staff to female patients who met the eligibility criteria. The exact number of study 
documentation packs distributed was not known, preventing writing to women who 
had not replied to the first invitation. This potential limitation was balanced by the 
duration of recruitment (September 2006 – July 2009) allowing potential recruits to be 
approached on several different clinic visits, therefore providing an opportunity to 
revise their initial decision concerning participation. Contact was maintained with all 
women who returned a reply slip/signed consent form.    
 
All women were required to provide consent prior to their involvement in the study, 
and consent was reaffirmed prior to commencing digital recording. Consent for clinic 
observation, both participants and the clinicians were made aware of each other’s 
consent. Consent was re-confirmed as arrangements were made for the follow-up 
interview, and again prior to beginning the interview.  
 
4.2.4.2 Confidentiality and anonymity 
Anonymity is defined as the means of securing the identity of those taking part in the 
study from anyone outside of the research team13 (Lewis, 2003). While clinicians were 
                                                 
12
 See Appendix 1 Study Documentation. 
13
 The research team refers to myself (Janine Winterbottom) and my two academic supervisors 
(Professor Gus Baker and Professor Ann Jacoby). 
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aware of women they had selected as meeting the inclusion criteria (and those 
observed in consultation), it was only the research team who knew the final study 
population. It was acknowledged within the study documentation that absolute 
anonymity could not be offered or guaranteed.  
 
Confidentiality in the context of qualitative research means the avoidance of attributing 
individual participant comments within any report, presentation, publication or the 
final submitted thesis. This includes both direct attribution, such as comments linked to 
a name or role, or place of residence, and indirect attribution such as by reference to a 
collection of characteristics that might reveal the identity of the participant (Lewis, 
2003). These issues were managed at the point of transcription, with all names 
removed and replaced by descriptors, such as [location]. Participants were assigned an 
alphanumeric reference. The ID code was recorded and only accessed by the study 
author, or academic supervisors if required, following ethical codes of practice. 
Digitally recorded audio files and transcripts were stored electronically and access to 
all computerised stored and generated data was password protected. Data collection, 
storage and disposal conformed to the Ethics and Clinical Governance approval 
warranted, and conformed to the Data Protection Act.  
 
Issues of confidentiality and the potential for indirect attribution were acknowledged as 
harder to guarantee and, therefore, the study documentation drew attention to this risk. 
Attempts to minimise the potential indirect breach of confidentiality was managed 
through the scrutiny of all reports and documentation (either verbal presentation, or in 
written form) by proof reading by the research team. The use of textual quotes when 
reporting the results reflects the need to sufficiently represent the links between the 
data and analysis, and the ability to portray meaning and understanding (Langdridge, 
2007; White et al., 2003).            
 
4.2.4.3 Protecting participants from harm 
The potential for harm fell into three main areas: sensitivity of topic; confusion 
surrounding the clinician-researcher role; and, managing disclosures which might 
indicate the participant’s risk of harm (Lewis, 2003). 
1. Sensitivity of topic – The potential for causing distress, either by the probing 
nature of interview/focus-group questions, or by the intrusion of the researcher 
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observing the participant’s clinic appointment, were addressed by the careful 
construction and revision of the topic guide (see Appendix 2), and by the 
explicit provision of support from a clinical psychologist being made available. 
Patient educational literature and details of the local patient voluntary services 
were also provided at the close of participant contact. 
2. Confusion surrounding the clinician-researcher role – My professional and 
employment background was made explicit within the study documentation to 
protect against the risk of exploitation through any confusion concerning the 
researcher role (Arthur and Nazroo, 2003). The non-interventional basis of the 
research was emphasised, with participants informed that the study was not 
therapeutic.  
3. Managing disclosures – Study documentation (see Appendix 1) defined the 
circumstances when interventions to manage disclosures would be justified. 
Consent to disclose information felt to be in the best interests of the participant 
was required; initially encouraging the participant to take action, and if 
necessary agreeing the content of any communication with their epilepsy 
clinician or General Practitioner. Duty to adhere to the guidelines for disclosure 
of suspicion of abuse was maintained by my substantive and honorary NHS 
contracts. Disclosures within the focus groups represented an additional 
challenge and was managed during focus group introductions, covering topics 
of disclosure and maintaining the privacy of fellow focus group participants as 
a form of respect (MW Smith, 1995). 
 
4.2.5 Quality Criterion – Methods of appraising quality and validity 
The methods for evaluating the quality of the study findings were informed by the 
characteristics of ‘good qualitative research’ established by Yardley (2000), and the 
methods of ‘ensuring rigour in qualitative research’ established by Seale and 
Silverman (1997) (Table 4.3). These two sources of quality criteria were felt sensitive 
to the study methodology and appropriate to support the final critical appraisal of the 
results of this study (presented as part of the Discussion – Chapter 10).  
 
4.2.5.1 Validity and Reliability 
The terms ‘validity’ and ‘reliability’ within qualitative health research have been 
interpreted as having different meanings to their traditional use within quantitative 
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research (Murphy et al., 1998). The reinterpretation of the traditionally quantitative 
definition of validity (a truthful correspondence of results with an objective reality) has 
been proposed – a useful alternative term ‘to avoid confusion’ is ‘credible’ which 
reflects the importance of credible qualitative findings emerging from systematic 
observations, and competent interpretations which correspond to the social reality 
experienced by the participants, and which in turn have meaning to those who read the 
results (Giacomini et al., 2000). 
 
Table 4.3 Methods for evaluating the research quality 
 
The traditional quantitative measure of reliability (as the consistency of the research 
instruments and their ability to replicate the research findings) has been reinterpreted to 
appraise qualitative research, such as, ‘trustworthiness’, ‘consistency’ and 
‘authenticity’, inferring that the internal elements, dimensions or meanings found 
within the study data are expected to recur outside of the study population (Lewis and 
Ritchie, 2003). Internal validity (referring to the ‘internal’ aspects of validity and 
internal logic of the research) is essential to expand upon the descriptive and 
explanatory accounts (Silverman, 2005). Triangulation as a method of testing 
emerging themes across the different study sites, testing findings from different 
methods to support comparison of different cases is felt to improve validity (Maxwell, 
2002). The extent of external validity (or generalisability) has been proposed as more 
adequately measured through the criterion of ‘transferability’ in which the ability to 
Quality criteria Characteristics Measurement techniques 
Sensitivity to 
context 
Theoretical; awareness of relevant literature 
used to corroborate &/or discriminate against 
interpretations.  
Focus on participant perspectives.  
Reflexivity. 
Representativeness of cases 
Detail of unexpected findings. 
Commitment to 
rigour 
In-depth engagement in field & data 
immersion.  
Completeness of data collection & analysis.  
Methodological competence/skills. 
 
Theoretical sampling. Triangulation.  
Deviant case analysis.  
Key word counts.  
Detailed transcription display 
systematic analysis. 
Transparency 
& coherence 
Clarity and power of description/argument. 
Transparent methods/data presentation. 
Fit between theory and method.    
Audit trail. 
Systematic data management.  
Reflexive to influences of external 
pressures or constraint. 
Impact & 
importance 
Plausibility of the results.  
Theoretical – Enrich understandings.  
Socio-cultural – impact upon practice. 
Practical application – for community, policy 
makers and health care.  
Testing hypothesis in data analysis and 
analytic induction. Generalisations 
supported by adequate evidence, counts 
of events, instances or themes. 
Adapted from the following sources: Bramley and Eatough (2005), Lewis and Ritchie (2003), Ried et al 
(2005), Seale and Silverman (1997) and Smith et al (2009) 
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evaluate the possibility of transferring findings across the wider community is 
dependent upon the researcher providing ‘thick descriptions’ of population studied 
(Murphy et al., 1998).  
 
4.2.5.2 Generalisation 
The term generalisation within qualitative research refers to either empirical or 
theoretical generalisations (Hammersley, 1992); where empirical generalisations are 
refer to the ‘transferability’ of the findings, and theoretical generalisations refer to the 
ability to build theory for wider, or even universal application (Lewis and Ritchie, 
2003). The use of generalisation within interpretative research is seen as inevitable, 
desirable and possible. It is defended by the cultural consistency within the social 
world studied by the interpretivist researcher as being the same cultural consistencies 
that make social life possible (Williams, 2000).  
 
4.3 Women with epilepsy preparing for pregnancy – Study methods  
This section will detail the application of methods through an audit trial of activities 
and decisions made during the conduct of the study. The study employed a qualitative 
design consisting of triangulation of both data source (interaction between patient and 
clinician plus participant accounts) and of method (gathering data by focus group 
method, interview and observation).  
  
4.3.1 Ethical approval 
This study was approved by Newcastle and North Tyneside 1 Research Ethics 
Committee (NRES reference number: 06/Q0905/62)14. Research and Development 
approval was granted from all recruiting centres: The Walton Centre NHS Foundation 
Trust; The Liverpool Women’s Hospital NHS Foundation Trust; Salford Royal NHS 
Foundation Trust; Wrightington, Wigan and Leigh NHS Trust, and Salford Primary 
Care Trust. 
 
4.3.2 Sampling and recruitment 
Decisions concerning recruitment were guided by the study objectives and pragmatics, 
which resulted in a study sample defined broadly as WWE of reproductive age (16-45 
                                                 
14
 Application for Ethical approval was submitted outside of the region to prevent delay in commencing 
data collection.  
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years15) and, more specifically, as women who had experience of pregnancy, women 
currently considering pregnancy, and women who identified pregnancy as a future 
aspiration. Pragmatic consideration of the extra costs of travel for a study based outside 
the region where the researcher lives, and the time anticipated as needed to 
successfully recruit eligible women led to the decision to locate the study population to 
the Northwest of England. The study locations were selected to reduce the potential 
variability between the types of service delivered, with the epilepsy clinics based at 
Salford Royal Hospital and The Walton Centre NHS Foundation Trust providing a 
regional multi-disciplinary epilepsy service. Liverpool Women’s Hospital was selected 
as providing access to WWE during pregnancy. 
 
Staged recruitment involved selecting women for involvement in either stage 1 (focus 
group discussion) or stage 2 (observation and interview). The initial goal of stage 1 
recruitment was to recruit sufficient participants to convene a minimum of four focus 
groups, reflecting a broad range of experience to capture women’s experience of 
preparing for pregnancy as it unfolded in their lives, in addition to the anticipation of 
events (capturing the stages of planning behaviour) and reflection of past experience 
(experience of unplanned and planned pregnancy) (Smith et al., 2009). Ongoing 
review of the recruitment process was iterative, providing the opportunity to focus 
recruitment on groups of ‘special interest’ (teenagers and mature women) convening 
additional focus groups to test emerging themes (Ritchie et al., 2003, p.84). The 
sample selected for observation of an epilepsy consultation involved WWE preparing 
for pregnancy, and anticipated the presentation of pregnancy-related risk information. 
By conducting staged recruitment, the findings from interim analysis of the focus 
group discussions could be used to structure and inform recruitment into stage two 
(theoretical sampling). The final composition of the study sample was not known until 
interim analysis revealed a detailed picture of the experience of WWE preparing for 
pregnancy and no new insights or themes emerged.  
 
Sampling involved attempts to ensure those selected reflected the wider UK population 
of reproductive aged WWE (see Appendix 2 Focus Group sampling frame). This was 
supported by use of published statistics, a method recommended by Hammersley 
                                                 
15
 Decisions concerning the age range are discussed in section 4.3.2.1 Inclusion criteria. 
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(1992), and achieved by gathering participant background information, including 
antiepileptic drug use, to compare with the UK Epilepsy and Pregnancy Register 
database (Morrow et al., 2006). The UK Epilepsy and Pregnancy Register was felt to 
represent a contemporaneous account of AEDs used among pregnant WWE. The 
nature of antiepileptic drug use was felt to influence the type of risk information 
presented to women preparing for pregnancy, and the range of prescribing decisions 
faced both by women and the clinicians they consulted. 
 
4.3.2.1 Inclusion criteria 
The study sample was defined through the application of the following purposive 
selection criteria, which addressed the demographic, diagnostic and personal 
characteristics of the intended study population:  
 Women aged between 16 years and 45 years.  
 Confirmed diagnosis and history of epilepsy of at least 3 months. 
 Experience of being prescribed antiepileptic medication for treatment of 
epilepsy. 
 Be able to participate verbally in a group (focus group recruitment only).  
 Able to converse in English. 
 Provide signed informed consent.   
 
The study objectives reflected the need to explore the lifecycle transition into 
motherhood. As preparation for pregnancy was implicit within the research question, it 
was felt justifiable on ethical and legal grounds to limit the age of selection to women 
16 years and older. An upper age was set at 45 years, reflecting the potential for 
increased age-related congenital malformation risks, and reduced likelihood of fertility 
neither of which were the focus of the research objectives 16. 
 
Women were selected to reflect a range of different stages of their reproductive lives. 
However, it was not an explicit criterion to include women who had experienced either 
planned or unplanned pregnancies. Therefore, women aged 16-45 years were selected 
with the assumption that they would reflect a range of reproductive life experiences, 
including the use of contraception, experience of contraceptive failure, adverse 
                                                 
16
 The risk of Down’s Syndrome increases with age; estimated at maternal age 20 years- 1:1500 risk, 
compared to maternal age 35 years- 1:270, maternal age 40 years- 1:100 and maternal age 45 years- 1:50 
and greater. Source: Gray, J.A.M. & Ward, P. (2004) National Down's Syndrome Screening Programme 
for England: A Handbook for Staff. UK National Screening Committee Programmes Directorate. 
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pregnancy outcome, and pregnancy loss or infertility. Women with a confirmed 
diagnosis of epilepsy were the focus of the study. In the majority of cases this implied 
their experience of more than a single seizure, and the recommendation to commence 
AEDs. The purposive selection criteria proposed eligibility commencing a minimum 
of three months after diagnosis, with no limiting factors for epilepsy duration. The 
inclusion criteria were established to reflect epilepsy as a chronic condition, taking into 
account its influence upon the quality of life trajectory proposed by Jacoby and Baker 
(2008), framed by the time from seizure onset/diagnosis and response to treatment, and 
shaped by a wider range of personal and social factors.  
 
4.3.2.2 Exclusion criteria 
Women were excluded from recruitment if they met any of the following exclusion 
criteria: 
 A diagnosis of non-epileptic attack disorder, psychogenic or dissociative 
disorders, and / or chronic depression or psychiatric disorder. 
 Significant learning disabilities.  
 Deteriorating neurological or terminal illness. 
 Additional chronic disease requiring preconception care and treatment through a 
future pregnancy, e.g. diabetes, asthma, hypertension. 
 Women who had received direct care from the author in the preceding 12 
months to study commencement. This reflected ethical concern for the need to 
distinguish between clinical and research role (see also Section 4.2.4 ethical 
considerations). 
 
4.3.2.3 Participant recruitment 
Participants were selected from two Northwest of England Regional Epilepsy clinics 
held in Manchester (Salford Royal Hospitals NHS Trust) and in Liverpool (The 
Walton Centre NHS Foundation Trust), the monthly Joint Neurology Obstetric clinic 
held in The Liverpool Women’s Hospital NHS Foundation Trust, and from two 
additional monthly satellite clinics held in Manchester and Wigan. Recruitment began 
in September 200617 supported by Multi-Centre Regional Ethics and NHS Research 
and Development approval. 
 
                                                 
17
 Recruitment at Wrightington, Wigan and Leigh NHS Trust began in November 2006 and was 
prematurely ended with the departure of the clinician responsible for the clinic leaving the Trust in June 
2007. Recruitment for the GP with Specialist Clinic was delayed until NHS R&D approval was granted 
in February 2007.  
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Women were recruited by the neurologists and epilepsy nurse specialists reviewing 
their weekly clinic lists, and by midwives and obstetricians recruiting women from the 
monthly Joint Neurology Obstetric clinic. Women meeting the inclusion criteria were 
identified as potential recruits, and offered study documentation18 by outpatient clinic 
staff on their arrival into the department on their scheduled clinic visit. Restriction of 
direct contact with potential recruits was stipulated within Ethics Committee approval 
(see section 4.2.4.1 Informed consent). This prevented my awareness of any 
differences between women motivated to participate in the study and those who were 
not. However, women were advised that the study author was present in clinic to 
answer questions and supplement study information. The decision for the author to 
attend clinic during recruitment was to provide early contact with women showing 
interest in participating in the study. Attendance was also felt to reduce the burden of 
additional workload upon the outpatient clinic staff and clinicians, with study 
documentation prepared in advance. All available opportunity to discuss the study with 
the recruiting clinicians was afforded to maintain momentum during recruitment. 
 
The majority of women had contact with the study author during initial recruitment, 
and this provided early insight into how women described themselves as planning 
pregnancy and descriptions of their stage of planning. This informed my 
communication with women showing interest in the study. There was sustained contact 
with all participants showing interest in the study, and for focus group recruits, 
continued contact was required to arrange a suitable date for focus group attendance 
and transport arrangements. For recruitment into the observed clinic visit, contact was 
maintained to capture any changes regarding observed appointment dates, and 
following the consultation to arrange a suitable date for interview. Both the process 
and progress of recruitment was closely monitored and participant selection was 
purposively and theoretically driven. Theoretical sampling directed recruitment of 
participants to confirm emerging themes and ensure adequate analysis of the study 
question. Staged recruitment first identified women eligible for focus group attendance 
and second, women who had informed their clinician of their plans for pregnancy.  
 
 
                                                 
18
 See Appendix 1 Study Documentation (personalised letter of invitation signed by their clinician, study 
information sheet and consent form). 
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4.3.2.4 Stage 1 Recruitment (focus group)  
Women who returned the reply slip were contacted and offered dates of planned 
focus group meetings. Initial contact offered women the opportunity to ask questions, 
clarifying information, and allowed me to begin to ‘get to know’ the focus group 
population. Group composition was structured by age and prior reproductive 
experience, in order to support group cohesion, and facilitate discussion of 
potentially sensitive topics (Finch and Lewis, 2003).  
 
The first focus group was held in January 2007 with five women attending (women 
were aged between 21-27 years and all considering future pregnancy). Appreciation 
of the commitment to maintain contact with women throughout the process of 
arranging and holding the focus groups was reinforced by experience in the third 
group as only one participant attended, with two other women giving notice of non-
attendance on the date of the group meeting. A decision was made on that day to 
conduct a personal interview using an adapted focus group topic guide (the decision 
was based on the participant’s commitment to attend, and her inability to attend a 
future focus group date). This experience was reflected upon, considering factors for 
poor attendance, acknowledging the need to over-invite the number of participants to 
allow for ‘drop-outs’, and the importance of confirming transport arrangements and 
venue information in advance. Reflecting upon the difficulties recruiting teenagers 
and mature women, changes were made to the recruitment process, which involved 
direct approach by the author in addition to postal invitation19. The last focus group 
(11th October 2008) invited mature women who had made reproductive decisions to 
limit their family size. Two women invited to attend this group, and who had been 
unable to attend any of the earlier groups, were interviewed individually using a 
modified focus group topic guide (discussed in more detail in Chapter 5 Introduction 
to the study population)20.  
 
 
                                                 
19
 Ethics and NHS Research and Development approval was obtained for substantial amendments to the 
study protocol version 4 14-07-08. The amendments addressed problems identifying teenagers, and 
retention of women who had previously shown interest in focus group attendance but due to logistic 
problems had been unable to attend, were invited into study stage two.      
20
 The decision to include these women within the study population was based on theoretically sampling 
decisions searching for deviant cases. The decision to amend the focus group topic guide and conduct 
individual interviews was discussed with my academic supervisors. 
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4.3.2.5 Stage 2 Recruitment (clinic observation and follow-up interview)  
Women who returned the reply slip were contacted and arrangements for observation 
of their next planned clinic visit were made. Participants wishing to attend their next 
clinic appointment accompanied by a partner, friend or relative were acknowledged. 
At the end of the clinic visit, arrangements were made for the follow-up interview. 
Interviews were planned to take place in the participants own home for their 
convenience, if inappropriate arrangements were made to use the focus group venue, 
as a central location, with suitable facilities to conduct an interview. The potential for 
a partner, relative or friend to be present during the interview was acknowledged, 
highlighting the likely content of the interview to allow the participant to make 
informed decisions as to whether they interviewed alone or with a partner or other 
person present. 
 
The total number of women provided study information was not recorded, as clinic 
staff did not consistently return unused study documentation, and any patient 
invitation letters were either taken by women and not returned, or were returned 
blank to the clinician or clinic staff (this action resulted in confidential disposal of 
study documentation preventing tracking non-responders).  
 
4.3.2.6 Recruitment of Clinicians  
Clinicians working with WWE at each recruitment site were initially approached 
during protocol development. This was in line with the local NHS Research and 
Development approval processes, as clinicians were familiar with their local 
committees. Clinicians were provided with study documentation, and requested to sign 
participant invitation letters to facilitate recruitment of eligible patients attending their 
outpatient epilepsy clinics. Clinicians provided consent for observation of their future 
consultations (See Appendix 1 Study documentation). 
 
3.3.3 Methods of data collection 
The data collected and analysed represents the verbal/written accounts shared by 
women during focus group discussion, within clinic observation and at follow-up 
interview.  
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4.3.3.1 Field Notes 
Field notes relating to focus groups included descriptions of group process and the 
seating order to facilitate transcription. Notes concerning the clinic observations 
reflected descriptions of the clinical environment and additional non-verbal 
communication/behaviour. Field notes were used to support analysis through 
questioning and memo writing, rather than being analysed within the corpus of data.  
 
4.3.3.2 Participant questionnaires 
Questionnaires were completed by all participants to gather background demographic 
and reproductive data (Appendix 2 Data collection tools). Questionnaire data were 
used to display simple descriptive statistics in the form of means and averages (see 
Chapter 5 Introduction to the study population).  
 
4.3.3.3 Methods of transcription  
All data were digitally recorded and transcribed verbatim. I typed most transcripts; 
however, taking account of the volume of data collected (especially from the focus 
groups) additional support was enlisted from two medical secretaries. The transcription 
methods were informed by interpretative phenomenological analysis and the role of 
the transcript was to produce written text of the research encounter to support analysis 
(table 4.4). Formal transcription methods advocated by conversational analysis were 
not required, and therefore prosodic aspects of the recording such as length of pauses 
and non-verbal utterances were not noted. The goal of transcription was to present all 
spoken words, spelt conventionally, unless the words themselves were ‘non-
conventional’. Non-verbal utterances such as laughter were presented in square 
parenthesis (Smith et al., 2009).  
 
4.3.3.4 Topic guides 
Topic guides were developed assist data collection for the conduct of the focus groups, 
observations and interviews (Appendix 2 Data collection tools). The question wording 
was carefully considered during protocol development, amended following participant 
contact, and informed by experiences, for example, re-wording a line of questioning to 
prevent ambiguity. Key words (pregnancy planning, planned, unplanned, risk and 
malformation) were avoided in the opening stages of the focus groups and interviews 
to reduce influence from my prior knowledge, and also to reflect the literature 
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concerning women not spontaneously using the terms of planned, unplanned, intended, 
unintended, wanted or unwanted, despite talking at length about the circumstances of 
their pregnancies (Barrett and Wellings, 2002).  
 
Transcription symbols displayed in results chapters 
C: Clinician 
P: Participant 
Line number refer to the consultation transcript 
[…] unrelated text. 
[Laughter] non-verbal communication or description of participant behaviours.  
[Hospital] used to indicate edited text removing names, locations to preserve anonymity. 
/ interrupted speech, participants talking at same time. 
To avoid breaking the text and aid readability, { } indicate the insertion of speech from the non-
dominant speaker, while the main speakers is acknowledge.  
Italic emphasis by speaker.    
Table 4.4 Transcription symbols 
 
4.3.3.5 Focus group methods 
I assumed the role of moderator following completion of formal training in focus 
group moderation21. Training in qualitative research methodology was achieved by my 
involvement in supervised training of the running of focus groups and having feedback 
on my development of moderator skills. My role as moderator was to support the 
individual participants form as a group; being aware of the different stages of group 
process, and supporting the participants feel comfortable discussing their experience of 
being a woman with epilepsy.  In practice, as women arrived at the focus group venue, 
signed consent was obtained, including consent for the use of audiotapes to record 
group discussion. The focus group topic guide (Appendix 2 Data collection tools) was 
used to focus discussion into three phases, supporting group process:  
1. The opening stage of the focus groups was structured by an opening 
statement which included general ground rules (Appendix 2 Focus Group 
introductory script). The introductory script and statements of ground rules 
was important to set the scene for group interactions and to indicate the 
expected role of the participants in discussing the research topic. Therefore, a 
key aspect of the ground rules was to emphasis that there are no right or 
wrong answers, and that everyone’s views are important, and that participants 
                                                 
21
 Training was accessed from NatCen (The National Centre for Social Research, London). The 1
st
 and 
4
th
 focus groups were observed by my academic supervisor Professor Ann Jacoby who provided 
feedback on my moderation skills to support my postgraduate research skill training. 
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should feel free to either agree or disagree respecting individual perspectives. 
Information about the venue such as fire exits, location of toilets, and the 
timing of a coffee break were included. The participants were reminded of the 
digital recording and general group behaviour and conduct, including 
maintaining the reciprocal confidences of their focus group peers. The focus 
group began by participant introductions. This was followed by an open 
ended question about their experience of epilepsy as a woman to prompt the 
start of discussion.  
2. The content stage was structured using open questions to gain an 
understanding of perceptions, beliefs, values and behaviours surrounding 
contraception, conception and pregnancy. The topic guide provided a list of 
potential prompt questions which were used to clarify points, or redirect 
discussion. The aim was to allow the participants as much relevant discussion 
as possible, probing for fuller responses to ensure issues are covered in depth. 
My role as moderator at this stage of the group discussion was to create a 
balance between individual contributions, by encouraging each participant to 
have a chance to contribute, and addressing dominant participants by inviting 
others to speak, such as ‘lets hear some other opinion’. A flip chart allowed 
participants to write statements, and to identify key issues for further 
discussion. A structured exercise was conducted in the second half of the 
group discussion – after the coffee break, and was used to direct group 
discussion on definitions and meanings of three risk framed statements. The 
exercise involved three different risk statements, read out, and both placed on 
the table and on the flip chart for women to read. Each statement was viewed 
in turn to generate comments and stimulate discussion (Appendix 2 Data 
collection tools).  
3. The closing stage drew the discussions to a natural conclusion. It is 
recognised as good practice to warn participants of the end of the session, to 
allow statements of clarity, and to allow the topics of discussion to be 
concluded. 
 
4.3.3.6 Procedures of non-participant observation 
The goal of observation was to capture for analysis the processes experienced by 
women during clinic attendance. It also served as a back up to audio-recording, 
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providing a record of who was present during the clinic observation, such as a 
partner, with discreet notes made if words were whispered or the participant became 
distressed.  My position within the clinic room was to allow observation of both the 
participant and clinician; and, out of direct gaze, to avoid any distraction to either the 
participant or clinician. It was not my intention to become involved in the 
consultation. However, the chance of participants asking questions was anticipated 
and managed by redirection of any question, repeating the question back to the 
clinician. The management of researcher-focused questions was discussed with the 
clinician prior to the onset of clinic observations, reminding the clinician of the 
purpose of the observation and my role as researcher, rather than as an epilepsy nurse 
specialist (my employment status).   
 
4.3.3.7 In-depth interview methods 
I assumed the role of interviewer following completion of formal training in in-depth 
interview techniques22. My role within the interview was introduced to the participant 
to clarify the non-interventional nature of the meeting, and the use of the topic guide to 
maintain focus on the key topics and issues reflecting the content of the participant’s 
consultation (see Appendix 2 in-depth interview topic guide). The interview was 
linked to the consultation, and provided the opportunity for the participants to reflect 
on their experience of risk information and decision-making as topics from within the 
consultation. The interviews were held between one and three months following the 
consultation. The interview started by asking women to reflect upon the content of the 
consultation and the significance of the information they recalled relating to their 
pregnancy plans. Open questions were asked, for the participants to consider their 
perception of decisions made about treatment and future pregnancy planning. 
Anticipating participant questions concerning aspects of their epilepsy management, 
patient literature was made available at the conclusion of the interview. 
 
4.3.4 Methods of analysis 
The purpose of analysis was to learn something about the participants and about their 
personal histories of life with epilepsy as reproductive aged women. The analysis was 
informed by the analytic style of interpretative phenomenological analysis and 
                                                 
22
 Training was accessed from NatCen (The National Centre for Social Research, London). 
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followed an iterative process of non-linear stages creating descriptive and 
interpretative accounts (Smith et al., 2009). The staged approach to analysis created a 
structure for initial analysis of focus group data. Stages 1-4 were repeated for 
subsequent focus groups prior to commencing analysis of clinic observation and 
interview data (table 4.5).  
 
Stage Analytic method  (Adapted from Smith et al., 2009) 
1. Line by line analysis (reading and re-reading) 
2. Initial noting 
3. Developing emergent themes 
4. Searching for connections across emergent themes 
5. Moving to the next case (participant/focus group) 
6.  Looking for patterns across cases 
7. Taking it deeper: Levels of interpretation
23
 
8. Organisation of transcribed data and thematic framework 
9. Group analysis 
10. Development of the written account 
Table 4.5 Stages of analysis (Appendix 3) 
 
1) Line by line analysis - The process of transcription assisted analysis by 
repeatedly replaying the participant’s speech, supporting immersion within the 
participant’s account. This stage was vital in creating an accurate written 
account of the participant’s case as a form of data management24. My 
involvement typing the majority of transcripts and verifying the accuracy of 
secretary typed transcripts required immersion in the recorded data, at the same 
time as reading the transcripts. Repeat listening to the recorded data supported 
review of my research relationship, reflecting upon the data collection 
processes, and informed the recruitment process. All transcripts were read 
repeatedly ‘line by line’ to highlight ‘significant statements’ and establish an 
overall chronological account of the data. Field notes further supported data 
management. 
2) Initial noting - Initial notes were written as annotations to represent ideas and 
comments concerning the meaning within the participant account relating to 
                                                 
23
 The analytic process developed by Smith and co-authors (2009) involved six levels, however was 
extended to look for deeper meanings, reflecting the larger sample, managing data to create an audit trail 
and group analysis. Stage 10 – writing-up is generally acknowledged as a creative and interpretative 
stage of the analytic process, rarely included as a formal stage of analysis (Smith, J.A., Flowers, P. & 
Larkin, M. (2009) Interpretative Phenomenological Analysis: Theory, Method and Research, London, 
Sage Publications.)   
24
 Data management was supported by NVivo 7. 
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key objects of concern (Smith et al., 2009). Comments were ‘exploratory’, 
concerning descriptions of experiences, practices or events of significance, or 
about the use of language, such as the use of metaphors. This supported 
interrogation of the transcript with questions such as ‘what had the participant 
meant by this?’ This involved reflexivity regarding the process of data 
collection, listening to how questions might have been asked to prompt the 
participant response, trying to ‘get closer to what the participant was actually 
saying’ (Smith et al., 2009). (See Appendix 3, Table A3.1) 
3) Developing emergent themes - The coded transcripts were reviewed to 
develop themes which offered both descriptive and interpretative contexts for 
the participant’s responses to risk and decision-making. The interpretative 
context of the accounts concerned statements of behaviour or actions, which 
were interpreted alongside conceptual theories of social cognition; together 
with empirical work on risk perception and decision-making. Returning to the 
participants’ verbal and written accounts, interpretations were checked both for 
convergence and divergence, commonality and nuance (Smith et al., 2009). 
This stage was important in reducing the volume of data into more manageable 
themes which represented sections of transcript text.  
4) Searching for connections across emergent themes - This stage involved 
creating a framework to organise the emerging themes, illustrating the 
relationship between the transcript text and the theme it represented. As an 
iterative process, this stage resulted in returning to the individual transcripts 
representing unique idiosyncratic instances and searching for other participant 
experiences that shared similar or presented alternate accounts. This stage was 
supported by focusing upon the differences rather than similarities in the 
participants accounts (Appendix 3: Table A3.3 and Figure A3.1).  
5) Moving to the next case - Stages 1-4 were repeated with individual and group 
transcripts to build and test themes. Focus group data required modification of 
the staged approach to analysis to take account of the individual perspective 
and the group dynamic (Smith et al., 2009) (see Appendix 3 table A3.4). The 
importance of considering group processes is recognised as attending to the 
ways in which individuals make experiential claims and how these are 
responded to within the group and by the moderator, implying a cyclical 
analysis of how relationships formed within the group, their influence upon the 
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participants use of stories and language, and how this in turn influences 
emergent themes (Palmer et al., 2010). It has been recognised the process of 
analysis starts from the personal perceptions and understandings of the 
phenomena before moving to shared meanings (Smith et al., 1999). In practice, 
once data collection was complete, the corpus of data required re-review, 
recognising that early (interim) analysis had served a dual purpose: firstly, 
informing theoretical sampling and secondly, to create an overall structure of 
the range of participant experience. Formal analysis started by reviewing 
patterns both within and across the cases. 
6) Looking for patterns across cases - Patterns within themes began to emerge 
through familiarity with the coded transcript extracts, and repetition of the 
emergent themes across the cases was taken as an indication of their status as 
recurrent themes representing the shared understandings that I was attempting 
to capture. (See Appendix 3, table A3.5) 
7) Taking it deeper: Levels of interpretation - The final stages of analysis 
involved interpretations of the individual case and entire study population as a 
process of within-case and across-case analyses (Ayres et al., 2003). The 
purpose of looking for patterns was to ‘find commonalities and variations’ of 
the experiences of reproductive aged WWE, and to develop a representative 
account to support generalisations through reference to the existing literature 
(Smith et al., 2009). The results of the Cochrane Systematic Review (section 
2.4) were central to making inference concerning the implications of the 
qualitative study results, to direct further research and influence healthcare 
practice within the wider community of reproductive age WWE. 
8) Organisation of transcribed data and thematic framework - NVivo 7 
supported data management by recording dates of all changes to emergent 
themes, such as changes made by merging codes or re-naming codes to 
reflecting new interpretations of participant accounts. The value of NVivo 7 
was to create an audit trail of all analytic changes and modifications, allowing 
additional comments relating to participant observation to be linked via memos 
to coded text and the research journal. 
9) Group analysis - The University of Liverpool MRES (633) Qualitative Data 
Analysis group provided the opportunity to present my transcripts for group 
analysis/discussion. Each bi-monthly meeting involved fellow PhD students 
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reviewing each other’s analytic work, and developed interrogation to help test 
themes and challenge and question analytic assumptions. Four transcripts (one 
focus group transcript and three observation/interview transcripts) were also 
read and coded independently by my academic supervisors (Professor Gus 
Baker and Professor Ann Jacoby). During supervision sessions the code text 
were compared for coherence and the plausibility of the interpretations. 
10) Development of the written account - The process of writing annual reports 
for the funding organisation, ethics committee and the University progress 
reports developed an expanding narrative account of the study methods and 
analysis from the point of project development, through early reflections on 
data collection, and finally detailing an interpretive account of participant 
experience. 
       
4.4 Summary 
There were two phases to this interpretative phenomenological analysis of the 
influence of risk perception and communication upon decision-making throughout the 
reproductive careers of WWE preparing for pregnancy: firstly, informing experience 
through focus group discussion and secondly, through observation of the participants 
clinic visit and linked in-depth interview. Women and clinicians were purposively 
recruited from two regional epilepsy clinics and a regional obstetric hospital in the 
Northwest of England. Analysis was informed by interpretative phenomenological 
analysis and was practically managed through the computer-assisted qualitative data 
analysis software NVivo 7. Appraisal of the methodology and methods will be used to 
assess the quality of study findings within the discussion chapter.  
 
The results of this interpretative analysis are displayed in the following results 
chapters. 
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Chapter 5 Results –An introduction  
Introduction 
This chapter presents the format of the following four results chapters: 
 
Chapter 5 Results - Introduction – the current chapter will introduce the total study 
population of 85 WWE and will illustrate their demographic and reproductive 
histories.  
 
Chapter 6 Pregnancy Planning – describes the experience of WWE preparing for 
pregnancy, highlighting the factors that contributed towards an unplanned or accidental 
pregnancy. 
  
Chapter 7 Communicating risk and uncertainty – examines the provision of risk 
information to women preparing for pregnancy, and the different risk management 
strategies adopted by women and clinicians in response to this information. 
 
Chapter 8 Decision-making in preparation for pregnancy – explores the experience 
of decision-making from the perspective of women preparing for pregnancy, and the 
influence of risk communication to inform and support their participation in both 
pregnancy planning and risk management. 
 
Chapter 9 A model of preconception counselling – describes a model of 
preconception care and illustrate its development from the three substantive themes 
presented in Chapters 6-8: pregnancy planning, the communication of risk and 
uncertainty, and decision-making in preparation for pregnancy.   
 
5.1 Introduction to the study population 
Women who were deemed eligible25 to participate in the study were provided with 
study documentation and contact made on return of the reply slip. The total number of 
women provided with study documentation was not recorded. However, 107 reply 
                                                 
25
 See Chapter 4.3.2.1 Study Methods - Inclusion Criteria, in summary: women aged 16-45 year with a 
confirmed diagnosis of epilepsy, and section 4.3.2.3 Recruitment. See also Appendix 1 Study 
documentation. 
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slips were returned by women showing interest in taking part in this study. Eighty-five 
women and twelve clinicians provided consent and were involved in producing the 
data for analysis.  
 
The majority of women showing initial interest in taking part in the study remained 
interested and provided consent to participate in the study (79%). Six women were 
excluded from the study26: four women had received care from myself in the preceding 
12 months, one women experienced her 46
th
 birthday in the time between recruitment 
and her focus group invite, and one woman disclosed a diagnosis of severe depression 
when contacted to arrange focus group attendance (Table 5.1). There were 101 women 
indicating interest in the study and who were eligible to participate in the study. The 
reasons for women not participating in the study fell into two main categories: could 
not be contacted by the researcher (62%), or unable to take time off work (25%).  
 
 No.   No.  
Reply slips indicating interest: 107   
Women meeting inclusion criteria  101   
Women meeting exclusion criteria 6   
Reasons for exclusion:  Reasons for non-participation:  
Aged 46 year 1 Emigrated 1 
Severe depression 1 Child care difficulties 1 
Contact with researcher  4 Work commitments 4 
  Could not be contacted  10 
Women consented for participation:   85 (79%) 
Table 5.1 Reasons for non-participation in the study  
 
5.1.1 Communication with study participants  
Study participants were contacted to confirm arrangements for participation in the 
study, and to initially answer questions regarding the study format. The purpose of my 
communication with participants was threefold; firstly to maintain interest in the study 
and by answering questions to begin to ‘get to know’ the participants, and respond to 
changing circumstance such as offering an alternate focus group date, or changing the 
time of interview. Secondly, stage-two participants were provided with a copy of the 
clinic transcript and summary of the observed consultation; this was posted to the 
participants prior to their follow-up interview. The clinic transcript and summary were 
                                                 
26
 See Chapter 4.3 Study Methods; section 4.3.2.2 Exclusion Criteria, in summary: women with a 
diagnosis of chronic depression or psychiatric disorder, women whom had received care (<12 months) as 
part of my NHS employment, women under the age of 16 years or over the age of 45 years.    
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provided to assist the participant reflect upon the consultation, and served as an aid 
memoir. Thirdly, participants were requested to provide consent to the disclosure of 
information to their GP concerning safeguarding issues of ‘best interests’. No 
circumstances arose that required disclosure of information to the participant’s GPs.  
 
5.1.2 Background demographics of the study population  
The mean age of the study participants was 27.8 years (table 5.2). The recruitment 
process was amended to target teenagers
27
 and women over 35 years (see also section 
4.3.2.4 Stage 1 recruitment). The amendments reflected the results of interim analysis, 
highlighting the need to explore the experiences of young women at the start of their 
reproductive career and women over 35 years, both of whom may have experienced 
adverse pregnancy outcome.    
 
The socio-demographic characteristics reflected mainly white British women. Three 
Asian women were recruited and contributed their reproductive experiences into study 
stage two. This represented fewer than might be expected, representing 4% of the 
study population, in contrast with the National Statistics in the NW of England 8.9% 
non-white population (Large and Ghosh, 2006). The research objectives required a 
breadth of reproductive experience and in the event, captured 43% of women whom 
had experience of pregnancy and 24% of women with live children. A further 14% of 
women were pregnant at the time of participation in the study, and 24 women (28%) 
identified themselves as planning a pregnancy. Twelve women were pregnant during 
study participation, of whom one was experiencing a twin pregnancy, and another 
conceived in the time between her observed consultation and follow-up interview 
(table 5.3). Fifty-five percent of women were reliant on contraception in the preceding 
six months before study participation. Marital and living arrangement status 
represented 55% of the participants as either married or cohabiting, a lower rate than 
that of the background population of women without epilepsy within the US and 
Denmark (Konda et al., 2009; Jennum et al., 2011). 51% were employed either full or 
part-time, comparable to other published results for populations of WWE and people 
with epilepsy; employment rates were comparable to the regional labour market 
statistics published for the NW of England (Office for National Statistics, 2011). 
                                                 
27
 Recruitment from the specialist epilepsy transition clinics, found many teenagers did not meet the 
inclusion criteria due to learning disability.   
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The total study population is the result of the staged recruitment:  
1. Stage one – focus group (n=61)  
2. Stage two – observed consultation and linked in-depth interview (n=24) 
 
Study population n=85  % (Number) 
Mean age - years (standard deviation, SD) 27.8588 yrs SD± 7.34061 
16-20 17.6 % (15) 
21-25 20% (17) 
26-30 29.4% (25) 
31-35 18.8% (16) 
36-40 7.1% (6) 
41-45 7.1% (6)  
Table 5.2 Age characteristics of the total study participants   
 
Study participants (n=85) No. (%) 
Contraception use in previous six months 47 (55%) 
Nulliparous
28
 54 (57%) 
Experience of pregnancy  32 (43%) 
Miscarriage 5 
Pregnancy loss 1 twin pregnancy 
Termination of pregnancy 6 (7%) 
Women delivering live children  20 (24%) 
Pregnant at time of study participation: 12* (14%) 
Preconception commencement of folic acid  8 (73%) 
Folic acid commenced in pregnancy  3 
Pregnancy taking polytherapy (2 AEDs) 3 
Pregnant taking sodium valproate 1 
* 1 twin pregnancy  
Table 5.3 Preconception demographics of the study population 
 
5.1.3 Introduction to stage one participants  
Sixty-one women provided consent to participate in a focus group. Of these, 58 were 
involved in one of 11 focus groups. Three women were interviewed using the focus 
group topic guide29. The average age of focus group participation was 27.77 years 
(range 16 years – 45 years) and 21 % were young women under the age of twenty. 
Forty-six percent of women were single, and 34% were living at home with their 
parents. Fifty-two percent of women were married or cohabiting and 54% were living 
                                                 
28
 Nulliparous refers to a woman who has never given birth to a viable, or live, infant. 
29
 One participant was interviewed at the focus group venue, and had been the only attendee of a planned 
focus group. The decision to interview the participant was made in response to her commitment to 
attend, and inability to return on a future focus group date. The participant agreed to an individual 
interview. Two participants interviewed in their own home due to their inability to attend any of the 
invited focus group dates due to family and work commitments. Both participants were purposively 
recruited to tests emerging themes of mature WWE modifying their reproductive plans (see Chapter 4 
Methodology and Methods section 4.3.2.4). 
                                                                                                                                  Results - An Introduction 
 92 
with their spouse or partner (either alone or with children), of whom eight saw 
themselves as housewives. Forty-seven percent of the focus group participants were 
employed (either part-time or full-time), while eight were students. Twenty-two 
percent of women were unemployed or claiming sickness/incapacity benefit (table 
5.4). A quarter of the study population held a valid UK driving licence, and a third of 
the participants reported no seizures in the six months preceding the date of focus 
group participation (31%). The majority of women rated their seizures as either very 
well or well controlled (Table 5.5). 
 
Demographics                                                              % (No.) 
Mean age of focus group participants 27.7705 yrs SD± 8.34744 
Martial status: (n=59)  
Married/cohabiting 52% (31) 
Single 46% (27) 
Divorced/separated 2% (1) 
Living situation: (n=59)  
Alone 9% (5) 
Living with spouse/partner 25% (15) 
Living with spouse/partner and children 29% (17) 
Living with parents 34% (20) 
Living with others 3% (2)  
Employment status: (n=59)  
Employed full-time 32% (17) 
Employed part-time 19% (11) 
Student 13.5% (8) 
Unemployed/incapacity/sickness benefit 22% (13) 
Housewife 13.5% (8) 
Driving status: (n=59)  
Driving 25% (15) 
Table 5.4 Demographic characteristics of the focus group participants 
 
Forty-four percent of women were medicated with a monotherapy AED regimen. 
Lamotrigine was the most common monotherapy, followed by carbamazepine, sodium 
valproate, and levetiracetam. Forty-six percent of participants were taking a 
polytherapy AED regimen, while three women were not taking treatment to manage 
their epilepsy. Four women were taking sodium valproate as part of a polytherapy 
regimen30, of whom one was taking sodium valproate, lamotrigine, levetiracetam and 
clobazam. Two women were taking sodium valproate as part of a three AED regimen. 
Three participants had surgical treatment for their epilepsy (table 5.5). Fewer focus 
                                                 
30
 The significance of women of childbearing age taking sodium valproate is discussed in greater detail 
in Chapter 2 Literature review, highlighting the increased congenital malformation risks associated with 
in utero exposure to sodium valproate polytherapy regimens, and including additional risks of neuro-
cognitive delay and conditions such as fetal valproate syndrome.  
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group participants were on monotherapy when compared to stage two participants 
(Table 5.7). The lower proportion of monotherapy within the focus group population 
may be associated with the group composition including women whom had completed 
their families and perhaps accepted more aggressive treatment to improve seizure 
control, however, the finding was alarming given the focus group participants also 
included teenagers and women considering future pregnancy. The focus group findings 
are, however, similar to those found by Pack’s et al (2009) cross-sectional survey of 
US reproductive aged women identifying 60% medicated with monotherapy. 
 
Epilepsy management characteristics                        % (No.) 
Seizure control: (n=59
31
)  
None in last 6 months 31% (18) 
Less than one per month 27% (16) 
One or more per month 41% (24) 
Not stated (1) 
Self-rated seizure control: (n=59)  
Very well controlled 39% (23) 
Fairly well controlled 37% (22) 
Not very well controlled 10% (6) 
Not at all well controlled 5% (3) 
Not stated (5) 
Treatment status: (n=52
32
)   
Monotherapy AEDs 44% (23) 
Polytherapy AEDs 50% (26) 
No treatment 6% (3) 
Monotherapy  
Lamotrigine 30% (7) 
Carbamazepine 26% (6) 
Sodium Valproate 17% (4) 
Levetiracetam  17% (4) 
Topiramate 1 
Phenytoin 1 
Polytherapy  
Polytherapy including Sodium Valproate 15% (4) 
Polytherapy 2 AEDs 77% (20) 
Polytherapy 3 AEDs 15% (4) 
Polytherapy 4 AEDs 8% (2) 
Epilepsy surgery: (3) 
Table 5.5 Epilepsy management characteristics of the focus group participants 
 
Twenty-six women had experience of pregnancy: 19 had delivered live children, four 
women experienced a termination of pregnancy, and one woman experienced two 
miscarriages (table 5.6). Eleven women were pregnant at the time of focus group 
participation, of whom six women were experiencing their first pregnancy. One was 
                                                 
31
 Number of questionnaires returned. 
32
 Of the 59 returned questionnaires, seven women did not answer the treatment question. 
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taking sodium valproate, and three were medicated with a polytherapy regimen with 
two antiepileptic drugs. Seven women had commenced folic acid 5mgs daily prior to 
conception, while three women started taking folic acid after discovery of pregnancy. 
One woman, not taking folic acid at conception, experienced pregnancy while taking 
both phenytoin and the oral contraception pill. Five women referred to their 
pregnancies as planned (45%), of whom three were experiencing their first pregnancy 
(see also, Chapter 6).  
 
Forty-seven percent of women reported using contraception in the preceding six 
months. Nine women were using the contraceptive pill, and 7 were using condoms. A 
further 6 women were using the coil, 3 were using the contraceptive implant; and 2 
women were using contraceptive injection. Two women reported using two forms of 
contraception: contraceptive pill and condoms; and contraceptive injection and 
contraceptive pill. Five women did not respond to this question, and one who reported 
not using contraception on the questionnaire disclosed during focus group discussion 
her use of the ‘withdrawal method’.  
 
Focus participants (n=61) % (No.) 
Contraception use in previous six months 47% (29) 
Nulliparous 57% (35) 
Experience of pregnancy  43% (26) 
Miscarriage (2) 
Pregnancy loss (1 twin pregnancy) 
Termination of pregnancy 6% (4) 
Women delivering live children  31% (19) 
One child 15% (9) 
Two children 15%  (9) 
Three children (1) 
Twins (1) 
Adoption (1) (2 children) 
Pregnant at time of focus group participation 18% (11) (1 twin pregnancy)  
Preconception folic acid  64% (7) 
Folic acid commenced in pregnancy  27% (3) 
Pregnancy taking polytherapy (2 AEDs) 27% (3) 
Pregnant taking sodium valproate 9% (1) 
Table 5.6 Reproductive history of the focus group population 
 
5.1.4 Introduction to stage two participants 
Twenty-four women provided consent to allow observation of their hospital 
consultation and all women were followed up with linked in-depth interview (study 
stage two). One woman who had been recruited during her second hospital 
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consultation to discuss pregnancy planning was interviewed without observation, as it 
was not possible to arrange clinic observation within the time allocated for data 
collection. All clinic observations took place in the out-patient clinic setting with pre-
arranged NHS hospital appointments. All women had a definite diagnosis of epilepsy 
and were taking antiepileptic drugs at the stage of recruitment (one woman disclosed 
her treatment withdrawal during her index clinic visit) (table 5.7). Eight of the 
observed clinic appointments were new patient visits and 15 were follow-up visits, 
illustrating the varied clinical histories captured within the observed clinic visits (see 
table 5.10). 
 
The mean age of women at the time of the observed consultation was 28 years with a 
range of between 20 and 35 years of age. The majority of women were single at the 
time of clinic attendance (n=17). Of these, twelve identified living with a long-term 
partner or co-habiting, two women identified themselves as engaged, one as living 
alone, and one living with her parents. Six women were married. The median age of 
seizure onset was 12 years (range 1-22 years). Thirteen women had been seizure free 
during the six months before their observed consultation, of whom six had achieved 
over 12 month seizure freedom and were driving. Of those continuing to experience 
seizures, six women were experiencing more than one seizure per month.  Seventy-one 
percent of women were taking a single antiepileptic drug (monotherapy), while six 
were reliant on polytherapy, and one woman had withdrawn treatment. The majority of 
women rated their seizures as very well controlled (n=19), while one woman rated her 
seizures as not very well controlled.  
 
One woman left school without qualification, while eleven women held GCSE, A level 
or vocational qualifications, and 12 women achieved professional or graduate level 
education (table 5.7). Seventeen women were employed either part time or full time, 
whilst one of these women identified herself as off-sick from her full-time position at 
the time of observation (this was attributed to a recent experience of seizure and the 
rationale for her referral for epilepsy review). One woman was an undergraduate 
student. Six women were not working - of whom one referred to herself as a 
housewife, four women were either claiming sickness or unemployment benefit, and 
one woman, who had been ‘in between’ jobs at the time of consultation, was about to 
commence a new job within a month of her follow-up interview.  
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Table 5.7 Demographic and background details of study stage two participants 
 
The preconception characteristics of study stage two participants are presented to 
contrast antiepileptic drug use compared to selection of contraceptive method, self-
related pregnancy planning intention and decisions to action clinical recommendations 
to change AEDs or commence folic acid (table 5.8)(See also Chapter 6, Section 6.2.3). 
Five women were taking sodium valproate based on the clinician’s reference to the 
patient hospital records and/or referral letters, one of whom was found during the 
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01 29 S/LtR 11 A level Ft N  M  N <1 /m VW  
02 22 Engaged 13 GCSE Unemployed N  M  N >1 /m FW  
03 23 S/LtR 12 Vocational Ft N  M  Y 0 /6m VW  
04 27 Single   16 Professional  Pt N  P  Y 0 /6m VW  
05 29 Single 16 A/Vocat Pt N  M  N <1 /m FW 
06 20 S/LtR 14 GCSE Unemployed N  M  N >1 /m FW 
07 32 Engaged 17 GCSE Ft N  M  Y <1 /m VW  
08 27 S/LtR 10 A/Vocat Student N  M  Y 0 /6m VW  
09 29 N  12 Graduate Ft N  P  N <1 /m FW  
10 30 Married 15 Professional Ft Y  M  Y 0 /6m VW 
11 24 S/LtR 15 Vocational Ft N M  Y 0 /6m VW 
12 30 S/LtR 14 Graduate Ft Y  P  Y 0 /6m VW 
13 28 Married 4 Vocational  Ft N  M  Y 0 /6m VW 
14 27 Married  10 GCSE Housewife  N  P  N <1 /m VW 
15 31 E/LtR 21 Graduate Ft Y  M  Y 0 /6m VW 
16 29 Divorced 12 None  Unemployed  N  M  N >1 /m VW 
17 33 Single  11 Graduate s/l N  M  N >1 /m VW 
18 21 E/LtR 2 Professional Unemployed  N  P  N >1 /m VW 
19 24 E/LtR 7 Professional Ft Y  - Y 0 /6m VW 
20 30 S/LtR 1 Vocational Pt N  M  N >1 /m NVW 
21 35 Single 9 Graduate Ft N  M  N <1 /m VW  
22 32 Married 13 Graduate Ft Y  M  Y 0 /6m VW  
23 30 Married 22 Graduate Unemployed Y  M  Y 0 /6m VW  
24* 31 Married 12 Graduate Ft N◊ P Y 0 /6m VW 
IO24* participant was interviewed only. 
Educational level: Participants OI05, OI08 reported A level &Vocat (vocational qualification) 
Employment: Ft (full time); Pt (part time); s/l(yes, sick leave); Stu (student); Unemployed (claiming 
unemployment benefit, Incapacity benefit or other benefits) 
Driving status: ◊ Participant IO24 ticked Yes to her driving status, she was not driving at time of 
study participation due to 12 month medical suspension, adjusted record. 
Treatment status: M monotherapy, P polytherapy 
Seizure frequency: measured in seizures per month (m). 
Self-rated seizure control: (V) Very well, (W) well, (F) fairly well, (NVW) not very well controlled. 
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course of her consultation to have withdrawn sodium valproate of her own volition. 
Six women were taking two AEDs, one in combination with sodium valproate, and 
one woman was taking a third AED, clobazam, intermittently to manage clusters of 
seizures. Seven women took action to change their AEDs, while one participant had 
collected her prescription for lamotrigine but had delayed switching from sodium 
valproate.   
 
Six women were not using contraception in the six months  prior to participating in the 
study, of whom only one identified that she was not in a sexual relationship, whilst 
three identified themselves as trying to conceive and were also taking folic acid. From 
this group, one woman reported changing the immediacy of her pregnancy intentions 
during the clinic visit, without changes to contraceptive or folic acid use. 
 
Eight women were reliant on condoms for contraception, of whom four reported taking 
folic acid33. The majority of women were not taking folic acid (n=17). Of these, one 
was taking sodium valproate and another was reliant on a polytherapy regimen (both 
participants commenced folic acid following the clinician’s recommendation). Nine 
women reported their pregnancy intentions as immediate and five were not using 
contraception at the time of observed consultation, and therefore at risk of pregnancy 
prior to receiving preconception review. Of the four women with immediate pregnancy 
intentions remaining on contraception, two women were using condoms and two 
women were taking the contraceptive pill. Six women had prior pregnancy experience; 
however, only one had a child. Three women had experienced miscarriage; two 
women had experienced a medical termination, of which one was due to pre-natal 
diagnosis of major congenital malformation; the other participant defined her 
termination as an abortion. One woman discovered herself pregnant and stopped 
treatment in the time between clinic observation and follow-up interview.  
 
                                                 
33
 High dose folic acid is recommended within NICE Guidelines for all women with epilepsy who are 
either planning pregnancy or felt to be at risk of accidental pregnancy (NICE, 2012). 
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Table 5.8 Preconception demographics of study stage two participants 
 
5.2 Introduction to the Clinicians 
Twelve clinicians consented to observation of their consultations with study 
participants. The majority of observed consultations were held with consultant 
Neurologists, and three with Registrar grade Neurologists. The gender of clinician 
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01 CBZ None Coil  F N R/Y N  0 - 
02 VPA Switch to LTG◊ Condoms  F N R/Y Y  1 M 
03 CBZ None  Coil  F N - Y  1 M 
04 VPA LEV None Pill   F  N R/N N  0 - 
05 LTG None Pill X N - N  0 - 
06 LTG Switch to CBZ None I N R/N N  0 - 
07 VPA None Condoms F Y - N  0 - 
08 LTG None Depo Provera F N R/N N  0 - 
09 LTG CBZ Reduce LTG Condoms F N R/Y N  0 - 
10 CBZ CBZ withdrawal Pill  I N - N  0 -  
11 LTG None Pill F N R/N N 0 - 
12 LTG TPM None Coil F N - N 0 - 
13 LEV None Condoms  F Y - N  0 - 
14 LTG TPM• None None  I Y - N  0 - 
15 CBZ None Condoms  F N R/N N  0 - 
16 VPA Increase dose None   N - Y  2 1/M 
17 LTG None Condoms  F N R/N Y  0 T 
18 LEV COZ None Condoms  I Y - N  0 - 
19 None§  None Pill  I N R/N N  0 - 
20 LEV Reduce dose  None  I Y - Y*  1 P 
21 VPA None Pill  F Y - Y  1 T 
22 LTG None None  I Y - N  0 - 
23 CBZ CBZ withdrawal Condoms  I N R/Y N  0 - 
24 CBZ AZM AZM withdrawal None I N - N 0 - 
Antiepileptic drug use: AZM Acetazolamide, CBZ carbamazepine, LTG lamotrigine, VPA sodium 
valproate, LEV levetiracetam, TPM topiramate, COZ clobazam • OI14 intermittent use of clobazam 
§ OI19 withdrew AEDs 
AED changes after consultation:  OI20 reduced treatment dose following observation, and stopped 
treatment on discovery of pregnancy. ◊ OI02 collected prescription but not started recommended 
treatment switch (see Chapter 6.2.3)    
‡ Pregnancy intention: reported desire to conceive, immediate (I), future (F) not stated/not clear (X). 
OI06 changed pregnancy intentions.  OI16 was not in a sexual relationship. 
Folic acid use: Yes (Y) No (N); commencement after consultation refers to participant action taken to 
clinician recommendation (R) no change in folic acid status (-). 
Experience of pregnancy: total number of pregnancy experiences independent of outcome,  
OI20 conceived shortly after the index consultation and stopped treatment on discovery of pregnancy. 
Pregnancy outcome: M (miscarriage), T (termination), P (pregnant), number of live born children 
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observations was evenly spilt, although all Epilepsy Nurse Specialist observed 
consultations were with female nurses (table 5.9). 
  
Professional title/grade (n=12) Gender No. of observations (n=23) 
 Male Female  
Neurologist 4 2 14 
Obstetrician - 1 1 
Neurology Registrar 1 2 3 
Epilepsy Nurse Specialist (ENS) - 2 5 
Table 5.9 Clinician characteristics 
 
5.3 Observed consultations 
The typical (median) consultation duration was 18 minutes 52 seconds, and 
consultations ranged in duration from 6 minutes 31 seconds to 67 minutes 50 seconds. 
The duration of clinic visit did not vary greatly between new and follow-up patient 
consultation, with the shortest new patient consultation 9 minutes 32 seconds and the 
shortest follow-up consultation 6 minutes 31 seconds. The majority of women attended 
their consultation unaccompanied (61%). Attendance with an accompanying adult, 
interruptions to the consultation, or the gender of the clinician did not alter the mean 
duration of consultations (table 5.10). There were few interruptions causing 
distractions with one exception; the clinician leaving the consultation room (OI06). 
 
The consultations were all held in NHS hospitals. The clinic settings were similarly 
structured in each location, with patients having contact with outpatient department 
clinic staff, waiting in an outpatient waiting room, before being called into the 
consultation room. The clinic room environment was typically formal with a desk 
separating the clinician and patient. The nature of communication between the patient 
and clinician was verbal; few clinicians provided written literature (although patient 
information was available within the waiting room). The outcome of the clinic 
appointment was dependent upon hospital policy regarding the provision of patient 
copy letters. This was observed practice in one hospital, were patients indicated a 
preference to receive copies of correspondence as they booked into the outpatient 
department; the topic was not routinely discussed by clinicians, observed in one 
consultation (OI19).   
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01 FU - ENS F 00:38:36  - - 
02 FU Partner ENS F 01:02:41 - D 
03 FU - Neurologist M 00:13:25 - - 
04 FU - ENS F 00:39:02 - S 
05 FU - Neurologist F 00:06:31 - H 
06 NP Carer Neurology Registrar F 01:07:50 Dr left room twice D 
07 NP - Neurologist M 00:37:47 - - 
08 FU Family x2 Neurologist M 00:15:21 - - 
09 FU - Neurologist F 00:17:27 Clinic door open H 
10 NP - Neurologist M 00:12:48 - - 
11 FU - Neurologist M 00:09:32 - - 
12 FU Partner Neurologist M 00:25:43 - - 
13 FU - Neurologist M 00:16:45 Clinic door open H 
14 NP Spouse Obstetrician F 00:14:55 - - 
15 NP - Neurologist M 00:24:37 - - 
16 NP Friend Neurology Registrar F 00:17:33 - D 
17 FU - Neurologist  F 00:16:54 - - 
18 FU - ENS F 00:24:57 - - 
19 NP Partner Neurologist F 00:18:52 - C 
20 FU - Neurologist M 00:23:53 - S 
21 FU - Neurology Registrar M 00:17:14 Clinician bleep - 
22 FU Spouse ENS F 00:37:30 - - 
23 NP Spouse Neurologist M 00:59:02 Clinic door open - 
24* - - Not observed - - - H 
Visit type: NP New patient appointment; FU Follow-up appointment 
Clinic outcome: (S) letter of support regarding benefits; (C) copy letter; (D) drug change schedule 
(H) Hospital policy to provide copy letter, not confirmed if participants had taken up this offer. 
Table 5.10 Observed consultations 
 
5.4 In-depth interviews 
The majority of women were interviewed in their own home; four women requested an 
alternate venue for their interview. Fifteen women were interviewed alone. Of the nine 
accompanied interviews, a partner / spouse were present in eight interviews, and one 
participant was interviewed with her sister and children present (OI16). Interviews in 
the presence of a partners / spouse did not substantially vary compared to 
unaccompanied interviews, and the majority of women maintained dominance in their 
role as interviewee. The structure of the interview format (see Appendix 2 In-depth 
interview topic guide) was similar in all interviews, women openly discussing their 
experiences. One participant interviewed with her husband, was an exception (OI14). I 
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needed to use my interview skills to encourage the participant to speak, using open 
questions directed towards the participant and giving positive reinforcement and 
maintaining eye contact with the participant, whilst acknowledging her husbands 
contributions. 
      
5.5 Summary 
The study population was the result of recruitment and continued engagement with 
both the participants and the clinicians. Eighty-five women and twelve clinicians 
contributed to the data for analysis, with the findings from analysis representing three 
broad substantive themes. This chapter has introduced the study population, using data 
generated from participant questionnaires to present to the participants’ background 
demographic and reproductive histories. 
 
The following four results chapters will present the study findings.  
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Chapter 6 Pregnancy planning 
Introduction  
‘Pregnancy planning’ describes the experiences of WWE as they contemplate their 
desires for family, their experience of preparing for pregnancy and the barriers they 
identify throughout their reproductive lives. These experiential findings have been 
used to structure this chapter as follows:  
1. Intentions to have a baby – describes the experience of desire for family 
formation in the context of changing life circumstance.  
2. The experience of planning pregnancy – describes the activities and priorities 
as defined by women through their interaction with clinicians; and  
3. The breakdown of pregnancy planning – illustrates the experience of 
unplanned or accidental pregnancy, and provides explanations and 
interpretations of the barriers to achievement of a planned pregnancy. 
 
6.1 Intentions to have a baby 
WWE acted on their desires for family formation, influenced by life events 
contemplating the appropriate timing for a future pregnancy.  
 
6.1.1 Desire for family 
The desire to have a family or wanting to have a child were described as natural and as 
being the same as for any woman in the general population, a taken for granted stage in 
the life of every woman.  
OI09:  My dream was always, I’ve wanted 3 children […] I’ve always had that 
mentality of, I want children… (29 year old, future pregnancy intentions) 
 
OI17:  I do want children of course I do, that’s just nature… 
  (33 year old, future pregnancy intentions) 
 
For some women the desire to have a baby was first recognised in childhood and 
developed with perceived maturity. Maturity was used to measure the degree of 
intentionality to act on desires for family, such as feeling responsible enough to have 
children. Desires to have a family were described as a natural life progression, 
illustrated by a 39 year old woman describing her experience of meeting “Mr Right”, 
getting married and then thinking of starting a family (FG123). Women tended to 
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construct a traditional or idealised social model of becoming a mother in the context of 
getting engaged, married and settling down in a house as prerequisite to starting a 
family. This construct shaped how women managed the disclosure of their plans to 
settle down and to start a family within the consultation, establishing a home with a 
partner first, before making the decision to discuss pregnancy intentions with their 
clinician.  
 
Women described their expectations of wanting to become a mother as an inevitable 
move into a stage in life when having children would become significant in response to 
their desires for family. For some women this view was rejected, proposing that the 
desire for children was not instinctive, but developed in response to life experience and 
opportunity. For these women, acknowledgement of not always having wanted 
children was important, placing emphasis on going to University, starting a career, or 
more practically getting settled in a relationship, marriage or house. Changes in the 
desire for children were central within these descriptions of family life, illustrated by a 
mother of a 12 year old child: 
OI16:  Well at first I used to always want a lot of kids. But as I’ve gotten older and 
think, like nowadays like, I haven’t really, I’ve thought about having kids 
even if I meet someone, I’ve thought maybe I could just have one more, if I 
do meet someone… (29 year old)  
 
For some women intentions for family formation were presented as emotional 
statements such as having one’s “heart on it [family]”, with the women expressing 
anxiety concerning their future ability to conceive and their intention to try for a family 
remaining tentative. Other women struggled to imagine not being able to have a baby, 
with one woman commenting on her desire for the “experience of a baby growing and 
feeling the baby kick” (OI04, 27 year old). The instinct to have children or extend their 
family was presented by some women as them feeling “blessed” by having a baby or 
family. Future pregnancy desires were described by women in response to their life 
experiences and relationships, and whilst the majority identifying future pregnancy 
intentions spoke of their perceived future achievement in meeting this goal; for some 
women, desires were dampened by life events such as troubled relationships or more 
active seizures (expanded further in Section 6.1.3).  
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6.1.2 The timing of intentions for pregnancy 
Statements about future intentions to conceive often specified a time frame. Within the 
consultation, changing circumstance such as moving in with a partner, or changes in 
relationship status were made with reference to an expected timescale, such as the date 
for a wedding: or in relation to estimating future intentions for pregnancy “I’d say next 
year two years, I’ve got to get married first” (OI09). The intentional status of women 
observed in clinic and followed up with interview (presented in Chapter 5, Table 5.8) 
categorises pregnancy intentions by the time frame of ‘immediate’ or ‘future’ 
reflecting descriptive terms used by women. Clinicians had a tendency to request more 
precise estimations of pregnancy plans and, whilst not always clearly stated, implied 
that consideration was needed of the time required to make treatment changes ahead of 
pregnancy. In contrast, women revealed tentative time scales around life events such as 
marriage, often influencing decisions to ask questions concerning the timing of 
conception: 
FG-I-02: when you sort of get to an age when you think, well this is the time I 
want to be having a family. I think when, you know yourself when you’ve 
reached a point in your career, that you think now’s the right time, I’ve met 
the right person, I’ve done this, and this and this at the right time. Yes, you 
think well this is the avenue that I want to be taking. The consultant is not 
going to know that, but he will know the timescale of your life where you 
are, so whether or not that’s the time you should be asking … 
 (36 year old, adopted two children) 
 
Clinicians were observed to place significance on estimations of future pregnancy 
intentions, revealing a tendency to judge intentional status as static: 
193. C:                                                                  […] Because years ago you  
194.  weren’t thinking about it, and we’ve certainly kind of, written that  
195.  down in our notes that it is not on the agenda …  
(OI01, 29 year old, future pregnancy intentions) 
 
The changeable nature of pregnancy intentions was also susceptible to women 
changing their mind and responding to their biological clock. Some women made 
reference to a perceived time scale, such as, “I better get a move on” and “I don’t want 
to be trying for a baby to a timetable”. For several, the practicality of successful 
conception, the logistics of pregnancy spacing, achieving their desired family size in 
the context of their age and the pressures of comparison with other women evolved 
into a sense of urgency. For one 30 year old woman, with immediate pregnancy 
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intentions, the change in her desire for pregnancy had moved towards an “urge”, which 
at the time of follow up interview had resulted in emotional distress: 
OI23:  … I haven’t always had like an urge, to want a baby. But I’ve always 
known that in the future I would want one. But now I have got the urge, 
definitely, and [husband] has always wanted children ever since I’ve met 
him. He’s crazy you know, he treats our dog as a little baby, he bought a 
paddling pool for him yesterday [laughs] a huge thing and I find it quite 
upsetting actually. [Starts crying] 
 
The following participant defended her need to conceive as soon as possible in 
response to the clinician’s request to delay conception (illustrated later in relation to 
prioritising improvements in seizure control ahead of conception, page 108): 
327. P: […] it takes ages for some people to get pregnant. 
328. C:  How old are you now [participant]? 
329. P:  20 
330. C:  Oh, you’ve got loads of time haven’t you? 
331. P:  No, it’ll, my time will go fast [clicked fingers] 
  (OI06, 20 year old, immediate pregnancy intentions) 
 
Judgements about the right time for pregnancy were not always the same as desires for 
children, resulting from the interplay between life events and an idealised future family 
life, as opposed to the reality of undertaking a pregnancy and having a baby. This point 
is exemplified by participant OI21; as she made reference to her feelings of missing 
out earlier on in life as a result of termination of pregnancy, following prenatal 
diagnosis of major congenital malformation when she was 16 years old (not 
illustrated). She reflected on her changing perspective about wanting a child; from her 
teenage experience to more recent consideration of artificial insemination while not in 
a relationship, through to the present day analysis of her desire for a child in the 
context of her current relationship. 
OI21:  … I always thought all I wanted was a baby or all I want to do is be a mum 
and have a big family… But now I have [a partner], it’s not something I 
really want, right now… But now I know I can, it’s not a big rush … I’m 
not ready yet to have a baby but, I’m just saying it because of my age, and 
I’m thinking if sort of looking at reducing it [the drug] now, in a couple of 
years I’ll be off it, and then I might be ready then, I’m just sort of planning 
ahead…  
Interviewer: So looking into the future 
OI21: I wasn’t picturing having a baby I was picturing having a child. Yes, or like 
teenagers… I think because my friends had their babies young, my friends 
got three teenage girls now, and I could, I’d be picturing that sort of life 
rather than a little baby   (35 year old, future pregnancy intentions) 
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The ability to time a future conception was described by women frequently in relation 
to the challenges in establishing effective contraception. Some women described the 
potential for AEDs to interfere with seizure control, while for others, the interaction 
between AEDs and hormonal contraception led to frustrations, as illustrated by a 33 
year old mother of a 6 year old child, and her perceived fight to locate an effective 
reversible contraceptive. Her desire to avoid sterilisation was an expression of concern 
for her perceived limited options to preserve her fertility.  
FG42:  Because like in later in life, in a couple of years, you might decide to have 
them. Because I never wanted children and then, we both didn’t want 
children. I never wanted another one until a few months ago, and then I 
thought, oh hang on, I might do. But you don’t know what’s around the 
corner.    
 
Clinicians were observed to recommend contraception to delay pregnancy until the 
‘right time’ was achieved such as completion of a treatment change. The following 
extract displays the typical guidance provided by clinicians in response to the questions 
about contraception:  
399. P:  … I was thinking about the pill, but I’m scared in case it 
400.  affects me epilepsy tablets, and I take a fit … 
  […] 
456. C:  Taking the pill, yes it would affect the epilepsy tablets, and it’s a 
457.  case then trying to adjust the tablet doses and things like that. But if 
458.  you are planning to fall pregnant, I suspect then the best thing to do 
459.  is use barrier methods things like either condoms, or just 
460.  barrier methods like that. Just so we can get the doses up and the 
461.  tablets right, but it is important for you not to fall pregnant when we 
462. are trying to get things right.   
 (OI06, 20 year old, immediate pregnancy intentions) 
 
Women revealed a struggle to cope with any delay in conception once the decision to 
start a family had been made, with a potential conflict emerging between the patient’s 
and clinician’s time-scale. For one 23 year old participant (OI03), her personal efforts 
to manage feelings of wanting a baby led to conflict with her partner’s intentions and 
her own desires, resulting in a two year trial without contraception and eventual 
pregnancy. Her earlier experience of pregnancy unfortunately resulted in a miscarriage 
which initially intensified her desire for a baby and subsequently led to a sense of 
urgency to conceive. On reflection, OI03 acknowledged her changing decisions 
concerning priorities in life, supporting a revised and perceived realistic timescale for 
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future pregnancy, with a recent change in focus to plan her wedding signalling relief 
from the pressure to conceive. 
OI03:  … now I’ve got my wedding on my mind I don’t mind waiting for kids but 
beforehand, when I had no plans for anything, it was like I want a baby and 
I want it now, my body was telling me I want a baby and it was like too 
much pressure on [partner]   
 
6.1.3 Influences on pregnancy decisions 
Decisions made by women to act on pregnancy desires were often influenced by 
changing circumstance and relationship status, and referred to as a joint venture 
between them and a partner. The importance of family support in pregnancy decisions 
was identified by the majority of women, and reflected their belief that pregnancy and 
future motherhood required additional support, implying recognition of the greater risk 
for things not going according to plan. In contrast, clinician’s advice on the staging of 
future conception drew attention to the development of a pregnancy plan:  
384.  C:  We’re not in a rush anyway because you are not/ immediately 
385.  P:                          /No, not yet, no  
386.  C:  for pregnancy so we can again have a further discussion 
 (OI07, 32 year old, future pregnancy intentions) 
 
For a small subset of women, epilepsy was used to explain a lack of confidence in 
becoming a mother, or a fear of losing seizure control leading to hesitation in taking 
action to pursue their desire for children. For one 30 year old woman, her earlier 
experience of a difficult to control epilepsy, her undertaking of epilepsy surgery, and 
outcome of near seizure freedom, had resulted in her concerns about a relapse to more 
significant seizures needing to be balanced against her husband’s desires for family: 
FG72:  I’d probably like a child in the future, at the moment, I’m on the pill […] 
But the only thing I’m frightened of is, because my fits are now controlled 
through the operation, and I still get the auras. I’m frightened if I get 
pregnant [laugh], that I might be back to square one, having fits again, 
that’s the only bit that’s quite off putting for myself. I don’t want to be, 
back in out of them seizures again, if possible […] I know my husband 
would love to have a child, but I’m not ready for one at the moment.    
 
Concerns regarding the potential risks associated with pregnancy were expressed in 
relation to a number of concerns including inheritance, fertility and future abilities to 
cope or bond with the desired baby. The latter point was exemplified by a 32 year old 
woman disclosing her earlier work to become seizure-free as requiring several 
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switches of AEDs and frequent hospital attendance until control had been achieved on 
lamotrigine 600mgs per day. Questions centred upon concerns about a seizure relapse 
and the potential for lamotrigine levels to drop in pregnancy, which had led to 
concerns about the possibility of resentment to a future child if these events occurred: 
145. P:  Because, I don’t know how I’d feel about, I just wonder how, I 
146.  don’t know how it feels to be pregnant but I just wonder how 
147.  attached I’ll be to the baby if, oh I couldn’t be, I don’t know [breath 
148.  exhalation sounds]  
149. C:  In what terms, are you thinking of the baby sort of when you are 
150.  actually pregnant 
151. P:  If, I’d, if, if having this child was making my life awful it makes me 
152.  worry that how would I feel about it, but probably a really silly 
153.  thing to think, but these are the kind of things you do think…  
  (OI22, 32 year old, immediate pregnancy intentions) 
 
For other women, the diagnosis of epilepsy in childhood had influenced their perceived 
future ability to become a mother and led to changes in their childhood ambitions for 
family, due to assumptions being made about the impossibility of pregnancy either 
with epilepsy or while taking AEDs. The influence of prior assumptions led some 
women to delay motherhood, leaving one 44 year old woman concerned about her age 
revealing regret at not providing her parents with grandchildren, reflecting that her 
fertility was coming to its end and her desire not to be the oldest parent at the school 
gate (FG-I-01). Age was seen to influence pregnancy decisions, emphasised by one 
participant recommending women with epilepsy consider having their pregnancy 
earlier in life. This participant revealed a preference for experiencing pregnancy within 
the age of “twenties to mid-thirties” which she associated as being “your best health 
wise” (FG21, 41 year old). In contrast, other women approached their thirties feeling 
tentative about future pregnancy and motherhood, and their opportunity to enter a 
suitable relationship or act on their desires; exemplified by a 29 year old participant 
stating “it’s something I would think about, just don’t know when” (OI05).  
 
6. 2 The experience of planning pregnancy 
Both women and clinicians were involved in making sense of and interpreting the life 
stage of pregnancy planning; and while the majority of women referred in ambivalent 
terms to planning for something to happen; for clinicians, ‘planning’ was more closely 
linked to definitions of preconception health care involving assessment, health 
education and interventions to improve epilepsy care.  
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6.2.1 What planning means to women with epilepsy 
There was a near consensus among the women as to what planning meant, with the 
majority simply describing planning pregnancy as intentionally wanting or trying to 
become pregnant. For example, one teenager saw pregnancy planning characterised by 
the US sitcom Friends (FG106):  
FG106: it really reminds me of Chandler and Monica off Friends, doesn’t it, like 
they are trying for a baby and stuff that’s what normally planning a 
pregnancy means.  (18 year old) 
 
Others defined the meaning of planning pregnancy as making the decision to have 
children and the majority of women included deliberation, suggesting planning 
involved thinking about what might be involved in preparing for pregnancy, as well as 
accessing information to support coping and caring for a future baby. For women who 
considered planning as a structured activity this involved getting to know everything 
that could happen including ‘the worst case scenario’. For these women, planning was 
a series of stages, and involved review of treatment and epilepsy stability. This was 
extended further by one teenager (FG103, 18 year old) who saw planning as being 
guided through the process, by talking about and doing everything advised to 
“minimise absolutely every single risk”. This point was illustrated by another 
participant as she retold her experience of termination of her second pregnancy 
following prenatal diagnosis of spina bifida (FG23). The 43 year old participant 
described her experience of planning her third pregnancy as involving getting her 
medication “sorted” and being taken off certain drugs to lessen the risk: 
FG23:  I think I had it planned more or less before I went with [neurologist] and he 
did this plan, and he said, we’ll take you off so much then, and we’ll 
withdraw you off them, and I was given a written plan of what to do, in a 
book. So, that was to me, was more sensible, and I had more. More comfort 
in the fact that. Well at least, I’m being sensible here. Before I go ahead 
with this pregnancy this time… 
  
FG23 emphasises two important defining features of pregnancy planning: the first, the 
potential to plan before commencing the formal process of planning with a clinician; 
and the second, requiring agreement between parties, the patient, her partner and 
clinician, with all parties committing to take action to complete the agreed plan. 
Commitment to planning also focused on women stabilizing their financial position 
and relationships, implying a need to be careful until planning was complete. 
Descriptions of planning also made reference to the benefit of planning as opposed to 
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reckless unplanned pregnancy, with a critique made by some women of an unplanned 
pregnancy as losing the opportunity to review AEDs, commence folic acid or establish 
a good diet. The evidence of FG23’s commitment to planning was exemplified by her 
commencement of preconception folic acid and adherence to the plan, both of which 
were described as providing reassurance that everything was being done, with the goal 
of improving the outcome of her next pregnancy:  
FG23:  And it was good, because [neurologist] said we’ll put you on a course of 
folic acid, keep taking folic acid right the way through … took me off the 
Epilim, weaned me off so much at a time so everything was sorted… I had 
to make sure I stuck rigidly to everything that was on this book… 
 
The outcome of her third planned pregnancy was referred to as having the sense of 
everything having gone according to plan, the visible proof of which was when her 
baby was born with his spine intact, all fingers and toes counted and with a “good 
birth” (FG23). 
 
The ability to plan ahead of a ‘planned pregnancy’ was identified by several 
participants to distinguish additional activities which lay outside of the formality of the 
clinician defined plan, and involved preparatory deliberations. For some this extended 
to more in-depth searches for information, and review of epilepsy management – 
getting the drugs sorted before starting to plan pregnancy. This defined the duration of 
planning as unique to WWE, in comparison with women without epilepsy. The 
significance of time was illustrative of commitment to “having planned everything” or 
the allocation of time such as committing “a year and a half, before I even tried to 
conceive” (FG86, 30 year old). In the case of FG-I-03, she defined planning in terms 
of the time required to achieve her desired objectives: 
FG-I-03: I think I’d definitely want to plan like every single, cover every single 
aspect I could of pregnancy, to make sure it all went right … I think I 
would probably plan 2 years ahead of when I wanted to get pregnant, when 
I wanted to start getting pregnant. (23 year old) 
 
Women focused upon the intentionality of planning, implying that to plan required 
preparatory activity; whether to simply withdraw contraception or, more of a 
challenge, to improve epilepsy management, illustrated by a 29 year old: 
OI09:  But I wanted a plan as in, in two years that is what I want, either one or two 
drugs, but something there that I know is working. With the pregnancy side 
as well [clinician] is thinking about the folic acid…  
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Within clinic, planning was frequently defined by clinicians in terms of a series of 
stages, making treatment changes to stabilise seizure control, before embarking into 
pregnancy:  
853. C:        […] first  
854.  basically we get the seizures better, second once the seizures are 
855.  better, we can plan for the pregnancy/  
  […] 
859. C: The fifth thing is the folic acid just in case, if in case you fall 
860.  pregnant, OK   (OI06; 20 year old, immediate pregnancy intentions) 
 
In the case of OI06, she defined her role in planning pregnancy in terms of “trying to 
become pregnant” once she had completed the switch of treatment (not shown). This 
view was supported by others, defining planning pregnancy as involving activities to 
improve seizure control and adherence to clinical advice as being “well on the way to 
planning” (OI07). To plan pregnancy for some women involved acting on health 
promotion activities such as commencing folic acid prior to decisions to start trying to 
conceive.  
OI08:  … it’s a process … isn’t it, so far as I’m concerned it would be a case of 
right okay, there’s engagement, marriage and there’s folic acid … 
  (27 year old, future pregnancy intention) 
 
The above participant exemplified a sub-group of women who defined planned 
pregnancy in terms of commencement of folic acid.  
  
6.2.2 Priorities in planning 
The main motivation for women to plan pregnancy was to reduce perceived risks by 
becoming healthy and thereby increasing the chances of a positive pregnancy outcome.  
FG74:  as a woman, you’re, you know you are this vessel, aren’t you. And you’re 
supposed to be as healthy as possible when you get pregnant (36 year old) 
 
Clinician priorities related to two main objectives, the first involving activities to 
improve epilepsy management, including attention to improving seizure control by 
review of AED selection. The second objective involved the delivery of information to 
support patient informed decision-making, and assist women in adhering to the clinical 
recommendations. Women interpreted medical interventions as implying the need to 
become seizure free before pregnancy could be considered; and to be taking the least 
number of AEDs, and ideally no treatment. For some, support from their clinician was 
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interpreted as providing assistance to structure a timetable for treatment change, 
allowing the charting of progress towards their goal. 
FG101: my medication is the big thing with this planning pregnancy it’s just the, it 
comes back to the medication all the time (18 year old) 
 
The setting of priorities in order to identify which activities required most attention 
within the planning process appeared inconsistent. Women frequently ranked talking 
to the doctor as the first planning activity to determine “what had to be done”, and to 
establish the main priorities for provision of information essential for decision-making 
in their approach and preparation for pregnancy:  
FG82:  the biggest thing is being properly counselled beforehand    (37 year old) 
 
Counselling was judged essential by women who anticipated increased anxiety 
surrounding their preparation for pregnancy; and who identified the benefits of 
“getting things into perspective” or dealing with “things” to relieve future worries in 
preparation for future pregnancy. 
 
6.2.3 The meaning of planning activities as preparation for pregnancy 
Women were able to identify pre-pregnancy preparatory activities. However, the 
majority did not locate these activities consistently within their definitions of a 
‘planned pregnancy’, suggesting a planned pregnancy was defined by making the 
decision to become pregnant. Table 6.1 illustrates the self-reported preparatory 
activities contributing to the experience of 12 women who were pregnant at the time of 
study participation.  
 
The majority of women highlighted the importance of getting their AEDs ‘sorted’ 
ahead of conception as preparation for future motherhood and essential for their ability 
to cope with and care for their children. The inclusion of improving seizure control as a 
preparatory activity was important, especially given the time required to complete this 
activity, a point illustrated by participants in their description of preparations for a 
future pregnancy. 
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FG81 28 0 24 ‘Planned’34 Introduced self as having planned pregnancy before 
discussing experience of epilepsy. Preconception epilepsy 
review, dose reduction, & folic acid. 
FG82 37 2 29 Unplanned 
“surprise” 
Planned second pregnancy following diagnosis of fetal 
valproate syndrome in 1
st
 child. No changes to AEDs 
between 2
nd
 and 3
rd
 pregnancy. 
FG84 23 0 20 Unplanned 
“big massive 
shock”. 
Pregnancy taking contraceptive pill (not taken protective 
measure during antibiotic use). Folic acid commenced at 17 
years, recommended as part of epilepsy review of risks 
associated with remaining on sodium valproate.  
FG85 23 0 29 Unplanned  
“unexpected” 
Pregnancy unexpected reported in relation to partner break-
up. Had discussed plans to try and conceive with partner. 
FG86 30 0 17 “Planned” 
stated during 
introductions.  
Epilepsy review with risks and benefits of remaining on low 
dose sodium valproate commenced folic acid and withdrew 
contraception before study participation. 
FG91 29 1 16 Not stated 
“not well 
planned” 
Withdrew contraception two years earlier. Experienced 
preconception review for 1
st
 pregnancy, reviewed risks and 
benefits and switched from sodium valproate to lamotrigine, 
remained on folic acid “just in case”. 
FG92 32 3 18 “Planned”35   Pregnancy discovery reported as a shock as it had taken 
longer than expected. Weight loss and stopped smoking 
before epilepsy diagnosis, delayed starting AED. 
FG93 27 0 12 Planned 
“shock” 
Started fertility treatment to stimulate ovulation as 
attempting to conceive >18m. Reduced smoking as part of 
fertility recommendations, preconception folic acid.  
FG95 25 0 11 “Definitely” 
unplanned 
pregnancy 
Pregnancy taking contraceptive pill, no preconception 
review, unaware of AED risks, not taking folic acid prior to 
current pregnancy. 
FG96 34 1 17 Not stated Spoke to GP before 1
st
 pregnancy, prior switch from sodium 
valproate to lamotrigine and withdrawal of AEDs before 1
st
 
pregnancy. 
FG124 32 1 8 “Planned” 
“worried”  
Preconception epilepsy review before 1
st
 pregnancy. 
Restarted folic acid 8 months before conception, modified 
diet and ‘healthy lifestyle’. 
OI20 30 0 5 Not stated  
“shocked 
discovery” 
Preconception epilepsy review, AED dose reduction and 
commencement of folic acid. Fertility assessment as 
attempting to conceive, withdrew contraception >12m ago. 
Believed infertile due to prior use of Epilim. 
Table 6.1 Pregnancy planning experience for women pregnant at time of study 
participation 
 
                                                 
34
FG81’s self-report of a ‘planned’ pregnancy may have influenced subsequent participant introductions.  
35
 Focus group 9 participants did not refer to pregnancy planning until prompted by the moderator in the 
latter stages of group discussion. This finding is in keeping with other researcher (Barrett and Wellings 
(2002)) (See Chapter 2 Literature review). The rate of planned pregnancy within this study based on 
participant self-reports is 42% and is similar to the reports of planned pregnancy reported by Fairgrieve 
et al (2000) and Pashley & O’Donoghue (2009).  
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The reality for one participant was that she had yet to achieve her planned objective of 
taking only one AED, implying future revision of her pregnancy plan or further 
attempts with alternate AEDs: 
FG55:  I’m planning. I’m planning two years in advance [laugh]; I’ve already 
started messing with my drugs, so you know that’s quite a long… I wanted 
to cut down to just one drug to reduce the risk. I couldn’t do it in the end, 
because as I reduced one of them, I started having fits again. But, that was 
one way I wanted to try and reduce the risks. I’m still on two [AEDs]… 
 (28 year old) 
 
Targeted clinical advice promoting the benefit of preparatory activities directed 
attention to the dangers of making abrupt changes to AEDs on discovery of an 
unplanned pregnancy. The following extract illustrates how the clinician responded to 
the patient’s hypothetical question regarding her requirement to stop treatment if she 
were to experience an unplanned pregnancy: 
376. P:    […] if in like the future. I mean I am definitely 
377.   not in the near future planning a baby. Because I haven’t 
378.   met anyone and I would need to be with them a few years 
379.   before I go there …     
   […] 
381.  P: If say like I found out I was couple of months pregnant but didn’t 
382.   realise, or something like that. Or as soon as I do find out I’m 
283.   pregnant, would I be best to literally stop or just cut straight 
284.   back {Well}the Valproate more than the Keppra 
285.   maybe, if I'm still on it, if that happens? 
386.  C:  Right, well usually we, as a rule of thumb, we do not make any 
387.   changes in pregnancy.  
  (OI04, 27 year old; future pregnancy intentions) 
 
An important component of preparatory activities defined by women related to being 
guided “in the right direction”, finding “a way around” perceived problems, and being 
able to “give that worry over” to whoever was helping plan the pregnancy. In a similar 
way, the provision of risk information was seen as “filling the gaps” in knowledge to 
support involvement in the planning process, while the opportunity to ask questions 
was also vital in supporting becoming “more prepared” for future pregnancy. The 
provision of information on topics such as pregnancy care and childcare was judged an 
essential preparatory resource to alleviate worry concerning abilities to cope with the 
demands of childcare, given the unpredictability of life with epilepsy. Reassurance was 
provided through the application of commonsense knowledge gained from preparatory 
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discussions with the epilepsy specialist on child safety topics – making the house safe, 
along with simple measures of risk avoidance such as not bathing the baby alone. 
 
Clinicians utilized the clinic visit as an opportunity to highlight preparatory activities 
for women to follow on their discovery of pregnancy, most commonly emphasising 
AED adherence during pregnancy, and informing of the potential requirement for 
future drug dose changes, such as the requirement for drug level monitoring and 
adjustment of dose during pregnancy. In a minority of observations, clinicians  
recommended early booking into antenatal care, and monitoring prenatal health by 
women making early contact with their midwife during pregnancy (the latter point 
made in a single clinic observation, participant case OI13).  
 
6.3 The breakdown of pregnancy planning  
Women described their ideas of what a planned pregnancy entailed and its influence 
upon their engagement in planning activities. For some, planning was influenced by 
past experience of pregnancy, with reference to the responsibilities involved, and the 
struggle to control fertility. Multiple factors influenced pregnancy planning, and for 
some this led to an eventual breakdown in planning.  
 
6.3.1 The influence of predetermined ideas on pregnancy planning 
One of the main barriers to planning pregnancy identified by the women was their 
perception of what planning involved, such as it not being natural, being hard work or 
an uphill mountain, an ordeal, awkward or regimented, and complicated so that they 
did not know where to start. Women used these statements often in defence of their 
experience of struggling to achieve a planned pregnancy, invoking worries about their 
plans not working out due to epilepsy related concerns such as poor memory and the 
need for additional support. The latter points are illustrated by the following 22 year 
old participant: 
FG57:  … if I was to plan to get pregnant, I think I would be focussing on all the 
bad things that could happen. And I’d just be trying to go about it ways 
where it wouldn’t affect me as much. That’s what, you just don’t know. I 
think, I don’t think I could possibly plan actually, because, I just wouldn’t 
know where to start. […] Like with my epilepsy, as well, it affects one part 
of my brain. Were I can’t, in day to day things like. I can’t, I’m not an 
organised person, I’m very forgetful. I can remember things like ten, fifteen 
minutes again. […] I’d need someone to come out of there way to, to help 
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me, and to guide me through it, I just wouldn’t be able to sit down on my 
own and plan. (22 year old) 
 
Women reflected on their frustration and longing for the ability to conceive 
“naturally”, with the ambivalent perspective of “if it happens, it happens”. In addition, 
frequent mention was made of the widespread lack of planned pregnancy in the 
general population, of women who were able to live each day as it comes, leaving 
pregnancy to chance and conception to nature, in contrast to the difficulties 
experienced by women with epilepsy struggling to live a planned life. 
OI23:  Do you know what I find a horrible thing like other people get pregnant and 
my friends “oh” unexpected, and then I was thinking well, it’s really awful, 
I feel I have had to be so regimented and to plan it. And often I think I 
probably would have, if it hadn’t been for the epilepsy, I probably would 
have fallen pregnant sooner. Because like I used to say to my friends, I 
don’t think it’s ever necessarily the right time to have a baby is it?           
  (30 year old, immediate pregnancy intentions)   
 
Clinicians also acknowledged failures to plan pregnancy as not being limited to WWE, 
but widespread across the general population. For example, one clinician noted: 
119. C:                     /Yes planning ahead. But not      
120.    everybody/  
121. Patient’s relative 1:     /Gets the opportunity to plan ahead do they 
122.   [laugh] 
123. C:   Most women, in fact most women don’t really plan that much  
124. Patient’s relative 1: No, no 
125. C:  But we like the planning aspect of it. 
  (OI08; 27 year old, future pregnancy intentions) 
 
The impact of the terminology used upon the potential breakdown in pregnancy 
planning was also apparent. Clinicians often used ‘planning’ referring to a series of 
interventions completed before conception. Women, in contrast, used the term 
‘planning’ as synonymous with trying to conceive, as illustrated by the partner of a 27 
year woman with immediate pregnancy intentions: 
Partner: We tend to say planning in the loose sense of the term you know, it’s like 
we say yes we want children and we’ll go through this. But it’s very loose, 
we’ve not said like by April…   (OI14) 
 
While the above quote implies this couple’s attempts to strive for a less regimented 
approach, there was nevertheless acknowledgement of a process of activities that 
needed to be worked through to finally achieve the planned pregnancy. Several women 
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made reference to their anticipation of engaging in preparatory activities ahead of a 
future pregnancy and motherhood, as illustrated by the following participant: 
OI01:  To be honest with you it’s just to do with giving myself the best chance, I 
think. Anything I can start doing, and start doing as earlier, I’ll start doing it 
really […] obviously you want your child to be fit and healthy and you’ll 
do everything you can to make sure that comes through…    
  (29 year old, future pregnancy intentions) 
 
However, despite OI01’s intention to give her future child the best chance, when 
questioned at interview about her intentions to quit smoking, she implied smoking 
would be the last thing she would give up – and that she would only do so within 
pregnancy, rather than prior to conception: 
OI01:  if I’ve got to do it [stop smoking], I will do it. And I would have to do it if I 
was pregnant, that would be something I’d be pretty hot on, I think, I’d be a 
nightmare to be around I reckon but I would do it… 
 
One 20 year old participant accepted the recommendations from her clinician to switch 
AEDs, her statements during interview implying agreement with the aim of improving 
seizure control in preparation for pregnancy (not illustrated). However, when asked her 
views regarding quitting smoking prior to conception, the participant suggested general 
health improvements as only requiring attention if she failed to conceive:  
OI06:  … if they said to me yes you can have children but at the moment you are 
not conceiving because you are smoking and you are not eating properly 
then I would change all that.  I would stop smoking and I would eat 
properly to make my baby, to try and get pregnant.  So that is what I would 
do, yes.  (Immediate pregnancy intentions) 
 
The lack of attention to preparatory activities, such as stopping smoking, reducing 
alcohol consumption, healthy eating, dieting and weight management, were significant 
especially within the observed consultations as the status of preparing for pregnancy 
defined the participants’ recruitment. From this group, weight loss had been mentioned 
by participants OI07 and OI18 as an intervention recommended by their GP and fertility 
specialist respectively, while participant OI13’s case was notable for the inclusion by 
the clinician of life style advice, including questions concerning smoking and diet. The 
following extract from this participant’s case illustrates the confusion between the 
terminology of ‘planning’ and the interpretation of preparatory health promotion 
activities. The clinician’s question was asked at the closing stages of the consultation to 
elicit any remaining issues requiring discussion. The patient’s reply illustrates the 
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failure to identify as components of her planned pregnancy her involvement in activities 
to improve seizure control and establish a healthy lifestyle: 
238. C:  Is there anything else you want to ask? 
239. P:  Not really the only thing I was wondering really was does it have 
240.  to be a planned pregnancy, with having epilepsy. What if 
241.  when  
242. C: Well, it is very important; well you have planned it really. So yes, 
243.  I mean, you need to know the risks in advance which are very 
244.  low, you need to be on the folic acid, you need to make sure that 
245.  you are healthy otherwise, which you are. So, I mean, you don’t 
246.  have to actually plan when you are going to conceive but, if you 
247.  are going to stop using the contraception after you get married, 
248.  then just wait and see what happens.  
249. P:  Right                  (OI13; 28 year old, future pregnancy intentions) 
 
Confusion surrounding the implementation of planning activities resulted in the 
following teenage participant’s comparison between the meaning of planned and 
unplanned pregnancy: 
FG45:  not unexpected I suppose.  Not sort of waking up and going oh I think I 
might be pregnant sort of a thing and sort of intentionally wanting a child 
sort of a thing and planning ahead for it as opposed to finding out you are 
pregnant and then planning sort of thing.  (19 year old)  
 
The above quote highlights a frequent error made by the women in defining planning 
as an activity which could also take place following the discovery of pregnancy.  
 
6.3.2 Control and management of fertility 
Fertility problems and the perception of a future struggle to conceive resulted in a sub-
group of women taking a more relaxed and ambivalent approach to pregnancy. This 
point was illustrated by several participants’ failure to use any contraception, and for 
those women using the combined oral contraceptive pill, failing to take the necessary 
action during illness or antibiotic use to prevent accidental pregnancy, defended by 
their belief that they were unable to conceive due to infertility: 
FG84:  I’ve been on the pill constantly and then I was on it was in the May, I was 
on antibiotics, and I just took my pill as normal and all that, and then 
obviously when, when they say you’re on antibiotics it can stop the pill 
working. But then I thought that’s not going to bother me, because I can’t 
get pregnant anyway. At that time, I was having a period every three 
months so it was, it was normal for me to have a late period and it was only 
collapsing in work […] I’d done a test, and my Mum was going just, and I 
was like Mum, I’m not pregnant, I can’t get pregnant, 
 (23 years old; 1
st
 pregnancy) 
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Women interpreted their bodies as unpredictable in response to the perceived 
interaction between epilepsy or AEDs and their reproductive cycle. In the case of OI03 
a 23 year old with future pregnancy intentions, she expressed frustrations in her ability 
to conceive when desired. She described her approach to a second pregnancy after an 
earlier experience of pregnancy resulting in miscarriage (not shown): 
OI03:  I assumed because it took so long last time, it could have been to do with 
the medication. So, because I was saying [to partner], well it took two years 
last time, maybe we should start trying now, because in two years time I 
will be wanting a baby and then I couldn’t have one. 
 
Fertility problems linked to the experience of menstrual disturbance were frequently 
attributed to polycystic ovaries, and a joint diagnosis in teenage years left some women 
uncertain of their current fertility status, despite the passage of time or changes to 
AEDs. The most commonly implicated AED ‘causing’ polycystic ovaries was sodium 
valproate. Women who had previously taken sodium valproate required additional 
work by the clinician to both reassure them that drug withdrawal would result in the 
return to full fertility and to suggest a lack of consensus between epilepsy specialists 
concerning the link between sodium valproate and polycystic ovaries. Other women 
perceived non-specific risks from epilepsy, questioning whether epilepsy per se could 
have influence upon the likelihood of experiencing fertility problems.  
OI06:  Yes because I have always wanted babies but with me I have always 
thought because people get pregnant quick I have always thought that there 
is something inside me that feels like I can’t have kids. 
 (20 year old, immediate pregnancy intentions) 
 
Age-specific fertility risks were included by clinicians in their advice concerning 
delaying conception, especially as women approached their late thirties. For one 
participant, the competing risks of conditions such as Down’s Syndrome were 
highlighted:  
63.  C:  As you get older the risk, the risk in pregnancy, 
64.  malformations in pregnancy increases in its own right,  
65. P:  Yes it does 
66. C:  Whether you have epilepsy, whether you’re on medication or  
67.  not 
68. P:  Yes I know       (OI21; 35 year old, future pregnancy intentions) 
 
Some women perceived their fertility as problematic, due to the difficulty achieving 
effective contraception, leaving them critical of achieving a planned pregnancy as an 
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unattainable luxury. One teenager identified her belief in being unable to prevent 
pregnancy despite utilizing available contraceptive methods as defence for her inability 
to plan a future pregnancy (FG102, 16 year old). In contrast, participant OI18, a 21 
year old young woman with immediate pregnancy intentions revealed her struggle to 
regain fertility following prior reliance on three methods of contraception: 
103.  P:  … they’re that up the wall my periods, it’s so hard to judge 
104.   what my cycle is/ 
105.  C:                     /Yes, and has that been since you came off your  
106.  contraception, they’ve/ been very erratic 
107. P:                   /All three forms of it, yes 
108. C:  Yes, right. I know because I noticed that you were using belt braces 
109.  and a few buttons as well/ weren’t you [laugh]?   
110. P:                   /Yes  (OI18) 
 
Participant OI18 reflected on her earlier choices of contraception method in the face of 
uncertainties over achieving her desired pregnancy:   
OI18:   […] I stopped taking the pill and the jab but they said just to be on the safe 
side with me weaning off topiramate, use condoms at the time because they 
said technically it is still in your system but it’s always best to be safe than 
sorry […] I said to my mum if I knew I would have this problem to try and 
have a family I wouldn’t have gone through all that precaution… 
 
Several women identified barriers to utilizing mainstream family planning clinics due 
to the limitations of health professional knowledge about the potential interactions 
between AEDs and hormonal contraception. A point made by one participant 
following receipt of new information concerning the ‘pill’ interactions with her current 
AED, leading the 24 year old to reflect upon her potential to have experienced 
accidental pregnancy: 
FG54:  I’m actually coming off a drug now, but apparently that drug interacts with 
the pill I’m on. So the pill and the prick36 don’t work. But I only found out 
about two weeks ago.  
 
The lack of confidence in contraceptive advice reinforced several women selecting less 
effective barrier methods including, for one woman, reliance on the unorthodox 
technique of the ‘withdrawal method’. The general lack of confidence in controlling 
fertility led this sub-group of women to discuss attempts to conceive as a test of their 
fertility, exemplified by one participant’s attempts to conceive despite her clinician 
advising delaying conception during an AED switchover (not illustrated):   
                                                 
36
 FG54’s use of the term ‘prick’ refers to the contraceptive Depo Provera, progesterone injection. 
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OI06:  …sometimes I do try for a baby but I’m not conceiving yet … 
 (20 year old, immediate pregnancy intentions)   
 
Women revealed distress when discussing the uncertainties of their fertility status and 
how this might influence their future ability to conceive, progress through pregnancy 
and deliver a future baby.  
OI23:  also there’s going to be the issue now of, am I going to fall pregnant […] 
it’s something that I’ve worried about since I was really little, would I or 
would I not be able to have a baby  
 (30 year old, immediate pregnancy intentions) 
 
Women dealt with questions concerning their plans for a family by hiding their failed 
attempts to conceive and making use of statements such as “not being bothered” with 
having a family, “not being ready”, or “not at the moment”. The perceived public 
awareness of their pregnancy intentions, such as “everyone knows”, was managed by 
one woman by pretending she “didn’t want” a baby, thus protecting herself from 
providing explanations about her perceived infertility (OI06).   
 
6.3.3 Responsibilities for pregnancy planning  
Women referred to their responsibility to plan pregnancy, requiring their commitment 
to return to see a specialist before conception, and to allocate sufficient time and take 
the required action on recommended interventions. Their responsibilities to recognise a 
right time to start discussing preparations for pregnancy were interpreted by women, in 
response to the clinician asking questions about their desires for family, as meaning 
they had reached an appropriate stage in their epilepsy control when pregnancy could 
be considered appropriate. This type of interpretation was illustrated by the following 
participant:  
OI08:  Because I mean if he didn’t think that I was at a level where I could 
perhaps think about it [pregnancy], then I don’t suppose it would come up 
in conversation really would it or that I would be eligible.                   
 (27 year old, future pregnancy intentions) 
 
For other women the importance of preventing an unplanned pregnancy was seen as 
avoiding the possibility of receiving punishment for failing to have taken adequate 
precautions in preventing a pregnancy: 
FG53:  I’ve been told if I was to find out that I was pregnant, I’d have to go and see 
my consultant straight away. Which makes me feel a like, I’ll have to go 
and get told off. And that I’d get in a lot of trouble. (23 year old) 
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Considering the activities involved in preparing for pregnancy as being hard work, 
resulted in some women perceiving their return for review as an obstacle to be 
endured: 
OI22:  I think it is responsible going to see [the clinician], I think it is, finding out 
[information]. Then actually braving yourself to go, but, that’s the 
responsibility I have. I don’t like going to hospital, I don’t like talking 
about all this, but I just have to. And if I don’t, and I just sort of risk it [get 
pregnant], it may have dire consequences so, I feel that is responsible…       
(32 year old, immediate pregnancy intentions) 
 
For other participants, their perceptions of what it meant to have epilepsy and the 
chance of their future child inheriting epilepsy required targeted preparatory activities 
focused on the potential for becoming a mother and child with epilepsy:  
FG101: I think epileptics have got to be more prepared than any other person to be 
honest. Because if they [the child] get it, you know what to do, because 
you've got it [epilepsy]. But if it, it can be a big problem to be honest and in 
the future like, because if you are not prepared …   (18 year old) 
 
6.3.4 The influence of past experience to improve pregnancy planning 
Receiving information concerning the potential risk of adverse events for the woman 
and her future offspring influenced some women’s experiences of planning pregnancy. 
For others, the experience of an earlier pregnancy with an adverse outcome caused 
worry and influenced future pregnancy decisions. The experience of OI17 exemplified 
the dilemma faced by such women, when discovering an accidental pregnancy exposed 
in utero to sodium valproate. The participant described her prior communication with 
clinicians and her awareness of the need to prepare for pregnancy, including her 
knowledge of the risks associated with in utero valproate exposure (not illustrated). 
Despite prior knowledge, OI17 described herself as being ill-prepared to progress with 
the pregnancy: 
OI17:  I think one of the things that does hurt me more than anything is I did make 
the decision to sort of like abort one child because I was worried about the 
fact that I hadn’t done the things that I was supposed to do, hadn’t planned 
it. The medics say plan it, take the folic acid but sometimes it just doesn’t 
happen like that.  But then I was seeing somebody that was saying well you 
have probably put your child at risk, well no I’ve not put the child at risk 
I’ve just been me, but it’s dead easy for people to say plan it, you can’t 
always plan it. (33 year old, future pregnancy intentions) 
 
The significance of unplanned pregnancy was interpreted by women with experience of 
delivering a baby affected by in utero AED exposure as a missed opportunity to manage 
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preparations for pregnancy, thereby failing to support pregnancy decisions. A 23 year 
old participant who was pregnant at the time of focus group participation (FG84), 
described her shocked discovery of an unplanned pregnancy secondary to her failure to 
maintain adequate contraception during antibiotic use (illustrated earlier in Section 
6.3.2, page 115). FG84 contributed further to the understanding of how “just in case” 
health promotion activities such as commencing folic acid may fail to influence future 
awareness of the importance of planned pregnancy.  
FG84: … when I was seventeen and I was thinking why is she giving me folic 
acid because I was seventeen then, and now I think, thank God […] if I 
decide to have another one, I’d like to prepare for it, go and speak to 
[clinician] and everything. Because with the, I got it all, I found out I was 
pregnant, and then it was like, you’ve got to get to hospital, and have a scan 
and find out exactly how far you’ve gone, because obviously because when 
the baby gets to the 90 days is it? Then it’s fully formed, so I got all the 
risks and everything after I’d been told I was pregnant. 
 
For a small minority of women the experience of an accidental or unplanned pregnancy 
had resulted in prenatal diagnosis of major congenital malformation and decision-
making concerning termination of pregnancy. These women made reference to the 
perceived missed opportunity to plan pregnancy either through a prior lack of 
awareness of the importance of preparation for pregnancy or information deficits 
concerning the risks associated with in utero AED exposure.  
 
In contrast, for one participant, her experience of miscarriage resulted in her reflecting 
upon a missed opportunity to have stopped smoking and to have avoided drinking 
alcohol prior to conception: 
OI02:  I think that’s why I lost my other baby, through drinking and smoking. 
Well I feel like it was, it’s stupid there’s no other explanation, why it died. 
But like, the night before I found out, I did have a little drink with my 
mates and then I found out that I’d lost it […] it has like crossed my mind, 
whether because I’ve got epilepsy, why I lost it,          
  (22 year old, future pregnancy intentions) 
 
This woman interpreted her experience of miscarriage by constructing an explanatory 
link to her behaviours of smoking and consuming alcohol, and in doing so excluded any 
potential causal link to her epilepsy or its treatment. During the observed clinic visit 
OI02 presented her first unplanned pregnancy occurring while she was taking sodium 
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valproate, a point clarified by the clinician who questioned whether OI02 had concerns 
surrounding future preparation for pregnancy: 
183.  P:  […] Well I have had a miscarriage … 
  […] 
186.  C:  Was that an unplanned pregnancy? 
187.  P:  Yes it was unplanned. 
188.  C:  Do you know how far on you where when you miscarried? 
189. P:  Two and half months.   
190.  C:  And presumably at that point, were you on Epilim then? 
191.  P:  Yes 
  […] 
196.  C:       […] have you got any concerns 
197.  about becoming pregnant, having epilepsy and your treatment is  
198.   there anything that’s especially worrying you? 
199.  P:  Not really is there 
200.  Partner: Just what they told us about the tablets, and about each  
201.  tablet to go moving them, have you? 
202. P:  [Clinician] had mentioned to me about my medication. 
203. C:  How do you feel about that? 
204. P:  Well at first I was not happy about it because I am happy with the 
205.  medication that I am on now. But obviously if I've got to change  
206.  then I’m going to have to aren't I, so. 
     (22 year old, future pregnancy intentions) 
 
The failure to associate the earlier experience of miscarriage to AED-related risk 
resulted in reinforcing OI02’s resistance to changing her AED and her preference for 
the status quo as opposed to the opportunity for an alternative future pregnancy 
outcome taking an alternative AED.   
 
The process of preconception counselling for some women is complex, involving 
treatment review and careful monitoring of seizure management, leading up to the 
patient’s attempts to conceive and, finally, support through the planned pregnancy. For 
other women the process of preparation is more straightforward with preconception 
review signalling the go-ahead of attempts to conceive. The significance of women 
receiving preconception information and epilepsy review was the opportunity to 
improve the outcome of pregnancy if the information was acted on prior to conception. 
Some women reflected on information deficits at a stage in their lives when they where 
trying to conceive, as illustrated by the following quote from a 34 year old woman who 
has had two children both affected by in utero exposure to sodium valproate:   
FG125: I fell pregnant accidentally with the kids I didn’t plan it, I was 21 with my 
son so I did no planning involved in it, and I did tell the hospital and stuff 
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like that, and I was told it was okay to take my medication. And then the 
same with my daughter, and it was only after my daughter then all, I 
discovered all the problems that the Epilim had caused in my kids.  So from 
then, that’s when I decided I’ll not have anymore.  
 
The majority of women accepted the opportunistic delivery of preconception and health 
promotion information, whether concerning contraception, folic acid status or focused 
information concerning the risks associated with in utero AED exposure and/or seizure 
related risks. The timely delivery of information was most frequently highlighted as an 
important component of any preconception review, whether pregnancy was imminent 
or not: 
FG-I-02: But I think the Consultant has that ability to just say, have you, are you, 
thinking about this now or shall we revisit this another time in another 
appointment. And then he can write that on the notes, you know, not 
wanting to consider family at this time, (36 year old) 
 
The above participant had, in fact, struggled with her experience of opportunistic 
delivery of preconception information, and while her opinion was not shared with the 
majority, a sub-group of women had struggled either with risk information increasing 
anxiety and worries or the mistiming of information (these issues are discussed further 
in Chapter 7). 
 
6.4 Summary Results: Pregnancy planning 
 Preparing for a planned pregnancy requires actions from both the patient and 
clinician in preparation for the future event of conception. The process requires 
review of patient-perceived anxieties, worries and fears which have been shown to 
influence women’s engagement in pregnancy planning activities.  
 ‘Planning’ as a descriptive term, relates to a woman giving forethought to the way 
she might achieve her desired future pregnancy outcome, and in this sense the 
activities of pregnancy planning were deliberative, rather than a set of observable 
behaviours.  
 The most significant finding from the analysis was the inconsistent use of the term 
‘planning’ both by women and their clinicians. Women frequently defined 
planning as the intention to conceive, implying that activities to improve epilepsy 
management were something that occurred prior to the formality of ‘planning’ with 
their clinician.  
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 For women who defined planning as involving more complex activities this 
required commitment to following the ‘plan’ and acceptance of delays in 
conception. Improving preconception health was acknowledged as improving their 
future pregnancy outcome. However, many of these women also reported longings 
for a more natural approach to achieving pregnancy, which could act as a potential 
barrier to adherence to preconception activities.  
 The influence of significant others upon the experience of women preparing for 
pregnancy, factors around timing preparatory activities, and the experience of 
difficulties in establishing reliable contraception all contributed to the potential 
breakdown in pregnancy planning.  
 Women had competing interests and worries concerning their ability to conceive 
and their fertility status, both combining to influence the use of contraception and 
the approach by women to avoid conception when advised by their clinician.  
 The influence of past pregnancy experiences, including the experience of 
miscarriage, pregnancy termination or abortion, had a significant impact upon 
how women approached future pregnancy, including the likelihood of engaging in 
preconception interventions ahead of a future pregnancy. 
 
The following chapter will focus upon the communication of risk and uncertainty. 
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Chapter 7 Communicating risk and uncertainty 
Introduction 
‘Communicating risk and uncertainty’ describes the perceptions of epilepsy and 
pregnancy related risks held by WWE, and their experiences interacting with their 
clinician. This theme is illustrated by three interconnected sub-themes which have 
been used to structure the presentation of findings: 
1. The presentation of information on risk and uncertainty – outlines the 
experience of being provided with information concerning the potential 
occurrence of adverse pregnancy outcomes.   
2. Focus on the health of the unborn child prior to conception – describes the 
perception of risks concerning the future health of the unborn baby following 
in utero exposure to antiepileptic drugs and seizures, and 
3. Risk management – illustrates the strategies used by women and clinicians to 
reduce, avoid, prevent and manage future pregnancy related risks.   
 
7.1 The presentation of information on risk and uncertainty  
The communication of risk information within the epilepsy clinic served to help 
women make sense of their prior perceptions of potential adverse pregnancy outcomes, 
and manage their fears of the uncertain outcome of pregnancy. Women anticipated the 
communication of risk concerning adverse pregnancy outcomes, and the recall of 
statistics had influence on how women perceived risk management.   
FG74:  I was given statistics of something like 14%, possible risk with that 
[Epilim], and then two other drugs greatly reduced in the risks. 14% 
seemed like quite a lot to me, and then I think one of them was mentioned, 
7%, and then Tegretol Retard was two, and that kind of figure, compared to 
fourteen, sticks in your mind.  (36 years old) 
 
Narrative descriptions of risk were used to illustrate specific malformations and 
present the uncertain risks associated with newer AEDs or the long-term risks of 
neurodevelopmental delay. 
 
7.1.1 Presentation of risk 
Within the epilepsy clinic, risk information was presented as estimations of the 
potential risk of an adverse pregnancy outcome. Data from the UK Epilepsy and 
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Pregnancy Register was quoted to support numeric comparison of the risks between 
established AEDs and the associated drug-specific MCM risks. These strategies are 
exemplified by the clinician’s presentation of risks to a 22 year old participant who 
attended clinic with her fiancé: 
273. C:           […] right now, just say you wanted to start 
274.   trying for a child and you kept your dose, you stayed on Epilim.  
275.  On a dose of 1500mgs a day […] your  
276.  risk would be higher than 9% chance of having a child with a major  
277.  malformation, OK […] in comparison with for instance  
278.  lamotrigine on a lower dose under 200 mg a day, the risk would be  
279.  around about 3% so there is quite a difference really […] the  
280.  other thing about Epilim is, we are talking about major  
281.  malformations such as spina bifida, you might of heard of that,  
282.  problems with the growth of bones, cleft palate, heart defects these  
283. are what we call major malformations …  
 (OI02; 22 year old, future pregnancy intentions) 
 
The clinician utilized percentage estimations of the size of risk and the naming of 
specific malformations as strategies to reinforce or frame the objective nature of risks 
to the unborn baby, positioning Epilim (sodium valproate) as more risky than the 
proposed alternative, lamotrigine. The quantification of drug risk supports the 
opportunity to reduce risk by lowering drug dose (discussed further in Section 7.3 Risk 
Management). 
328. C:  […] If you’re on a lower dose of Epilim then that risk falls.  
329.  And if you were on less than 1000mgs your risk would in the region 
330.  of, just over 5% chance. So being on a reduced dose does  
331  reduce the risk…    (OI02)              
 
When proposing AED changes, the clinician included warnings against accidental 
pregnancy resulting in additional fetal drug exposure (two AEDs during the switch-
over compared to one AED before and after the switch-over). In the case of OI02, the 
importance of preventing pregnancy while making changes was highlighted through 
provision of the evidence of increased risk:  
337. C:                             […] What we do know is the combination of  
338.  Epilim if it is with other treatments the risks then become really  
339.  very high indeed. It would be past 10% upwards if you fell  
340.  pregnant on Epilim and lamotrigine together.  
 
From the perspective of the clinician, the purpose of presenting risk information was to 
support consideration of what was involved in the proposed treatment changes, such as 
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the risk of developing a hypersensitivity reaction to the proposed new drug, 
lamotrigine.  
598.  C:                                             […] there is also a risk of a rash, a risk  
599.  of an allergic reaction. It can happen in something between 3 to 5% 
600.  of people.       (OI02; 22 year old, future pregnancy intentions) 
 
The presentation of patient-specific risk information concerning adverse reactions to 
AEDs was variable, and extended to include the drug-specific risks such as liver 
failure and death (OI07). The risks of seizures were common examples of patient-
specific risk information, utilized to communicate seizure relapse risk for patients 
having entered remission while taking AEDs, and to communicate the potential risks 
of seizures during pregnancy and delivery. Epidemiological data from the Medical 
Research Council (MRC) Antiepileptic Drug Withdrawal Study (Chadwick et al., 
1996; Anonymous, 1993b) was quoted to support numeric comparison of the seizure 
relapse risks between alternative treatment strategies, remaining on AEDs, or gradual 
AED withdrawal. Seizure relapse risk information assisted OI23 consider the 
opportunity to withdraw her treatment following an 8 year remission from seizures:   
404. C:    […] a big study has shown that the risk of seizure 
405.  recurrence is very high like between 20 and 40% or something  
406.  like that 
407. P:  Yes  
  […] 
410. C:      […] But there is, there was a fairly high 
411.  risk and because of that, people say maybe we should give  
412.  people a five year course, but there are no rules written in tablets of 
413.  stone.   
414. P:  Right  
415. C:  The risks are probably lower now, than at five years 
   (OI23; 30 year old, immediate pregnancy plans) 
 
The risks of seizures in pregnancy were discussed in 20 out of the 23 observed 
consultations. Clinician’s presented warnings against stopping AEDs as a cause of 
status epilepticus or death and the likelihood of worsening seizures in approximately a 
third of women. This approach is illustrated by the following two participant cases:  
1.   390.  C:  don’t make any changes, don’t suddenly stop taking your 
391.  medication, because if you suddenly did that, you could go on and 
392.  go into status epilepticus which is continual tonic-clonic seizures 
393.  and that is extremely dangerous. You know people have been 
394.  known to die through status  
  (OI04, 27 year old, future pregnancy intentions) 
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2.   173.  C:  we particularly don’t want you having convulsions …  
  […] 
176.  tonic-clonic seizures it can increase the risk of having a miscarriage 
  (OI18, 21 year old, immediate pregnancy intentions) 
 
The value of presenting risk information was to highlight alternative and unexpected 
future outcomes. For example, the unpredictable course of pregnancy where things 
could go wrong for both mother and baby was a perspective several women preferred - 
knowing the ‘worst case’ scenario. From the perspective of the clinician, the purpose 
of presenting risk information was to advise and support informed patient decision-
making to fulfil their ethical duty of care. The presentations of risk information 
supported women to consider the differing outcomes from decisions made, and the 
potential for seizure relapse was an unwanted outcome for many women, and required 
alternative treatment options to be consider. The utility of risk information to clarify 
the choices available was exemplified by participant OI20 as she considered her 
options which include: remaining on the current AED with proven effectiveness (7-8 
year seizure remission), weighted against a “5% chance of any physical 
malformations”; or, switching to an alternative AED:    
386.  C:  … if you are switching over from one treatment to another,  
387.  you know it can destabilize your condition, and  
388.  you could go on to having seizures. 
  […] 
390.  C:  […] you might start a different medication, and you feel 
391.  well on it, and have the same control, and it have a slightly, 
392.  say have the 2%, risk of the physical abnormalities 
393.  but, you might still have, you might go on to have 
394.  seizures, we don’t know. 
(OI22; 32 year old, immediate plans for pregnancy) 
 
7.1.2 Response to risk information 
Women interpreted risk information mainly as helpful and informative, in line with 
perceptions of the clinician’s duty of care. There were exceptions, and for one 
participant (OI06) the purpose was interpreted to scare and deter her pregnancy plans: 
229.  P:  They said because like with the tablets the baby could become 
230.  disabled so I was a bit scared about that, 
  […] 
239.  P:                 […] that’s what my doctor [GP] said I  
240.  don’t know if she was trying to scare me… 
  […] 
247. C:  […] you are taking these tablets, which would put the unborn 
248.  child at risk of having problems. But the risk is about 4%, that we 
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249.  say, in terms of pregnancies. And some women would then 
250.  say oh then would I need to take the tablets. But in 
251.  someone like yourself you are having lots of fits. We, there is  
252.  a risk to the unborn child if you’re having fits that its not /controlled 
253. P:                  /But if I 
254.  had a baby like about me, could I die or something? 
255. C:  Usually when patients have epilepsy and if it is controlled, a  
256.  lot of women with epilepsy have children with no problems and  
257.  they go through their pregnancy and the delivery with no problems.  
  (OI06; 20 year old, immediate pregnancy intentions)  
 
The above quote highlights the important relationship between using risk information 
to inform and its use to direct the patient’s attention to their role in adhering to 
treatment recommendations (lines 249-51). By challenging the patient’s fears about the 
risk information provided by her GP, the clinician focuses attention on the opportunity 
for the patient to reduce the risks to herself and her future baby. The importance of 
seizure control and the role of AEDs in achieving it are highlighted, rather than simply 
focusing on the drug-related risk. This supports warnings to the patient considering 
stopping her tablets, and allows the patient to re-consider her own prior judgements of 
pregnancy risk. The clinician adopts the role of advisor, focusing the patient’s attention 
on her continued need for treatment, the inevitable risk she faces from frequent 
seizures and, at the same time, offering the outcome of healthy children when seizure 
control has been achieved. OI06 reflected upon the receipt of risk information 
comparing the ‘high risk’ she understood from her GP’s message and the optimistic 
‘lower’ risk as reassuring:  
OI06:  With the 4% it made me feel a little bit better because it’s not really, to me 
that's not a high risk, that’s like, kind of a low risk…but the way the (GP) 
was speaking, it to me, she just said oh it’s a high risk and like it made me 
feel like she was putting me off… 
 
Preconception risk information was judged by some women as focusing their attention 
upon future pregnancy, projecting worry concerning the outcome of pregnancy, 
illustrated by the following extracts: 
OI22:  I don’t think I will enjoy being pregnant […] I really don’t think I will, I 
think I’ll just, be wanting it to end… 
 (32 year old, immediate pregnancy intentions) 
 
Partner: …We’ve spoke about it a hell of a lot really because we want, the first is 
find out how bad it is, because I’d rather she’d be healthy than have 
something happen wrong, you know instead of having two, have nothing…  
(OI14; 27 year old, immediate pregnancy intentions) 
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Questions raised during preparation for pregnancy revealed the extent of worry 
concerning the risk of seizures at the time of delivery as an added source of anxiety. 
From the patient perspective, there was a need for reassurance regarding the risks of 
uncontrolled seizures. This was managed by a minority of clinicians playing down the 
chance of seizures influencing pregnancy outcome, and emphasising the risks as only 
becoming significant if the woman required admission into an intensive care unit. For 
many women, this type of reassurance was counter-intuitive, illustrated by the 
following 39 year old participant reflecting on her experience of seizures in pregnancy 
and her concern for her unborn baby: 
FG123: I started fitting … and then I was coming round and just wanted to curl up 
and die … I felt so awful yet the fear set in and this little baby inside me is 
it going survive, am I killing this baby off.  I couldn’t control it and I just 
didn’t know what was going on. I was in and out, in and out and then as I 
say she arrived and I had this little girl and I couldn’t believe it   
 
For one participant (OI23), the potential for worsening seizures during pregnancy 
raised additional concerns. The clinician (who had neurology training) played down 
the risks associated by maternal anxiety upon pregnancy outcome – although obstetric 
opinion is sometimes in opposition to this view:  
596. Partner: … from my perspective, it was if you’re going to have a 
597.  baby it needs to be worry free, and if you’re going to worry more 
598.  doing, going one path, that’s probably going to have a greater effect 
599.  on how the pregnancy goes, I would have, from my point of view, 
600.  but 
601. C:  Yes, well if, you would still be fine  
602. P:  Yes  
603. C:  Even if you worry a little bit, your baby will still be fine (OI23) 
 
OI23:  … how I feel now is I’m worried about having the seizures in pregnancy, 
but I suppose the reason I am getting upset and crying, is because I’m 
scared of the actual seizure itself.   (30 years, immediate pregnancy plans) 
 
Clinicians addressed these concerns by reinforcing the importance of optimising 
epilepsy management prior to pregnancy, and recommendations for booking early into 
obstetric care on discovery of pregnancy.  
 
Describing a future child, as ‘being at high risk’ either due to seizures or in utero AED 
exposure, required women to compare their desires for pregnancy against the needs of 
the unborn child. Blame was the most commonly expressed emotion identified by 
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women across the entire study population, while for some this emotion was interpreted 
as selfishness (see also, Chapter 9, section 9.2 The Selfish Decision), as illustrated by 
the following participant: 
OI08:   […] I suppose some people would say that I was selfish, if I knew there 
was a 10% possibility of a child being disabled. Because I still want to have 
a baby, then perhaps I shouldn’t do it? But, why shouldn’t I, there’s people 
taking heroin and they’re still doing it.  
  (27 year old, future pregnancy intentions) 
 
The presentation of risk information in percentage terms was objected to by a small 
group of women as failing to support their informed decision-making, which required 
more detailed narrative description. From this group, one participant who had 
experience of delivering two children affected by in utero exposure to sodium 
valproate, expressed her response to being presented with the percentage chance that 
something could happen if she were to consider further pregnancy: 
FG21:  […] but the thing is, if you’re that one percent you know it’s hard. If you’re 
that one person,      (41year old) 
 
The perceived risk could be zero if reviewed retrospectively when the outcome of 
pregnancy is known, whereas if the adverse event occurred you would reflect that your 
risk had been 100%. Avoiding a focus upon numeric risk was managed by some 
women by reliance on luck. Illustrated by the following participant as taking the 
chance that the desired healthy outcome of her pregnancy would occur: 
FG121: […] I suppose I was just a bit naive in thinking that everything would be 
okay… we both decided to just sort of take the chance and see what 
happens.  Luckily you know she is fine now… I’ve not been too bad 
through the pregnancy, so it is something that we maybe looking to do 
again some time in the future. So I do think I am fairly lucky as in how, 
how it affected my pregnancy ...  (32 year old) 
 
Reference to luck, in terms of relief that a potential risky outcome did not occur, 
implied a perceived lack of influence upon the management of risk. It also detracted 
from the work of the clinician in supporting pregnancy planning and future decision-
making, implying the participant’s good outcome was the result of fate. 
 
7.1.3 Presentation of uncertainty 
The context of uncertainties surrounding the newer AEDs required women to make 
decisions concerning treatment recommendations based on limited or no knowledge of 
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the teratogenic risks. Two main sources of uncertainty were discussed by women, 
relating to: the uncertainty of AED effectiveness; and the uncertainties in predicting 
pregnancy risk as a consequence of in utero exposure to AEDs and/or seizures. The 
following participant exemplifies the former concept, as she describes her approach to 
locating evidence as part of her preparations for pregnancy:  
FG57:  There’s no one in this world that actually knows the answers to everything 
about epilepsy. There are still people researching it, studying it. We will 
never know I don’t think. All we can do is just trial and error with 
medication. (22 year old)  
 
During consultation, discussions of pregnancy risk often highlighted ongoing research 
emphasising the delays associated with gathering information on adverse events, a 
point emphasised by one clinician: 
127. C: We don’t really know, because the drugs are relatively new and 
128.  there are not many women who have been exposed to these drugs 
129.  during pregnancy, because they are relatively new. 
  […] 
180.  C:  … it takes decades to find out properly… (OI12; 30 year old).  
 
The lack of research to provide meaningful evidence to direct epilepsy management 
was illustrated by the following clinician: 
296. C:                […] we haven’t actually carried  
297.  out a study where we are looking specifically at the dose. But we do 
298.  have this gut feeling, or this, I think we feel that it’s dose dependant. 
   (OI07; 32 year old) 
 
The nature of medical research was also called into question, both in relation to the 
length of time required to detect rare adverse events, and the ethical limitations on the 
type of research designs possible:   
956.  C:  […] we can’t really do randomised controlled trials  
957.  in humans in this subject. And also we need a long time to  
958. follow the children   (OI23; 30 year old) 
 
The clinician extrapolates the limited evidence on newer AEDs such as levetiracetam 
(Keppra): 
265.  C:    […] Keppra we don’t know so much about in animal 
266.  studies; we know that it doesn’t cause problems in the babies of rats 
267.  and mice, but that does not necessarily mean that it’s going to be a 
268. safe drug in adults.   (OI02; 22 year old) 
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Utilizing the UK Epilepsy and Pregnancy Register as a source of reference the 
clinician extends the account of uncertainty in human testing, and the ever-changing 
numbers of in utero AED exposures. The clinician provides reassurance about drug 
safety (by making reference to the human children born to mothers) resulting in the 
presentation of a kind of ‘pseudo-certainty’ (lines 173 & 180-1), which is used to 
defend the lack of certainty that problems could still occur: 
149. C:  […] And the difficulty we’ve got is these other tablets, these newer  
150.   tablets. We don’t really know for certain where they lie between the 
151.   tablets that might be very safe and the tablets that are very 
152.   dangerous. But, what we know so far is that the Keppra tablet seems  
153.   to be a pretty safe one. 
154.  P:   Right  
    […] 
168.  C:            …These numbers are always changing,  
169.   but I think there’s about a hundred women so far, who have children  
170.   only taking Keppra, […] 
   […] 
173.  C:  … And so far, none of them, have had any problems… 
    […] 
180.  C:           … it seems to be as far we can tell, a reasonably  
181.   safe drug, we can’t give you a hundred per cent guarantee… 
   (OI13; 28 year old) 
 
The difficulty applying population data to predict individual patient risks emphasizes 
the uncertain outcome of changing treatments: 
112:  C:          […] we could reduce topiramate a bit and 
113.  see what happens. Or put you on an entirely new drug which is 
114.  something we wouldn’t do in pregnancy, but you could try and do it 
115.  now, but, then it is totally unknown territory, you have never used 
116.  anything other than these two drugs before, and we don’t 
117.  know if your seizures would be worse or better.  
  (OI14; 27 year old)  
 
The following extract illustrates the uncertainty when extrapolating individual patient 
risks from epidemiological modelling from trial data on the risk of seizure relapse:  
215.  C:       […] What’s more difficult to  
216.  predict is whether you fit into that 20% who maybe have an  
217.  increased risk or not. The fact that you haven’t had any seizures  
218.  after being on medication, is a potentially good sign, it’s  
219.  obviously been easy to control and so it’s well controlled.   
220.  But again, nobody could guarantee that you wouldn’t have a seizure, 
   OI15 (NP, 33 year old) 
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A further example of uncertainty was raised by women questioning the potential to 
‘pass on’ epilepsy. The risk of a child inheriting epilepsy was a subject of discussion 
for 40 participants, and women raised questions in seven of the observed consultations. 
The inheritance risk was presented as complex and dependent on a number of factors 
including, whether one or both parents had epilepsy and the type of epilepsy. Risks 
were presented by clinicians as uncertain and therefore an unquantifiable risk. 
However, one woman constructed her personal risk: 
FG122: It is a risk that people take, isn’t it.  Fifty percent of one parent is epileptic 
and more so if you have got two parents that are epileptic that the child will 
be… that’s just like a risk, you know a risk factor that they could be  
 (43 year old, two children) 
  
In the case of participant OI20, she reflected on earlier meetings with clinicians where 
the provision of information about the life-time prevalence of epilepsy provided 
reassurance: 
OI20:  I was talking to the [clinician] and she said everybody has got a 5% chance 
of getting epilepsy, so I really wouldn’t worry about it. Because I was 
thinking, oh is my baby going to be born with what I’ve got and she said 
don’t worry, she said everybody has their risks, so don’t be panicking about 
this, that and the other, and I was thinking when you put it like that it 
makes sense though doesn’t it? (30 year old) 
 
The above quote emphasises the search for meaningful risk information – which this 
patient felt enabled her to interpret the risk as small, and manage her personal worries 
concerning her future child’s genetic inheritance. Similarly, in the case of FG122, 
although she had calculated a higher personal inheritance risk, she also drew comfort 
on the probability that it might not occur suggesting her estimate represented “a risk 
factor” rather than statement of fact. In contrast, OI13 expressed worries about her 
ability to cope in response to the clinician emphasising the concept of genetic 
endowment, implicating the patient as the sole contributor to the risk of her child 
inheriting epilepsy: 
49.  C:  So, and so there is nobody else in the family with epilepsy?  
50.  P:  No  
51.  C:  And your husband to be does he have epilepsy? 
52.  P:  No  
53.  C:  So it’s just really you, isn’t it? 
   […] 
254. C:   There might be a slightly increased risk of the baby having epilepsy, 
255.   but you’ve gone through life pretty well without, with 
256.   the seizures, and it’s not a reason obviously not to have a baby, and 
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257.   the risks are pretty small, if there is only one of the parents has 
258.   epilepsy.  (OI13)      
 
OI13:  Because there’s nobody else in my family at all, that’s got it. So I mean 
mine must have just been a fluke kind of thing. But that was one of the 
things when I first started [planning pregnancy]…if there is a child that I 
will need to give care to, I would just panic … would I be able to give that 
care or would it affect my health as well kind of thing. 
  (OI13; 28 year old, future pregnancy intentions) 
 
Women interpreted uncertainties on the part of their clinician as frustrating, 
highlighting the unpredictable nature of their condition and its management. For 
individual women, clinicians’ reliance on gut feelings to direct decision-making 
emphasised the degree of uncertainty, while for other women, interactions with their 
clinician left them feeling they had no certainties in life, since the clinician was unable 
to provide the necessary precision, exemplified by the following participant:  
OI20:  no one has given me a percentage yet … they haven’t got enough 
information to say it could cause this, this, this, so how do I know? 
 […] 
OI20:  it just makes me feel like a bad mother …you are just pumping your body 
full of drugs, which no one can give you a clear answer what its doing. 
  (30 year old, pregnant at time of interview) 
 
The uncertainty surrounding the long-term effects of in utero AED exposure on infant 
neurodevelopment was also a source of anxiety, sufficient to influence the acceptance 
of drug withdrawal in preparation for pregnancy. The following participant illustrates 
an extreme response to the unfolding picture of limited information, in which she 
considered an uncertain future with potential for “repercussions” such as the discovery 
of the risk of “learning difficulties” leading to make comparisons with thalidomide: 
OI10:  … you start thinking oh, and all these things go into your mind and 
spinning round a bit, and you think oh, do people know enough about these 
drugs because obviously they didn’t about that [Thalidomide]. … When I 
went to see [clinician] and he said about the learning difficulties. I thought 
ooh… because last year no one knew about that, and then suddenly this 
year and then you think, in another years time will they be finding more 
things … you start worrying about all these things that start stacking up a 
bit, don’t you, and all these possible that don’t show their face now, but in 
years to come … they could say oh well see all these problems it’s because 
of that.   (30 year old) 
 
The experience of OI10 illustrates an important aspect of clinic communication; where 
the content of risk information is mainly selected by clinician’s. For some women, the 
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later discovery of information concerning risks or the extent of uncertainty had 
influence on their reflections both on their earlier informed decision-making and their 
doctor-patient relationship, as illustrated by the following discussion of two pregnant 
women:  
FG82:  I was really annoyed, because my neurologist, […] I changed medications 
for my second baby, an he was saying oh, this it’s superb, it’s great, an, I’m 
sure it is. But then, when I had my 20 week scan, the lady said, “oh, it’s 
only been out for 7 years”, and for me, that was a step back, because I 
thought, hang-on a minute, like, he’s pretty confident in it {Yes} but 7 
years isn’t a long time {No} To tell if there’s cognitive, you know it’s not a 
long time, {Yes} an even then, I kind of felt, I’ve been?  
FG83:  Tricked? 
FG82:  Because, number one I felt I hadn’t been told everything, until I met 
[epilepsy nurse specialist] [laugh] and that was really annoying. Because I 
just, you need to know. (FG82, 37 year old; FG83, 34 year old) 
 
7.1.4 Stories of risk from practice 
The usefulness of the clinician sharing past patient experience about in utero drug risk, 
emphasising the majority of pregnancies being successful despite exposure to 
combinations of drugs, and the value of experience and personal opinion assisted 
women to make comparisons with other women with positive experience and 
reinforced the perception of a small risk of adverse pregnancy outcome. 
IO24:  giving me examples of people who’ve been on a multitude of tablets and 
had 11 children and they’ve been okay … just by knowing things like that, 
makes you think oh well actually … just giving me some facts and figures 
about people, and the numbers and it’s really small isn’t it   (31 year old)   
 
For other women, seizure risks were contextualised by stories of patients having 
healthy babies notwithstanding experience of tonic clonic seizures, as illustrated by the 
following extract: 
189.  C:           […] We don’t really know how bad the epilepsy has 
190.  to be in order to damage the fetus, but we know that we have lots of 
191.  women who have lots of grand mals during pregnancy and the baby 
192.  has been entirely normal. (OI08; 27 year old) 
 
Stories from practice were used to provide both positive and negative illustration of 
potential future pregnancy outcomes for women: in the former, to encourage patients 
to consider the proposed intervention as achievable; in the latter, to bring the patient’s 
attention to potential negative outcomes: 
527.  C:  Sometimes people are OK to reduce it down to the last tablet and  
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528.  when they drop that one, the auras recur, and having said that  
529.  I’m optimistic that if you would get your auras or your seizures  
530.  back, that you would have the auras first, and then you would know 
531.  that you had reached a critical level 
532.  P:  Yes  
  […] 
839. C:  Most women are OK that I’ve seen, but I’ve seen patients, mothers 
840.  who then have to look after the spina bifida as well… 
  […] 
929. C:                                                       […] I see all my patients  
930.  making a happy and quick recovery from them [seizures]. 
 (OI23; 30 year old) 
 
The power to direct attention to the negative outcomes was illustrated by one 
participant’s request for assistance evaluating the risk of adverse pregnancy outcome, 
both in relation to her plans to delay conception and making changes to her AED 
regimen until she had successfully emigrated and become settled: 
225.  P:  Yes, so what do you suggest that I do? [Laugh] 
    […] 
278.  C: And I don’t think I can make that decision for you? But if I was a 
279.  woman, I wouldn’t want to stay on two drugs while I was pregnant, 
  […] 
281. C:                 […] But, looking after a 
282.  disabled child that would be a great tragedy for anybody {yes} in 
283.  what ever country.  (OI12; 30 year old) 
 
7.2 Focus on the health of the unborn baby prior to conception 
The expression of concern for the unborn baby was an important finding in the context 
of women receiving preconception risk information. The importance related to the 
timing of these statements within women’s reproductive career, often highlighting a 
projection of worry ahead of planning pregnancy and conception. 
 
7.2.1 Perceived risks to the baby from in utero exposure to drugs and seizures 
Risks were perceived as dangers and potential harms to the unborn baby. Women were 
observed to weigh up the balance between seizure and drug-related risks to the unborn 
baby, revealing a tendency to value the health of the baby above their own, and in 
doing so, placing greater emphasis on AED-related risks while minimising personal 
seizure risks. Focusing attention on the risks of in utero drug exposure led some 
women to question the benefit of medication in relation to their baby’s health. The 
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majority of women viewed their treatment as risky, exposing the baby to the dangerous 
properties of the drug, emphasising the risk of delivering an AED-affected baby.  
FG105: If people our age get pregnant now it is probably not planned … but isn’t it 
more likely that the child would be disabled like spina bifida or something 
quite severely wrong with them because of our medication.  (19 year old) 
 
Women discussed the tension between public health messages about drug use in 
pregnancy and their requirement for continued medication:   
FG74  …you get bombarded with press messages about, don’t drink that, and 
don’t eat that and so knowing that internally that, the baby’s getting a 
medication, for which it’s got no need, you need it’s very impure. It’s a 
very impure feeling for me… 
[…] 
FG75  …your baby doesn’t need it. It’s you that needs it, and it’s going into your 
baby unnecessarily…            (FG74 36 year old, FG75 26 year old) 
 
Patient questions illustrated the powerful imagery of their future baby’s vulnerability 
to in utero drug exposure, while emphasising their requirement for protection. The 
following extract exemplifies the typical response from clinician’s:  
267. P:  So what can Epilim do to the baby? 
268. C:  Well Epilim in particular it can induce certain malformations, OK 
269.          [...] There is a range of possibilities and it can 
270.  cause significant disability to the child but there is different degrees.  
271.  OK from the studies carried out so far [...]  
272.  We haven’t actually looked into the specific dosages, OK, that can 
273.  potentially harm the baby but on a large population of people who 
274.  take or women who take Epilim and have had a child  
275.           […] In the majority of cases we see some 
276.  minor neuropsychological impairment and so if. 
277. P:   Right, so it is more with the brain 
278. C:   Yes it can cause certain, 
279. P:   Not disabilities with their limbs. 
280. C:   If you will, retardation or learning difficulties if you will, and 
281.   the development of the brain would be some what slowed 
282.   down.  
283. P:   Alright, OK     (OI07 32yr old; planning first pregnancy) 
 
The perceived unnecessary exposure of the baby to medication was inevitable when 
women were advised of their own continued need for treatment throughout pregnancy. 
An equally difficult scenario faced women who were in remission from seizures and 
offered the choice to withdraw medication. In either situation women were required to 
make judgements, in the former to agree with recommendations to continue treatment, 
in the latter to consider AED withdrawal, albeit a proposal not entirely risk-free.  
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Expressions of fear by women concerning the implications of in utero AED exposure 
for their baby had the effect of emphasising the vulnerability of the baby over the 
woman. Her own potential vulnerability to seizures and the consequences this might 
have, in extremis, maternal mortality, was down-played. Clinicians’ warnings to avoid 
introducing instability in seizure control by impromptu changes to medication were 
supplemented by statements of their prior experience, of women struggling to regain 
seizure control, the risk of seizure relapse, and of seizure control being harder to 
achieve. For some women the impact of receiving such warnings was to increase their 
anxieties concerning the chances of achieving seizure control either prior to or during 
pregnancy. In the following extract, the participant reveals her concern that she will be 
unable to have nine months free from seizures, and so will be limited in her ability to 
influence the outcome of a future pregnancy: 
FG-I-03: Because I just probably feel a bit guilty. If something bad were to  
 happen. I don’t think I would feel too terrible, because its something you 
can’t help … I mean it’s 9 months, it’s a long time too ... Especially for 
myself at the minute, I don’t think, for 9 months, yes I’d definitely have 
more than one or two fits. I couldn’t see a pregnancy going right, I really 
couldn’t … I think that would probably cause a lot of grief actually. In fact 
I reckon. But my health, would definitely come second, the most important 
thing would be the baby.    (23 year old) 
 
Women appeared to project their concerns regarding seizure risks towards their baby, 
rather than themselves, exemplified by the following case (OI07):  
OI07:  …the only thing that frightens me is if I put that child at risk. So, me 
having a seizure would put that child at risk. So that is the only thing that 
frightens me. If there was nothing wrong with me … I wouldn’t even think 
about it at all. It wouldn’t bother me.  (32 year old) 
 
The projection of concerns to the unborn baby is reinforced in this graphic quote from 
a 19 year old participant: 
FG45 …you have got the whole thing of when you’re having a fit that your brain 
is starved of oxygen so of course you are starving the baby of oxygen and 
that could have just as much risk as the medication does as well… 
 
Seizure risks were almost constantly referred to by clinicians in terms of risks 
associated with maternal tonic clonic seizures, while reassurance was offered 
concerning the likely risks from non-convulsive seizures: 
149. C:     […] and I think the risk 
150.   of your seizures to the baby would be quite small… 
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   […] 
153. C:           […] Because you 
154.   have only these petit mal type attacks {that’s it} 
155.   there’s the risk to you, isn’t it, you might be doing something in  
156.   your petit mal like, ironing and burning yourself {yes}… 
 (OI10; 30 year old, future pregnancy intentions)      
 
Several women articulated the struggle to make judgements about pregnancy 
outcomes, and the tension between their personal fears of seizures versus their 
desperation to avoid harm to their unborn baby. This is illustrated by the following 
quote by a 30 year old woman with immediate pregnancy intentions: 
OI23:  […] the reason I keep saying selfish is because I’m thinking about my own 
feelings, and being scared of having seizures. Whereas I am not just 
thinking about the risks to a baby, but it’s not that I am not worried about 
those things, because I am desperately…  
 
7.2.2 The perceived risk of delivering an AED-affected baby 
Women made frequent reference concerning the visibility of major malformations and 
the long-term risks to child development and learning. Risks to the unborn baby 
accounted for the majority of the distress experienced by women when weighing up 
their need for continued treatment versus their abilities to cope if they had an AED-
affected child. Worries centred on the potential for disability, the uncertainty of 
discovering a deformity at birth, or concerns about the hidden nature of neuro-
cognitive delay as a future as yet undiscovered: 
FG42:  I was also worried about what, like what had the medication, what it done 
to [name of child] as is, spina bifida in her body, but also the effects if it 
had on her, mentally if you like, if it would slow her down or. 
  […] 
FG42:  If I thought it would do anything like that to her. I mean up to now it hasn’t 
she is bright as a little button but I worried about that as well.  (33 year old) 
 
Clinician’s advice to women taking sodium valproate focused on future risks to the 
child in relation to minor malformations and to neurodevelopmental delay, illustrated 
by the case of OI02, a 22 year old with future pregnancy intentions:  
288. C:                                          […] those minor malformations could be a 
289.  form of, almost a form of a learning disability we are seeing in some 
290.  children as they are growing up, starting school, they might have 
291.  problems with their speech, delayed speech, they might have 
292.  behavioural problems, they might have minor malformations in their 
293.  faces that most people would not notice but people who are in the 
294.  know might notice. High foreheads, just a certain look called the 
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295.  fetal valproate syndrome, so it is something that we are watching 
296.  and research continues looking at these minor malformation rates… 
 
In the case of OI02, she is positioned as reliant on experts, who would be able to 
identify the future baby as looking different and showing signs of ‘fetal valproate 
syndrome’. The graphic description of the AED-affected child and the need for 
continuing research reinforced an uncertain outcome. Difficulties knowing whether a 
child had been affected by AED exposure were emphasised by comparisons between 
the apparent ease of seeing physical malformations at birth and the difficulties in 
detecting neuro-cognitive delay until a child had reached school age: 
134. C:  And there is a possibility that the drugs can even cause more subtle 
135.  damage to the baby, {Oh} which is not visible at birth, but only 
136.  within the, five years we see them, perhaps not as clever as 
137.  they should be. {Are right, oh} Or, they have delayed speech or 
138.  developmental things like that 
139. P:  Oh, I never knew that. 
140. C:  But that is far less certain,  
141. P:  Yes  
142. C:  Because it’s quite difficult to measure. 
143. P:  Yes 
144. C:  Whereas the malformations at birth, that’s an the easy thing, 
145.  everybody can see 
  (OI10; 30 year old, immediate pregnancy intentions) 
 
The visibility of major malformations at birth was a source of guilt for one pregnant 
participant: 
OI20:  But it’s the fact that it could have really bad deformities, that’s what 
worries me the most. It’s like facial deformities, and I don’t know whether 
I can cope with that. And with me being on meds, and like just pumping 
my body I’d feel responsible for that. (30 year old) 
 
Women appeared to struggle with the uncertainty of predicting the health of their 
future baby leading to increased worry, as illustrated by a 24 year old participant 
planning pregnancy in the future: 
OI11:  Just the risks of being pregnant and worrying at the back of your mind 
while you’re pregnant, is it going to be born with heart defects, a disability. 
I don’t know, I guess I wanted a worry free pregnancy, as much as you 
could. 
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Women expressed concern about their ability to cope with having a disabled child. For 
some, this intensified during pregnancy, focusing on a sense of uncertain future, such 
as how they would know if something had gone wrong:  
FG42:  […] when she came out I, the first thing I said … is her mouth alright.  
[Laughing] That was the first thing is her mouth alright ... but that was, the 
thing they couldn’t say but it, that is all the time, that is, the whole 9 
months because I still didn’t know she was alright […] Because of the my 
medication the problems she could have had, it was 9 months of worry, of 
the medication, she could have had spina bifida, water on the brain, there 
was a list of problems and it was just 9 months of worry.    (33 year old) 
 
While the risk of specific malformations such as spina bifida were rarely the focus of 
the drug-specific risk information within observed consultations37, for the above 
participant the certainty of risk became a statement of future fact, rather than a 
probability. Therefore, following delivery of her baby, she needed reassurance that her 
baby had not been affected. In contrast, participant FG82, who was pregnant with 
twins in her third pregnancy, was reassured by being informed of the treatment risks as 
a guide to what to expect: 
FG82:  …because I’ve changed medications, for my second, because as you know, 
an I was panicking, and [clinician] just told me the worst case scenario 
which was fine. I knew what to look for.       (37 year old) 
 
7.2.3 Fears of harming the baby or child 
The perception of risks concerning becoming a mother and caring for a baby were 
mixed, with most women optimistic about their ability to cope. Others focused on the 
potential for accidents, and even the death of their infant, as a source of increased 
anxiety. Expressions of worry concerning childcare risks were not restricted to women 
with experience of pregnancy or childcare, but also had the power to influence the 
judgements of women preparing for pregnancy. The following 16 year old participant 
exemplifies the concerns expressed by young women anticipating their ability to care 
for a baby while managing their own seizure risks: 
FG113: When I’m asleep and I take my fits everything just blanks out and I can’t 
hear anything, so if I have a baby and the baby is screaming I wouldn’t be 
able to hear it so there is that chance of things like a baby maybe wanting 
its milk and all that and I might not hear it […] the baby could have a 
chance of dying and all that so like that has really put me off and 
everything.              
 
                                                 
37
 The risk of spina bifida as an AED-related risk was raised in 6 of the 23 observed consultations. 
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Worries concerning the inadvertent killing of a baby/child during or secondary to the 
experience of a seizure were vividly displayed across the entire study population. The 
majority of women managed their worries concerning child safety through engagement 
with their clinician and actions, such as adhering to their AEDs as a means of 
preventing future accidents. Some women were unable to provide themselves with the 
desired sense of reassurance, becoming distressed during their preparations for 
pregnancy:  
610.  P:  … what also worries me, is the future OK. I have a, I come off 
611.  my medication, successfully, fall pregnant, have a baby everything’s 
612.  fine then what if I’ve got a little kid and I’m crossing the road…  
  [Patient became distressed, comforted by her partner]  
614. P:  Oh I’m sorry, I know you can say that about anything couldn’t you, 
615.  anybody could have like a heart attack at any /time but it’s not,  
616. C:          /Well that’s very fair  
617. P:  /and it’s not, but   /or 
618. C:  /comment isn’t it, /Yes, your risk of causing harm to your baby or  
619.  suffer an injury is really low, do you know/  
620. P:                /It’s not just that though, 
621.  it’s selfish as well, it’s because I’m so terrified of having another 
622.  seizure… (OI23; 30 year old, immediate pregnancy plans) 
 
OI23 projects her perceived future responsibility to her child, and through her 
disclosure of an imagined ‘worst case’ scenario is offered support. The clinician 
provided advice about the need for common sense surrounding activities, such as 
sitting on the floor when feeding the baby to avoid the risk of dropping baby if a 
seizure were to occur. Participants made reference to their responsibilities of caring for 
a baby/child as a mother with epilepsy which resulted in restrictions, and required 
additional vigilance or adaptations, such as, not being left alone with a baby in case of 
holding a baby at the onset of a seizure and dropping or squeezing a baby, or requiring 
ground floor accommodation or shower facilities.  
FG73: … it’s looking after the baby… like I’ll be looking after it, I’d be on my 
own … I can like daydream, and now I like, I’m dribbling, and the next 
thing, lately I’ve been falling asleep. If I’m looking after my child … 
giving it a bath, if I have a seizure and dribbling, next thing falling asleep 
… next, I wake up in the next 15 minutes, and bathing a baby, it could be 
dead. It would be floating, it’s like [gasp], “oh my God, what have I done”. 
And it’s like, it takes me a few/ 
FG71:               /But that’s were the planning comes in, isn’t 
it, because what you would do then, is not/ 
FG73:                   /But, I’ve just killed my own 
baby   (FG71, 45 year old; FG73, 31 year old) 
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Childcare risks were considered during preparation for pregnancy and resulted in 
concerns surrounding future abilities to cope, requiring risks to be managed: 
IO24:  So I think, well I need to make sure that I’m okay, because if I’m not okay 
then you shouldn't risk looking after a child or whatever… 
 (31 year old; immediate pregnancy intentions) 
 
7.3 Risk Management 
Risk management involved the processes of assessing risks and benefits, and was 
reliant on women making judgements concerning which risks were perceived to be 
acceptable and which required management. The selection of risk management 
strategy was often the result of discussion with the clinician and significant others 
(partner, friends or relatives), and involved decisions concerning the preferred 
approach to be taken during pregnancy preparation – whether to avoid risk, reduce or 
prevent risks.  
 
7.3.1 Risk benefit assessment 
Risk assessment was reliant on women receiving risk information and being able to 
make comparisons between perceived risks: 
226. C:  Are you aware of the potential side effects of the Epilim? 
227. P:     […] the only thing I think is that  
228.  I can either come off my Epilim and risk a seizure whilst I am  
229. pregnant which is quite dangerous or stay on my Epilim which is  
230. also quite dangerous to the baby and that’s all I know...  
 (OI07; future pregnancy intentions) 
 
Women were involved in making a complex set of judgements. These judgements 
were not restricted to women with immediate pregnancy intentions but, rather, 
changed in response to experience and life circumstance, as illustrated here by two 
participants. The first woman drew on her experience of work with and knowledge of 
individuals with disabilities; the second on her prior experience of an adverse 
pregnancy outcome: 
1. OI12:  Some people will be willing to risk it wouldn’t they of having a child but 
it’s like he said the disability, but I work with people with disabilities and I 
wouldn’t want one. (OI12; 30 year old, future pregnancy intentions) 
 
2.  OI21:   If I found out I’d had an accident now and I was pregnant, I would be 
mortified … I don’t think I’d be able to cope with it, because I’m on 
Epilim. It’s not the fact of having a baby it’s the fact that I’m on Epilim, I 
couldn’t cope with the thought of being pregnant on that…I know there’s a 
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risk with everything, with any operation, any drug, anything that you do in 
life. The thing isn’t the, if it had never happened to me, I’d say, I wouldn’t 
even think about coming off it because it’s such a small risk, there’s risks 
with everything, and that’s how I normally look at things. But because it’s 
happened to me I’m looking at it completely different…  
  (OI21; 35 year old, future pregnancy intentions) 
 
There were differences between women and clinicians in their approach to risk 
assessment, with the women frequently placing seizure-related risk and treatment-
related risk in opposition, while clinicians were observed to advice a balanced 
approach. The following quotes from two teenage participants illustrate the difficulty 
in reaching an acceptable compromise:    
FG106: …you take the tablets your baby could be disabled or don’t take the tablets 
you have a fit you fall over and the baby might be disabled. So there are 
disadvantages either side…   (18 year old) 
 
FG111: […] when you are pregnant because on the tablets … It’s the first 3 
months of pregnancy that really get affected. So I am going to have to be 
taken off the tablets for the first 3 months of pregnancy, and then I could 
have a seizure. And I could end up losing the baby so it is like it is all a big 
vicious circle really and it is scary… (16 year old) 
 
Both women and clinicians acknowledged that poorly controlled epilepsy would 
influence general quality of life, work, driving and home life, as well as future 
relationships and family plans. The process of assessing risks required women to 
balance perceived risks of continued seizures with a relapse of seizures or in utero 
AED exposure to the unborn baby, as well as the perceived threat to their quality of 
life as a result of adverse pregnancy outcomes. Risk assessment required women to 
make judgements often in the form of gambling odds: 
FG43:  … what is the best thing to do, for yourself and for your baby? You know 
there is implication on both sides isn’t there really. If you come off you 
could have more fits and that would have implications on your child and 
vice versa… (35 year old) 
 
The clinician’s approach to risk assessment tended to focus on an assessment of 
objective evidence of risks: 
99.  C:         […] Obviously, we have to weigh the risks and benefits  
100.   and in the past going through your notes earlier on, I noticed every 
101.   time we’ve tried cutting things down you’ve had more seizures. And  
102.   looks like you do need what you are on at the moment … 
   (OI14; 27 year old, immediate pregnancy intentions) 
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An alternate approach during the consultation was for clinicians to present the ideal of 
optimal pregnancy care, emphasising the target of the least amount of treatment 
required to maintain best possible seizure control prior to conception: 
350. C:            […] what we want to do is to 
351.  try and optimise what you are taking, so that we don’t need to 
352.  change it during pregnancy ideally 
  […] 
380. C:    […] we want to get that balance between the seizure 
381.  control and any potential adverse effects and so, I think the dose,  
382.  /as low-ish 
383. P:      /as low as possible 
  […] 
388. P:  It gains me good stead if I do become pregnant then obviously. 
389.  I’m on a bit more, lower dose {yes} than I am, {yes} than 
390.   what I was on.   
   (OI20; 30 year old, immediate pregnancy intentions) 
 
Risk assessment was most commonly introduced by the clinician. However there were 
exceptions, illustrated by the following extract: 
165.  Patient relative:      … if you balance out like you  
166.  are saying like reducing the dosage to sort of about 200mg instead  
167.  of 500mg a day what is the risk of, to the baby if she has fits  
168.  because if she is not having enough medication.  
169. C:  I know 
170. Patient relative: So is that risk higher than the risk of taking the higher 
171.  dose of the drug do you know what I mean is it  
172. P:  Is it more harmful to the baby? 
173. Patient relative: Do you, what I mean is it more harmful to risk a fit and 
174.  then deprivation of oxygen to the baby is that more of a risk than 
175.  taking the higher dosage of the drug. 
176. C:  Both risks are pretty low.  
  (OI08; 27 year old, future pregnancy intentions) 
 
The process of assessing risks and benefits frequently presented the potential for gains 
and losses or pros and cons38. Gains were cited by women as achieved through 
establishing an acceptable balance between seizure control and the selection of AEDs 
guided by risk information, with the intention of increasing the chances of having a 
healthy baby, a concept expanded upon by the following 33 year old participant 
considering future pregnancy intentions: 
OI17:  I think in terms of the Epilim and this sounds really, I don’t know it sounds 
really selfish I suppose, I think any parent … or any person who wants to 
have a baby, they want to give that child every opportunity … I don’t want 
                                                 
38
 See also, Chapter 9 The model of preconception counselling. 
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to add to the risk factors so I would like to be able to do everything I can to 
ensure that any child I conceive has the best chance … I would be scared 
that if I stopped taking the medication full stop that they would never stop 
[seizures] …even though I would want my child to be healthy and happy 
to, I mean how good a parent would I be then if I was having seizures every 
single day because then you’ve got into a new sphere of can you actually be 
the primary carer for a child. So to me that would be the risk. (33 year old) 
 
Making comparisons between drug and seizure risks reveals the struggle to find the 
right balance between the risk of increasingly frequent seizures during pregnancy and 
concerns for continuing to adhere to medication to reduce seizure risk. The following 
extracts illustrate the struggle to achievement of a successful balance between the risks 
and benefits of epilepsy management prior to and during pregnancy:  
356.  C.  … we’d want to optimise it before pregnancy and then ideally keep  
357.    it stable because poorly controlled epilepsy is potentially more 
358.  harmful than the medication   
  (OI20, 30 year old, immediate pregnancy intentions) 
 
FG123: …trying to find that right balance with the medicine … and I’m looking at 
the tablets I am actually resenting taking them… (39 year old) 
 
When opportunities to reduce or avoid risks were perceived to be limited, acceptance 
of the inevitability of risk allowed some women to accept their limitations of being 
able to avoid all risks: 
OI15:  But like I say, you’d never have a baby would you if they thought about all 
the potential problems before doing it. So, I guess you just have to be 
willing to accept that risk [carbamazepine]… And I am willing to accept a 
slightly higher level of risk, for the benefit of trying to remain seizure free 
really… (31 year old, future pregnancy intentions) 
   
7.3.2 Risk reduction 
Efforts to reduce risk most commonly required women to consider one or other of the 
following: reducing the number of AEDs taken; switching to an alternative AED with 
lower malformation risk; or, consider withdrawal of AEDs. Reducing the total number 
of AEDs was presented by clinicians utilizing evidence from the UK Epilepsy and 
Pregnancy Register. For other women drug withdrawal was proposed to reduce risk: 
440. C:                   […] The 
441.  question is whether you could like to try coming off all together  
442. P:  /Well I do 
443. C:     /While you are trying for the baby. It would reduce the risk 
444.  further a little bit wouldn’t it? Because there are children who 
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445.  are born with spina bifida on carbamazepine. It’s a low-ish risk 
446.  but it’s a risk, and it’s high, slightly higher than background risks 
447.  its fair to say.  (OI23; 30 years immediate pregnancy intentions) 
    
Outside of the consultation, women revealed a tendency to consider the prevention of 
delivering a disabled baby as priority and judged the opportunity to stop treatment as a 
method of reducing or minimising perceived AED-related risk and thereby reduce the 
likelihood of the unwanted outcome.  
FG104: But, but I know how hard it is to bring up a disabled child so I don’t think I 
would want an unplanned pregnancy, I won’t want to get pregnant right 
when I’m taking my medication. 
FG106: You would want to minimise the risks wouldn’t you? 
FG104: Exactly, so I would stop my medication  
(FG104, 17 year old; FG106, 18 year old) 
 
Women described their attempts to reduce all potential risks as much as possible; a 
point illustrated by a 31 year old with immediate pregnancy intentions:  
IO24: nobody wants a poorly child, and you try and eliminate it … you just think 
well it’s, everything is going to be okay, and it’s just a case of doing what 
you need to do, to make sure everything is going to be okay … So by 
coming off the acetazolamide, and reducing my carbamazepine, and doing 
everything I can do, I feel that should be okay   
 
There was no consensus in the preferences between the reduction of seizures or 
treatment-related risks. For some the priority was to reduce seizure-related risk rather 
than reduce AED-related risks. In the case of pregnant participant FG84 she evaluated 
her baby as dependent upon her maintaining her own health.  
FG84:  I’m not just looking after myself, and I can’t be selfish. I’ve got, I’ll have 
someone else to look after, so I need to protect myself to protect them. So if 
I’m seizure free, then I’m constantly able to look after the baby…  
 (23 year old) 
 
One participant, who was diagnosed with epilepsy and started AEDs shortly before she 
discovered herself pregnant, expressed anger as she reflected on the missed 
opportunities: 
FG22:  Nobody ever said to me […] do you think you should take him out on your 
own, and bearing in mind I’d only just been diagnosed […] all they knew is 
this person has never had a fit in her life, she’s suddenly had one, she’s got 
pregnant […] she’s been on drugs she doesn’t know it hasn’t worked, she’s 
on  this other one which was Epilim which is dangerous for people who are 
pregnant, she’s had a baby and that was it.  I was just left, nobody came 
near me. Now I was dead lucky because I didn’t have anymore for a while. 
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But I could have gone out with [son] and thrown him under bus or all of us 
gone under a bus.  (45 year old, one 8 year old son) 
 
The failure to highlight risk at the appropriate time (both during pregnancy, concerning 
treatment-related risk, and following delivery, concerning child safety) resulted in the 
participant evaluating her successful progress through early motherhood as ‘lucky’, as 
she had been able to engage in risk reduction or avoidance strategies during her 
pregnancy and after caring for her child. 
 
7.3.3 Risk prevention and avoidance 
Risk prevention and avoidance strategies were presented during clinical consultations 
as opportunities to avoid in utero AED exposure, and were managed using similar 
strategies to those discussed in the previous section. Risk reduction strategies were 
accepted by many women as a compromise between the perceived ideal of a risk-free 
pregnancy and the balance between seizure and treatment-related risks. For other 
women, risk avoidance was the preferred option and resulted in more extreme views. 
From the clinician’s perspective, risk avoidance was presented as the opportunity to 
consider switching from high risk AEDs, most notably sodium valproate: 
404.  C:     […] ideally we would have wanted to have  
405.  tried you without the Epilim before you fall pregnant. So if you do 
406.  {yes} have a lot of seizures then we want to obviously 
407.  avoid that because of the risk to you, but you know you  
408.  are not risking your pregnancy as well.  So we do like to try the 
409.  changes before there is a chance that you may 
410.  become pregnant {yes}.   
  (OI04; 27 year old, future pregnancy intentions) 
 
From the patient perspective, selection of the least risky alternative was required; and 
in this context, women had preference for avoiding risks towards their future baby, and 
accepting their own higher risks such as worsening seizures. This approach is 
illustrated by a 34 year old participant who had delivered her 2
nd
 baby seven weeks 
before focus group attendance:  
FG83:  All the time, what damage can those tablets do, what damage, and if 
[epilepsy nurse specialist] said well that’s got a 3% chance and this has got 
a 10, I would always, whether that was more effective, I would still go on 
the 3% one […] Because that to me, I know how the epilepsy had impacted 
on my life. And I’d do anything to try and prevent any kind of damage or, 
even if it meant me having, a few more seizure, to prevent any … I would 
take that risk    
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Drug withdrawal was a preferred option both for women and clinicians and, for the 
following 30 year old participant; it offered the opportunity to eliminate all her 
perceived risks in advance of pregnancy: 
116.  C:  And, and that the carbamazepine is still better than other 
117.  drugs {Yes} but it’s not entirely risk free/ 
118. P:              /Yes, 
119. C:  It is probably better to come off the medication isn’t it? Than 
120.  /putting up with anything, well 
121. P:  /Well yes I thought, because even a 2% risk I suppose it’s just a 
122.  woman thing, isn’t it. You don’t want to I'd hate to 
123.  think there’s any kind of risk really if I can help it  (OI10) 
 
The idea of risk avoidance achieved through drug withdrawal is further emphasised by 
the following 28 year old: 
FG61:  Thinking about risk, even, that, I would definitely come off all my 
medications, I’ve said it before. I would want to come off all my 
medications to make sure there was no harm to the child what so ever. You 
know, full stop. And then get back up support […] No drug is safe, that’s 
the reality…    
 
A number of alternate avoidance strategies were considered, including delaying 
conception, presented by a 24 year old participant as the opportunity to test whether 
she had “grow-out” of her epilepsy: 
FG62:  …first before I even think about getting pregnant. To see how, leave it for a 
few years first, and then hopefully I will have grown out of it, and until I’ve 
grown out of it, not while I’m. Not while I’m still having them, it’s too 
dangerous; you could be holding them, or anything. Don’t want to put the 
child’s life at risk…  
 
While for one participant her attempts to reduce weight prior to conception revealed 
her strategies to avoid the added risks of obesity influencing the health of her future 
child: 
OI13:  to be honest with you, I’m trying to lose weight at the moment … I don’t 
want me being an obese mother because that puts your child at risk as well   
(OI13; 28 year old, future pregnancy intentions) 
 
For other women, prior experience of pregnancy motivated their attempts to eliminate 
future risk and, for one woman, her experience of a medical termination following 
diagnosis of a major malformation led her to plan drug withdrawal prior to a future 
pregnancy (OI21). For this woman the option of switching to alternative AED was 
insufficient to relieve her concern: 
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Interviewer: …would you consider an alternative treatment to Epilim? 
OI21:  I just think I’d put it off completely the plan of being pregnant. Because 
another drug would be another, would be an unknown wouldn’t it. I’m 
quite happy to have the unknown risks of my own age and natural things 
that happen, but not the unknown risks of a drug… 
 (35 year old, future pregnancy intentions) 
 
The uncertainty concerning drug-related risks was judged to be unacceptable when 
related to the uncertain future of a child’s development and learning. This is illustrated 
by the following participant as she struggled to manage remaining on treatment and the 
potential for guilt and self-blame if she delivered an AED-affected baby: 
OI10:  … with this learning difficulty thing I thought, oh god …when you balance 
that with a baby, and all the things that could go wrong, I’d rather be off 
my tablets and risk having an attack then, have a baby have it, have 
something wrong with it, and then, I’d feel like that’s my fault then, 
because I’ve, you know… (30 year old, immediate pregnancy intentions) 
 
For participant OI20, the discovery of her first pregnancy during the time between the 
observed consultation and follow-up interview offered a unique insight into the 
application of risk management strategies. OI20 had questioned the clinician 
concerning her actions in the event of discovering the pregnancy and later during 
interview revealed the dilemmas she faced making decisions regarding the 
continuation of treatment: 
346. P:     […] you know when I do actually become 
347.  pregnant will I have to come off my medication 
348. C:  No  
349. P:  Altogether or would you just 
350. C:  No, no we would want you to stay on … 
 
OI20:  … because I am pregnant I am a bit overprotective … paranoid a bit and I 
think that’s why it probably clicked into my head, what am I doing here, 
why am I putting these drugs into my body. Because obviously if I’m 
taking it, the baby’s going to be taking it as well. And I think I just thought 
it’s just not fair, how could you, I just couldn’t live with myself if anything 
happened to the baby …    (30 year old) 
 
The experience of being presented with risk information and its influence on perceived 
risks shaped the experience of women in their preparation for pregnancy, and 
supported their subsequent decisions with regard to accepting, reducing, preventing or 
avoiding risk. In the final quote, perceived risks were managed by avoidance, as the 
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participant chose adoption in preference to her perceived risk of having a “deformed” 
child:  
FG-I-02: …there was a high risk of us having a child with deformities … they 
could be very minor from something like having a cleft palate, to cardiac 
deformities to, it was quite, it went right across the broad spectrum, but did 
emphasise that it could be quite marked, and could reduce the life 
expectancy of the child … he [consultant] reckoned it was something like 
20-25%, chance of having these problems […] just before I got married, he 
actually brought up the subject of children, and discouraged us from having 
children due to the epilepsy … and the Consultant did say, when I said 
about the medication and the family … that it would have no effect if I was 
to come off medication however, the child would still have a deformity, if I 
was to have no medication at all. So it was very cut and dried, from his 
point of view … We felt that it was a sign for ourselves, that maybe 
adoption is the best way for us. So we have adopted …    
 (36 year old; 2 adopted children) 
 
7.4 Summary Results: Communicating risk and uncertainty 
 The communication of risks and uncertainties within the reproductive lives of 
women served to both inform and guide pregnancy planning and preparation. 
 The main functions of risk communication were to highlight the significance of 
AED-related risk alongside seizure-related risk information to encourage 
discussions of the potential opportunities to manage risk in a timely manner, and 
to support informed decision-making, crucial to maintain the safety of the future 
mother and baby. 
 The communication of risk which focused on the health of the unborn baby/child 
had a persuasive element, defining the nature of risk in terms of the vulnerability 
of unborn baby to in utero AED exposure and maternal seizures, and extended to 
include concerns for the child’s vulnerability to heredity risks.  
 The presentation of risks concerning pregnancy and motherhood were influential 
for women preparing for pregnancy, and resulted in perceptions of high risk 
pregnancy and perceptions of increased risks for child safety. 
 Women engaged in making judgements concerning which risks were perceived 
acceptable, and which required management through strategies of risk prevention, 
reduction or avoidance. The choice, application and adherence of risk 
management decisions reflected individual preferences and, in extremis, resulted 
in decisions to avoid or restrict having a family.  
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 The significance of risk messages that over-inflated the risks to the future child 
following in utero AED exposure or exposure to maternal seizure risk was the 
resistance to new more favourable information, suggesting the irreversible hazard 
resulting in the shadow of doubt difficult to erase.  
 
In the next chapter, the interpretation of risk and uncertain information upon decision-
making in preparation for pregnancy will be explored. 
                                                                                               Decision-making in preparation for pregnancy  
 156 
Chapter 8 Decision-making in preparation for pregnancy 
Introduction 
This chapter presents findings about women’s involvement in decision-making 
concerning preparation for pregnancy, illustrating their experience of making multiple 
decisions throughout their childbearing years, and the importance placed upon 
information to support participation in decision-making to achieve their preferred 
reproductive outcomes. These findings have been used to structure this chapter as 
follows: 
1. The decision to prepare for pregnancy – outlines the experience of women 
preparing for clinic attendance and their access to information.  
2. Factors influencing decision-making – illustrates the emotive context in which 
decisions are made during preparations for pregnancy; and 
3. Negotiated outcomes – describes the mutual agreements, discussion and 
compromise between women and their clinicians, and highlights preferences 
regarding the reproductive outcome of decisions made by women. 
  
8.1 Decisions to prepare for pregnancy 
Women were required to identify their future pregnancy intentions and take the 
necessary action, such as recognising the importance of allocating sufficient time to 
complete preparatory interventions before attempting to conceive. This required 
women to identify pregnancy planning as both a reason to consult with health care 
professionals and as an item for clinic discussion. 
  
8.1.1 Decisions to attend the epilepsy clinic 
Decisions to discuss planning pregnancy were motivated by the need for additional 
information, advice and reassurance. There was an expectation that women who had 
been discharged from clinic during seizure remission would return to review their 
epilepsy management prior to attempting to conceive. The recall of recommendations 
made in childhood was a challenge. One 24 year old (OI19), who had last attended 
hospital aged 14 years, had no memory of statements reinforcing the importance of 
returning for specialist review either to reconsider future drug withdrawal or for 
preconception review. The GP referral letter made reference to OI19’s continued use 
                                                                                               Decision-making in preparation for pregnancy  
 157 
of Epilim, a treatment she had withdrawn on her own volition approximately two years 
earlier.  
OI19:  I came off the tablets, but I went to see my GP and asked my GP if they 
had any advice on like, not so much getting pregnant, but about being an 
epileptic and being pregnant. And they basically said well you will 
definitely have to come off the tablets, because it can effect if you have a 
baby, it can effect the growth of the baby whilst inside you. But we can’t 
give you the ins and outs whether you still need the tablets or not. 
(Immediate pregnancy intentions) 
 
OI19’s actions had been prompted by several competing agendas - frequently missing 
treatment, becoming more independent with plans to move in with her partner, and 
contemplating pregnancy. The potential negative consequences of drug withdrawal, 
such as a potential relapse of seizures or her need to withhold from driving during drug 
withdrawal, had not been considered, although OI19 admitted that not telling her 
mother was to avoid causing worry.  
 
For other women, their experience was reliant on friends and family. Participants OI10 
and IO24 illustrated this route back into epilepsy care. In the case of OI10, a 30 year 
old with immediate pregnancy intentions, she revised her prior judgements concerning 
the inability of WWE to have successful pregnancies following a chance meeting with 
a friend with epilepsy who had had a positive experience. In the case of IO24, her 
mother’s experience of epilepsy had reinforced the importance of preconception 
review. This had inadvertently reinforced her belief in the safety of her treatment, a 
point which was challenged by the GP practice nurse. Whilst IO24 had decided to 
disclose her pregnancy intentions to the practice nurse, this had been to initiate 
appropriate preparation which she felt involved monitoring her epilepsy. The practice 
nurse warning, “I will refer you to the hospital to come off your tablets”, raised 
concern of the potential for drug-related risks. 
 
Referrals for epilepsy review required discussions with the GP, and additional work by 
women to bring about a new patient referral, both bringing pertinent information to 
their GP’s attention and negotiating referral to their preferred health 
professional/service. The experience of previous consultations with hospital clinicians 
was often associated with the experience of seizures and/or changes with AEDs. For 
one woman this resulted in a wariness of returning to the epilepsy clinic:  
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OI22:  when I was put on lamotrigine the Consultant in [location] said look I’ve 
put you on this, because you will probably have children. She said it to me 
when I was 21 and I thought it was quite funny […] But when you are so 
young you just sort of go yeah! Okay! But equally you do look on the 
internet and you do read things […] I knew that I would have to go through 
a process of again going to the hospital, this time through my own choice 
[…] any messing about with my tablets I’m a little bit nervous of. First of 
all, it takes such a long time to be weaned off one and on to the other, but 
there is always that element, of we might be back to square one…  
 (32 year old, immediate pregnancy intentions) 
 
The above participant’s anxiety about the outcome of clinic attendance and her 
investment of time in internet searches revealed the extent of her concern about the 
potential to destabilise her epilepsy. For other women, there was less evidence of any 
expectation for preconception epilepsy review39, as exemplified by participant OI06 
who had attended her GP for pregnancy testing. The GP’s referral only came about due 
to a negative pregnancy test result. This case demonstrates the experience of a sub-
group of women, in which making decisions to conceive did not take into account the 
significance of preconception care:  
170. C:     […] Your GP sent you back also, in the letter there 
171.  was a mention about pregnancy and your worries about that. 
172. P:  Oh yes. I asked for the test, because I thought I was pregnant, 
173.  because I was late on my period.  
  […] 
176. P: … They said because if you have a baby now, with the tablets that 
177.  you are on, your baby could be disabled, there could be 
178.  something wrong with its lip or could have spina bifida or something 
179.  like that she said. So really I wouldn’t try yet while you are on those 
180.  tablets. I would speak to your specialist first and let them give you 
181.  advice and tell you what they think of it. 
182. C:  Are you planning to be pregnant? 
183. P:  Well I do want to have a baby, but, I just wouldn’t want to have 
184.  a baby now and it was disabled.   (OI06; 20 year old) 
 
This case highlights the role played by GP’s to identify and refer women at risk of 
unplanned pregnancy. The significance of the GP’s warning to delay attempts to 
conceive while continuing the current treatment was that it highlighted the risks of 
having a disabled baby and revealed knowledge deficits. From the clinician’s 
perspective, opportunistic questions about pregnancy intentions were an attempt to 
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 There was a tendency for women who had infrequent epilepsy clinic attendance to experience a lack of 
awareness of the importance of preconception epilepsy review; in the case of OI06 she had stopped 
attending clinic despite continuing to experience frequent seizures.  
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manage knowledge deficits concerning the importance of preconception review. Some 
women appreciated opportunistic questioning since it relieved them of the potential 
embarrassment of broaching the subject of their intentions to conceive:  
OI22:  …it was quite good that my doctor [GP] actually brought the subject up, 
because it prompted to me to sort of start talking about it … 
  (32 year old, immediate pregnancy intentions) 
 
8.1.2 Experiences of directing the clinic agenda 
The ability to influence the clinic agenda was questioned by some women, referring to 
‘being in the dark’ and having limited information concerning pregnancy related 
issues. The search for information was presented as a request for advice, and included 
questions concerning aspects of epilepsy management and updates on research: 
IO24:  I just wanted to know why, why a) you need to come off the tablets, why, 
and I felt that I’d not had any, he’d not really give me any information, 
because he was just saying there’s risks for this and risks for that. And I 
was saying where’s, how do you know there’s risks. Because people have 
always said to me, they can’t test pregnant women, so then if you can’t test 
pregnant women, and when they’re on their medication when they’re 
pregnant, how do you know what the risks are…  (31 year old) 
 
For the majority of women, the agenda also included the search for reassurance and 
peace of mind concerning their ability to have a successful pregnancy. In the case of 
IO24, she had questioned the accuracy of previously provided information, requiring 
additional information to offer reassurance. The approach taken by women to direct the 
clinic agenda was variable, from simply answering questions asked by the clinician 
through to asking their own questions and making comments concerning their AED 
regimen and future pregnancy intentions. In the case of OI17 the GP referral letter had 
requested review of seizure management; however, during OI17’s initial hospital visit, 
the 33 year old had informed the clinician of her additional requirements to review her 
pregnancy intentions:  
OI17:  when I first saw [clinician] and felt that she was, I mean I didn’t walk into 
the clinic with the intention of going yes I want kids because I had my 
mum sat with me. But after listening to her and her understanding of my 
condition, I felt at that point I could say well actually I have been thinking 
about this for months, what do you think about it and felt that her advice 
was really supportive. (Future pregnancy intentions) 
 
The transfer of information between patient and clinician required both parties to 
identify gaps in knowledge and to share new information updating changes in personal 
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circumstance. Participant OI13 exemplified this point through her contact with the 
clinician’s secretary to inform of her wedding date and request a consultation. The 
disclosure of information was judged as her responsibility:  
OI13: Basically it’s whatever is going on with you, at the time. If you’ve not 
expressed that you’re into that, they obviously don’t know that you’re 
thinking of having a family or anything, so they don’t know what best 
advice. So it is up to you to a point, to tell, if like when they’re asking what 
is going on with you at the moment, it’s not. But then I think it should be 
good to give like the information.  
(28 year old, future pregnancy intentions) 
 
The role played by women in directing the clinic agenda was implied by women 
asking questions or making statements which required the clinician to respond. The 
clinician made explicit enquiries concerning pregnancy intentions in 19 of the 23 
observed cases; of which 7 involved new patient appointments. In the case of 
participant OI23, a 30 year old with immediate pregnancy intentions, she confirmed 
her pregnancy intentions as both the reason for the consultation and for her specific 
requests about risk information and clinical opinion: 
251. P:  … well my ultimate goal is that, we would like to try for a 
252.  baby,  
253. C:  I think that’s a very good idea 
254. P:  I saw [name] in [city] about a year ago because we were 
255.  discussing it and, we came to the conclusion that I was going to 
256.  come off my medication after we got married in August. But then I 
257.  had these funny, this vertigo thing, and it knocked me for six… 
  […] 
275.  P:  But I don’t know, I wanted to know what the risks are of 
276.  what, what your thoughts are really (OI23) 
 
The clinician’s role in initiating discussion concerning pregnancy was reliant on 
knowledge of the patient’s stage in life, relationship status, work and home 
circumstance. The approach adopted by the clinician focused attention on the range of 
issues needing to be discussed, and the value of the patient’s involvement in providing 
detail to support the clinician’s work: 
107. C:  […] your doctor’s sort of, put all the relevant things in the  
108.  letter {yes} really the issues about potentially thinking about  
109.  pregnancy. {Yes} Also mentioned about what job, what  
110.  kind of job you do {yes}, and the fact that you rely on driving for  
111.  that as well. 
112. P:  Yes, I mean, I don’t, I could not drive if it was absolutely  
113.  necessary {yes}. But I mean I do at the moment drive  
114. C:  Yes, OK  
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115. P:  Both commute to work and then drive  
116.  occasionally /for work, so.  
117. C:    /right OK. I mean the issues kind of  
118.  linked in a way. And I’ll explain {yes} what I mean by that. In that, 
119.  if you’re in the situation that you are in, which is 
120.  essentially, being 10 years without any seizures? Then, I 
121.  think essentially we’ve got three options. We, you could consider 
122.  drug withdrawal completely and we need to discuss the pros 
123.  and cons of that. You could stay completely as you are, or 
124.  we either consider reducing the dose or switching to another drug. 
125. P:  Right  (OI15; 31 year old, future pregnancy intentions) 
 
The above extract highlights the provision of treatment choices from which the patient 
needed to consider her preference before reaching a decision. The implications of her 
treatment decision extended beyond her plans for pregnancy, and directed the patient 
to also consider driving and employment. 
  
8.1.3 Having information to inform decision-making 
The experience of attending the epilepsy clinic was interpreted as providing an 
available resource of specialist advice and information, which could be easily accessed 
when the perceived need arose:  
FG74:  Well I really do go about my business on information, it’s crucial to me. 
Whether or not, the pregnancy was planned. As soon as it was, I wanted to 
know everything I could possibly know. Especially to counter the things 
that are said that don’t help … I want to be armed, with as much 
information as I’ve got. Knowing that, no two people are the same. 
Knowing that, no two births are the same. Doesn’t matter, I just want to 
know, just tell me everything tell me everything, and I will base it on that, 
and I read everything. Information is crucial to me. Really is.  
  (36 year old with one child) 
 
The information offered at diagnosis and during follow-up visits was interpreted as 
beneficial. One participant described her relationship with her GP as reinforcing her 
search for information which she felt had prevented her from experiencing an 
accidental pregnancy. For many women their search for information involved:  
1. Joining voluntary organisations such as Epilepsy Action40 
2. Links to experiences of WWE via internet chat rooms  
3. Attending local libraries - searching the general health and self-help manuals 
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 Epilepsy Action is one of two national voluntary organisations in the UK (the second, the National 
Society for Epilepsy). 
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4. Reading the problem pages of women’s magazines/mother and baby 
magazines 
 
The internet was judged by one 19 year old participant as a convenient resource and 
“more convenient than booking an appointment” with her doctor (FG45). The 
accessibility of appropriate information was a challenge for some women, especially in 
relation to the time pressures within the clinic environment, where guidance in locating 
trusted information was important for the majority of women. This point was 
emphasised by several participants who had benefited from the support of being 
offered several visits to discuss pregnancy-related topics and receive information in 
stages, in preferences to ‘a whole load of information’ being given at once and the 
associated pressure of needing to ‘try and take it all in’. Frustrations were expressed 
relating to the desired content of clinical advice compared to the perceived reality, 
resulting in searching for reassurance and the request for honesty and openness from 
the clinician:    
FG-I-02: I just felt they were keeping themselves on the wall, on the fence. Not 
giving an answer because they were scared of the consequences if they give 
you incorrect advice sort of thing ... he just said well there is an increased 
risk. It’s the unknown at the moment or something, but very, very vague 
[…] he just said if you do decide to go, despite the risks [laugh], then we’d 
want you to register with this pregnancy thing but that was it. It was very 
much like if you go against my advice, this was the first Consultant; if you 
go against my advice then you join that register, so it’s just [laughs]. So it 
was very, it did feel very, very negative, and that I was just glad that my 
husband was there, and he could try and take some of it on board as well, 
because I felt very bewildered.  (36 year old) 
 
8.2 Factors influencing decision-making 
The perception of additional risk and responsibility towards the unborn child resulted 
in expressions of guilt, worry, blame and fear concerning the outcome of decisions 
made during preparation for pregnancy.  
 
8.2.1The influence of anxieties, worries and fears upon decision-making 
Women experienced both positive and negative emotions in response to risk 
information and, for some; risk information was seen as relieving anxiety by providing 
reassurance about the likelihood of successful pregnancy: 
OI09:  The information from past hospitals I’ve had I think has hindered my 
opinions and everything on having children, I always wanted it, I’ve had 
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that mindset about I always wanted children but I think I had too many 
worries on my mind of what was going to happen […] it’s helped 
[observed consultation] a lot just putting my mind at rest about simple 
things, maybe it’s just even talking out loud, I don’t know. I don’t like 
talking sometimes to my family because they just worry. 
 (29 year old, future pregnancy intentions) 
 
The recall of previous presentations of risk information was an important factor for 
both patient and clinician, and the poor recall of both pregnancy and epilepsy-specific 
risk information had the potential to influence or bias the outcome of decisions made 
by women. The provision of new risk information required that it be sufficiently 
credible to alter prior beliefs, a concept illustrated in relation to two women 
challenging each other’s prior beliefs during group discussion: 
FG45:  […] for the ones I’m on and sodium valproate there is more chance; I think 
there’s a 40% increased chance of abnormalities which is quite a lot. And 
that, if I was to intentionally want to get pregnant, I would have to come off 
my medication which worries me. 
 
[Brief change of subject by a participant discussing the experience of seizures …] 
 
FG45: Well I think that’s what [clinician] said, I might be wrong. I mean that to me 
is a significant amount. If they’d said to me 5% or 10% I would probably 
be less worried.  But when they give such a significant percentage that/  
FG44:                          /You see I was given a different percentage than that when I 
was on sodium valproate. 
FG45:  Well I might of got it wrong, that’s what I remembered. 
FG44: Yes, I know in your mind it seems a lot doesn’t it.   
   (FG44, 29 year old; FG45, 19 year old) 
 
The involvement of women in reviewing their epilepsy management and considering 
possible treatment options rested on being able to make judgements concerning 
preferred outcomes, all of which had a strong emotional association. The following 
extract illustrates the clinician checking the patient’s recall of pregnancy related issues:  
244.  C:   […] So do you want to tell me what you remember because  
245.  that’s quite helpful for me to remember what you need to, [laugh] to  
246.  know what your knowledge is, because people go, yeh yeh, and then  
247.  they are so stressed it all goes out of their heads [laugh] 
248. P:  What was my understanding from last time was they lower 
249.  the effectiveness of the lamotrigine  
250. C:  But what about the, what I was saying, what your understanding is 
251.  of the effect of lamotrigine on the pregnancy? You know because 
252.  you were worried about there being problems in pregnancy, and any 
253.  problems with the baby?   
254. P:  I can’t recall 
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255. C:  You can’t recall 
256. P:  Sorry (OI17, 33 year old, future pregnancy intentions) 
 
The above participant had completed a switch of treatment (sodium valproate to 
lamotrigine) following her last clinic visit, and the observed consultation was to review 
her progress, and presented an opportunity to confirm her knowledge and 
understanding. Within this context the significance of OI17s poor recall was her 
inability to remember the information which had informed her decision. This case 
illustrates a common problem cited by women, concerning their ability to remember 
the content of clinic discussion from one visit to the next, a problem intensified by the 
emotionally charged decisions surrounding pregnancy. 
 
Information concerning drug-specific risks was frequently presented in the context of 
clinical recommendations, resulting in emotional responses with the potential to 
influence the preferences for drug selection or action to be taken. For other women, 
decisions to make changes with treatment raised their fears of possible changes to 
seizure control, tied into responsibilities towards the future child. Women considered 
the opposing risks of seizures versus AEDs harming the unborn baby in their attempt 
to manage the dilemma raised by clinical recommendations to switch treatment, 
exemplified by a 22 year considering pregnancy within the next 12-18 months: 
OI02:  … the last big fit I had scared me, really did scare me… it is more risky 
isn’t it to have kids without being on this special medication. But, it’s nerve 
racking to get on to it, but I know I’ve got to do it, because I know that 
there could be something wrong with my baby if I don’t take it… It’s got to 
be the lamotrigine hasn’t it because she [clinician] did turn round and say 
to me, that that’s the only one that’s more than likely not to be risky for 
anything to be wrong with the baby. The Epilim it’s more risky to be 
something wrong with the baby, and that’s why I don’t want to, I do want 
to start the lamotrigine. It’s like of a night when I can go to take my tablets, 
I do get them out to take them. And I just look at them, and just, it’s just 
dead scary, I think, am I going to wake up in the morning in a hospital…     
 
The clinical implications of eliciting fear in response to risk information were that for 
many women, uncertainties surrounding pregnancy or personal uncertainties around 
starting new treatment were heightened. Individual responses to risk information 
included the influence of personal blame and claims of selfishness: 
FG-I-02: It was more to do with the things like the cardiac problems I think that 
had more of an impact on us. That it was going to change that child’s life in 
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such a dramatic way, their quality of life would be poor. So it was those 
things that were keyed into us. (36 year old) 
 
For other women, the potential for changes in seizure control influenced pregnancy 
planning decisions by increasing uncertainties concerning the experience of pregnancy 
on a new drug. The fear of seizure relapse had become an obstacle to the decision-
making for one participant (OI23), influencing her approach to pregnancy planning 
(see also page 113). However, it was the uncertainty of developmental delay that 
influenced her final decision to withdraw from treatment:  
OI23:  The thing that I suppose that hit a nerve, I think really changed mine and 
[husband’s] decision, was when he was talking about the developmental 
problems that we don’t know about […] I was thinking well if you’re born 
with a child, whose struggling at school, whatever, you’d just be wondering 
well is it my fault, is it because I didn’t do that. Or, but you don’t know, it 
might have nothing to do with it, but there’s so many variables. (30 year 
old, immediate pregnancy intentions) 
 
Uncertainties, both surrounding drug-specific risk and the patient’s response to a new 
drug, were the most common source of worry, resulting in more tentative decisions 
concerning the likelihood of future pregnancy: 
OI12:  …we do want children but I don’t think there is any point in saying we 
definitely, I don’t think there is any point in getting your hopes up that you 
are going to have them. Because it might not happen, I’ve not changed my 
medication, I don’t know whether the medication is going to work, and I 
don’t think I’d want to risk being on this medication and having them 
[children]  (30 year old, future pregnancy intentions) 
 
For several teenagers, drug-specific uncertainties influenced their anticipated future 
judgements concerning both drug selection and pregnancy decisions, illustrated by the 
following 16 year old: 
FG111: Personally if you gave me, if you said you can go on this drug or this one 
which we’re uncertain of, I’d go on the one where I know what the risks 
are […] I couldn’t have pregnancy where I was uncertain, when like the 
baby came out, whether it would have 6 fingers stuff like that. 
 
The influence of uncertainty upon treatment choice was expressed as feeling 
uncomfortable and confused about ‘the unknown’. For participant FG111, her response 
to uncertainty implied selection of a drug with known risk as providing ‘peace of 
mind’. The influence of emotions upon decision-making was exemplified by 
participant FG92, who was diagnosed with epilepsy three months prior to discovering 
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she was pregnant. She faced decisions concerning the progression of her pregnancy 
alongside clinical recommendations to start treatment: 
FG92:  To me, I think it was just more the protecting the baby, than anything. I 
know it was probably, if I did have a fit, and then if something did happen 
to the baby, then it would be my own fault for not taking the tablets. But 
then, it’s just like you’ve got all these things flying through your head, an 
you just don’t know what to do for the best, but I’ve started to take them 
yesterday anyway, so, hopefully, everything will be alright now  
 (32 year old, 4
th
 pregnancy) 
 
Risk information was provided as reassurance and support for the revision of prior 
negative beliefs, and for some women influenced both treatment and pregnancy-related 
decisions. For others, decisions either to have children, or to revise plans for a larger 
family, revealed a tension between prior expectations and the reality of their 
experience of life with epilepsy: 
FG123: it just wasn’t through selfishness or anything, epilepsy was the main 
reason why we decided cut off no more [children] … the epilepsy it just 
totally flipped it over and it did and that was what our decision was.  I 
would have had about four, I’d gone like my mum and had about four, I 
always wanted four deep down.  (39 year old)  
 
Decisions to restrict family size (two children) were influenced by fears concerning the 
safety of her future baby and her own safety during pregnancy, as well as by her 
responsibility to care for her family which would not be possible if her seizures 
restarted. Decisions concerning risk management required women to reconcile their 
emotional responses of blame and guilt. Women articulated a struggle to ‘live with 
themselves’ in coping with the perceived inevitable worry of remaining on treatment 
during pregnancy versus delivering a disabled child. One 18 year old expressed her 
motives for planning pregnancy as a method of coping with the need to be ‘careful’, as 
she considered the options set out in front of her (see figure 8.1). 
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(Flip chart diagram drawn by FG101 (18 years old) Teenager focus group 1) 
Figure 8.1 The influence of epilepsy upon decision-making  
 
8.2.2 Assistance in making informed decisions 
The support needs of women planning pregnancy were commonly met by being 
offered sufficient time and opportunity to ask questions and having access to expert 
knowledge and opinion. Clinicians skilled enough to communicate in a reassuring 
way, and their ability to pre-empt patients’ informational needs, were also considered 
helpful qualities, and used to justify reliance on the clinician to guide decision-making:  
FG96:  Because you’re going to the likes of [hospital] and the clinics for sort of 
medical advice, and reassurance from specialists and expertise. And so 
therefore you want to hear something, definite and concrete, and the 
research says this and this, and this is your, it’s 96% and the 4% could be 
this, and this is what the sorts of things we could be talking about, and that 
differs from the general population, by x,y,z so, And, you can make your 
own decision […] based on the facts… (34 year old, 2nd pregnancy) 
 
The importance of up-to-date information was also to offer reassurance, exemplified 
by participant OI22:  
OI22:  … you spend a lot of time worrying about what’s going to happen, and I 
think perhaps I’d put off having a baby because, I know it’s going to be a 
                                                                                               Decision-making in preparation for pregnancy  
 168 
big deal. But you do worry and you spend a lot of time before you are even 
planning, and you read all the negatives, so you already know all the 
negatives. It’s just a good thing to go to somebody and them say it, actually 
it’s a really good idea, and it’s going to be alright. This might happen, but 
this is what will happen at the end, it’s probably going to be a good 
outcome x amount. We’ve got all these women who have babies in 
[location] and they’re all very happy, and you need that, as opposed to 
putting the fear of god into people. It’s just, because, you already go there 
expecting to hear bad things. (32 year old, immediate pregnancy intentions) 
 
Support in managing risk information was considered by one participant OI01, who 
considered herself a ‘planner’, as helping her manage the negative aspect of ‘thinking 
about things too much’:  
OI01:  […] I mean, I could sit there and think oh no, but you’ll be getting pregnant 
and you’ll be worrying about the baby, and then you’ll get yourself all 
stressed out, and then that will just lead to a fit […] but I think knowing the 
stuff that I know now […] when the time came I think I would be able to 
make a decision, yes, yes far better than I would have been able to do a few 
months back  (29 year old, future pregnancy intentions) 
 
Women highlighted the importance of having access to information alongside their 
need for support, as illustrated by OI01’s reliance on the clinician to deliver timely 
information updates. The expert knowledge of the clinician was seen as a resource to 
be accessed by women involved in making their own decisions concerning pregnancy. 
However, the responsibility for making decisions rested with the participant alone, and 
implied an appreciation of the responsibility to consider clinical recommendations: 
OI13:  once you are given that information, you do need to think about it and 
make some decisions. Whether you want to even think about changing your 
drugs and things like that … (28 year old, future pregnancy intentions) 
 
The above participant positioned decision-making as happening outside of the clinic 
environment, whereas other women valued the chance to be offered a follow-up visits 
and the opportunity for ‘talking things over again’. Several participants were critical of 
the lack of accessibility of support when needed, and the availability of appointments. 
The criticism was extended by one participant (FG-I-02)41 who considered the 
organisational constraints on the epilepsy clinic to respond to individual patient need, 
resulting in her feeling isolated and ‘let down’ by her consultant who she saw as not 
wanting to see her again for ‘six or twelve months’. Deficits in service provision and 
                                                 
41
 See also participant extract page 159. 
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professional knowledge were raised as practical constraints to informed decision-
making: 
FG75:  It’s just a whole minefield, and you say, well you can get Epilepsy Action42 
to give you leaflets about having children when you have epilepsy, and you 
can get different information from your GP and your midwife […] If there 
was some kind of package that was put all together, especially for people 
with epilepsy in pregnancy, that would be amazing. I mean you read and 
you say well you get preconception counselling, I mean what’s that? I’ve 
never been offered that, sounds amazing but I’ve never had it, I have 
15minute slots with my consultant and he’s usually running an hour and 
half behind, and he hasn’t got time. […] when you’re about to embark on 
something, it’s seems scary, because it’s the not knowing, and it’s the what 
ifs […] if someone could sit you down and say, this is our service provision 
(FG75; 26 year old) 
 
For the majority of women, assistance in making informed decisions required up-to-
date information and two additional elements: the provision of support, and the 
provision of reassurance. For one participant, her decision to withdraw sodium 
valproate required the approval of her clinician: 
OI21:  I know I’ve made my decision, but I still think it’s the doctor that’s made it 
for me. Well, helped me make it, agreed to it, say. 
 (35 year old, future pregnancy intentions)  
 
Reassurance served as support for decisions made especially surrounding pregnancy 
decisions. The assistance provided by family members was seen as being a form of 
psychological support, both as the emotional support to reconcile the perceived 
difficult decisions needing to be made, and also practical support in dealing with the 
outcomes of the decisions made, such as practically coping with caring for a disabled 
child. Information about the availability of support (whether practical support in the 
form of maternity services and Local Authority provision for childcare, or emotional 
support in the form of reassurance from discussion with other WWE) were identified 
as helpful in reducing the perceived obstacles to planning a successful pregnancy, and 
thereby assist decision-making during preparation for pregnancy.  
 
8.3 Negotiated outcomes  
The decisions made by women involved a complex process of appraising information 
concerning pregnancy related risks, assessing its significance in relation to their 
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 Epilepsy Action produce a wide range of written literature, internet services, and membership for 
patients, carers and professionals.   
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personal circumstance, and pregnancy intentions weighted against the available 
epilepsy management options and perceived risk management strategies. This involved 
negotiation and compromise between the differing views held by women, their 
clinicians and significant others, and resulted in a perceived challenge for women 
making decisions concerning pregnancy.  
 
8.3.1 Decisions concerning risk management 
The decision to become pregnant was seen as ‘massive’ and ‘potentially life changing’, 
requiring women to consider the ‘extra worries’ associated with the role taken by 
women in making decisions concerning risk: 
FG22:  It’s your risk, and it’s for you to make the decision whether to take the risk. 
But you need to have advice on what the risk is. And there’s the medical 
risk, and it got to be explained in ways that you can understand. There’s the 
psychological risk which is, are you going to be able to cope with the stress 
of having a baby and looking after it, and your family and all the rest of it. 
So it’s having the information to make the choices…  (45 year old) 
 
The ability for women to make judgements concerning AED selection during 
preconception review relied on them feeling sufficiently informed and having trust in 
the evidence presented by their clinician, a point illustrated by the following 
participant’s frustrations: 
FG53:  They keep changing, every time they change my drugs, they always say, 
oh, yes, actually I know we changed the drugs last time, and said these 
drugs are better for having babies on, but the, now the drug company have 
said they’re not actually better for having babies on [laugh]  (23 year old) 
 
The nature of the decisions facing women preparing for pregnancy reflected the need 
to make choices, and resulted in women’s tentative approach to make decisions to 
review treatment, often associated with anxiety concerning the outcome of the review 
such as recommendations to switch or withdrawing treatment. Preconception review of 
AEDs is an opportunity to switch to alternative less risky AEDs, especially in the case 
of women taking sodium valproate.  
FG45:  I think I would be more inclined to swap if I found one that was sort of like 
a low risk one; I think I’d be more inclined to swap than come off  
 (19 year old) 
 
The approach taken by FG45 reflects the desire to switch to lower risk AEDs. The 
significance of this extract is to illustrate the competing rationales (importance of 
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seizure control versus low risks to fetus) informing her preference, especially as FG45 
was taking sodium valproate: 
FG45:  I got told to take the full dose of 1000 milligrams and I’m actually only 
taking 600 milligrams because I don’t need the full dose in my opinion … 
So I felt I was in control of that, but I think that was because I didn’t want 
to go on them at first because my epilepsy isn’t that severe 
 
FG45 rationalised her treatment decisions on the grounds of seizure severity and her 
initial response to treatment, rather than considering the immediate needs of a future 
child. However, in her earlier statement, she makes reference to an awareness of drug 
risk. For women who decided to remain on sodium valproate, they justified their 
decision as a necessary evil, and used risk information to counter the criticism of 
having made a ‘selfish decision’ (see also Chapter 9.2), illustrated by a 30 year old 
pregnant participant: 
FG86:  Am I doing damage to it? Is it right to do this? Even though it’s what you 
know, is it the right thing to do, is it a selfish act or sort of thing, and as I 
say after speaking to [epilepsy nurse specialist] and [consultant] at 
[hospital]. […] I think the percentages that [epilepsy nurse specialist] gave 
me it was something like 5% and if you look at percentages for anything, 
new time Mum for anything… I think with me, it was that selfishness 
{Yes} Am I doing the right thing, and the planning? {Yes} That I feel, that 
I’ve put into it … And looked and weighed everything up and spoke to 
[clinician], the same sort of chance, went on the folic acid all that […]   
  
Participant FG86 decided to remain on a low dose of sodium valproate (600mgs daily). 
However, reflecting on her pre-pregnancy decision during her current pregnancy, she 
revealed a tension between her earlier rationale for deciding to remain on the ‘worst 
drug’ and her current anxieties:   
FG86:  … my pregnancy was planned, I’m 16-17 weeks pregnant and just living 
on my nerves really [laughter] but other than that [laughter] excited and 
looking forward to the future. (30 year old) 
 
FG86’s decision to commence folic acid was used to reduce her perceived risks while 
remaining on sodium valproate. Folic acid was a common recommendation by 
clinician’s justifying the ‘just in case’ rationale. Whilst there was frequent reference to 
‘just in case’ recommendations for folic acid, there were instances of 
misunderstandings illustrated by the case of one 16 year old, believing she was at 
increased risk of accidental pregnancy:  
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FG111: it scared me when they went you have got to go on folic acid just in case, 
and my mum was like what, just in case what.  And they were like, just in 
case she gets pregnant. And she wasn’t very pleased with that, but erm my 
dad said it was like she is preparing for a pregnancy which it scared me as 
well because I was like there must be a chance then. (16 year old) 
 
For other women, there experience was of clinicians highlighting the importance of 
preconception commencement of folic acid through descriptions of early fetal 
development, and the limited benefit if commenced only on discovery of pregnancy:  
413.  C:    […] the folic acid as well to reduce the risk  
414.  of things like spina bifida {yes}. It's ideal for you to be 
415.  taking that before you become pregnant. Because most of the  
416.  time, by the time ladies have actually have found out that they're  
417.  pregnant the bony spinal column has actually been formed. So  
418.  {yes} those sort of defects have taken place already so it  
419.  is best that you take the folic acid.  Usually they say about three  
420.  months before you become pregnant, so it is well in your system 
421.  {yes} and it is going to have its positive effect for you… 
  (OI04; 27 year old, future pregnancy intentions) 
 
Eleven participants observed in consultation received a recommendation to start folic 
acid, of whom four had commenced folic acid by the time of interview. A further 
seven women were already taking folic acid prior to their observed clinic appointment 
(see Chapter 5, Table 5.8). The availability of information about the benefit of folic 
acid was inconsistent. Informant OI03, who had spoken to her pharmacist before 
attending the observed consultation, had required further reassurance from in her 
epilepsy clinician about the best time to commence and her perceived risk of ‘getting 
caught out’. The clinician’s reassurance was not prescriptive about when to start folic 
acid, but implied that their was wisdom in starting folic acid in advance of conception, 
a point not picked up by this 23 year old participant with future pregnancy intentions:  
OI03:  the fact that I know now to take the folic acid just when you get pregnant 
really so, because I thought I would have to take it for a while, while I'm 
planning, and I was panicking in case I got caught pregnant and I had not 
took it. I thought that could cause problems but it's quite a good thing that 
it’s just when you find out you're pregnant. (OI13) 
  
Delays in taking action to commence folic acid were attributed by OI17 to her failure 
to appreciate the significance of not taking folic acid before pregnancy: 
OI17:  when I was 21, I saw a Consultant … the only thing I remember when I 
was leaving he said just remember if you want to have a baby you’ve got to 
take folic acid …and then when I saw the Consultant in [location] again 
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and was pregnant that’s what he talked about [folic acid] and talked about 
you know worst case scenario was when a woman was taking sodium 
valproate you can have a child born without a limb and I was like Whoa!  
But it was stuff that nobody had ever sat down and said this is the truth    
(33 year old, future pregnancy intentions) 
 
Accidental pregnancy resulted in women needing to decide whether to progress with 
the pregnancy and revealed an increased level of worry which was not entirely relieved 
by the availability of ultrasound scanning. These issues were illustrated by FG95, who 
had conceived while taking both the contraceptive pill and phenytoin:  
FG95:  when I became pregnant … we just wanted to make sure that, everything 
was OK with the baby because I was on medication, I was on my 
medication from the start of the pregnancy, I wasn’t taking any folic acid 
… I had fits, so it’s like the stuff that you hear, like from the internet, and 
when you read the leaflets, and things like that just panic’s you a little bit 
more, like you’ve got this much percentages of normal, abnormalities 
you’ve got this much percentage of this, this, this and this. For me and 
[partner] it was like, right, we are pregnant, but, we’re not going to get too 
over excited …get as many tests and screens done as we possibly can, to 
know that everything’s is OK, and that’s when you can get excited…   
 (25 year old, 1
st
 pregnancy) 
 
The utility of prenatal diagnosis when used to manage anxieties concerning 
preconception decisions to remain on AEDs relied on women’s awareness of the 
routine use of ultra-sound scanning to detect abnormality. Clinicians referred to this 
technology as a means of reducing risk through the early detection of something 
having gone wrong: 
282.  C:     […] with the lamotrigine you don’t tend to get  
283.   abnormalities of the formation of the spinal cord, OK. But, but there 
284.   could be a whole range of different abnormalities, and they’re often 
285.   picked up on scans. And what we do say to people when they do get 
286.   pregnant, we plug them into the obstetric hospital 
   (OI17; 33 year old, future pregnancy intentions) 
 
For some women reliance on ultrasound scanning was problematic, identifying the 
limitations both of time to access scanning and take action on the results, and the 
ability to detect ‘all’ abnormalities. For one woman, this was crucial in her 
preparations for pregnancy, supporting her treatment decisions as whether to remain on 
lamotrigine and topiramate or switch to either monotherapy with topiramate or 
levetiracetam (the clinician had recommended the latter option as preferable, to reduce 
as much risk as possible):      
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OI12:  I would like to know now that this can be detected before it gets past that 
stage where I could have an abortion. And I think I need to know all them 
figures as well … if it had spina bifida we could tell before it got past that 
point and we could obviously give you the options and the same with the 
other defects, if it could be detected […] if it was a 95% chance, or 98% 
chance that all birth defects, major ones, were detectable then yes […] it 
being detectable, be given that choice, then I would be quite happy staying 
on this medication    (30 year old, future pregnancy intentions)  
 
The potential to detect ‘all’ abnormalities by ultrasound scanning was an unrealistic 
expectation. However, discussions about ultrasound scanning during preconception 
review consultations resulted in many women judging prenatal diagnosis as a backup 
resource to detect adverse outcomes should they occur as a result of AED treatment 
decisions. The role of prenatal diagnosis during pregnancy was to assist women assess 
risks and benefits and served as decision support. Discussions about prenatal diagnosis 
during preconception counselling also served to assist women feel able to manage the 
uncertainties of pregnancy-related risks (from AEDs) and was especially important for 
women who felt they had limited options to switch from their least preferred treatment. 
 
8.3.2The experience of making decisions 
Decisions were made by women as part of their daily life with epilepsy, and concerned 
adherence to treatment, continuation of contraception, and whether to take action on 
pregnancy intentions. Within the consultation, women appeared comfortable about 
making decisions, and the majority used ‘I’ to indicate their central role and ownership 
of decisions.  
OI21:  I feel like I made a decision to come off it [Epilim] eventually, because if I 
do decide to have a family I don’t want to be on it at all, and for me there’s 
more of a risk being on it than there is being off it. Because I’ve been off it 
for so many years, and I’ve been fine, and even if I did have a seizure while 
I was off it, there’s less chance of a problem occurring with an unborn baby 
than there is of me taking it. So I’ve took all that into account, and that’s 
the decision I’ve made.  (OI21; 35 year old, future pregnancy intentions)  
  
Patient decision-making was influenced by clinical recommendations. For example, 
‘we should do this first’ before considering pregnancy, and set the boundaries for 
decisions by proposing what options were available and requesting the patient consider 
her preferences concerning the available options before embarking on pregnancy. The 
experience of involvement in decisions was variable, and while many referred to their 
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responsibility, the reality of involvement in treatment decisions appeared limited, 
exemplified by the following participants: 
FG53:  They keep changing, every time they change my drugs, they always say, 
oh, yes, actually I know we changed the drugs last time, and said, these 
drugs are better for having babies on, but the, now the drug company have 
said, they’re not actually better for having babies on [laugh], well now you 
know. 
FG55:  You do feel like guinea pigs. 
FG53:  Yes   (FG53, 23 year old; FG55, 28 year old) 
 
One woman felt her involvement in decision-making had changed both with maturity 
and personal experience of previous consultant-led decisions: 
FG61:  …it does feel quite equal. But, I think it’s because I’ve had that many 
consultants in the past that have told me, and medications that turn out to 
be the wrong one. I am now, more keen to take control of my side of the 
medication. (28 year old) 
 
In contrast, FG-I-02 was unable to recall participation in decisions to withdraw folic 
acid: 
FG-I-02: it was done [folic acid] as, in case an accident happened, so someone 
must have then deemed that an accident wasn’t going to happen because 
I’m not on it now.  (36 year old) 
 
From the perspective of the clinician, they were involved in making the patient aware 
of potential risks, commonly the risk of unplanned pregnancy and hitherto unforeseen 
consequences from the patient perspective: 
517. C:      you have got a lot at stake here if you do end 
518.  up falling pregnant when you are not planning it. 
  […] 
757. C:  But I am just anxious I just don’t want you to be on 2 drugs and end 
758.  up getting pregnant, alright.  
  (OI02; 22 year old, future pregnancy intentions)  
 
The expression of urgency reflected the priority of concern perceived by the clinician. 
The opportunity to action these decisions changed outside of clinic, with differing 
priorities from the patient’s perspective, for example, worry about seizures and her 
plans for a worry free wedding resulting in the patient’s decision to delay acting on 
clinical recommendations: 
OI02:  I think when the wedding is out the way, then I would really start it 
[lamotrigine] but, hopefully I do want to start it now. Just for in case, it’s 
just, I don’t know it’s just that it’s hard like […] yes, I think it would be 
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just start the lamotrigine like to come off the epilim and then, plan for a 
family like      (22 year old, future pregnancy intentions) 
 
The time required to make treatment changes often resulted in women feeling a sense 
of urgency to achieve the recommended treatment plan. This point was illustrated by a 
26 year old participant who was taking topiramate, carbamazepine and levetiracetam: 
FG75:  I’m concerned with only having two different kinds left, because obviously 
I’m being on three different medications, because obviously wanting to 
have children and I know you’ve got to be on, only a few medications to 
have them, ideally … 
     
The window of opportunity to decide to switch treatment or take action on clinical 
recommendations was frequently missed, and resulted in women experiencing 
pregnancy on their least preferred treatment option. In the case of participant OI21, she 
reflected on her experience of termination of pregnancy at 16 years of age following 
diagnosis of spina bifida which was attributed to in utero sodium valproate exposure: 
OI21:  I think the pregnancy probably would have still happened, because I was, 
young. But, with you saying earlier, teenagers miss medication and they 
don’t take it regularly, I remember now, I didn’t take it regularly. But when 
I found out I was pregnant, I took it more because I thought oh something 
might happen if I don’t take it. Yes, so that would have changed, I wouldn’t 
have took it.   
Interviewer: So knowing more about medication 
OI21:  Yes, because I’m thinking I need to take it more than I normally do, to 
prevent any problems, whereas if I’d have just, not touched it things would 
have been different… (35 year old, future pregnancy intentions) 
 
The significance of this extract is to illustrate the differing approaches to decision-
making: 
1. The laissez-faire approach to teenage pregnancy, in contrast to 
2. The decisiveness to improve adherence on discovery of pregnancy 
 
OI21 was critical of her lack of drug-specific information and how it had contributed 
(in her view) to ill-informed treatment taking decisions at the time of pregnancy 
discovery. Faced with a similar dilemma of taking sodium valproate, one woman 
recognised her impatience and intended to switch treatment to avoid missing her 
opportunity: 
OI04:  I want to do it now, when I’ve got no plans what so ever of having a baby 
and do it safely. So it’s the Keppra just in my system for a couple of years, 
on its own. And as I say, even if I did get caught pregnant by accident, 
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either I’d be doing the folic acid long term by then anyway, and so I 
wouldn’t have to worry about that, and I wouldn’t have to worry about the 
quick come off the Epilim, because I’d be already off it and I’d have been 
off it for a few years, hopefully […] I’m thinking if it does come to a point 
where I want to have a baby, so, I’m thinking I won’t be able to wait three 
months for the folic acid and, I’m not soft, it’s a very serious thing, so I 
would, but I’d find it very hard and that’s were I’m thinking I might find it 
really, really stressful because I’m too over excited, and I’m annoyed 
because I want to get it over and done with. 
 (27 year old, future pregnancy intentions) 
 
The opportunity to take early action implied a responsibility on both the woman and on 
their clinicians to make appropriate recommendations and provide the necessary 
reassurance about the benefits of early intervention. In the case of participant OI10, the 
practical barriers to deciding to act are illustrated. She had visited a neurologist twelve 
months before the observed appointment and delayed taking action: 
91.  P:  … and at the time we weren’t thinking of having a family or 
92.  anything, so I just thought, because he said to me you’d 
93.  have to come off the tablets, and, well he said it was up to me. But, 
94.  he said, I could come off my tablets, but that means I’d 
95.  have to stop driving and all the rest of it. And because we weren’t 
96.  planning a pregnancy then, I just said well I’ll stay as I am 
97.  then because I want to carry on driving. But since then we 
98.  have started/ talking about it. 
99. C:             /Changed your mind, and you are 29 now, 
100.  anyway now aren’t you/   
101. P:         /I’m 30 now, yes     
  (OI10; 30 year old, immediate pregnancy intentions) 
 
The outcome of OI10’s consultation had been to commence drug withdrawal, a 
recommendation which had been made a year earlier. The delay in implementation had 
resulted from OI10’s assessment of her readiness to consider family. The timing of 
decisions to make changes was frequently referenced by women as presenting missed 
opportunities. Attempting to salvage a missed opportunity, several participants 
considered the ability to benefit from drug changes after discovery of pregnancy: 
OI05:  But obviously if you just, if you get pregnant and then you say, well what 
do I do now? Then it’s kind of you’ve, it’s like you’re rushing things really. 
If you kind of maybe, do it earlier, then you have to do, like change 
medicine that you need to do, than that I think is a lot better. 
 (29 year old, pregnancy intentions not stated)  
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8.3.3 Negotiating the preferred outcomes of pregnancy planning 
Negotiation was a feature of decision-making, and questions were asked by both 
clinicians and women to challenge each other’s beliefs. For some women, a failure to 
receive a clinical opinion resulted in seeking a second or third opinion. For others, 
managing disagreements and conflict also required acceptance of compromise in 
preferred pregnancy outcomes, including acceptance of the least preferred treatments 
or considering delays in conception until alternative treatment options had been fully 
explored. The development of shared treatment plans focused upon the preference for 
best treatment and/or seizure control. Participant OI09 presented her preference to the 
clinician in response to enquiry about pregnancy plans: 
41. P: … thinking about it [pregnancy] within the next year, but, it’s to 
42.  do with the medicine because as I said last time, I think my 
43.  neurologist from the other hospital said this is not a safe 
44.  combination. 
45.  C:  Well, lamotrigine or Tegretol itself is {safe}, fine, or safe, 
46.  reasonably safe. I mean nothing is safe even though you don’t take 
47.  the medication there’s no 100% chance that you will have a healthy 
48.  baby {No} […] 
  […] 
54. C:                            /If you are on only one 
55. P:  That’s what I was thinking. And I was thinking if I had to be 
56.  on one/ 
57. C:          /Which one?/ 
58. P:              /I have had carbamazepine, I know its 
59.  worse, not worse but stronger, but I know that has worked before 
60.  and I’ve never had lamotrigine by itself so I don’t 
61.  want to try and mess with something that I’ve never had […] 
  (OI09; 29 year old, future pregnancy intentions) 
 
The dilemma of competing interests between self and baby were countered by the 
effectiveness of AEDs to stop seizures versus the immediate priorities in life and the 
need to maintain the status quo, resulting in women searching for the ideal safe option. 
In the case of OI04, her preference to remain on polytherapy with sodium valproate 
was judged a short-term measure, grounded in her unstable home circumstances. OI04 
agreed with the clinical recommendation to withdraw sodium valproate at a future date 
before pregnancy, and to avoid accidental pregnancy in the interim: 
436.  C:  Ultimately any treatment choices are yours, we aren’t telling you 
437.  what to do it’s just suggestions and you are weighing up the risks 
438.  and benefits of any medication change for yourself. So if you are 
439.  happy to leave things as they are at the moment then that is fair 
440.  enough. Just make sure that you don’t get pregnant, if you can. 
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441. P:  I know, God you know, that is the last thing on my… 
   (OI04; 27 year old, future pregnancy intentions)  
 
Non-adherence to recommendations implied women’s preferences not matching those 
of the clinician, exemplified by participant OI02; who had received recommendations 
to switch from sodium valproate during previous clinic visits, but preferred to defer 
decisions. Clinical recommendations which emphasised the dangers of actions taken, 
whether highlighting the dangers of accidental pregnancy on sodium valproate or 
suddenly stopping treatment, were cited as an influence by several women. The 
influence, however, was not always to direct acceptance of clinical recommendations 
as illustrated by OI02s response: 
OI02:  The risks scared me but I’ve had that before, exactly like the first time I 
went into see the nurse, even more scary then […] I know that there can be 
something wrong with my baby if I got caught pregnant now. Obviously no 
one wants anything wrong with the baby, surely try the best for anything, to 
make sure that nothing like that happens. But it’s just the lamotrigine I’m 
just scarred of getting on to it really, and fitting. I’m just nervous […] it’s 
just risk in everything that I do, it’s just. It’s horrible.  
 
It was typical for the clinician to ask the patient’s opinion concerning seizure control 
and treatment as a means of reviewing consensus about the treatment plan. This type of 
questioning supported the patient revealing concerns or changes of opinion which 
might have occurred. From the clinician’s perspective, these questions assisted their 
appreciation of the patient’s overall preferences and opinions relating to their desired 
approach to seizure management. OI20 had questioned the action to stop treatment if 
she became pregnant, resulting in the clinician’s recommendation to reduce her dose 
down to the lowest to maintain acceptable seizure control and warning against abrupt 
withdrawal. Despite her initial action in adhering to the clinician’s advice, in the time 
between observation and interview OI20 found out she was pregnant and stopped her 
treatment: 
OI20:  you just feel like a bad mother, don’t you, just filling your body full of 
drugs, and I just, I don’t know. Because obviously you want to give your 
kid the best start in life, don’t you and I just feel like I’m not, with the 
drugs, putting the drugs in? […] I’m still taking the folic acid … but I just 
feel bad in myself pumping my body full of drugs. I just feel like just a bit 
selfish looking after myself like, when you should be looking after two 
really isn’t it. (30 year old) 
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OI20’s decision to stop treatment revealed her preference to value the health of her 
baby in preference to valuing her own health and seeing herself as ‘a bad mother’. The 
opportunity to consider drug withdrawal prior to pregnancy was a treatment option 
offered mainly for women in remission. The need to amend prior assumptions about 
treatment preferences included revision of intentions to withdraw treatment. For OI23, 
her initial agenda had revealed her concerns about seizure relapse, which were later 
revised as she decided to begin drug withdrawal: 
OI23:  Yes I have just changed everything around, decided to start reducing my 
medication […] well I have actually dropped down my first 100mg two 
weeks ago, and that night I didn’t sleep at all, I was absolutely petrified. 
But then after that, I’ve been really positive, and I think because the 
decision has now been made. I feel it’s out of my control, and to what will 
be will be sort of thing […] But my goal is now just to try and get it as low 
as possible. Because I thought well anything has got to be positive hasn’t it. 
So I am not thinking about if I do have a baby, what it’s going to be born 
like. I’m kind of accepting, I’m just doing what I can 
 (OI23; 30 year old, immediate pregnancy intentions) 
 
Patient preferences for seizure control were variable. Many women struggled with 
needing to weigh preferences for their own health or social needs against those of a 
future child. Participant OI22 illustrated the value of preserving seizure control: 
OI22:  women do want to maintain their lifestyle, and it’s not through being 
selfish for the child, you almost have to have a lifestyle to look after it.   
 (32 year old, immediate pregnancy intentions) 
 
Other participants expressed a preference to avoid changes to seizure control, such as 
experiencing seizure during the daytime: 
OI04:  One thing that worried me […] if I was to just suddenly have a fit in the 
day, and I hadn’t been asleep, would anything like that? I think I’d actually 
have a heart attack; because to think oh my god my world’s turned upside 
down now.  (27 year old, future pregnancy intentions) 
 
Several participants stressed the importance of the clinician’s role as a guide to 
advocate on behalf of their best interests. Their comments implied the clinician’s role 
as mediator, to guide patients away from ‘risky decisions’, and to highlight the 
potential unforeseen consequences. This was exemplified by OI07, whose motivation 
and eagerness to proceed with switching drugs from sodium valproate to lamotrigine 
after a brief description of drug risks was deferred by the clinician, advising the 
importance of additional information and discussion: 
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224. P:   Yes I mean recently I got engaged so we both want children and 
225.   I’m 32 now so I think I better get a move on. 
   […] 
247. C:  It is not an incredibly high dose of Epilim {yes} it’s a fairly 
248.  standard dose. But at that dose we have found significant problems 
249.  already, OK {right}, and lamotrigine would be essentially a safer 
250.  drug. I think instead of going ahead and you know through the 
251.  change over straight away, erm because you are not in a sort of a 
252.  rush to become pregnant are you. 
253. P:  No we do want to get married first anyway so I guess 
254. C:  So we have time to go through further discussions and we have  
255.  an excellent epilepsy team here and you can have further 
256.  discussions with the [title of clinician]. 
257. P:  Right OK (OI07, 32 year old, future pregnancy intentions) 
 
For OI07 the clinic outcome had been a second visit to receive further information 
concerning the alternative treatment options. However in the time between observation 
and interview, OI07 experienced a prolonged seizure resulting in admission to 
intensive care. The experience of seizure resulted in OI07 reflecting on her 
opportunities to change treatment, the added motive had been her loss of confidence on 
her current treatment, and the loss of driving (not illustrated): 
OI07:  … once you are given that information, you do need to think about it and 
make some decisions. Whether you want to even think about changing your 
drugs and things like that, so I think it was better the way its been done  
 
The role of the clinician in mediating the patient’s involvement in decision-making 
was exemplified by informant OI17’s case who had attended her initial appointment 
with her mother. The mediation of the clinician enabled the OI17 to challenge her 
mother’s aversion to treatment change: 
OI17:  … basically I’ve had treatment for nearly 20 years I mean my family have 
been dead set against it because they thought I am going to have fits 
because I’ve changed my medication. But at the end of the day I was 
already having those bloody fits, wasn’t driving, I can’t work at the minute 
so why not change and I think [clinician] was really, really good because 
my mum is kind of over protective over my epilepsy and she sort of said if 
your daughter has made her mind up, she’s made her mind up.  
 (OI17, 33 year old, future pregnancy intentions) 
 
The opportunity for participants OI07 and OI17 to consider alternative treatment 
options were further motivated by their loss of driving licence, meaning they had less 
to lose even if the AED switch did not proceed according to plan. Further, in the case 
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of OI17, her knowledge of fetal valproate syndrome had influence upon her treatment 
decision: 
OI17:  I think maybe that’s why I decided, I mean I hadn’t heard of anything 
called lamotrigine syndrome… 
 
The majority of women felt challenged by the unpredictability of their condition and, 
for some, this extended to the uncertainty of the risks of inheritance. This presented 
new challenges as interventions were not available to influence the outcome of 
inheritance. The preferred outcome of pregnancy was a healthy non-disabled baby, and 
women preferred their baby not to have inherited epilepsy – a point exemplified by a 
21 year old who had questioned her ability to cope with the outcome:  
FG12:  I know it sounds pathetic but one of these days if I was to have a child, and 
if the child was to be born with epilepsy, I would, I couldn’t help but feel 
that would be my fault and I couldn’t help but, I’d be constantly waiting for 
that day when that child would turn around and say to me “mum, how 
would I, how did I get my epilepsy?” what would you say back to that child 
“erm, well I passed it on to you.  By the way, I passed it on to you”?  I 
know it’s not your fault but it’d be one of them things that you have to live 
with every day of your life  
 
The selection of preferred pregnancy outcomes was reliant on receipt of risk 
information to support consideration of the positive and negative outcomes of 
decisions made to change treatment, whether the outcomes affected their own health or 
that of a future baby, and whether the positive or negative outcomes were acceptable. 
Participant FG71 reflected on her experience of agreeing to take AEDs during 
pregnancy: 
FG71:  To get all the facts, to know everything it’s really important I think, 
because nine months is a long time, to wait, you’re carrying that little baby 
around. I mean when we were waiting for [name of eldest child] to be born, 
to see whether he’s going to have a deformed lip. That was like the worst 
ever. But, it was my choice. Even though, I was still on edge and worried. 
It was my choice. And if he was born with a, hare lip, then there was, they 
told us there was operations, and. So there are positives all the time. 
There’s always, a way out of things. (45 year old) 
 
Participant FG71 highlights the comfort she had taken from her receipt of information 
about the management of cleft lip abnormalities, while she had remained hopeful for 
the best outcome of her pregnancy. 
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Pregnancy related decisions were made in response to information, and through the 
processes of risk communication women responded to treatment recommendations and 
interventions to negotiate their preferred approach to their first and subsequent 
pregnancies. The case of participant OI16, who had a 12 year son, revealed her 
ambivalence towards a future pregnancy and preference to increase her dose of sodium 
valproate to improve seizure control and improve her own quality of life. OI16 
accepted the clinician’s warning of potential future risks if she were to plan pregnancy, 
revealing her decision to restrict family size had been influenced by the unpredictable 
risks of seizures:    
OI16:  I think a lot especially if I am going to have kids in the future… I think 
about it that much that I’m thinking I might not have any more kids 
because of my epilepsy. Because especially at night, I find it very difficult, 
if I’m up too long, I don’t get enough sleep and things like that, how am I 
supposed to do it, if I am going to have another, a baby? Because when I 
had my boy, I dropped him a couple of times because I had a little jerk and 
that’s kind of like put me off as well, having any more kids.  
 (29 year old, pregnancy intentions not stated) 
 
The discovery of pregnancy in women who judged their pregnancy as planned also 
resulted in a struggle to feel comfortable with the possible outcome of their 
preconception decisions: 
FG124: I mean, you know read up as much, I mean probably excessively but as I 
said I still decided to go ahead but I mean I was happy with the lamotrigine 
[…] I didn’t really enjoy my pregnancy as I wanted to because I was just a 
nervous wreck for 9 months […] so I’m 8 weeks now and I haven’t told 
anybody {Group offers congratulations} […] I mean it is planned and this 
is what I want but it is just going to be a whole 9 months now of fear but 
obviously it has been okay the first time round I just hope it is the same 
again. (32 year old)  
 
Negotiation was central throughout the process of preconception decision-making, and 
women relied on the provision of information and clinical opinion before making 
decisions, needing to be aware of the available options to support advanced planning. 
 
8.4 Summary Results: Decision-making in preparation for pregnancy 
 Decisions to review pregnancy plans were motivated by the need for additional 
information, advice and reassurance. Decisions to avoid or delay the approach for 
review were influenced by assumptions about the anticipated content of advice 
and information, and by the prior experience. 
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 Decisions concerning life-style changes were interpreted as a natural part of life 
(e.g. moving in with a partner, getting married, starting or stopping contraception 
and deciding to try to conceive) and were not seen as being part of the epilepsy 
clinic agenda. Updates on preconception information were an opportunity to 
introduce these topics into routine epilepsy review. 
 Judgements concerning the preference for, and acceptability of, decisions made 
concerning future pregnancy plans were not static and were subject to change. 
This point emphasises the potential influence of new information on prior beliefs 
and the need to update preferences. 
 Negotiation of pregnancy decisions refers to the sharing of treatment preferences. 
The preferences of both clinicians and women were not static and were influenced 
by changing opinions, changing trends in prescribing and the influence of new 
information.  
 Decisions concerning preferences for pregnancy were emotive and influenced by 
the content of the risk message and the situation of its delivery. These were 
influenced by the presentation of available options and the emphasis of 
responsibilities towards the health of the future baby. 
 Informed decision-making was dependent on having a trusting relationship with a 
consistent health care provider able to provide the ‘best advice’, which included: 
sufficient time for women to consider the information provided, supported 
questioning and provided direction to trusted sources of additional information. 
 Women were found to require practical and emotional support when making 
changes with treatment due to the fears of the impact of changes both upon 
seizure control and life-style.  
 Fearing the consequences of decisions made about treatment (whether to remain 
on treatment, switch to an alternative or withdraw treatment) did not always result 
in adherence with clinical recommendations due to the uncertainties of predicting 
individual response, and the uncertainties surrounding the impact of AEDs on the 
health of the unborn child.  
 Risk benefit assessments supported decision-making and women anticipated a 
proposed treatment plan, which was agreed without compromise, amended or 
rejected. Negotiation of treatment changes needed to address women’s 
anticipation of time commitment. 
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Chapter 9 A model of preconception counselling  
Introduction 
The preconception counselling model draws together the study findings of the three 
inter-related substantive themes of ‘pregnancy planning’, ‘communicating risk and 
uncertainty’ and ‘decision making in preparation for pregnancy’. This chapter 
describes the development of a model of preconception counselling (see Figure 9.1). It 
illustrates the ‘pregnancy contemplation ladder’ with supporting evidence, before 
testing the model’s explanatory function through analysis of women’s interpretations 
of making ‘selfish decisions’ in relation to preparation for pregnancy. 
 
9.1 Description of the model of preconception counselling 
The aim of developing a model for preconception counselling (the model) is to help 
target the delivery of interventional activities that mirror the reproductive life-cycle of 
women, while recognising the inconsistencies seen in clinical practice in relation to 
decision-making both from a clinician and patient perspective. The model targets 
promotion of shared decision-making as an approach to elicit patient preferences and 
practically support decision-making within the context of uncertainty, when the ‘right’ 
decision depends on the patient’s own needs and outcome goals (Coulter and Collins, 
2011, p.11-12).  
 
9.1.1 The pregnancy contemplation ladder 
The model has been developed as a bi-directional continuum to reflect the 
interventional stages required to accommodate the changing life circumstance, 
motivations for pregnancy, and preferences for risk management experienced by 
WWE. The model builds upon existing social cognition theories including self-
efficacy, risk perception, planning behaviours, and outcome expectations as active at 
differing stages of behaviour change (Whitelaw et al., 2000) - a point emphasised in 
Biener and Abrams’ (1991) Contemplation Ladder, which was originally developed to 
identify an individual’s motivational stage to consider smoking cessation. The 
‘contemplation ladder’ and other stage theories have been applied to predict 
reproductive health behaviour change, including folic acid consumption and condom 
use (Prochaska et al., 1994; Milan and White, 2010). 
                                                                                                             A model of preconception counselling  
 186 
 
Figure 9.1 A model of preconception counselling  
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Precontemplative / Future pregnancy 
intentions 
Review epilepsy management: 
▫ Review preconception health 
promotion opportunities 
▫ Commence folic acid 
Assessment of pregnancy risk: 
▫ Provision of risk information 
Review risk management options 
Question risk management preferences: 
▫ Agree a preconception action plan 
Barriers to planning 
Knowledge deficits: 
▫ Preconceived ideas of planning 
▫ Perception of infertility 
Ineffective / no contraception 
Not considering pregnancy a risk 
Negative outcome expected  
Perceived lack of support 
 
Contemplative / immediate 
pregnancy intentions 
Optimise epilepsy control: 
▫ Review treatment objectives 
Review preconception health: 
Confirm adherence to folic acid 
Update risk assessment: 
▫ Update risk information & details of 
the UK Epilepsy & Pregnancy Register  
Review risk management preferences & 
reconfirm preconception action plan   
Decision Support 
Question areas of concern about 
pregnancy and planning: 
Review responses to changes in life 
circumstance. 
Question changes to pregnancy 
intentions? 
Preferred risk management 
strategies?  
              
 
Taking action / trying to conceive 
Optimise epilepsy control: 
▫ Warn against abrupt AED withdrawal 
▫ Maintain preferred treatment 
Review preconception health 
▫ Maintain folic acid 
▫ Review & update information needs 
▫ Confirm risk management preferences 
& preconception action plan targets 
▫ Reinforce importance of maternal 
health needs. 
  
Decision maintenance /trying to 
conceive: 
Maintain epilepsy control & promote 
preconception health (continue folic 
acid)  
Maintain agreed treatment targets and 
action plans for pregnancy management 
Update risk information  
 
Barriers to implementing plans 
Fears of perceived risks: 
▫ Mistimed/accidental pregnancy 
▫ Failure to respond to changing 
circumstances 
Risk avoidance strategies: 
▫ Abrupt AED withdrawal 
▫ Termination of an otherwise 
wanted baby 
Desire for ‘normal’ pregnancy 
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The model (Figure 9.1) presents a ‘pregnancy contemplation ladder’, which was 
adapted as an indicator of readiness to prepare for pregnancy. Each rung of the ladder 
represents the position an individual is at in their stage of thinking about the health 
behaviour, such as in Biener and Abrams’ (1991) ‘contemplation ladder’ where the 
first rung indicated ‘no thoughts of quitting smoking’. Within the model each rung 
indicates a stage of pregnancy intention. The stages of change are ranked in order of 
level of pregnancy intention, from: no thoughts of pregnancy (precontemplation), 
beginning to think about pregnancy in the future (contemplation), through to deciding 
to try and conceive (taking action) and maintenance of preconception behavioural 
change during the interval between trying to conceive and conception (maintenance). 
The relevance of adapting the ‘contemplation ladder’ to predict pregnancy intentions 
and readiness to action preconception health recommendations relied upon making an 
association between Biener and Adrams’ (1991) validation study developing a single-
item self-report measure of an individuals motivational stage, and the psychological 
concept of motivation. Motivation is influenced by risk perceptions and perceived 
threat (such as, considering the risks of treatment in relation to the risk of experiencing 
accidental pregnancy, as motivation to use contraception), which help to stimulate 
outcome expectances (such as, considering the use of contraception to prevent 
accidental pregnancy and reduce the risk of experiencing pregnancy on a least 
preferred treatment), which further stimulates self-efficacy (such as, confidence in 
preventing pregnancy until completion of a treatment change) (Schwarzer and Fuchs, 
1995).  
 
The contribution of the ‘contemplation ladder’ to the present study findings was the 
potential to assess a woman’s pregnancy intentional stage and thereby target 
preconception interventions likely to motivate positive changes in reproductive health 
behaviour. The contemplation ladder has wider application within the present study, 
and figure 9.2 illustrates my own adaptation of the ladder for WWE considering 
commencing folic acid, a stage which represents women at the precontemplative stage 
of pregnancy intentions within the model.  
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Figure 9.2 Contemplation ladder 
(Adapted from: Biener and Abrams, 
1991)43 
 
 
 
 
 
 
 
 
 
 
 
The contemplation ladder addresses the motivations expressed by women as they 
consider approaching their GP to access referral for preconception counselling; 
representing the contemplation stage (steps 3-6). This stage involves women reviewing 
AEDs, continuing contraception, commencing folic acid and seeking information such 
as internet searches or contact with voluntary organisations.  
FG-I-03: … you plan to get pregnant, you can plan that yourself sometimes, can’t 
you, or it just happens and it’s a happy accident or whatever. But I think 
planning it while you’re epileptic is a lot to plan, I think.  (23 year old) 
 
The model recognises the bi-directional staging of pregnancy planning reflecting the 
experiences of WWE; which requires interventions to focus on both optimisation of 
seizure control and pregnancy intentionality, while remaining sensitive to the 
communication of risk messages as motivation for women to adhere to clinical 
recommendations, and their completion ahead of decisions to try to conceive 
(Schwarzer and Fuchs, 1995, p.163-4). 
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 Reproduction of the contemplation ladder with permission from Professor Lois Biener (02-07-12)  
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No thought of 
starting folic acid 
Think I need to 
consider starting 
folic acid someday 
Think I should start 
folic acid but not 
quite ready 
Taking action to 
start folic acid 
(e.g. seeing GP 
for prescription) 
Starting to think 
about how to take 
folic acid as part of 
my drug regimen 
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9.1.2 Contemplating pregnancy 
Awareness of the importance of planned pregnancy was critical if women were to 
make timely access to epilepsy review, and was a pre-requisite to supporting informed 
decision-making, illustrated by a 34 year old pregnant participant reflecting on her 
experience preparing for her first pregnancy: 
FG96:  I know I went, before I thought of becoming pregnant the first time, I just 
went to the GP, because of the sort of conversations I’d had with the 
epilepsy nurses over the years about getting pregnant, and having to think 
about it with this history… He [GP] referred me to the, is it the 
preconception clinic, or something like that, but also said, there’s no 
particular concerns just carry on… by the time I got the appointment for 
this preconception clinic at the hospital, I was actually pregnant, so 
anyway, that was sort of superseded by events. But, it was quite reassuring, 
it was the sort of medical advice really, I think. By the time we’d made a 
decision to start trying, we didn’t do anything until we went to see the 
doctor [GP], and then, he said, that no particular issues, but had he, had that 
advise been slightly different, then that would have influenced me    
 
The reassurance she reported from her GP had inadvertently reinforced her attempts to 
conceive, rather than delay pregnancy until she had attended preconception review. 
This action had acted as a barrier to opportunities to improve pregnancy outcome by 
reducing preventable adverse risks before conception. The experience of FG96 reflects 
a common experience of women presenting pregnant at the time of preconception 
review as a consequence of making separate decisions: initially deciding the stage of 
immediate pregnancy intention; secondly, deciding to stop contraception; and thirdly 
deciding to attend clinic. The significance of this finding is its ability to shed light on 
the failure to associate consequences of separate/isolated decisions (involving 
behavioural actions), all of which have influence upon the effectiveness of 
preconception counselling to reduce adverse pregnancy outcomes.    
 
9.1.3 Stages of pregnancy intentions    
Women made changes to their pregnancy intentions in response to personal 
circumstances (changing relationship status) including, motivational influences (for 
example, changes in job or career influencing timing to commit to family plans), 
changes in epilepsy control (the relapse of seizures, or changes with AEDs), and in 
response to new information. Participant OI01 exemplifies changes in pregnancy 
intentions: 
186.  P:     […] if you’d of asked me 3 years ago, I’d  
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187.   of said no children ever.  But I don’t know, once you are happy with  
188.   somebody you kind of change your perspectives doesn’t it.  So,  
189.   yes, I mean, if an accident happened, then, you know, I would be  
190.   quite happy with that, but I mean, I’d be looking within maybe the  
191.   next 2, 2 or 3 years. (OI01; 29 year old, future pregnancy intentions) 
 
An important barrier to implementing preconception interventions was perceived 
infertility, exemplified by a sub-group of women who interpreted their failure to 
experience accidental pregnancy as proof of their infertility. Not using contraception 
was a barrier to accessing preconception review and resulted in mistimed and 
‘accidental’ pregnancy: 
OI16:  I just thought yes I’m getting married now, and in the future I’ll have kids, 
you have all these thoughts when you are a young girl, you’re going to get 
married, have kids. I just thought OK I’ll get married, and we’ll see what 
happens and then I got pregnant. 
Interviewer: Yes, so a bit sooner than you anticipated? 
OI16:  Oh yes.  Definitely   (29 year old, 12 year old child)  
 
The experience of surprise for OI16 upon discovery of pregnancy despite not using 
contraception reveals knowledge deficits concerning fertility, and implies not being 
adequately prepared for pregnancy. Women were receptive to opportunistic reminders 
of pregnancy planning activities and updates of their information needs. Women taking 
action on the provision of information and requesting preconception epilepsy review 
(contemplators) were receptive to recommendations to alter AEDs and commence folic 
acid. For some, this extended to accepting health promotion activities such as stopping 
smoking and abstinence from alcohol, especially when reinforced by information 
about the health benefits. In contrast, precontemplators were defensive about 
recommendations to make changes to their epilepsy control, as they lacked the 
motivation for change, and the potential outcome of destabilizing epilepsy control for 
some was judged as a higher risk than a future pregnancy. 
 
9.1.4 Acting-on pregnancy intentions 
Pregnancy intentions, expressed as a woman’s desire to try to conceive represent the 
decision to engage in behaviours likely to result in the desired outcome (pregnancy), 
such as withdrawing contraception. Eleven focus group participants were pregnant at 
the time of participation. Five of these referred to their pregnancy as planned, defined 
by some level of intentional behaviour change prior to conception (stopping or 
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reducing smoking, discussion with epilepsy specialist, maintenance or commencement 
of folic acid and/or stopping contraception). Of the women experiencing unplanned 
pregnancy, two, were in their second pregnancies, had received preconception 
counselling prior to their first pregnancy and had not returned for preconception 
update. Another woman experiencing her third pregnancy had attended preconception 
review in preparation for her second pregnancy, while her current twin pregnancy (7 
months gestation) was reported as a surprise (both in relation to her experience of 
pregnancy despite reporting use of condoms, and in relation to her discovery of twin 
pregnancy). One 23 year old participant (FG84) admitted to thinking about pregnancy 
in response to several of her friends becoming pregnant and, whilst her own pregnancy 
was unplanned and complicated at conception taking high dose sodium valproate44, 
FG84 reported her response to pregnancy discovery as being ‘absolutely made-up’ 
tempered by ‘finding it hard to come to terms with’: 
FG84:  I started to read up on everything I can about pregnancy and epilepsy and 
all these websites I went on I just broke down because it showed you all 
these pictures of deformed babies with cleft palates  (1
st
 pregnancy) 
 
In contrast, women were able to be supported to plan pregnancy and benefit from 
engaging in preconception health promotion, for example, commencing folic acid 
ahead of withdrawal of contraception: 
FG124: I think you just try to because of the risks, the high risks that you have with 
your medication, causes high risks and things. I think I just try to 
compensate thinking if I can eat healthier and just daft things like. So that 
was part of my planning I tried to be healthier. (32 year old, 2
nd
 pregnancy) 
 
9.1.5 Preconception counselling interventions 
The model challenges women’s preconception health beliefs by raising awareness of 
the benefits of taking action in advance of pregnancy intentions, thereby increasing 
preconception folic acid consumption and improving overall preconception health. By 
challenging beliefs of pregnancy risk and fertility status, targeted preconception 
interventions will support informed decision-making regarding contraceptive use and 
practice, thereby assisting women better time conception. Knowledge deficits about 
folic acid use and its value in preconception risk reduction were barriers to making an 
informed decision-making about commencing supplementation prior to attempting to 
                                                 
44
 The significance of women of childbearing age taking sodium valproate is discussed in greater detail 
in Chapter 2, highlighting the dose-related congenital malformation risks and dose-related risks of neuro-
cognitive delay and conditions such as fetal valproate syndrome. 
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conceive. Recommendations from the clinician and supply of a prescription for folic 
acid improved women’s adherence despite having knowledge deficits: 
FG111: [Clinician] told me about this the other day.  It decreases if you are on 
more than a 1000mgs with Epilim this is just what I know, then you have 
got a 10% chance if you give birth to your child is going to have 6 fingers 
or spina bifida. I have only got like a 5% chance of it but if I take folic acid 
it would like cut in half. So I’m not sure what they do but it must be good 
[…] I was just told that because I have been with my boyfriend for, so it is 
like a long-term relationship, that the doctors put me on it [folic acid] just 
in case. And that was it really that was all they told me. (16 year old) 
 
9.1.6 Risk communication 
Risk communication is required at all stages of pregnancy contemplation. The 
differing needs for increasing women’s awareness of potential risk, and their needs for 
risk information in response to their stage of readiness to plan and take action to try 
and conceive must be taken into account. In contrast, the barriers to implementing 
planning activities included women’s emotional responses to risk information, and 
their preference for information which emphasised the certainties of drug-specific risks 
rather than uncertainty. The emotive responses to risk information were also shown to 
result in women making decisions based on the powerful imagery of risks to the future 
unborn baby.  
 
The discovery of pregnancy has been described by several women as arousing their 
fears concerning the risks associated with continued AEDs use and/or their experience 
of seizures and the consequences upon the health of the unborn baby - a response 
suggested as ‘the fear setting in’. The implications of fear arousal were to heighten the 
perceived threat of adverse outcomes:  
FG75:  finding out you’re pregnant, and you’ve got epilepsy. It’s amazing, but 
there’s also that element of fear of the implications. And then, when you’ve 
had the baby, how the isolation. But also the, if I have a seizure, and I’m 
looking after my baby, bathing my baby, blardy, blardy blar, am I going to 
be me more prone to postnatal depression?  (26 year old) 
 
The model focuses upon interventions that develop personal coping strategies, by 
assisting women develop preconception action plans and supporting their involvement 
in appraising the available options to manage future pregnancy risks. Women will be 
supported to question their risk management preferences within preconception and 
epilepsy review visits.  
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9.1.7 Barriers to planning and implementation 
The model focuses on addressing knowledge deficits, for example, prior assumptions 
and misinterpretations of pregnancy risk as significant barriers to women engaging 
with epilepsy services prior to pregnancy. The conflicting definitions held by some 
women and clinicians of what preconception counselling is, along with predetermined 
ideas of what pregnancy planning might entail, resulted in women failing to recognise 
the significance of health warnings to complete changes of treatment prior to trying to 
conceive, or to commence folic acid and securing effective contraception during 
preconception review. 
 
9.1.8 Decision Support 
The purpose of decision support is to prompt consideration of the ‘pros and cons’ of 
pregnancy planning at all stages of pregnancy contemplation. The questions focus on 
preferences for pregnancy preparation, in which the ‘pros’ are seen as the strength of 
motivation to action preconception recommendations, while the ‘cons’ are the 
disadvantages and perceived negative outcomes of the proposed preconception 
interventions.         
 
Successful preconception review requires women to make judgements concerning their 
intentions for pregnancy and to establish goals for achievement of a planned 
pregnancy. This requires changes in behaviours and attitudes concerning pregnancy 
and perceptions of pregnancy-related risk. The support is intended to reflect women’s 
requests for assistance in engaging in preparatory discussions concerning future 
pregnancy intentions, by opportunistic questions about changes to intentional status, 
and review of their likely responses to changing circumstance so that appropriate 
interventions can be targeted.  
 
9.2 The ‘selfish decision’  
The sub-theme ‘selfish decision’ emerged as an extremely emotive response to 
describe decisions to have a baby and as a rationale for risk management, which I felt 
required further investigation in the context of the model.  
 
 
                                                                                                             A model of preconception counselling  
 194 
9.2.1 Participant cases constructing the ‘selfish decision’ 
The majority of women referred to managing their emotions surrounding the decisions 
they made during preparation for pregnancy as a necessary stage they had to endure, 
seeking to defend themselves against any potential criticisms by defining their 
decisions as, one, being justified, and two, what any woman would have chosen under 
similar circumstances. Emotional responses influencing women’s decision-making 
have been shown to include blame and guilt and to result in anxieties, worries and 
fears, and for a sub-group extended to include concerns about being identified as 
‘selfish’. Table 9.1 illustrates the word frequency of the terms selfish and selfishness in 
comparison to more common terms such as risk, pregnancy and planning, 43 instances 
were found of the term selfish/selfishness in relation to reproductive decisions made 
within 16 participant accounts (19% of the total population)45. The term ‘selfish 
decision’ in the context of reproductive decision-making implied women had a free 
and open choice of a range of differing options. However, the reality for many women 
was of epilepsy management presenting a polarized choice between trying for a baby 
and accepting the pregnancy-related risks or accepting not having a child. Seizure 
freedom as the goal of epilepsy management resulted in women being presented with 
choices either to withdraw treatment or to manage self regret if a future child were to 
have a disability. 
 
 Word frequency 
 
Study stage 1 
Focus Group 
Study stage 2 
Clinic observation/Interview Total  
Self 51 38 89 
Selfish 5 57 62 
Selfishness 4 7 11 
‘Selfish decision’ 6 37 43 
Risk, risky 549 1383 1932 
Pregnant, pregnancy 905 1455 2360 
Plan, planned, planning 532 615 1147 
Table 9.1 Analysis of transcript word frequency 
 
9.2.2 Placing personal interests ahead of the needs of the future child 
Table 9.2 summarises the interpretation of ‘selfish decisions’ as those decisions made 
by women placing their own personal interests ahead of the health of a future child. 
                                                 
45
 Nineteen percent of the total study population referring to a ‘selfish-decision’ appears high, however, 
many women made a single references (6 participants), whereas one participant (OI23) refers to her 
selfish-decision in eleven instances. 
                                                                                                             A model of preconception counselling  
 195 
Whilst the majority of women found an acceptable balance between meeting their own 
needs and those of the unborn baby prior to conception (Chapter 7, Section 7.2), 
exploration of the process of assessing risk information by women who interpreted 
their pregnancy decisions as selfish implied a defence against perceived future 
criticism of their responsibility to meet the interests of the unborn baby prior to 
conception.  
 
Stacey et al (2011) has shown the value of decision support in promoting shared 
decision-making in her Cochrane Systematic Review evaluating the support needs of 
people facing treatment and screening decisions. Decision aids were defined by Stacey 
et al (2011) as evidence-based tools designed to prepare a patient to participate in 
decision-making. Decision aids should ‘provide detailed, specific and personalized 
information’ about a health condition and the ‘benefits, harms, probabilities, and 
scientific uncertainty’ concerning the treatment decision. The goal of using decision 
aids is to increase the patient’s awareness of the ‘value-sensitive nature of the 
decision’, and ‘provide structured guidance’ in the steps they need to consider when 
making a treatment decision’ (Stacey et al., 2011, p.3). These authors identified the 
need to improve informed values-based choices when patients are presented with 
differing treatment options, where ‘choices’ between treatments are offered, and where 
each option has benefits and harms which may be valued differently (Stacey et al., 
2011). Stacey and colleagues (2011) found decision aids were found to be ‘more 
effective than usual care to improve patient’s knowledge of their treatment options’ (p. 
19). Interventions using decision aids were found to improve the accuracy of patient 
perceptions of their outcome probabilities and reduce decisional conflict. Stacey et al 
(2011) felt these findings were clinically important, concluding ‘usual care may not be 
good enough when informing patients about complex, value-sensitive decisions’ 
(Stacey et al., 2011, p.19).  
 
The context of making of a ‘selfish decision’ which resulted in bring a disabled child 
into the world was interpreted as being selfish as a consequence of placing of one’s 
own desires or interests above those of the baby, or deciding to have a baby despite the 
presence of additional risks and uncertainty. Expanding on the latter point, several 
women struggled to cope with their pregnancy-related decisions and defined 
themselves as selfish because they had not felt able to imagine a future in which they 
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could cope with, care for or love a disabled baby. The finding that decision aids were 
not use within the observed epilepsy consultations, may have resulted in some women 
experiencing decisional conflict. These findings led to the development of the model of 
preconception counselling, as a means of supporting women as they considered 
pregnancy decisions; decisions that were felt to be both complex and highly sensitive.   
 
Participant ID & 
pregnancy 
intentions 
No. of 
quoted 
instances 
Participant definition of ‘selfish decision’ 
OI23 Immediate 11 Preference to stay on AEDs to avoid seizures and blame for disabled child 
FG-I-01 None 2 Preference to avoid deterioration in seizure control 
FG84Unplanned 
pregnancy 
1 Mature approach to improve seizure control, sign of being a good Mum   
FG86Planned 
pregnancy 
2 Preference for safety net of Epilim to maintain seizure control 
OI17‡ Future 4 Duty of parent to protect baby from risk 
OI13 Future 2 ‘Fairness’ to desire a child and motive to plan pregnancy 
FG123 None 1 Restriction of family size due to epilepsy 
OI22 Immediate 4 Preserving lifestyle, selfish towards future child 
OI12 Future 3 Focus on personal lifestyle preferences, avoidance of disability 
OI01 Future 1 Prioritise personal healthcare and priority towards future child 
OI20§ Immediate 5 Not wanting a child with disability, inability to cope with disability  
OI10  Immediate 2 Justification for not wanting a child with disability 
OI04 Future 2 Avoiding inheritance risk, dilemma of partner’s family history of epilepsy 
OI05 Not stated 1 Avoid parenthood in relation to probability of child’s inheritance risk 
OI21‡ Future 1 Avoidance of guilt associated with a 2nd pregnancy taking Epilim 
OI08 Future 1 Judgement of ‘others’ concerning acceptable risks 
§ (OI20) conceived shortly after index consultation, intention was immediate at clinic observation with no 
prior experience of pregnancy. 
‡ (OI17 & OI21) participants experienced termination of pregnancy, OI21 due to in utero diagnosis of spina 
bifida.  
(FG84 & FG86) participants in 1st pregnancy at recruitment and focus group participation. 
Table 9.2 Defining a ‘selfish decision’  
 
The terms selfish and selfishness were also used in response to the perceived public 
moral judgement either directed to them as a woman with epilepsy allowed to have a 
baby, or towards their abilities to care for a disabled baby as a mother with epilepsy. 
This revealed the complex dual focus of identity transitions - from a woman 
contemplating her future pregnant and motherhood identity, while simultaneously 
constructing the identity of their future fetus (this stage is significant as only 3 
participants in this analysis were pregnant at the time of study participation). 
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9.2.3 Decisions to conceive 
Selfishness was used to defend decisions: either not to have children (FG-I-01), or 
have children and accept the status quo. In the case of FG-I-01, the decision not to 
have children shed light on her beliefs about unmanageable worsening seizure control 
if she acted on her pregnancy intentions. FG-I-01 reflected over the decisions she had 
made when she had contemplated pregnancy and the uncertain disruptions to her 
seizure control caused by changes to AEDs and commencement of folic acid, both of 
which were felt to cause unforeseen adverse reactions, and finally within pregnancy 
and future motherhood, the influence of added stress and sleep disturbance: 
FG-I-01: I used to work with a girl … she was epileptic and she had a family ... she 
had really bad seizures because she was coming off her medication, and 
having the folic acid … But she’d gone through it, she carried on through it 
…. And I don’t think I could. In a way really I suppose you could say I’m 
too selfish for it, because I didn’t want the pain of sort of like, and the 
knocking of confidence if you like. To go through all that … now my 
immediate thought with kids is, night feeds and this kind of thing ... So I 
think, like getting overtired, and the stress of having the babies, you sort of 
think well why? […] the uncertainty of having to change your medication, 
the side effects of the medication and if it would affect the epilepsy side of 
it. […] And like I say the selfishness of it, the tiredness, financial and just 
everything else sort of stems up from that […] I think it is the consequences 
of what would happen if things sort of started to go pear-shaped […] and 
I’m not particularly bothered about kids anyway, I just don’t see the point.   
 (44 year old) 
 
The conclusion of FG-I-01’s self-assessment had been her decision to reject any desire 
for pregnancy, as she was ‘not bothered about kids’. The weighing of ‘pros and cons’ 
during contemplation of future pregnancy revealed FG-I-01’s emphasis on the 
consequences of making changes to her epilepsy management, and the influence of 
uncertainty supporting her rejection of any personal benefits that might have resulted 
from her experience of pregnancy and motherhood.       
 
Participant OI22 preferred to maintain the status quo, by deciding not to make changes 
to her AEDs. The following excerpt exemplifies the emotional struggle needing the 
clinician’s approval that her decisions were justified:  
47.  P:  Cause this sounds really selfish but I just don’t want my life to  
48.   change. I don’t want to go back to it, not  
49.   being able to drive or stuff like that 
50.  C:  Yes, yes. I mean 
51.  P:  It probably does sound selfish on my child, but I just   
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52.  C:  Well, I mean, if it’s, everybody is different, everybody  
53.   has there own agenda in a sense, of what they want, and  
54.   it sounds to me like, your driving obviously is very  
55.   important to you. As you say, it sounds like your work   
56.  P:  Yes  
57. C:  Sort of is very much dependent on your driving  
58.  P:  Yes and I can’t have disruptions at work, I just can’t 
 […] 
665.  C:  Has that sort of covered what you think, and you are you alright? 
666.  P:  I’m probably the worst I probably come across the most selfish 
667.  Partner: Yes 
668.  C:  Listen, no not at all, I mean all your worries they are very valid,  
669.   and I don’t think that at all, and I understand where  
670.   your anxieties are coming from, you are just like thinking, thinking  
671.   through everything aren’t you and you’re trying to cover all bases 
672.  P:  Yes and you do think, yes and you do, well naturally, you think I  
673.   better prepare myself, because it is easier to do that than suddenly  
674.   have a shock   (OI22; 32 year old, immediate pregnancy intentions) 
 
The clinician accepts OI22’s preference to retain the ability to drive as grounded in her 
need to maintain employment and her current lifestyle. OI22 reveals her motivations to 
eliminate the uncertain probability of losing seizure control during pregnancy 
alongside the dual motive of preserving her driving status. The result of OI22’s 
presentation of her preferred risk management strategy is the clinician’s reassurance 
about the normality of preserving seizure control, in both her desire to manage 
perceived risks and to prevent unexpected outcomes. 
 
9.2.4 Moral dilemmas 
The tendency for women to value the health of a future baby prior to conception 
highlights the competing interests between maintaining epilepsy control and the 
desires to reduce or eliminate the potential adverse risks for a future baby. For some, 
this dilemma revealed a struggle to reconcile beliefs about the value of life of all 
children, independent of disability, against a desire to avoid delivering a baby affected 
by disability, implying a woman’s moral responsibility:  
OI10:  Well like I say [Clinician] only said, about the skull malformation thing at 
first, so I thought, straight away, so I just thought, oh no that’s terrible 
[laugh]. And then when I found out about the learning difficulties I mean 
I’ve got a [relative] who’s got cerebral palsy … I know it’s probably a 
selfish way of looking at things. But like I see my [relative], he’s 21 now 
and he’s still in nappies, she’s had so much hassle, and I think, oh my god. 
You worry about all these things, and I think well [breath exaltation sound] 
if in the planning if you like, before the baby … If I had a baby and it had 
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learning difficulties or it had some kind of you know, due to me taking 
tablets, if, I’d feel terrible. Because they’ve got that for life, or what ever. 
So I think something as simple as coming off your tablets and just doing 
without driving for a few months if that could prevent anything like that, 
then that suits me. So I don’t know if that’s the right way to be, I don’t 
know   (30 year old, immediate pregnancy intentions) 
 
OI10 rationalized her decision to withdraw from treatment as being to avoid having a 
disabled baby, as opposed to a selfish decision to have remained on treatment during 
pregnancy. The perceived selfish decision to want a pregnancy reveals a tendency to 
evaluate the pregnancy options as either having a pregnancy or not, and the pregnancy 
outcomes as either delivering a healthy non-disabled child or not, with the outcome of 
a having a child with disability as being a lifelong commitment. 
 
In contrast OI05 considered the commitment to having a child as requiring her to 
provide a safe future for her baby and protect against the harms from exposure to 
seizures. This illustrates a process of weighing up to the ‘pros and cons’ of pregnancy. 
Treatment options are seen to offer the opportunities to reduce risk, whereas focusing 
on inheritance risk reinforced personal traits that could not be changed. In the case of 
OI05, her choice not to contemplate pregnancy was to prevent cruelty to a future baby 
and her moral duty by preventing passing her epilepsy on to the next generation: 
OI05:  if I did have a child, then if the child would inherit it. If it did, I couldn’t do 
it, definitely, couldn’t. But I think as, as time goes on, I’d know more. But 
at this stage, that is definitely my main concern … even if it didn’t inherit 
it, with what I’ve got, I’d be petrified if I had a weird feeling and then to 
that stage were I would have a full blown, and if say, I was holding my 
child, I dread to think, I actually don’t, I do dread to think, no I couldn’t, 
definitely at this point, if I was to have a child, I’d say no. I would say no if 
I was given, if I was given the chance to do it, definitely no. But, things can 
change can’t they […] But I think for me, it will, probably still be as strong 
in the future as it is now. Probably, because I couldn’t be selfish and say oh 
I want a child, so I’ll have a child […] does that sound cruel? 
Interviewer: What makes it feel cruel? 
OI05:  To the child, because what I’ve got, is what I’ve got. And I wouldn’t want 
any, I wouldn’t wish it on anyone, because it’s not nice to have, but I 
definitely would not want to pass it on if I had a child, I would not want to 
pass it on. (29 year old, pregnancy intentions not stated) 
 
OI05’s case sheds light on the process of considering reproductive choices and 
attempts to predict future outcomes, such as, the experience of seizures (or likelihood 
of relapse), response to treatment (if changes were made), the outcome of pregnancy 
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and child neuro-cognitive development, or the future child’s chance of inheriting 
epilepsy before it has occurred. 
 
9.2.5 Identity and the transition to pregnancy and motherhood 
The model developed from participant accounts, which highlighted the value placed on 
adopting an internal locus of control46 over their own health as a means of optimising 
future pregnancy outcomes. Constructing the ideal of a ‘good mother’ required women 
to demonstrate their ability to achieve a planned pregnancy and their ability to cope 
with becoming a mother with epilepsy. This was socially constructed through 
interactions with other women (including family and friends), health professionals, and 
the wider social community including social media. The experience of women’s 
interaction with other women, in the main, was through contact with women who did 
not have epilepsy. Only a minority of participants identified role models in a friend or 
relative with epilepsy. For other women, positive role models of women with epilepsy 
were not readily available, and the internet a ready source of frightening pictures of 
things that could go wrong. Attending the epilepsy clinic, in contrast, offered the 
majority of women the opportunity for information updates, and access to the 
clinician’s experience of women having successful pregnancies and healthy babies:     
OI13:  because you don’t think about yourself when you think you are planning on 
a child. You think now I hope the child’s fine, all this, so that is the main 
thing. Because again if the risks are high for the child then, and if they are 
extremely high then I wouldn’t be happy about it but I would have to give 
up the thought of having a child, because that would just be my own 
selfishness, if I went ahead with it kind of thing. So that is the biggest thing 
for me, if the child would be safe or what the risks are for the child.  
 (28 year old, future pregnancy intentions) 
 
The importance of helping women to be able to see themselves, as being able to be a 
good mother, was fundamental to the construction of decisional support to challenge 
the barriers to planning and implementations of pregnancy action plans. WWE have 
been shown to be vulnerable to unplanned pregnancy as a consequence of knowledge 
deficits, adding further to their support needs:   
OI21:  I can’t describe it, it’s just because I had that termination I’ve lived with the 
guilt for so long. But at the same time I know I did that right thing, because 
since then I’ve [employment] with spina bifida and oh my god it would 
have been so awful to see that. But it’s affected my whole life, I’m 35 now 
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and it’s shaped my whole life that happening to me. It’s not just something 
that happened and I got over it straight away, I know no one really gets 
over things like that, but, yes it’s affected every single thing since that 
happening to me […] maybe I am just being selfish, I don’t know 
 (35 year old, future pregnancy intentions, experience of termination of 
pregnancy at 16 years of age, following diagnosis of major malformation) 
 
Women with prior experience of termination of an unplanned pregnancy were able to 
reflect on the impact upon their contemplation of future transitions into pregnancy and 
motherhood. For one 33 year old, the decision to prepare for a future pregnancy was 
seen as identifying herself as responsible both for her own health and that of the future 
child by instigating preconception review and accepting recommendations to switch 
AEDs as preparatory action: 
OI17:  … if I was planning, but at the moment I couldn’t even consider not taking 
my medication. Maybe that sounds selfish on my part or on any, it’s a 
dilemma isn’t it … maybe if I was pregnant its something I’d go yes stop 
taking it but from my point of view and the support [required] I would 
never consider I don’t think, I mean this is me in a position of not being 
pregnant, but I would never consider not taking my anticonvulsant 
medication […] It’s worth managing this risk … something that can be to a 
degree could be managed. And that isn’t being selfish. There are two sides 
to that […] People could think that you are being selfish but I don’t. There 
is part of me that thinks no actually not … it’s about the planning its about 
being aware and balancing the risk of me dying and dying with a child or 
me managing that risk being monitored … you would rather that 
percentage than not give birth at all   (future pregnancy intentions) 
 
9.2.6 Conclusion       
The analysis of women’s ‘selfish decision’ has served to support the model’s validity 
by deepening understandings of the processes in which women seek to defend their 
approaches preparing for pregnancy. The model is able to highlight women ambivalent 
towards their pregnancy intentions by focusing interventions to improve preconception 
health and encourage adherence to contraception especially in the precontemplative 
and contemplative stages of pregnancy intentions. The model is also able to 
accommodate women’s ‘selfish beliefs’ concerning reproductive decisions through its 
focus on the emotional support required by women during stages of decision-making, 
and concerning recognition of changes in circumstance that influence motivations to 
take action on pregnancy intentions.   
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9.3 Summary Results: A model of preconception counselling 
 The findings presented in this Chapter demonstrate pregnancy planning and 
intentions to conceive as multidimensional concepts, which extend beyond the 
presentation of risk information into aspects of decision support required by 
women as they navigate the emotionally charged stages in their reproductive 
lives.   
 The model of preconception counselling presented targets both barriers to 
pregnancy planning and the barriers to implementation of pregnancy plans, by 
focusing interventions to improve self-efficacy in the areas of epilepsy self-
management, and to increase awareness of the benefits of risk prevention 
through targeted health promotion interventions.  
 The staging of interventions along a continuum of pregnancy contemplation 
was designed to enhance a woman’s self-awareness of her pregnancy intentions, 
and support delivery of appropriate interventions to minimise fear arousal and 
promote preconception awareness and self-efficacy. 
 Consideration of the ‘selfish decision’ sheds light on the processes of staging 
pregnancy preparation. This highlighted women’s responses to pregnancy 
intentions and challenges current practice by recognising the complex roles 
adopted by women considering preconception interventions and the barrier to 
implementation. Elements of the model need clarification, suggesting further 
investigation of such issues as its predictive function, and extensions of decision 
support to assist women commence preparatory actions in collaboration across 
the wider multidisciplinary healthcare team.  
 
In the next Chapter I will discuss the thesis findings presented in the five Results 
Chapters in the context of previous published work in this area. I will critically 
appraise the study methods and findings against the Quality Criterion described in 
Chapter 4 as well as in relation to previous research. The final Chapter will draw 
conclusions upon this thesis before directing future research and clinical practice in 
this area.        
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Chapter 10 Discussion 
Introduction 
This chapter provides a discussion of the thesis findings. The major outputs from this 
work are two-fold; first the completion of a Cochrane systematic review of 
preconception counselling to reduce adverse pregnancy outcomes for WWE, found no 
high quality evidence of the effectiveness of preconception counselling interventions. 
The Cochrane review recommends further investigation to prospectively evaluate the 
outcome of preconception counselling, delivered at different stages of a woman’s 
reproductive life likely to influence pregnancy planning behaviour (Chapter 2); and 
secondly, the qualitative analysis of the experience of WWE preparing for pregnancy 
(Chapters 6 – 9). This qualitative study set out with the aim of exploring perceptions of 
risk and probability of adverse pregnancy outcome from the perspective of 85 WWE 
of reproductive age; identifying a complex set of responses to risk which presented 
challenges to women before, during and after clinic attendance and had a significant 
influence upon their responses to pregnancy planning, risk management and 
reproductive decision-making. The discussion will demonstrate the interconnectedness 
of these findings and their contribution to extending the extant knowledge in five 
important ways: 
1. Pregnancy planning – Women define “planning” differently to health 
professionals. 
2. Communicating risk and uncertainty – Women perceive risks as frightening 
and fearful. Not all women perceived or managed risks and uncertainties in the 
same way. 
3. Decision-making in preparation for pregnancy – Decision-making is not easy; 
in practice decisions are complex, challenging, and spread over time.  
4. Model of Preconception Counselling – Preconception Counselling can be 
integrated into a continuum of stages supporting women’s pregnancy decision-
making. 
5. Methodology – Qualitative analysis has provided a sensitive approach to 
considering the context and processes of reproductive decision-making. This 
final section, will evaluate both the strengths and limitations of the approach 
taken throughout this thesis.      
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10.1 Pregnancy planning 
This study’s findings reaffirm the struggle experienced by WWE to plan pregnancy 
(Fairgrieve et al., 2000). Fairgrieve et al (2000) estimated less than half of all 
pregnancies in WWE are planned, and rates remain comparable to those quoted in the 
general population (Gipson and Santelli, 2011).  
 
10.1.1 What planning means 
The current study’s findings present a possible explanation for the continued 
experience of unplanned pregnancy despite preconception interventions, suggesting 
differing meanings and interpretations are used to define pregnancy planning whereas 
women describe planning in terms of trying to conceive, clinicians describe planning 
as involving activities to change treatment, improve seizure control and improve 
general health. Women defined their plans to become pregnant as involving 
withdrawal of contraception. For some this was the only activity implemented prior to 
trying to conceive. A minority of women associated planning with starting folic acid. 
The result is that women are being asked by their clinician to plan (to conceive), with 
the result (becoming pregnant) counter to what the clinicians had meant for them to do.  
 
Preparations for pregnancy were found to be reliant on a number of factors extending 
beyond the recognition of plans for pregnancy – including changes in circumstances, 
such as marriage and settling down in a home, and age influencing the perceived ‘right 
time’ to attempt to conceive. Women described their individual desires for a family as 
stages within their preparations for pregnancy, judged simultaneously as 
normal/natural and high risk, and motivating the search for additional information 
and/or request for preconception epilepsy review. Desire for a family represented a 
variable focus of attention, with some women describing plans for pregnancy as 
progressing towards an ‘urge’, while for others, changes in circumstance resulted in 
desires shifting focus. The US qualitative study by Stanford et al (2000) identified the 
importance of understanding a woman’s lifetime goals for childbearing as relating to 
values and desires for family, motivating fertility behaviours, and influencing 
perceptions of the right time for pregnancy. Stanford et al’s (2000) findings highlight 
the implications of WWE failing to account for changes in their fertility behaviour and 
the relevance of epilepsy review in relation to their experience of planning pregnancy.  
                                                                                                                                                        Discussion  
 205 
The observed link between women’s struggle to interpret pregnancy planning activities 
and their actions to optimise epilepsy management might be illustrated by Figure 10.1, 
a theoretical framework informed both by the study findings and the work of Fishbein 
(1972), Prochaska et al (1994) and Connor and Norman (1995) concerning social 
cognition. This presents a linear perception of pregnancy intentions and decisions to 
try to conceive, in which epilepsy review is seen as a delay or deviation as a 
consequence of misunderstanding what is meant by ‘planning’. One implication for 
practice is the possibility that clinicians will need to take account of women’s changing 
circumstances in the context of recommended treatment changes, and explicitly 
enquire about contraception use and pregnancy desires. 
 
 
Figure 10.1 The process of preparing for a planned pregnancy 
 
The term ‘mistimed’ pregnancy has been applied by Barrett and Wellings (2002) to 
describe women experiencing pregnancy before the perceived right time, highlighting 
that women define ‘planning’ as ‘associated with producing a birth at a specific time’. 
A similar conclusion was drawn by Earle (2004) who proposed the term “laissez-faire” 
pregnancy to describe women who were less clear of their pregnancy plans, were not 
using contraception, and described their approach to pregnancy such as “if it happens it 
happens” (Earle, 2004). Earle’s findings are similar to those in the present study of 
women’s ambivalence about planning by the partner of a woman receiving fertility 
assessment, who suggested they used the term ‘planning’ ‘loosely’ as they no longer 
Preparations for 
pregnancy/ 
Epilepsy Review 
Searching for information 
& seeking support from 
health professionals 
Presentation of risk and 
uncertain information 
Decision to action 
preparations for pregnancy 
Attempts to conceive 
Motivations for pregnancy 
– decisions concerning 
personal circumstances 
Influence of significant 
others 
Recognition of pregnancy 
intentions 
Withdrawal of contraception 
Knowledge deficits 
Knowledge deficits 
Barriers WWE defined pregnancy plan  
                                                                                                                                                        Discussion  
 206 
felt able to conceive to a timetable. This point is further illustrated by Oakley (1979, 
1981) in her sociological analysis of the transition to motherhood: 
Few organise their lives according to some overall plan … the subject of children 
provokes ambivalent feelings, so that ‘planning’ is an euphemism for allowing one 
particular feeling or pressure to gain an upper hand. An additional complication is 
that conceiving a child is not like buying a three-piece suite: demand and supply 
may not be easily equated (Oakley, 1979, p.32) 
 
As implied by Oakley’s quote, the term ‘planning’ can hold differing meanings for the 
same women at different times in their life and in relation to different life events. The 
notion of allowing one’s desires to gain the upper hand was also found in the accounts 
of women in the current study, for example, the expressed desire for a ‘natural’ 
approach to becoming pregnant – interpreted as letting nature decide (“if it happens it 
happens”). These findings corroborate those of earlier UK qualitative analysis of the 
abilities of women in the general population to ‘exercise agency with respect to 
conception’, suggesting the concept of planning represents an ‘illusion’ of control 
(Earle and Letherby, 2002). The current study also highlights the difficulties 
experienced by WWE interpreting recommendations to plan pregnancy. The 
proposition that intentions to become pregnant are more accurately measured as a 
continuum between ‘planned’ and ‘unplanned’, with most pregnancies positioned 
between the two extremes (Bachrach and Newcomer, 1999), is strengthened by the 
findings of Barretts et al (2004) that women occupy a range of positions relating to 
pregnancy planning. Earle (2004) highlights the varied experience of planning in 
which some women’s definitions of planned pregnancy most closely resembled 
contemporary health promotion, linking planning to consultation with health 
professionals and commencement of folic acid. In a UK study, Pashley and 
O’Donoghue (2009) identified 46% of their study population of WWE as experiencing 
planned pregnancy defined by the authors as ‘steps a WWE should take before 
pregnancy to minimise harm to the infant’, a definition they suggested ‘avoids the 
complex and fluid notion of whether a pregnancy was intended’.  
 
An integral part of the meaning applied to the term ‘planned pregnancy’ was translated 
into reproductive behaviours (stopping contraception) and ‘preconception activities’ 
(starting folic acid). Epilepsy management activities, such as changes to AEDs in 
teenage years or early adulthood, were not readily described as activities forming part 
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of a ‘planned pregnancy’. The failure to define such preparatory activities as part of the 
process of ‘pregnancy planning’ requires attention, especially as Pashley and 
O'Donoghue (2009) and Meador, et al. (2011) have suggested causality between 
adherence to preconception activities and the outcomes of pregnancy. Within the 
recent epilepsy literature, there has been a tendency to compare pregnancy planning 
status with pregnancy outcome (Betts and Fox, 1999; Pashley and O'Donoghue, 2009). 
In particular, preconception folate use was found by Meador’s group to be associated 
with higher verbal outcomes in children and was therefore proposed as a key 
preconception intervention (Meador et al., 2011). However, further research on this 
topic needs to be undertaken before the association between preconception folic acid 
supplementation and improved fetal outcomes is more clearly understood. Studies 
which take these preconception variables into account will need to be undertaken, 
consistent with recommendations by Nicolai et al (2008) for preconception recruitment 
of women in studies investigating neurodevelopmental delay in children exposed in 
utero to AEDs.  
 
10.1.2 Barriers to planning 
The majority of women accepted guidance on preparing for pregnancy from health 
professionals, a finding in keeping with others (Thompson et al., 2008; Griffiths et al., 
2008). This was illustrated by women referring to receiving preconception information 
at an earlier stage in their life (when they had no thoughts of pregnancy) as raising 
their awareness of their future needs (precontemplative stage of pregnancy planning). 
Women welcomed their GP’s opportunistic questioning of pregnancy intentions but, as 
shown by others (Fairgrieve et al., 2000), their ability to recall preconception 
recommendations and reliably action their return to the epilepsy clinic before 
pregnancy remains uncertain. Crucially, the timing of clinicians’ questions concerning 
pregnancy plans was important. Some women preferred to be asked about their 
information needs, rather than being expected by the clinician to raise the topic. This is 
consistent with Prunty et al’s (2008) analysis of motherhood choices by women with 
multiple sclerosis. The current study’s findings are in support of opportunistic delivery 
of preconception information. They are consistent with a multidisciplinary approach 
involving GPs, raising preconception awareness during routine primary health care 
visits, and enquiring of pregnancy plans, and the offer of preconception counselling as 
part of their annual epilepsy review (NHS Employers and British Medical Association, 
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2011)47. The importance of finding opportunities for GPs to initiate and extend the 
availability of preconception counselling has been reported previously in a randomised 
trial in a general population sample in the Netherlands, which found increased service 
uptake by women considering pregnancy in the next 1-2 years, without increased 
worry (de Jong-Potjer et al., 2006; Elsinga et al., 2006). Finding women reassured by 
the opportunistic provision of preconception information was important in the context 
of the current study, as it highlighted the potential unmet information needs in this 
group. The need for additional information led some women to search the internet, and 
whilst some women found the internet a convenient resource; others sought guidance 
from their clinician to direct them to trusted sources of additional information. This 
latter finding is supported by De Santis and colleagues warning of the ‘variable quality 
of online medical information’ which ‘cannot be considered a substitute for informed 
medical advice’ (p.157).   
 
Receipt of uncanvassed pre-pregnancy risk information was problematic for some 
woman within the present study, who felt the clinician should first enquire about their 
requirements for such information. The exception to this rule was raised by women 
experiencing an accidental pregnancy, where knowledge deficiencies were felt 
instrumental. Acceptance of opportunistic questions concerning pregnancy plans was 
also supported by a subgroup of women who identified their preconception 
information needs as for ‘advanced planning’, including of what to expect during 
pregnancy in advance of when needed, and what their future pregnancy plans might 
entail. However, an important finding in the present study was that some women 
interpreted the clinician’s questions about their plans as indicating approval to ‘go 
ahead’ and consider pregnancy. 
 
The finding that women felt embarrassed raising topics concerning pregnancy and 
contraception helps to explain failures sometimes to disclosure changes in personal 
circumstances, and highlights the importance of opportunistic reminders about 
preconception information and of adequate time to prepare for pregnancy. In keeping 
with this study’s findings, other qualitative research examining women’s decisions 
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drugs who have a record of information and counselling about contraception, conception and 
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about the timing of motherhood identified a number of individual, familial and societal 
factors influencing personal beliefs and values about the readiness for motherhood 
(Benzies et al., 2006). Furthermore, Benzies et al (2006) supported this study’s finding 
that adolescent women were as likely as older women to express their life plans for 
motherhood and family. Supported by the work of Miller (1994) on the timing of 
pregnancy, desires for pregnancy were found to relate to perceptions about the ‘right 
time’ for pregnancy. Other studies have also shown that attitudes towards pregnancy 
are not static and develop in response to changing circumstance and over time (Miller, 
1994; Oakley, 1979). This was illustrated by women reporting a sense of urgency to 
conceive at the perceived right time, and responding to the influence of their biological 
clock. As shown elsewhere (Stanford et al., 2000), some women were concerned about 
their ability to conceive when the right time had arrived.  
 
A belief expressed by several women was that epilepsy or AEDs could influence their 
chances of becoming pregnant. This is in keeping with reports of higher rates of 
infertility and menstrual difficulties experienced by women with epilepsy (Davis et al., 
2008), and concerns about fertility expressed by women considering pregnancy in the 
future (Crawford and Hudson, 2003). Previous pregnancy did not eliminate all these 
concerns, congruent with findings from the current study that women struggled to 
change prior beliefs and concerns despite clinicians’ reassurance and provision of new 
information. This emphasises the requirement for preconception information to be both 
credible and trusted (Douglas, 1990, p.11-12). Further complexities around pregnancy 
planning behaviours are illustrated by the finding that women with experience of 
adverse pregnancy outcomes were no more inclined to plan future pregnancy or 
implement preconception recommendations. This is comparable to the findings from 
Holing and associates (1998) who, in their study of diabetic women’s experience of 
pregnancy, were unable to demonstrate a link between preconception knowledge 
deficits and the likelihood of a planned pregnancy (Holing et al., 1998). The influence 
of preconception knowledge deficits on pregnancy planning and upon delays in 
accessing antenatal care have been documented by Mayer (1997) in their hospital-
based survey of postpartum women without epilepsy. A similar pattern emerged in the 
present study among the sub-group of women pregnant during study participation, 
where the experience of an unplanned pregnancy was associated with perceived delays 
in the discovery of pregnancy. Fairgrieve and colleagues’ (2000) UK prospective study 
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of the care of pregnant WWE is frequently cited in relation to the preconception 
knowledge deficits associated with unplanned pregnancy.  
 
Analysis of the barriers to a planned pregnancy in the current study population 
identified a widespread belief that WWE were unable to plan pregnancy. This was 
further supported by the clinicians drawing attention to the general population of 
women being ‘poor planners’. Further, the general view held by participants about the 
unpredictable consequences of ‘life with epilepsy’ was seen to inhibit planning 
opportunities and restrict options for health improvement prior to conception, a finding 
in support of others in the field (Thompson et al., 2008; Pashley and O'Donoghue, 
2009; Crawford and Hudson, 2003; May et al., 2009). The current study revealed three 
distinct motives for non-attendance for preconception counselling: women’s concerns 
about the ‘public gaze’ focused on them by openly stating their ‘plans for pregnancy’; 
the issue of ‘hiding failed attempts to conceive’ and preventing unwelcome questions 
drawing attention to possible infertility; and perceptions of the likely chances of 
getting pregnant being improved by preconception interventions. These findings are 
supported by the work undertaken by Hosli and colleagues (2008) in a non-epilepsy 
population, which explored why Dutch women did not participate in preconception 
counselling and found that almost half of their participants associated preconception 
counselling with advice about (in)fertility. These authors concluded that the aims of 
preconception counselling should be made more explicit and that there is a need to 
challenge what is considered ‘sufficient knowledge’ both of the preventive role of 
preconception counselling and personal risk (Hosli et al., 2008).  
 
In the present study, teenagers with epilepsy, who were in most cases at a 
‘precontemplative’ stage in relation to pregnancy, were found to be receptive to the 
clinician proposing a time scale for initiating AED changes in relation to their future 
pregnancy plans, and willing to accept delays to conception until the AED changes 
were complete, especially when they perceived a low risk of adverse outcomes on the 
new AED. The timely delivery of preconception messages was crucial, and several 
teenage participants identified that they were in established relationships and had 
immediate desires for family, prompting their search for information and guidance. 
The findings from the Oregon Pregnancy Risk Assessment Monitoring System 
(Adams et al., 1993) survey raised concern about the unmet preconception health 
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needs of adolescents in their population sample, finding only 9.2% to be taking folic 
acid and that these adolescents more likely to report unintended pregnancy (62%) 
when compared to older women. This resulted in recommendations for focused 
interventions among young women who are not contemplating pregnancy (Rosenberg 
et al., 2003).  These findings are extended by the current study, which highlights 
women’s variable responses to preconception recommendations as associated with 
stage of pregnancy contemplation rather than age per se, with women preferring to 
delay taking action to change AEDs, or preferring to commence folic acid as affording 
some protection while remaining on ‘higher risk’ AEDs. The provision of risk 
information at the precontemplative stage was revealed as not always motivating 
women to implement recommendations and prepare for pregnancy, and the study 
highlighted an important finding around women’s precontemplative attitudes towards 
pregnancy.  
 
The current study adds to the literature in the field, revealing that while WWE share 
many of the same challenges as women in the general population over timing of 
pregnancy, and similar beliefs to women with other chronic illnesses about likely 
fertility difficulties, the low rates of planned pregnancy amongst WWE can be in part 
explained by confusion surrounding the terminology used to promote ‘planned 
pregnancy’, and requires clinicians to ask appropriate and timely questions to identify 
women at greatest need of preconception interventions. The implications for the design 
and conduct of future research evaluating the effectiveness of preconception 
counselling, is the need to specifically define the preconception interventions; 
including, clearly defining the role of both the health professionals and WWE, and the 
context of interventional delivery targeted at a woman’s stage of pregnancy intention 
(See Reviewers' conclusions in JB Winterbottom et al., 2008, and also Chapter 2.4).  
 
10.1.3 Summary 
The importance of understanding pregnancy planning behaviour has been the focus of 
public health research, emphasising the significance placed upon preconception health 
improvements for maternal and infant health (Kost et al., 1998; Carson et al., 2011; 
Gipson and Santelli, 2011), and for reducing maternal mortality for WWE (Lewis, 
2007; de Swiet et al., 2011). In the present study, the significance of women’s 
perceptions of what pregnancy planning means, defined as attempts to conceive, may 
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explain the frequent withdrawal of contraception and resultant pregnancy before 
receiving preconception counselling. Deviation from the perceived natural process of 
pregnancy planning requires acknowledgement of the additional work entailed in 
advance of conception, especially as that may represent unwelcome delays to 
conception. This finding is supported by Thompson et al (2008) in their ‘moral 
guidelines of reproduction’, who reported the experience of receiving specialist advice 
in advance of planning pregnancy as variable, with a focus upon warnings against 
pregnancy on certain AEDs, failure to warn against avoiding pregnancy during 
recommended treatment changes and clinicians making recommendations judged as 
‘counter intuitive’ to what women perceived as being a ‘good mother’.    
 
10.2 Communicating risk and uncertainty 
The majority of women had some awareness of the risks of pregnancy, perceiving 
AEDs as potential sources of disability for their future baby and seizures as potentially 
life threatening either to themselves, their baby, or both. The most significant findings 
were: 1) that not all women perceived risk in the same way, and 2) women’s responses 
to preconception information were often highly emotive. Both of these factors had 
influence upon women’s approach to risk management. 
 
10.2.1 Risk perception 
Women perceived risk as potential dangers and harms (e.g. “dangerous drugs”), and 
uncertainties surrounding, for example, the long-term affects of in utero AED exposure 
upon an infant’s neurodevelopment as sources of anxiety. Fear was a central concept 
within the analysis, representing an emotional reaction to risk communication 
influenced by the vividness of descriptive imagery around the anticipated outcome. 
Risk information was interpreted by study participants as both reassuring and 
threatening. The measure of reassurance or threat were found to be both person 
specific and topic specific, with similar risk information presented to different women 
resulting in differing responses. The differing perceptions of risks held by women were 
important findings, paralleling the study by Helbig et al (2010), who found individual 
perceptions of risk, and personal values and beliefs, were influential upon perceptions 
of the effects of epilepsy.  A number of authors have reported over-estimations of risk 
with study participants quoting figures considerably higher than published data 
                                                                                                                                                        Discussion  
 213 
(Marteau, 1989; Jasper et al., 2001). The same pattern emerged for the majority of 
women in the present study, though a small group of women denied awareness of any 
issues concerning pregnancy and epilepsy. A similar conclusion was reached by Pack 
and colleagues (2009) who assessed awareness of the teratogenicity of AEDs, and 
reported most women as not knowing whether AEDs affected fetal development, and 
some believing there was no teratogenic effect of category D AEDs48. The latter is 
consistent with the present study finding. Several women identified their risks as 
related to epilepsy per se rather than AEDs or seizures, and utilized risk information to 
reassure themselves and see their risk as equivalent to women in the general 
population.  
 
The pervasive character of pregnancy-related risks identified by Turner et al (2008) 
may help explain the responses to pregnancy-related risks of present study participants, 
where AED and seizure-related risks were most commonly referenced, and more 
limited reference was made to the AED-related risks upon neuro-cognitive 
development and risks of Autism Spectrum Disorder for children exposed to AEDs in 
utero. Santucci et al (2010) examined women’s experience of being counselled about 
medication-induced birth defects, and reported that women preferred comprehensive 
information on all potential impacts, a finding consistent with those of the current 
study, where women questioned the content of risk information and the clinician’s 
provision of the latest research or reference to the Epilepsy and Pregnancy Register.  
 
10.2.2 Communication of risk 
In the present study, clinicians’ presentation of seizure-related risks included 
statements of the probability of experiencing a seizure during pregnancy as dependent 
upon pre-pregnancy seizure control and relative to adherence to AEDs during 
pregnancy. The possibility of changes in seizure control during pregnancy and the 
unpredictable nature of seizures were commonly cited by both women and clinicians 
as barriers to considering drug changes and reasons for maintaining the ‘status quo’. 
Changes in seizure control were perceived as risking harm to the developing fetus and 
to the woman as a result of seizure-related injury and the possible social consequences, 
for example, driving eligibility. Risks were also framed by time, both specifically in 
                                                 
48
 US Food and Drug Administration’s category D drugs includes AEDs with positive evidence of 
human fetal risk: carbamazepine, phenobarbitone, phenytoin, primidone and sodium valproate.   
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relation to pregnancy, and more loosely relating to the uncertain lengths of time of 
preparing for pregnancy and future-time concerns around motherhood and childcare 
safety. The temporal nature of definitions of pregnancy-related risks is consistent with 
Heyman’s (2010) analysis of risk communication in clinical practice, suggesting 
personal time framing has the potential to create variance in perceptions of ‘time 
horizons’, leading to conflict and misunderstandings. Heyman (2010) characterises the 
influence of time framing surrounding pregnancy, suggesting the risk time horizon 
may focus on the length of pregnancy, whereas for others it may become ‘embodied’ 
in a future envisaged life with a disabled child (p.114-5). Applying Heyman’s 
perspective in the context of the preconception epilepsy review would require 
clinicians to ‘appreciate the variety of temporal perspectives adopted’ by women ‘and 
the implications of such differences for risk management’ where presentation of risk 
information emphasising causation can inadvertently create worry about the future, 
which itself can become a risk factor (Heyman, 2010, p.115). The results are also 
consistent with those of other studies and suggest that perceptions of risk status vary in 
response to a women’s reproductive status and plans for further children, as first 
highlighted by Lippman-Hand and Fraser (1979a) in their qualitative study of 
women’s experiences of genetic counselling: 
…recall of rate information depends on the relevance of this information to the 
family at the time they are asked to remember it. Those whose families are 
incomplete are likely to retain these facts: others are not. Thus, recall can be 
expected to change with time. (Lippman-Hand and Fraser, 1979a, p.55)   
 
Research into communication of the risks concerning fetal alcohol spectrum disorder 
(FASD) identifies that health messages framed around loss (i.e. presenting the baby as 
suffering from FASD) were more effective in promoting preventive health behaviours 
and in promoting seeking information. It highlights the importance of targeting risk 
information to women’s intentional stage, since women at the precontemplative stage 
viewed the threat of FASD as far distant from them (Yu et al., 2010). Extrapolation of 
such findings to the current study must, of necessity, be tentative. Further research is 
required into the impact of risk framing upon WWE preparing for pregnancy 
generally, and specifically upon women treated with sodium valproate who face the 
greater risk of having a baby affected by fetal valproate syndrome.  
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The work of May and colleagues (2009) examined the implications of heightened 
perceptions of risk for WWE, who experienced ‘great worry’ during pregnancy 
concerning malformation risks to their newborn child. Women’s heightened 
perceptions of having a disabled child both prior to and following consultation, and the 
potential barriers to engaging in preconception consultations following the initial 
arousal of fear, requires further investigation. Observations in the epilepsy clinic 
highlighted the use of communication strategies by the clinician emphasising the 
objective nature of risk (with frequent reference to the results of the UK Epilepsy and 
Pregnancy Register or MRC AED Withdrawal Study (Chadwick et al., 1996)). Implicit 
within clinician presentations of risk information was the suggestion of ‘high risk’ 
labels, constructing risks relative to exposures to AEDs or having seizures, or risks 
relative to clinician-supervised AED withdrawal versus the heightened risks of abrupt 
AED withdrawal. In contrast, the probabilistic status of risks to fertility (lowered), 
inheritance (increased), childcare safety (increased) were emphasised by the narrative 
presentation of risk. The communication of risk framed negatively was found to 
influence both risk perception and ‘informed’ decision-making, in keeping with 
conclusions made by Jasper et al (2001) about the influence of framing bias upon 
decision-making. Experimental research into risk perceptions has found that decisions 
were more likely influenced by interventions in which outcomes or the status quo were 
framed positively than when negatively framed (Marteau, 1989). This contrasts with 
the current study, where some participants were reassured by negatively framed risks. 
Extending earlier research by Gordon et al (1996), the present study also identified 
variability in what constituted acceptable risk of seizure recurrence. Some women, 
presented with percentages of up to 10% risk of delivering a child with major 
congenital malformation, interpreted the risk as lower than anticipated, in contrast to 
other women who judged any risk to the health of their child as unacceptable.  
 
The experimental study by Choi and colleagues (2011), comparing numeracy among 
adults with epilepsy compared to normal controls, presents a possible alternative 
explanation of women’s variability in response to risk presentation. Choi et al (2011) 
found many patients had poorer numeracy skills and were more likely to exhibit 
framing bias, misunderstanding the risk information typically presented by clinicians 
and being at risk of making uninformed decisions. This difficulty may have been 
extended for women in the present study when clinicians combined numeric and 
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narrative risk information. A limitation of applying the findings by Choi and 
colleagues (2011) within the context of the current study is their failure to differentiate 
gender differences within framing bias. As shown elsewhere (Knapp et al., 2004), the 
tendency for clinicians to present narrative descriptions of the probability of adverse 
pregnancy outcome may lead to overestimations of the level of harm and may result in 
patients making inappropriate decisions about whether or not to take medications. 
 
The use of narrative information about treatment risk or outcome probabilities is seen 
as established healthcare practice, using first or third person stories of experience to 
assist patients to make sense of their situation and support decisions concerning 
treatment options and illness management (AE Winterbottom et al., 2008). The 
persuasiveness of the clinician’s use of ‘stories from practice’ have been linked to the 
‘vividness of information’ and ‘credibility of the speaker’ (AE Winterbottom et al., 
2008), with the most striking finding from the current study being how several 
participants changed their minds in response to descriptions of the risk to their future 
child affected by neuro-developmental delay secondary to in utero AED exposure.   
 
The unpredictability of responses to the communication of risk among women 
interpreting the risks of adverse pregnancy outcome following in utero exposure to 
AEDs emphasises the findings of others. For example, Einarson, et al. (2001), 
researching women’s abrupt discontinuation of antipsychotic drugs during pregnancy, 
reported reasons for discontinuation included fears of birth defects and harming the 
fetus, concerns extreme enough for one woman to elect termination, and others to 
remain off treatment despite experiencing adverse withdrawal effects. The authors 
found counselling did not reassure all women about the safety and benefits of resuming 
treatment, and whilst 61.1% restarted their medication, not all were sufficiently 
reassured to breastfeed (Einarson et al., 2001). In a systematic review of genetic risk 
perception and decision-making, clients’ unpredictable responses to risk 
communication was emphasised (Sivell et al., 2008).  
 
Despite the relative importance of women’s judgements about their clinician as being a 
source of accurate and personal risk information, many were critical when reflecting 
upon the content of risk communication and critical of clinicians’ expressions of 
uncertainty. Uncertainty was perceived as a source of worry, highlighting the unknown 
                                                                                                                                                        Discussion  
 217 
risk of adverse pregnancy outcomes. For some women, this led them to be critical of 
clinicians’ statements of uncertainty, seeing this as discrediting their expert status a 
finding consistent with the work of Douglas (1990). Douglas (1990) examined the 
cultural debate about risk, in which experts’ reference to risk has been ‘unequivocally 
used to mean danger from future damage’ and where the degree of risk exposure can 
be taken for granted as ascertainable. Therefore, Douglas (1990) proposed that anyone 
insisting on the presence of a high level of uncertainty could leave themselves open to 
be judged as ‘opting out of accountability’- for example, in the context of the current 
study, a clinician’s insistence on the level of uncertainty around drug-related risks may 
heighten a woman’s sense of responsibility for the outcome of pregnancy and increase 
the likelihood of her discontinuing drugs upon discovery of pregnancy (p.9). 
Understanding women’s response to uncertainty has important practice implications, 
emphasising the value of developing strategies that promote self-efficacy. Whilst 
clinicians can not eliminate uncertainty as inherent in medicine, encouraging women to 
gain confidence in their ability to take positive action; to plan pregnancy, optimise 
seizure control and commence folic acid, has been demonstrated in the current study to 
help some women manage uncertainty.    
 
10.2.3 Risk management 
The presentation of risk information was seen as essential for women to be able to 
compare their available options and clinicians often requested women consider the 
risks and benefits of proposed treatments. Corbin’s (1987) study of pregnant women 
with chronic illness identified women as ‘balancing’ perceived benefits of medical 
interventions against the risks of intervening, the women as being torn between 
competing interests. This finding is supported by the current study in which WWE 
managed their perceived pregnancy risks by acceptance of interventions judged as ‘not 
adding to the risks’ and tending to adhere to clinician recommendations, with some 
responding by ‘doing everything possible to give their future child the best possible 
chances’ a response termed by Corbin (1987) as ‘protective governing’. In the context 
of the current study, some women were found to accept less favourable odds of their 
epilepsy remaining stable through pregnancy in preference to reducing or stopping 
treatment, whereas others justified maintaining seizure control as a way of avoiding 
additional seizure-related risks to their future child. The variable responses to risk by 
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WWE were in keeping with the earlier research by Gordon et al (1996) concerning 
parental responses to their child’s seizure relapse risk. 
 
Fear was an unexpected response to the clinician’s risk message, and might be 
tentatively explained by Witte’s (1997) research evaluating ‘fear appeals’. Witte 
(1997) reported variable responses to fear, as either motivating behaviour change by 
promoting risk reduction opportunities, or representing a barrier through denial or 
defensive avoidance, and where failure to provide information about the preventive 
opportunities influenced ‘fear control processes’. For example, Witte (1997) found 
teenagers who perceived the high threat of pregnancy, but had low efficacy to prevent 
the threat, responded by avoidance and ‘not thinking about getting pregnant’, 
suggesting the effectiveness of risk communication was reliant on clearly defining the 
threat and defining the strategies to intervene.    
 
The similarities between attitudes towards risk expressed by women in the current 
study and those described by Witte (1997) support a link between clinician 
communication about pregnancy risks, and women’s avoidance of thinking about AED 
risks. In the present study some women struggled to envisage a positive outcome for 
pregnancy due to their concerns about harming their baby, while other women were 
able to moderate these concerns as not requiring their attention until they were 
pregnant or had delivered their baby. Further, the sub-group of participants pregnant at 
the time of study participation described themselves as ‘living on their nerves’, and 
talked about worries as to whether they might deliver an AED-affected baby as a 
consequence of their AED adherence during pregnancy. At the same time, their 
worries were tempered by the increased need to know the ‘worst case scenario’. It is 
possible, therefore, that some women’s response to fear maybe to avoid seeking 
information or discussing pregnancy with their clinician. These findings are in contrast 
to others, such as Lupton’s (1999) positioning of the pregnant woman as protecting the 
fragile fetus, wherein risk avoidance behaviours are considered a moral enterprise 
relating to a woman’s need to adopt self-control and accept ‘institutional and expert 
objectives’ (p.90). Miller (2005) suggests women’s interaction with the medical model 
during pregnancy provides reassurance by the ‘authoritative knowledge’ in which the 
use of screening technologies and compliance is judged as being safe and responsible 
(p.49-52). These differences in findings can help explain the varieties in responses to 
                                                                                                                                                        Discussion  
 219 
risk by the women in the current study, where only limited reassurance was offered by 
ultrasound screening to detect the extent of AED-related risks.        
 
The responsibilities expressed by women in terms of their guilt and self-blame 
concerning pregnancy decisions, focused upon risks as distinct categories of competing 
concern, for example, mother versus baby, or seizures versus AEDs. This resulted in 
decisions being interpreted as difficult and some women struggling to make them, 
while others saw themselves as selfish and subject to public scrutiny if they gave birth 
to a disabled baby as a consequence of decisions they had made. This finding 
corroborates the ideas of Lippman-Hand and Fraser (1979a) in relation to genetic 
counselling who suggested: 
The difficulty of decision-making was brought on not only by the risk these 
women faced but by the fact that something could go wrong (either-or) and there 
would be social (and psychological) implications if they took a chance and lost  
(Lippman-Hand and Fraser, 1979a, p.61) 
 
Women in the current study were found to perceive blame from their partner’s family 
for anticipating making a bad decision, and the consequences of the results of selecting 
their needs above the unborn child. Perhaps the most striking finding from this thesis 
was the emotional response to risk and its influence upon decisions to plan pregnancy 
and decisions to act on intentions to conceive. Whilst other authors have reported 
emotional responses of blame, this has been limited to the study of pregnancy or 
retrospective accounts of experiencing pregnancy (Corbin, 1987; Lane, 1995; Miller, 
2005; Berg and Honkasalo, 2000). Few have studied perceptions of risk during 
preparation for pregnancy. Supporting the current findings, Thomas (1997) in her 
study of disabled women considering pregnancy, reported women’s self-blame for the 
consequences of their decisions: 
[…] considerations of ‘risk’ were an important feature of the women’s 
reproductive journeys […] disabled women often share, albeit sometimes 
ambivalently, in the wider social and medical discourses about what constitutes 
reproductive ‘risks’. Having a child with an impairment is seen as something to be 
avoided, and if it occurs, is experienced with feelings of ‘guilt’ which spring from 
the knowledge that their actions in having a child are widely seen as both 
irresponsible and ‘unfair’ to the child. (Thomas, 1997, p.631) 
 
The finding that women’s assessment of risk differed from the advice offered by their 
clinician has important implications for risk management decisions made by women in 
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the current study. Turner and colleagues (2008) investigated worries about childbirth 
in WWE compared to women without epilepsy, reporting that women with higher 
seizure frequency experienced significantly higher levels of fear about childbirth both 
during pregnancy and after delivery. Similarly, in the current study, women pre-
conceptually reported anxieties about worsening seizures during childbirth. One 
participant reflected on her heightened fears concerning her own mortality and that of 
her unborn child, fearing she was killing her baby because of her inability to prevent 
her seizures worsening. Turner and colleagues (2008) openly questioned women’s 
fears about pregnancy, identifying WWE were significantly more likely to fear 
delivering a baby with malformation when compared to non-epilepsy controls, who 
were more fearful of pain in childbirth. These findings are extended by the current 
study, which identifies women as expressing worries and fears concerning their 
likelihood of delivering a baby with malformation even before pregnancy.  
 
The limited opportunities for WWE to know other women with epilepsy with positive 
experiences of planned pregnancy was highlighted by the present study, with huge 
value placed on positive role models and reliance on the clinician’s use of ‘stories from 
practice’. Prior studies into clinical consultation have noted the importance of the 
clinician’s choice of exemplars as sources of bias outcomes being influenced by the 
case selected and nature of risk being emphasised (Charles et al., 1998). The type of 
exemplar case selected by clinicians within the current study was found to influence 
women’s perceptions of the likelihood of AED-related harm to their future baby. The 
data from the present study confirms Charles et al’s (1998) proposition, with examples 
of children affected by learning disability heightening women’s awareness of their 
ability to care for a future affected baby, one participant making comparison to 
thalidomide.  
 
Uncertainty information influenced risk avoidance behaviour, some women perceiving 
themselves as having limited options for achieving a successful outcome of pregnancy. 
The most extreme example of this was one participant preferring adoption as a means 
of avoiding unwanted outcomes if she became pregnant. The concept of choice and the 
limitations on choice has been reported elsewhere in relation to women facing the 
option of amniocentesis and their expressions as feelings of selfishness in relation to 
their own self-determination and desires to avoid fetal suffering (Rapp, 1999, p.90-92 
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& p.136-140). Greater understanding is required of women’s responses to risk 
reduction strategies, with Corbin’s analysis of risk management in pregnancy 
suggesting that women may feel they have fewer management choices when risks are 
perceived as high (Corbin, 1987, p.327). The diversity of risk information content and 
variable framing strategies selected by health professionals, including the use of 
‘stories from practice’ may not meet the needs of all patients, especially when 
measured against individual preference and stage of readiness for changing 
reproductive health behaviour. Clinicians need to be sensitive to the information needs 
of WWE, the importance of directing women to trusted sources of additional 
information, and the support required by some women to interpret their pregnancy risk 
requiring the clinician to confirm the information presented has been understand as 
intended. In addition, finding the inconsistent provision of patient copy letters may 
represent a missed opportunity to assist women recall the content of risk information 
and action preconception recommendations. Women observed during their clinic 
appointment, described the benefits of receiving a summary of their consultation, 
provided as part of study participation. Other women highlighted the importance of 
receiving all possible information as a means of managing their perceived barriers to 
informed decision-making. This finding is applicable for practice, where provision of 
tailored clinic copy letters providing a summary of the content of the consultation may 
act as an aid memoir and reinforce clinician recommendations. Further investigation of 
the influence of different presentation formats of risk messages is required, as is work 
to extend the qualitative observations in the present study of preferences concerning 
the framing the risk and its influence upon reproductive decision-making. 
   
The current study also found not all women felt confident about their abilities to cope 
with motherhood. Some participants revealed anxieties and fears about the risk of their 
future baby being killed as a consequence of their loss of awareness during a seizure. 
These findings parallel those of Thomas (1997), who found disabled participants 
vulnerable and insecure, questioning their ability to cope, and their need for additional 
assistance or surveillance. While the majority of the current study participants felt 
confident about their ability to care for their babies, the risks involved in childcare 
were frequent topics of discussion between women and their clinicians. These 
experiences of living ‘at risk’ and of guilt and blame have been investigated in relation 
to the increased likelihood of postpartum depression for WWE (Turner et al., 2009). 
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Further, the assessment of childrearing knowledge and practices by WWE was the 
focus of investigation by the Kerala Registry of Epilepsy and Pregnancy (Saramma et 
al., 2011), which found WWE had significantly poorer scores in childrearing practices.  
 
10.2.4 Summary 
The current study revealed a tendency for women and clinicians to focus upon seizure 
and AED-related risks during consultations and this may inadvertently have detracted 
from the promoting of routine antenatal preparations for childcare, with the potential to 
further disadvantage children born to mothers with epilepsy. The same conclusions 
have been reached by others (Bagshaw et al., 2008; Bromley et al., 2011). Bromley et 
al (2011) highlighted the need for further research, with potential confounders such as 
social class and economic status being adequately controlled. The current study further 
highlights the need to investigate the effectiveness of preconception risk information in 
influencing maternal awareness of child development and ways to reduce preventable 
child injury.   
 
10.3 Decision-making in preparation for pregnancy 
10.3.1 The nature of decision-making for WWE 
This study confirms the complex and challenging nature of reproductive decision-
making experienced by WWE. Such decision-making represents a range of both 
discrete and interconnected decisions, with women active in the process: accessing 
information to increase their preconception awareness; requesting referral for 
preconception epilepsy review; deciding to secure effective contraception until 
epilepsy management has been optimised; and, finally deciding to try and conceive. 
Throughout this process women are faced with a series of decisions, including about 
treatment, among which they are required to weigh up the possible outcomes or 
consequences of their actions. The term ‘decision problem’ has been applied by 
Tversky and Kahneman (1981) to the behaviours observed by the decision-makers 
considering the acts or options from which a choice must be made, the possible 
outcomes or consequences of those acts and the conditional probabilities relating to the 
outcomes following from those acts, all of which is framed by the person’s norms, 
habits and personal characteristics (p.453). The context of the ‘decisional problem’ 
facing WWE planning pregnancy was found to relate to two main concerns: the 
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potential for pregnancy to destabilise seizure control; and the requirements for AED 
use in pregnancy. The implications of epilepsy-related risks upon decision-making 
have been reported in the literature:  
Most life decisions are governed by an assessment (conscious or unconscious) of 
the consequential risks and benefits, and treatment decisions in epilepsy care are no 
exception… assessment of the risk to benefit ratio is difficult. It has to be made on 
the basis of information which is often incomplete and it must account for disease 
[and] personal treatment factors which are themselves often neither quantified nor 
predictable (Perucca et al., 2000, p.180). 
 
Prior studies in decision-making have noted the importance of affect, uncertainty and 
perceived risk status upon rational decision-making. They identify the strong 
relationship between outcome preferences (e.g. healthy baby, no change of seizure 
control) and the influence of risk information framing, such as the use of scenarios to 
guide choice, the preference sensitivity of the decision to be made (e.g. the value of 
retaining a driving licence), and the potential for decisional conflict and regret 
(Lippman-Hand and Fraser, 1979a; Tversky and Kahneman, 1981; Janis and Mann, 
1977; O'Connor et al., 2007). The nature of pregnancy-related decisions facing 
WWE have been referred to as ‘moral work’ (Thompson et al., 2008), and in the 
context of the current study there was a tendency for clinicians to emphasize 
women’s ownership of decisions both relating to acting on clinical recommendations, 
and to choices not to act on them or defer decisions to a later date. The experience of 
making decisions among WWE emphasised the temporal nature of their decision-
making, for example, to complete a treatment change in advance of contemplating 
pregnancy. This finding about the timing of decisions is consistent with Corbin and 
Strauss’s (1987) concept of the ‘biographical work’ involving in living with a 
chronic illness, in which ‘the process is rarely complete and recurs each time there is 
a major trajectory or biographical change’. This is mirrored in the current study by 
women facing multiple decisions concerning the future whilst also attending to 
decisions in day to day life, such as adhering to a treatment regimen (Corbin and 
Strauss, 1987, p.266). The duration of the decision process was also highlighted by 
Lippman-Hand and Fraser’s (1979a) study as not ending with the choice to 
reproduce or not, but as a process that continued to be questioned. In the current 
study, women where often found to revise earlier decisions in light of new 
information.    
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Women in the present study saw clinicians as having privileged information or 
understandings able to guide their decisions. This contrasts to other clinical settings 
such as genetic counselling, which is associated with nondirective counselling, a 
position which Sarangi and Clarke (2002, p.166) suggests results in the explicit 
handing of responsibility for decisions to the person being counselled (Sarangi and 
Clarke, 2002, p.166). The suggestion that women making childbearing decisions 
(described by Miller, 1994), are liable to experience ‘post-decision regret’ might help 
explain why some WWE made decisions to withdraw AEDs upon discovery of an 
unplanned pregnancy, which were counter to clinical recommendations and liable to 
expose the woman to significantly greater risks. This finding has practice 
implications, and emphasises the role of the clinician in the provision of 
preconception counselling for WWE. The significance of the variable nature of 
counselling provision observed in the current study requires further investigation, to 
evaluate the potential impact of clinicians receiving counselling training upon 
women’s satisfaction of preconception decision-making, and motivation to engage 
with services.   
 
Decisions to prepare for pregnancy and the fact that women in the current study 
attempted to exercise agency in relation to planning pregnancy and achieved some 
degree of capacity to control their outcomes is only partly consistent with the majority 
of published results. There was a difference in the present study, since some women 
experienced outcomes that failed to match their intended preferences. Women reflected 
on their failure to heed warnings about the risks of pregnancy, with several participants 
using the term ‘roulette’ in relation to considering the pros and cons of pregnancy 
especially when their final decision was to opt for chance rather than planning. The use 
of the term ‘roulette’ by women in the current study parallels the term ‘reproductive 
roulette’ described by Lippman-Hand and Fraser (1979c) in the context of genetic 
counselling, suggesting that a ‘non-decision’ (or ‘fatalism’ a term used by Pashley and 
O’Donoghue, 2009) was considered a ‘valid alternative to a deliberate choice of 
reproduction or contraception’:  
A woman who knows she is taking a chance of getting pregnant and clearly 
chooses to take this chance is not behaving in an undecided fashion, but is 
selecting a course of action that for her may best neutralize the dilemma. 
(Lippman-Hand and Fraser, 1979c, p.81) 
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As noted earlier, Helbig et al (2010) have pointed to the influence of risk perception 
upon reproductive decision-making in WWE. The decision not to have a family was 
related to perceived restrictions on having a family successfully. These related mainly 
to the consequences of AED-related or seizure-related fears and concerns and, for a 
minority of women, the judgements of others including family and friends had 
influence, as did patient’s desires for a family. These experiences are not unique, 
however, in relation to conditions in which positive outcomes can not be assumed. 
Luce (2005) has shown that in patients approaching a very different clinical condition, 
cancer, risk information provided to motivate patient involvement may actually 
increase the ‘decision-related threat’ and discourage the patient from considering all 
available options. These conclusions are in agreement with the current study, in which 
some women retained pregnancy as a future goal, while others revealed their decision 
not to pursue pregnancy, either restricting family size or deciding not to pursue 
pregnancy at all. 
 
Consideration of pregnancy revealed women as balancing their responsibilities 
towards the unborn baby against their own preferences and values, resulting in 
‘conflicting interests’, a concept described by García et al (2009) in the context of 
prenatal screening decisions. In support of the findings of García et al (2009), the 
majority of participants saw the use of antenatal scans and prenatal testing as a way of 
balancing conflicting interest during their deliberation of preconception decisions, with 
some women accepting prenatal diagnosis and others rejecting it. García et al (2009) 
examined women’s motivation for using prenatal testing, identifying parental duties 
towards the unborn child and towards other children as countered by perceptions of 
responsibility to their own health. Women in García’s study who declined prenatal 
diagnosis shared a similar rationale to those in the current study, opting to avoid the 
risks associated with screening. The routine offer of ultrasound screening was 
highlighted as challenging informed decision-making in Baillie’s et al (2000) 
qualitative analysis of women’s experience of receiving false positive screening 
results, confirming the need for health professionals to explicitly inform women of the 
purposes and potential outcomes of screening. Failure to do so has clear implications, 
given women’s translation of perceived risks into binary form (either having an 
affected baby or not) and the increased anxiety waiting to confirm the outcome of 
pregnancy.   
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Several women in the present study questioned whether they had received sufficient 
information to make informed decisions and, for some critical of prior contact with 
their clinician, this resulted in seeking a second opinion. Consistent with the 
investigation by Viguera and colleagues (2002) of reproductive decision-making 
following prepregnancy psychiatric consultation, the current study identified women’s 
actions as motivated by locating expert knowledge, and responding to prior 
recommendations to return to the epilepsy clinic when planning pregnancy. McCorry 
and colleagues (2008) have suggested that few patients with epilepsy hold treatment 
preferences prior to their routine epilepsy review appointment. In contrast, the current 
study found the majority of women anticipated the need to consider the suitability of 
their current treatment(s) and the possibility that pregnancy could destabilise seizure 
control, leading some women to request AED changes. Women had clear expectations 
and hopes for the outcome of the consultation. They made specific requests to switch 
from AEDs perceived as holding unacceptable risks or for which they had prior 
experience of adverse outcome, and they required reassurance for worries raised by 
their personal research. Pashley and O’Donoghue (2009) describe a similar pre-
consultation agenda for WWE planning pregnancy.  
 
10.3.2 Negotiation and preference in decision-making 
Women’s active involvement in shaping the consultation agenda is in line with UK 
government targets to promote shared decision-making throughout the NHS (Coulter 
and Collins, 2011, p.1). There is an increasing focus upon the epilepsy consultation 
and the need to move away from paternalistic decision-making (Toerien et al., 2011; 
McCorry et al., 2009). The epilepsy consultation as the site of patient decision-
making concerning treatment was the focus of investigation by Toerien and 
colleagues (2011), confirming observations in the current study that women invest 
time in searching for information prior to the consultation, and then use such 
information to present alternate possibilities when negotiating with the clinician over 
his/her recommended course of action.  
 
The current study identified the negotiation of preferred outcomes by WWE, 
revealing their perceived responsibility as an inherent aspect of the ‘preference-
sensitive’ nature of the reproductive decisions they faced. The term ‘preference-
sensitive decisions’ has been applied to a range of healthcare decisions, where 
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available treatment options are equally valid and the ‘best choice’ is dependent upon 
the patient’s view of the ‘advantages and disadvantages of the various treatment 
options’ (O'Connor et al., 2007; Wallace et al., 2010). The nature of ‘preference 
sensitive’ decisions facing WWE was emphasised by reference made by clinicians to 
there being ‘no right or wrong answer’, whether relating to seizure control or 
pregnancy. The differing choices identified by the current study participants illustrate 
the complex nature of epilepsy review and mirror the work of Corbin and Strauss 
(1987) relating the ‘temporal character’ of the illness trajectory among individuals 
with chronic illness, wherein management of their illness is only one of many of life 
events (p.264).  
 
Where no treatment option is free from potential undesirable outcomes, individuals 
have been proposed to face a ‘choice dilemma’ characterised by ‘decisional conflict’ 
(O'Connor et al., 2002; Janis and Mann, 1977, p.85), a point well illustrated within 
the current study. In terms of Janis and Mann’s theory (1977, p.85), WWE are placed 
in a position of ‘relatively high decisional conflict resulting from two clashing types 
of threat that make it impossible to adopt any easy resolution’. The relative 
importance of choice about pregnancy outcomes in the current study is consistent 
with Amir et al’s (1999) conclusions about the impact of epilepsy upon quality of 
life, with lack of control and uncertainties identified as central to the subjective 
experience of living with epilepsy and managing seizures. Amir and colleagues 
(1999) emphasized opportunities to improve quality of life for patients with epilepsy 
through counselling and treatment interventions designed to reinforce the sense of 
perceived control and mastery and encourage ‘self-management’. This was also 
identified as key within the model of preconception counselling developed in the 
present study which encompasses the emotional context of decision-shaping 
preferences and the availability of support, both practical and psychological, from the 
woman’s clinician and significant others.  
 
Research in the field of genetic counselling has highlighted the possible outcomes of 
decisions made in circumstances of uncertainty described as ‘a-rational’ and 
susceptible to regret (Lippman-Hand and Fraser, 1979b, p.330). In this context 
findings from the current study are in marked contrast to the paternalistic clinician-led 
decisions described by McCorry et al (2009). Whilst evidence of delegating decisions 
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was found, the majority of women acknowledged the importance of taking control of 
their reproductive decisions, in keeping with an informed decision-making model 
proposed by Wirtz et al (2006). The question of rational decision-making within this 
context requires attention, as labelling as irrational decisions at odds with the clinicians 
recommendations, has been cautioned against by Lippman-Hand and Fraser (1979b). 
The fact that the WWE searched for the ‘worst case scenario’ and placed value on the 
‘clinician’s use of stories from practice’ can be explained by Lippman-Hand and 
Fraser’s (1979b, p.330) analysis of how parents processed the facts of their genetic risk 
situation to formulate their choices with those parents deciding to try for pregnancy 
relying on strategies to limit or neutralise uncertainty. Likewise, in the current study, 
the weighing-up by women of the potential outcomes of their decisions drew on the 
use of ‘scenarios’ around which deliberations could be focused, thereby allowing the 
importance of differing consequences to be considered (Lippman-Hand and Fraser, 
1979a, p.63). The finding that women deliberated the potential outcomes of their 
decisions, describing their imagined worst case scenario or finding comfort in 
clinicians’ reports of patients having healthy children despite taking AEDs can  also be 
located in the work of Corbin and Strauss (1987) who describe an ‘ideational process’ 
in which decisions are rehearsed over time: 
Reviews are the reflective parts of actions and involve the use of day-dreams and 
various types of imagery for recapturing the past, examining the present, and 
projecting the future – reviews often serve as a basis for future action. the person 
mentally rehearses or thinks through how he or she will handle a problematic 
situation (Corbin and Strauss, 1987, p.268) 
 
A concerning finding in the present study was that WWE did not consistently decide to 
return for preconception review between pregnancies, nor did their experiences of 
adverse pregnancy outcome consistently motivate them to engage in preconception 
activities. One subgroup of women reported experience of adverse pregnancy 
outcome: among those with children with developmental problems, the delay in 
diagnosis was reported as influencing their decisions to have a second child. 
Observation of participant consultations offered further insight into the resistance of 
some women to action recommendations to switch or withdraw AEDs. For one 
participant, neither repeated clinical recommendations to switch from sodium 
valproate nor her experience of miscarriage were sufficient to counter her fears for her 
own safety, were she to experience a relapse of tonic-clonic seizures. For other 
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women, the experience of prenatal diagnosis of congenital malformation often resulted 
in the decision to terminate pregnancy. Interestingly, though the experience of a 
pregnancy whilst on sodium valproate was found to influence decisions to terminate 
pregnancy, it did not consistently result in immediate engagement with epilepsy 
services. Their perceptions of the risk of adverse pregnancy outcome, and of subjection 
to the public gaze once pregnancy intentions were announced, were the explanations 
given by a small number of women for their non-initiation of preconception review, 
with these women admitting to secretly trying to conceive and purposefully choosing 
not to discuss their intentions with health professionals. Lippman-Hand and Fraser 
(1979a) also examined this phenomenon, highlighting the difficulty for women making 
pregnancy decisions, both in relation to the risks and the chance something could go 
wrong which, if linked to a purposeful decision, could result in blame (p.61). For this 
reason, an accidental pregnancy was seen as a preferred outcome. That women in the 
present study also avoided initiating preconception interventions was also consistent 
with Fishbein’s (1972, p.216) theory of behavioural intention in the area of family 
planning, which proposes an individual’s appraisal of their risk status as determined by 
their ‘beliefs and attitudes’ towards the consequences of implementing a given 
intervention. The potential conflict between women’s preferences and clinicians’ 
recommendations were highlighted within the current study through the finding that 
the differing appraisals of risk were managed by a willingness to negotiate. This 
findings is in support of Corbin (1987) who identified pregnant women with chronic 
illness as taking action to minimise risks and negotiating differing opinions about the 
appropriateness of a particular interventions so that ‘decisions could be mutually 
agreed’ (p.334-336).  
 
10.3.3 Summary 
Perhaps the single most important finding from the present study is the women’s use of 
negotiation and compromise as strategies to utilize the available support. A similar 
pattern emerged in the qualitative study by Lippman-Hand and Clarke Fraser (1979a) 
regarding the ‘burden of decision-making’. The current study highlights women’s 
struggle to make decisions about preconception care within the wider context of the 
trajectory leading to pregnancy. This is addressed by the development of a model of 
preconception counselling, discussed below. 
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10.4 A model of preconception counselling for women with epilepsy 
The model was developed during analysis of women’s experiences of preparing for 
pregnancy, as a theoretical underpinning to the application of preconception 
interventions in practice and support for further research into the conditions required 
for effective preconception counselling to reduce adverse pregnancy outcomes. The 
model reflects the longitudinal nature of investigation aimed at capturing both private 
actions and targeting socially acceptable decisions and the important links between 
responses to changes in personal circumstance. Few previous studies have attempted to 
addresses the limits of evidence of effectiveness of preconception counselling to 
reduce adverse pregnancy outcomes in a population of WWE.  
 
10.4.1 Pregnancy contemplation ladder 
Adaptation of the ‘contemplation ladder’ was seen helpful here. Appreciation of the 
stages of pregnancy intentional behaviour was supported by the constructs of self-
efficacy (Bandura, 1997) and health locus of control (Wang et al., 2006; Spirito et al., 
1990) as integral to motivating increased pregnancy planning and implementation of 
preconception interventions, in keeping with others (Charron-Prochownik et al., 2001; 
Bastani et al., 2010; Weisman et al., 2008). The current study highlights an association 
between women’s information seeking behaviours and their experience of receiving 
risk information. The outcome, motivating women to take action on preconception 
interventions (high sense of self-efficacy) is in agreement with Bandura (1997), and 
helps explain why some women felt information alone was insufficient to motivate 
them to take action. This raises questions of ‘what needs to be done’ and what are the 
requirements of practical and psychological support (developing ‘self regulatory 
skills’, ‘goal setting’ and ‘self –incentives for personal change’) (p.302-3). Movement 
up or down the contemplation ladder appeared influenced by epilepsy-specific factors 
(i.e. changes in seizure control), AED-specific factors (i.e. high versus low risk AED, 
polytherapy versus monotherapy) and lifestyle factors such as changes in employment, 
driving status and relationships. Changes in women’s pregnancy intentions may not be 
known or shared with their clinician, whereas the clinician may be aware of epilepsy or 
AED-related risks which may not be known to the women. Therefore, communication 
is found to be vital to support shared decision-making between women and their 
clinicians throughout the all stages of planning pregnancy.  
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10.4.2 Implementing preconception interventions 
The model developed throughout this analysis highlights the process of decision-
making as being made-up of incremental decisions, such as the decision to prepare for 
pregnancy, deciding to continue adhering to contraception, and decisions to implement 
interventions prior to attempting to conceive, before finally deciding to try to conceive. 
This finding is supported by O’Connor’s et al (2002) concept of a ‘cascade of 
decisions’ requiring women to balance the potential benefits against losses from 
choices they face as they progress through the transition from pregnancy to 
motherhood. The finding that some women perceived themselves at low risk due to 
their endeavours to live a healthy lifestyle, considered themselves to have sufficient 
knowledge to assess their own risk status as low and similar to everyone else, and that 
they derived reassurance from their clinicians’ questions about their pregnancy 
intentions as implying low risk status were in keeping with the research of others 
(Hosli et al., 2008; Parsons and Atkinson, 1992). Further, for a small sub-group the 
delivery of a ‘healthy baby’ despite AED exposure implied evidence of their low risk 
status, reinforcing ambivalence towards planning a future pregnancy, an approach 
interpreted as ‘fatalistic’ by Pashley and O’Donoghue (2009). The prospective study 
by Lum and colleagues (2011) of women without epilepsy planning pregnancy aimed 
to determine women’s intentions to modify their behaviour during the preconception 
period. Despite women reporting intentions to change their alcohol and smoking 
behaviours prior to pregnancy, few women actually made changes. This highlights the 
disparity between reported intentions and enacted behaviours, and underlines the 
importance of gathering baseline data prior to implementation of preconception 
interventions, especially if relying on measures of behavioural intention as an outcome 
measure of the effectiveness of such interventions (Lum et al., 2011). Lum and 
colleagues (2011) identified two important findings replicated by the current study:  
1) Women were likely to delay commencement of health protection behaviours, 
initially trying to conceive, and motivated to changing health behaviours only 
if they became concerned by perceived fertility problems;  
2) Women attended preconception review already pregnant, having decided to try 
and conceive before requesting preconception consultation. 
  
These findings highlight the significance of the timing of receipt of preconception 
information and the location of decision-making as frequently being away from the 
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consultation. Further barriers to the achievement of planned pregnancy were 
perceptions of the decision to plan as involving a regimentation of natural processes. 
Therefore, planning only became relevant if they had not managed to conceive 
naturally within their perceived time scale. 
 
Miller (2005) reports that, among the wider population of pregnant women, acceptance 
of professional support is judged as an appropriate way to reduce risk and act 
responsibly (p.72). Miller (2005) suggests this perspective compels women to accept 
expert advice and avoid risk through appropriate behaviours and self-management 
(p.49). Miller’s observation of perceptions of uncertainty leading to dependence on 
authoritative expert knowledge is supported by the behaviour of WWE in the present 
study, with many women seeing their epilepsy specialist as an expert, best suited to 
provide guidance regarding appropriate preparations for pregnancy. 
 
Women’s involvement in preconception decision-making was reliant upon being 
offered interventional and treatment choices. The majority of women anticipated 
taking part in decision-making and, whilst some referred to their clinician as taking the 
lead, all made reference to the final decision either to proceed with the recommended 
interventions and/or try to conceive as their own. These findings contrast with those of 
others researching involvement of adults with epilepsy in treatment decisions. For 
example, McCorry et al. (2009) identified few patients using the pronoun “I” to denote 
“decisional ownership” (p.213). In contrast, women in this study both deliberated 
proposed AED-related options and proposed their opinions concerning the preferred 
course of action. In addition, the current study contributes to understandings of how 
women interpret and utilize risk information when faced with reproductive decisions 
(Helbig et al., 2010), and is in agreement with the findings of others, highlighting 
decisions about whether and when to have a child, and the number of children, as 
among the most important decisions individuals and couples face during their 
reproductive years. However, the findings also suggest women struggle to maintain the 
role as decision-maker, as evidenced by their reported ‘changes of mind’ and their 
reported emotional responses to the requirement to make judgements concerning 
competing and equally valued outcomes (the personal ones relating to seizure control 
and those held on behalf of the unborn baby). Given the nature of decisions facing 
women, a model of shared decision-making would be advantageous in the provision of 
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support. Coulter and Collins (2011) describe the model of shared decision-making as 
based on the assumption that clinicians and patients bring differing, yet equally valid 
forms of expertise to the decision-making process thereby supporting negotiation and 
compromise within the consultation. This, however, is dependent on the clinician 
eliciting the patient’s attitudes to risk and preferences concerning probable outcomes, 
informed by the clinician’s expert knowledge of the available treatment/intervention 
options. The contribution of Stacey and colleagues’ (2011) evaluation of the positive 
effects of decision aids to enhance patient active participation in informed decision-
making are applicable to the development of a model of preconception counselling. 
The benefits of the use of decision aids within the preconception counselling 
consultation and specifically to support decision-making as part of the model of 
preconception counselling, may provide a useful format of presenting pregnancy and 
treatment-related risk information, supporting women explore the possible benefits and 
harms of the available options, and consider their values and preferences of the 
outcomes of their decisions thereby enhancing patient-clinician communication when 
used by WWE in preparation for the consultation, and by both the patient and clinician 
during the consultation.  
 
The purpose of the model of preconception epilepsy review for WWE was three-
fold: first, to gain additional information about treatment options, what needed to 
done before pregnancy and what to expect during pregnancy and future motherhood; 
second, to seek advice concerning available options for improving epilepsy control; 
and third, to gain reassurance concerning treatment and seizure related risks, and 
more generally about their ability to cope with the outcomes of pregnancy. The 
importance placed on information seeking as a resource both supporting and 
influencing decision-making is in keeping with research focusing on reproductive 
decision-making by women with multiple sclerosis (Smeltzer, 2002). Seeking risk 
information was considered by Corbin (1987) as a prerequisite for balancing and 
controlling risks during pregnancies complicated by chronic illness, suggesting 
management involved women ‘weighing the degree of benefit of a potential option 
versus the degree of risk it presented’(Corbin, 1987, p.331,333).  
   
 
 
                                                                                                                                                        Discussion  
 234 
10.4.3 Summary 
The implications of the study findings support conceptualisation of the model’s staged 
approach in terms of theories of shared decision-making, the effects of applying 
decisional support alongside a pregnancy contemplation ladder, and social cognitive 
theories of predicting health behaviours. The potential benefit of developing the model 
for validation in current practice is improvements in women’s recall of preconception 
options and outcomes, and more accurate perceptions of outcome probabilities. 
Further, the development and testing of a theoretically structured model and decision 
support for preconception counselling will both address the limitations of evidence of 
the effectiveness of preconception counselling, while developing practices to assist 
women comprehend their preconception options and make judgements about 
preference based on the benefits versus the harms of the probable outcomes.  
 
10.5 Methodology 
The research methods were designed to produce valid and trustworthy findings 
adhering to the quality criteria established by Seale and Silverman (1997) and Yardley 
(2000) (Chapter 4, Table 4.3). The importance of evaluating the conduct of the study is 
two-fold:  
1) To confirm the quality of data produced for analysis and the quality of analysis 
to answer the research question, and  
2) To meet the study objectives as a moral obligation to the participants, funding 
body and sponsors. 
 
10.5.1 Appraisal of methodological quality (Table 10.1) 
A qualitative methodology informed by an interpretative phenomenological analysis 
was chosen as appropriate to answer the research question, which required a sensitive 
approach to the subjective experiences of women preparing for pregnancy and a focus 
upon participants’ perspectives of reproductive decision-making. A quantitative 
methodology was felt unsuitable, due to the assumptions such an approach would 
involve of how preconception counselling is understood by women, and the limitations 
for exploring potential explanations about women’s experiences preparing for 
pregnancy. My study objectives were a response to the practical challenges I had 
professionally encountered working within the field. My first step was, therefore, a 
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systematic review of the evidence of the effectiveness of preconception counselling to 
reduce the risk of adverse pregnancy outcomes for WWE; leading to construction of 
the empirical research study questions:  
1) How do women with epilepsy interpret risk information when presented within 
consultation?  
2) What factors influence decision-making, do women use risk information when 
making decisions, and following consultation, are women prepared to make a 
risk-benefit assessment and potential modifications to their epilepsy 
management and or health behaviour?  
3) What are women’s perceptions of the influence of communication of risk upon 
decisions made? 
 
The research context was informed by awareness of the needs of WWE, national and 
international guideline documents, copious review papers, and the dearth of high 
quality evidence to inform of the effectiveness of preconception counselling (JB 
Winterbottom et al., 2008). The results of a Cochrane Systematic Review (Chapter 2) 
identified the limitations of available evidence concerning the evaluation of 
preconception counselling interventions, and sets the research agenda with reference to 
the Medical Research Council’s (2000) framework concerning development and 
evaluation of randomised control trials of complex interventions to improve health, 
establishing the need to develop a theoretical understanding of the processes of 
preconception decision-making. This framework raised the importance of 
understanding the differing organisational factors surrounding preconception 
counselling delivery, the “underlying assumptions in relation to the intervention”, the 
need to “determine which groups of participants are most likely to respond positively 
to the intervention”, the appropriateness of using qualitative research to identify the 
“active” components of preconception counselling, and the relationship between these 
components “which may act both independently and inter-dependently” to influence 
the outcomes (MRC, 2000, p.2,9; Craig et al., 2008, p.9, 19).  
 
The aim of this qualitative analysis was to explore the ‘uniquely embodied and 
situated’ experience of preparing for pregnancy in the lives of WWE (Smith et al., 
2009, p.29).  The current study methods were not looking for a representative sample 
as defined by quantitative methodology, but rather an idiographic account which 
valued the individual richness and detailed interpretations made by WWE. The ability 
to generalise from the current findings was to produce a detailed account which 
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supported theoretical insights. This approach was felt to represent the differing 
meanings of planning pregnancy, and be able to reflect the emotive nature of risk 
information and the complexity of decision-making which could prove useful if 
transferred into other clinical contexts. The ability to transfer the findings into other 
groups of WWE, such as those from differing ethnic and religious backgrounds 
requires further research. By recognising that other groups of WWE may share some 
similarity with the current study sample; the differences would be the focus of future 
research.       
 
Quality criteria Application of criterion within the current study 
Sensitivity to 
context 
Reflexivity to researcher-participant relationship was ensured by careful construction 
of study documentation, making explicit my employment as an Epilepsy Nurse 
Specialist, and my role as a researcher. 
Sampling and recruitment techniques ensured the study population was similar to the 
wider population of WWE, reflecting the consistency between AED use between 
study participants and registrants within the UK Epilepsy and Pregnancy Register. 
Reporting techniques were evidenced by the depth of descriptive data supporting 
theoretical generalisations. This was achieved by openly displaying the participant 
accounts, thereby supporting ‘the reader to evaluate the transferability to persons in 
contexts which are more or less similar’ (Smith et al., 2009, p.51).  
Details of the extreme case of ‘selfish decision’ were highlighted as an unexpected 
finding used to test the model, and reflected sensitivity within reporting style. 
Commitment to 
rigour 
The development of research skills was a practical measure of commitment to rigour, 
and was part of the expectation of PhD student research training. The author’s 
commitment to the progress of this study extends beyond the time of postgraduate 
study; as time was required to negotiate release from an NHS contract and to secure 
funding. Within the conduct of the study, rigour within data collection techniques 
focused on a thorough and systematic approach. Within data collection sufficient 
‘probing’ through questioning, and a flexibly applied to follow up on participant 
cues, digging deeper for explanation and interpretation (Smith et al., 2009). Rigour in 
data management involved detailed transcription and electronic storage of the data.  
Transparency 
& coherence 
Opportunities to present the findings were availed within peer group analysis 
sessions as part of the post graduate qualitative analysis and reading group accessed 
as part of my research training at The University of Liverpool. The consistencies of 
applying themes were enhanced through supervision and peer group analysis 
sessions in addition to oral presentations and annual reporting. An audit trail was 
established with NVIVO7 qualitative analysis software and further supported 
reflexivity tracking the development of themes and changes coded text vital as the 
process of analysis was lengthy. 
Impact & 
importance 
The significance of the prolonged exposure to perceptions of blame, fear and guilt 
have been identified within the current study findings as requiring further 
investigation, considering the influence upon pregnancy planning for WWE, and the 
influence of framing AED and seizure-related risks prior to pregnancy. Further, the 
clinician’s use of exemplar cases and ‘stories for practice’ has impact upon the 
pervasiveness of risk perception for women at the start of their reproductive careers 
and as they moved towards pregnancy and progressed into motherhood. 
Table 10.1 Appraisal of the quality and validity of the current study 
 
 
                                                                                                                                                        Discussion  
 237 
The value of the qualitative methods within this study is the production of rich data, 
able to extend existing evidence of the complex and challenging experiences of WWE 
preparing for pregnancy. This was illustrated through participants’ openness in sharing 
their experiences both with each other during focus group participation, with their 
clinician during observed consultations, and with me during individual interviews. The 
study revealed women as welcoming questions from their clinician concerning future 
pregnancy intentions and the offer to review past experiences and factors influencing 
their reproductive decisions. The majority of women identified participation in the 
study as beneficial and an opportunity to reflect on their experiences, and for the focus 
group participants as providing the first opportunity to meet another WWE.  
 
The triangulation of data collection methods provided an opportunity to explore 
women’s experience from multiple perspectives, with each method contributing to the 
strength of the findings in three important ways: 
1) Focus group data explored diverse and contrasting accounts of women’s 
differing epilepsy trajectories, their influence upon perceived pregnancy-
related risks, and perspectives concerning preconception decisions. The focus 
group participant is positioned to present their own views and experience while 
hearing those of others. It is through this reflective component that participants’ 
own standpoint becomes clear.  
2) Clinic observations proved valuable in illustrating the context for risk 
communication, allowing me to gain insights into the interactions between 
women and their clinician, observe discrepancies between the clinician’s 
recommendations and actions taken by women in whom the influence of their 
relationship and the negotiation of decisions became apparent.  
3) In-depth follow-up interviews were vital to uncover the range of emotional 
reactions underpinning the multiple and complex decisions faced by women as 
they began to consider pregnancy. The interviews presented women with an 
opportunity to explore their feeling about preparing for pregnancy, revealing 
them as moving between competing interests and priorities of interest as they 
approached decision-making. Within this context the extent of emotional 
investment became apparent, with responses of blame and guilt and questions 
about selfishness.  
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The benefits of focus group data have been emphasised by the ‘experiential 
discussions’ of Dunne and Quayle (2001) and by others, as bringing individuals 
together who share an experience and providing opportunities to discuss issues of 
personal meaning within a group setting, gaining access to accounts which may 
otherwise be inaccessible (Wilkinson, 2008). The development of the topic guide was 
designed to encourage in-depth accounts, in keeping with Finch and Lewis’s (2003) 
work utilizing focus group techniques. Focus group findings informed non-participant 
observations, offering the opportunity to explore and understand the processes of 
preconception counselling. Observations of the consultation as a naturally occurring 
event have successfully been applied within health research, for example, women’s 
decision-making regarding contraception (Lowe, 2005). The observational research by 
Lowe investigated the complex power relationships within the negotiation of 
contraceptive decisions and revealed the gendered roles within the consultation (Lowe, 
2005), a point extended within the current study. The value of in-depth interviews is 
the opportunity they offer to enter the psychosocial world of the participant (JA Smith, 
1995). The aim of the interview within the current study was to elicit detailed stories, 
thoughts and feelings from the participant in their own words, utilizing techniques 
described by Legard et al (2003) and Smith et al (2009), and with the use of probing 
techniques, to expand on initial statements to gain depth, nuance, clarity and further 
understanding.  
 
Interpretative phenomenological analysis, informed from a psychological perspective, 
was felt to suit the overall research objectives: supporting detailed examination of the 
process of preparing for pregnancy, and analysis of risk perceptions and decision-
making experienced by WWE. Smith et al (2009) considers interpretative analysis as 
contributing to making sense of the lived-experience of the research participant, 
furthering understandings of ‘beliefs’, ‘attitudes’ and ‘behaviours’, and supporting 
development of a model to interpret the main study findings (p.183).  
 
10.5.2 Limitations of the research 
There are three main limitations to this qualitative analysis of women’s experience 
preparing for pregnancy: first, the sample was limited to mainly white British women; 
second, the data were gathered at a single time point, with no attempt to gather 
prospective longitudinal data able to reflect the decision-making process in more 
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detail; and third, the sample size was over-large within the discipline of interpretative 
phenomenological analysis. The reason for the first limitation concerning the fact that 
only 4% of the total study population are Asian women reflected the struggle to recruit 
a multiethnic study population. The experiences of WWE from differing ethnicities 
requires further study to ensure services are sensitive to both ethnic and religious 
differences. Analysis revealed several focus group participants who referenced 
religious factors as influencing their use of contraception and views concerning 
termination of pregnancy. However, the study provides a detailed account of the study 
participant’s experiences, and provides an opportunity to ‘transfer the findings to other 
persons in context which are more or less similar’ (Smith et al., 2009, p.51). The 
findings may not however, be directly transferable into other populations, such as non-
white British WWE. The opportunity to conduct a follow-up study looking at multiple 
perspectives may help develop a more detailed account of the meanings of 
preconception care from the points of view of, for example, Asian women in the North 
West of England. For this reason the findings, discussion and implications of this 
thesis must be considered with caution, as the transferability to other populations of 
WWE maybe limited.  
 
The second limitation resulted from the decisions being made at study design stage, to 
focus on the breadth rather than the depth of reproductive experience and on reporting 
a detailed account of a wide range of participant experience to provide illustration and 
support theoretical generalisation. The limitations of gathering data at a single time 
point were balanced by the opportunity to follow up women observed during 
consultation. This study is therefore the first observational study reported in the field of 
epilepsy to incorporate a prospective account of decision-making, albeit limited in 
duration of follow-up. The study has highlighted the tension women experienced 
between competing interests, finding decision-making as not easy and spun out over 
time. Further, the process of pregnancy planning reflected a staged model of behaviour 
change, supporting development of a ‘pregnancy contemplation ladder’. The findings 
challenge assertions of paternalistic decision-making during routine epilepsy 
consultations, identifying a shared decision-making approach providing both practical 
and psychological support for WWE preparing for pregnancy. 
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The third limitation was that the level of analysis may not have done justice to the 
large sample size and corpus of data for interpretive analysis (Smith et al., 2009, p.52). 
An alternate approach would have been a case study design, recruiting a small group of 
women representing the different stages of pregnancy contemplation and producing a 
detailed examination of the processes of decision-making.         
 
10.5.3 Strengths of the research   
This research has a number of strengths that allow its results to be viewed as reliable 
and applicable to the wider group of reproductive-aged WWE. These strengths 
include:  
1) Transparent recruitment processes, offering a description of the study 
population as representing a broad range of WWE of reproductive age from the 
North West of England, comparable to women with epilepsy recruited into 
published registries and cohort studies exploring pregnancy outcomes (Meador 
et al., 2008), and thereby supporting transferability of the study findings.  
2) The recruitment of a population of WWE reflective of other reproductive-aged 
women’s experiences of preparing for pregnancy highlights the opportunities 
to research this population. The current study supported a process of 
recruitment in which amendments to the study protocol helped establish 
contact with teenagers and maintain contact with women during changes in life 
circumstance while remaining flexible to support their participation. In keeping 
with Brown’s et al (1997) descriptions of the tentative nature of women’s 
pregnancy plans, caution was exercised during recruitment in order to be 
sensitive to life events such as separations, financial difficulties and other 
unfavourable events, as well as favourable events such as engagement and 
moving in with a partner.  
3) The current study provided a description of the women’s demographic and 
reproductive characteristics to support transferability of the results into the 
wider population of WWE.  
4) Evidence of specific stages of planning was gained, confirming the possibility 
of both identifying women during the precontemplative and contemplative 
stages of pregnancy planning, and retaining their interest in participating in the 
study until completion. All women showing interest in taking part in the study 
remained happy with the researcher contact. There was no loss to follow-up 
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between observed consultation and interview completion, supporting analysis 
of a full range of experiences.  
5) In keeping with Seale and Silverman’s (1997) description of hypothesis testing, 
the current study looked for patterns across ‘cases’, identified recurring themes 
and served to test the representativeness of emerging themes, for example, it 
was possible to describe a variety of individual planning experiences. The 
analysis also identified outlying beliefs and opinions, locating women who had 
defined their approach to planning in terms consistent to clinicians and helping 
to draw attention to the ‘outliers’. This work to identify similarities and 
differences in cases studied as described by White et al (2003), contributed to 
development of original explanations which form part of the overall 
conclusions. 
6) Comprehensive and objective recording of data was maintained. Data 
collection was completed on the 22
nd
 July 2009, with 85 women and 12 
clinicians taking part in the study, generating 74 hours 14:45 minutes of 
recorded data all of which was transcribed verbatim, and entered into NVIVO 
7 qualitative computerized software to ensure a systematic analysis of all the 
available data. 
7) Attention to the closeness of “researcher-informant relationship” was 
acknowledged within study documentation, use of topic guide and introductory 
discussion with the participant prior to data collection. Further, in keeping with 
Hamberg’s et al (1994) examination of qualitative rigour, I reflected upon the 
potential influence I might have had during data collection and throughout 
analysis, providing an account within my research journal, and utilizing 
opportunities for group analysis to check my interpretations of the data against 
those of fellow PhD students. In contrast to Hamberg et al (1994), I was 
cautious to avoid direct clinical work with research participants, in an attempt 
to support my observations as an ‘outsider’. However, my position as 
researcher-clinician underpinned the development of rapport with the 
participants and contributed to the richness and quality of data. 
8) The study provided original in-depth insight into the psychosocial aspects of 
preparations for pregnancy and reproductive decision-making, delineating a 
model of preconception counselling reflective of individual perceptions of risk 
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communication and the importance of defining meanings of the pregnancy 
planning process to support the needs of WWE.  
9) Examination of both the processes and experiences of WWE preparing for 
pregnancy offered a fuller understanding of possible preconception counselling 
interventions, identifying barriers and facilitators. Often research in this area 
has focused on detailing pregnancy experience, with few studies including a 
process evaluation. As described by Craig et al (2008), there has therefore been 
a failure to explain the discrepancies between expected and observed 
outcomes, and continued high rate of unplanned pregnancy. The current 
findings of significant discrepancies between women’s and clinicians’ 
definitions of planning have helped reveal women’s unmet support needs. 
 
Based on the discussions drawn here from this study and previous published accounts, 
conclusions and future directions of research in this area are outlined in the final 
chapter. 
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Chapter 11 Conclusions and future directions 
I will conclude by reviewing the contributions of my work to practice and the 
implications for future research.  The findings reported in this thesis are the product of 
seven years of study, more than half of which was spent in the field, gathering data, 
transcribing individual and group accounts, and undertaking an interpretative 
phenomenological analysis with the purpose of answering the research question. 
 
11.1 The contribution made by this research  
The principles of preconception counselling of WWE are well documented within the 
epilepsy literature, with more than 87 guideline documents and narrative reviews 
examining the topic published between 1950 and February 2012 (see Chapter 2). This 
preoccupation with review and guidance is somewhat misleading, as the Cochrane 
Systematic Review I led identified no robust evidence of the effectiveness of 
preconception counselling to reduce adverse pregnancy outcome in WWE. In addition, 
current national guidance is based on level III or IV evidence, or ‘good practice points’ 
developed from the clinical experience of the NICE Guideline Development Group 
(NICE, 2012). In contrast, the numbers of publications documenting teratogenic effects 
of AEDs have gathered momentum, with recommendations pointing to preconception 
counselling to ‘convey reliably the full risk to the child’ associated with in utero AED 
exposure (Bromley, 2009, p.229). The findings here indicate attention is required to 
providing high level evidence of the effectiveness of preconception counselling to 
deliver on these recommendations. I now highlight a number of unique contributions 
made to achieve this goal:  
1. The results of the systematic review of the effectiveness of preconception 
counselling to reduce adverse pregnancy outcome in WWE identified no high 
quality evidence, with only one study meeting the inclusion criteria. Due to 
methodological limitations and risk of bias, conclusions about effectiveness of 
preconception counselling remain unanswered. The current study has gone 
some way to underpin future research by identifying individual variance likely 
to influence the identification and recruitment of preconceptual WWE, and the 
requirements of risk communication strategies likely to influence women 
acting on preconception recommendations as intended. In practice, clinicians 
and WWE may benefit from the development of targeted communication 
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strategies that; a) support clinicians identify the appropriate information and/or 
intervention to best meet a woman’s pregnancy intentional stage, and b) 
support women identify their pregnancy intentional stage, such as applying the 
contemplation ladder as a single-item self-reported measure of the stage of 
contemplating pregnancy.      
2. The findings from this study contribute to the current literature by explaining 
the differing responses of WWE to recommendations to plan pregnancy. For 
many women planning simply meant trying to conceive, an implication of this 
being the possibility of women withdrawing contraception earlier than 
anticipated by their clinicians. This may explain why women continue to attend 
clinic pregnant before receiving preconception counselling. The timing of care 
delivery is essential if the objectives of preconception counselling are to be 
achieved, i.e. optimizing health prior to conception, management of teratogen 
exposure, and informed reproductive decision-making on the part of the WWE. 
The practical application of this finding will require changes in the nature of 
communication between women and clinicians, requiring changes in 
questioning style to open a dialogue concerning future pregnancy intentions, 
and opportunities to share definitions of what preparing for pregnancy means 
for each party.  
3. The results of this study have highlighted the emotional implications of risk 
communication and the influences upon decision-making for WWE preparing 
for pregnancy. The key themes emerging from analysis highlight the 
importance of developing a shared meaning of the concept of pregnancy 
planning, which promotes the benefit of preconception epilepsy review. The 
implications of failing to account for the active role women assume during 
assessment and management of risk is likely to contribute to a sub-group of 
women taking action by risk reduction or avoidance strategies at a time when 
contraception techniques may not be adhered to, increasing in the risk of 
unplanned pregnancy. 
4. This study has provided a unique opportunity to observe risk communication 
between women and their clinicians in action, during the epilepsy consultation 
and within the context of women making plans and preparations for pregnancy. 
This has revealed several interesting aspects of women’s decision-making and 
the strategies adopted to manage decisions which could be simultaneously 
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viewed as ‘selfish’ and complex, requiring careful management of risk 
information. The implications of this finding for practice and future research 
highlights the opportunity to study risk communication in practice, and the 
ability to gain valuable insights into what influences women making decisions 
within the context of the epilepsy consultation. In clinical practice, increased 
awareness of the potential for women experiencing decisional regret 
emphasises the importance of clinicians understanding of how they might 
influence the outcome of decisions, and the potential benefits of clinicians 
receiving counselling training.        
5. The findings offer the opportunity to direct an important public health message 
about the value of planned pregnancy, given the responsibilities faced by 
WWE to protect the health of their future child, whilst managing risks to 
themselves from seizures and treatment. 
6. Risks are presented both numerically and as narrative, to provide reassurance 
by the reframing of prior over-estimations of risk, and the rationale to action 
health promotion advice. While communicating risk and uncertainty remains a 
challenge, the women’s preconception counselling agenda is dependent on 
beliefs regarding the significance of pregnancy and seizure risk within a wider 
social context of health priorities, pregnancy intentions and general risk 
awareness. The recognition of the social context of a woman’s plans for 
pregnancy is essential for interpreting poor treatment adherence on discovery 
of pregnancy.  
7. Preparing for pregnancy was a complex issue. When interpreted against the 
health and social science literature, women’s definitions of planning were 
revealed as not resembling those endorsed by the epilepsy professional 
community. Lay definitions were socially constructed and influenced by the 
experience of living with epilepsy, views of spouse, friends or family, and 
distrust of taking medication. This analysis reveals the importance of 
increasing understanding of how women define ‘preparing’ for pregnancy. It 
has high relevance for promoting uptake of preconception counselling through 
the development of targeted interventions focus on changing health beliefs, 
increasing self-efficacy and supporting women’s awareness of the benefits of 
preconception interventions and increasing their confidence to take action. 
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8. The impact of preconception counselling upon the experience of decision-
making has focused women’s attention on a part of their lives many have tried 
hard to distance themselves from. For some, the focus of attention upon the 
risks about pregnancy heightened their fears associated with treatment and 
seizures, or with the uncertainties of life or pregnancy with epilepsy. 
9. The experience of difficulties in making decisions was interpreted by women 
as due to the unpredictability of the outcome that was out of their control, and 
requiring their acceptance of a ‘threatening’ drug. This was found to place 
personal responsibility upon the woman, not only to make this “huge massive 
life changing decision”, but ultimately to face the consequences of that 
decision, which were located outside of the clinic and, for some, resulted in 
avoidance strategies. Public perceptions of blame and responsibility for the 
outcome of decisions made resulted in a sub-group of women interpreting their 
decisions as selfish. 
10. The most significant finding was that not all women perceived risks in the 
same way, responding differently to information concerning risks and 
uncertainties, with implications for clinical practice and the communication of 
preconception information as influencing women’s risk management and 
decision-making. 
 
11.2 Unexpected outcomes 
This study provided a unique opportunity to observe prospectively WWE and their 
clinicians engaging in risk communication within the context of the epilepsy clinic, 
and to gain insight into the real life perspectives of women preparing for pregnancy. 
This opportunity enabled a ‘fly-on-the-wall’ account of decision-making and 
supported the interpretation by women of their role within the clinic consultation and 
subsequent decisions made and actions taken. 
 
The most significant unexpected result has been the degree of difference between 
definitions of pregnancy planning held by clinicians and patients/participants in 
comparison to guideline definitions. This was first noticed during recruitment, and was 
explored through focus group discussion and interviews. The findings revealed that 
both women and clinicians have a tendency to judge planning as the activity of trying 
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to conceive, whereas planning is defined in epilepsy guidelines as the review and 
management of epilepsy treatment and seizure control prior to attempting to conceive, 
and as involving commencing folic acid and optimizing seizure control and treatment 
before withdrawal of contraception. While clinicians were observed to review and 
attempt to optimize treatment and seizure control, there was a tendency not to include 
this activity within their discussion of the importance of planning pregnancy. From the 
perspective of women there was also a tendency to separate improvements in epilepsy 
care from their activities of planning pregnancy. This finding has significance as 
women are frequently recruited or categorized for analysis within studies based on 
their statement of pregnancy planning intention, such as in recent questionnaire studies 
to assess the knowledge of women regarding preconception issues.  
 
WWE preparing for pregnancy were found to be a vulnerable group, due to their 
reliance on health professionals identifying their pregnancy intentions within referral 
documentation, the resultant risk being either a failure to assign urgency to review or 
appropriate allocation of clinic or clinician. With the exception of women with recent 
relapse of seizures or active epilepsy, referrals failed to acknowledge the urgency of 
need for preconception review, resulting in potential delays in appointment allocation 
during a time when contraception had most likely been stopped as women were trying 
to conceive or ‘planning pregnancy’.     
 
11.3 Implications for practice 
This study’s findings have implications for clinical practice in relation to care and 
management of WWE during their childbearing years, and also regarding future 
service developments:  
1. There is increasing pressure to communicate the results of the ongoing research 
into the potential adverse pregnancy outcomes associated with in utero 
exposure to AEDs. These studies report on the risks associated with in utero 
AED exposure and require both clinician and patient to interpret and discuss 
the results. There is also pressure for the communication of these results to take 
account of the continued uncertainties both in relation to the extrapolation of 
population data to individual patient care, and in predicting individual 
responses to changes to AED regimens and the emotional responses of 
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individual patients. The results of this project have immediate applicability for 
the development of clinical practice, supporting improvements to risk 
communication strategies and the delivery of preconception counselling.  
2. The results highlight the important role of the clinician in communicating risk 
and acting in an important health promotion role, by supporting informed 
decision-making crucial to maintain the safety of the future mother and baby. 
Communication of risk which focuses on the health of the unborn baby/child 
has a persuasive element, given the vulnerability of the unborn baby to in utero 
AED exposure and maternal seizures. The patient’s perspective was as 
recipient of risk information delivered by the clinician, and the study revealed a 
variability and individuality of the responses among women towards their 
perceived risks and uncertainties, with the power to influence their assessment 
and management of risk both prior to and during pregnancy. 
3. The communication of risk was challenging for both women and clinicians, 
and no consensus was observed with regard to the content of risk information 
delivered by clinicians. This finding is significant for future practice 
development, as no clinical protocols currently exist to guide counselling 
practice, despite the increasing likelihood of more complex sets of risk 
information data requiring communication, such as the Epilepsy and Pregnancy 
Registers and prospective studies examining neurodevelopment outcome. The 
literature acknowledges the limitations of clinician communication skills in 
translating population estimates into individual susceptibility. This area 
requires urgent attention and the current study findings support 
recommendations to investigate development of communication support both 
for clinicians and patients, the use of decision aids and the application of 
prospective observational studies to extend findings longitudinally within a 
lifespan perspective.     
4. The model of preconception counselling highlights opportunities to offer 
support to women when assessing their pregnancy intentional status, 
suggesting a need for interventions to improve self-efficacy for WWE to 
influence their engagement in epilepsy management and health promotion 
strategies to improve seizure control and overall health prior to conception. An 
implication of these findings is that pregnancy intentions were both 
independent of age and highly emotive, with the latter influencing engagement 
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in planning activities. The study identified a sub-group of teenagers with 
clearly stated intentions, reinforcing the need for delivery of targeted 
interventions to improve awareness of preconceptual issues from the earliest 
opportunity and repeated over time.  
5. The implications for practice will require a shift in the perceptions of clinicians 
regarding the role played by women in assessing, interpreting and managing 
perceived risk and uncertainty relating to pregnancy planning. Clinicians will 
be required to make known their personal interpretations of what they mean by 
the terms ‘planning pregnancy’ and to develop a shared meaning of planning 
behaviours early within the clinical relationship. This requires an open 
dialogue, with the clinician reviewing the patient’s perceived anxieties, worries 
and fears concerning pregnancy planning. 
6. WWE have been found to take an active role both interpreting and negotiating 
the preferred outcomes of pregnancy. However, the results have revealed a 
disparity between what interventions WWE and clinicians expect and want to 
include within the preconception review. Communicating risk is a vital 
component of any preconception review and the results of this study have 
shown the powerful influence the content and methods of delivery can have 
upon risk management strategies accepted and acted upon by women. 
 
11.4 Future Directions of Research 
This research study has illustrated the acceptability of observations of clinical practice 
and the value of providing women with feedback in the form of follow-up interview. It 
is likely that this method of research would be applicable both in practice development 
and future research to analyse the differing methods of delivering risk information and 
the impact of risk communication strategies upon preconception decision-making. 
Further research in this field would be of great help in raising the profile of this clinical 
area, and the practical application of developing risk communication and 
preconception care interventions to improve future pregnancy outcomes. This 
highlights the importance of collaborative research, such as considering inclusion of 
preconception recruitment within the WWE national epilepsy and pregnancy registers, 
and prospective cohorts investigating in utero AED exposure and the risk of 
neurodevelopmental delay.  
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The current study has contributed to the design of future prospective studies, clearly 
defining the participant groups of interest, namely patients and clinicians, in which 
clinicians could be further defined as involving: 1) primary care clinicians including 
GPs, practice nurses and community pharmacists, and 2) secondary/tertiary care 
clinicians involving a multidisciplinary team of neurologists, specialist nurses, 
obstetricians, midwives and psychologists. The patient group for future studies 
requires a wider population sample, involving women with a confirmed diagnosis of 
epilepsy, identifying women at the time of diagnosis, or in the case of teenagers, 
identifying young women prior to first sexual encounter. These women could be 
prospectively monitored to answer questions such as “what clinical and behavioural 
interventions provided before pregnancy will improve pregnancy outcomes for WWE 
and their offspring”, and including satisfaction scales and economic evaluation as part 
of the research protocol (JB Winterbottom et al., 2008).  
 
The Cochrane Systematic Review of the effectiveness of preconception counselling 
identified several topics requiring further investigation including the need to address 
the limits of methodological quality of the current evidence. It is proposed the 
development of prospective randomised-controlled studies, prospective cohorts and 
controlled before and after studies, powered to detect difference between interventions 
will be able to provide evidence effectiveness. These studies would need to collect 
sufficient data for analysis of significance, making comparisons at baseline and over 
several data entry stages during the study, with sufficient duration to collect long-term 
outcomes of pregnancy.  
  
The methods of research have been acceptable to both women and clinicians. They 
have consented to the invitation for observation and digital audio recording of the 
epilepsy consultation, revealing a future opportunity to extend the application of these 
research methods into larger prospective studies which will evaluate the effectiveness 
of future developments in the presentation of risk information within the preconception 
counselling consultation.   
 
The presentation of pregnancy-related risk information consists of multiple sources of 
data, requiring a clinician to have full awareness of the current literature and be skilled 
to translate risk data into meaningful messages that will help women make informed 
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reproductive decisions. It is also recognised women require suitable comparisons when 
facing risk decisions, for example, when making choices between teratogenic risks 
within a proposed treatment regimen (Nicolai et al., 2008). The development of a 
model to support the communication of risk information requires further refinement to 
allow for changes in risk framing and the content of risk information. 
 
The model of preconception counselling requires further testing of the predictive 
function of the model components, including further investigation of the ability to 
predict an individual’s pregnancy intentional stage and accurately tailor individual risk 
information to accommodate preferences. The model was based on social cognitive 
theories and, it is proposed, presents an opportunity for experimental studies to test the 
‘active components’ of preconception counselling interventions, for example, which 
factors promote or inhibit pregnancy planning behaviours, the ability to identify stages 
of pregnancy contemplation, and the influence of risk communication strategies upon 
the stages of change to achieve the desired outcome. It is likely further mixed methods 
studies will best suit this type of investigation, with the application of further 
qualitative research to examine the social context of women’s reproductive decision-
making alongside quantitative studies to measure the variance of factors within the 
complex process of undertaking preconception counselling during preparation for 
pregnancy. 
 
11.5 Final conclusions 
The findings here reveal women with epilepsy contemplate pregnancy and make 
decisions to try and conceive within the context of their whole life with epilepsy. 
Planning for pregnancy has been shown to vary in meaning between women and 
clinicians and requires further defining to support women taking advantage of the 
opportunities afforded from a planned pregnancy. Experiencing prior adverse 
pregnancy outcome did not consistently motivate women to engage in preconception 
counselling, with women often requiring assistance to consider an alternative course 
through a future pregnancy. The research presented here finds communication of risk 
and uncertain information is an emotive topic associated with risk management 
strategies which may act as barriers to pregnancy planning and receipt of 
preconception counselling. Decisions made during preparations for pregnancy are 
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multiple and often complex, requiring women to achieve a balance between their 
preferred outcomes. For some, this emphasised responsibility towards the health of the 
unborn child, while for others decisions to place one’s own health above the child 
(exemplified by decisions concerning treatment adherence during pregnancy) were 
judged as selfish. The findings reported here regarding decision-making during 
preparation for pregnancy highlight the importance of predicting the pregnancy 
‘contemplative stage’ thereby supporting women with targeted interventions. Women 
experience additional worries both preparing for and during pregnancy concerning the 
uncertainties of pregnancy outcome, and the evidence suggests as Evans (1952) noted, 
pregnancy need not feel a ‘grim problem’, but rather the potential adverse effects of 
preconception counselling maybe mitigated by supportive counselling and positive 
framing of risk information. 
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Appendix 1 Study documentation 
Study documentation includes: 
1. Participant invitation letter 
1.1 Focus Group 
1.2 Clinic observation and follow-up interview 
2. Participant information sheet 
2.1 Focus Group 
2.2 Clinic observation and follow-up interview 
3. Participant consent form 
4. Clinician information sheet 
5. Clinician consent form 
 
Study documentation Version 4 is illustrated here, reflecting changes made during the 
recruitment process. An example of the clinic observation & follow-up interview 
participant invitation letter and study information sheet is presented here; focus group 
documentation met ethical approval, and followed a similar format. 
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                   To be printed on hospital headed paper of the recruiting clinicians Trust. 
 
Letter of invitation to participants (14.07.08 version 4) 
 
Letter of invitation to participate in observation of clinic appointment and follow-up 
interview. 
 
Dear Patient’s name 
 
Study Title: A research study of women with epilepsy preparing for pregnancy. 
 
This study may be of interest to you, and I would like to offer you the opportunity to 
consider taking part in the study, which would involve the researcher observing a 
future clinic appointment, and interviewing you a few months later.   
The study is designed to increase understanding of how women with epilepsy make 
decisions about pregnancy.  
The aim of the study is to obtain a range of differing views and experiences, of women 
at different stages of their reproductive lives, in order to better understand how doctors 
and nurses can best provide advice and support.  
 
The researcher (Janine Winterbottom) is a trained nurse, and a post-graduate research 
student at Liverpool University. This study is part of her research training.  
Please take the opportunity to read through the study documentation enclosed.  
If you would like to take part, and would be happy for the researcher to contact you, 
please return the reply slip below in the envelope provided, or you can approach the 
researcher by telephone, email, text, or in person when you attend for your hospital 
appointment.  
 
Thank you for taking the time to read through the information provided. 
 
Name of recruiting Clinician: - _____________________________ (in capitals) 
 
Signature……………………………………….. 
 
 
--------------------------------------------------------------------------------(tear off slip)------- 
 
Return to –  Janine Winterbottom at The Walton Centre for Neurology and 
Neurosurgery NHS Trust in the stamped addressed envelope provided. 
 
Study Title – An in-depth analysis of women with epilepsy preparing for pregnancy.  
 
I would like to take part in the above study, and I am happy for the researcher to 
contact me. 
My name and address (please print)……………………………………………… 
…………………………………………………………………………………………  
Telephone number………………………….. Best time of contact -……………..     
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     To be printed on hospital headed paper of the recruiting clinicians Trust. 
 
Patient information sheet-  Observation of clinic visit and follow-up interview.      
(14.07.08. Version 4) 
 
An in-depth analysis of women with epilepsy preparing for pregnancy. 
 
You have been invited to take part in a research study. 
 
Before you decide whether or not to take part, it is important that you understand why 
the research is being done and what it will involve.  Please take time to read the 
following information carefully. Talk to others about the study if you wish.  
Part 1 tells you the purpose of this study and what will happen to you if you take part.   
Part 2 tells you how the study will be conducted. 
Please ask if there is anything that is not clear or if you would like more information.  
Take time to decide whether or not you wish to take part. 
 
Part 1 
 
What is the Purpose of the Study 
The study aims to provide a greater understanding of the preparations women with 
epilepsy make when considering pregnancy.  
At present, we do not know the best way to provide relevant information to women 
with epilepsy thinking about pregnancy. We also don’t know how best to help women 
with epilepsy make decisions about pregnancy. 
The study is part of my research training and education. I am a part-time student at the 
University of Liverpool, and an epilepsy nurse specialist working at The Walton 
Centre for Neurology and Neurosurgery NHS Trust in Liverpool.   
 
Why have I been chosen? 
You have been invited to take part in the observation and interview stage of a study 
concerning being a woman with epilepsy, and your past, present or future pregnancy 
plans. I am interested in talking to women with epilepsy with differing ages and 
experiences. To complete this stage of the research I need to involve approximately 20 
women in the observation of their clinic appointment and follow-up interview.  
 
Do I have to take part?  
No, it is up to you to decide whether or not to take part.   
If you agree to take part and sign the consent form, you remain free to withdraw from 
the study at any time, without giving a reason, and without affecting the standard of 
your care. (Further information is given in Part 2) 
 
What will happen to me if I take part? 
You have been invited to take part in a study to increase awareness of the range of 
issues concerning being a woman with epilepsy. 
Your part in the research will involve meeting with me on two future occasions.  
 
The first meeting will take part at your next planned clinic appointment in 
approximately 3-6 months time. 
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Observation of your clinic visit 
I will be present with you in your clinic appointment with your epilepsy specialist.  
Your appointment will be audiotape recorded.  
I will take no part in your appointment, and will simply be present to observe, and 
make occasional notes, about how the discussion within your appointment flows. The 
clinic visit will last as long as your usual appointment. 
My role is to observe the process of the clinic appointment, with the audiotape 
recording the content of the discussion.   
In the time between the first meeting and the follow-up interview, I will study the 
observations I make to develop my ideas and produce a summary. You will be sent a 
copy of the summary before our next meeting. The summary report is for your own use 
as an aid to your memory. 
Just before our 2
nd
 meeting, I will make contact to arrange a suitable date and time to 
meet in your own home, or if inconvenient, an alternative venue can be agreed.  
 
The second meeting will take place approximately 3 months after your observed clinic 
appointment. 
 
Follow-up interview 
The interview will be audiotape recorded and last no longer than two hours.  
It will involve me asking you some questions. These will cover several different topics 
I’d like to hear your opinions and feeling about. 
 
The success of the research rests on you feeling able to share your experiences, 
beliefs and views within the interview, and I will wholeheartedly respect your 
involvement in the study and your confidence, by protecting your identity within any 
written reports or presentations.   
 
Expenses 
I do not anticipate that involvement in the study will cause any additional expenses. I 
appreciate that the interview will require you giving of your time. However, by being 
flexible I hope this will limit any inconvenience to you. 
If meeting in your own home is inconvenient, I will arrange to reimburse any travel 
costs to an alternative venue on production of a receipt. Public transport or taxi travel 
costs will be reimbursed. 
 
What are the possible disadvantages or risks of taking part?   
There is no physical risk associated with taking part in the observation or interview, 
although because sensitive topics may be discussed you may feel upset or distress. 
Therefore, there will be an opportunity for de-briefing at the end of both the observed 
appointment, and interview, making available a range of literature. (De-briefing will 
offer the opportunity to ask questions, or clarify any issues raised)  
If personal issues are revealed through taking part in any stage of study, facilities are 
available for referral to the Clinical Neuropsychology service at The Walton Centre 
for Neurology in Liverpool.  
 
What are the possible benefits of taking part? 
I cannot promise the study will help you personally. However, the information 
generated in discussion might help improve the future care of women with epilepsy.  
This study is designed to update the recent epilepsy guidelines published by the 
National Institute of Clinical Excellence. 
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What happens if there are problems? 
If you have any concerns or feel harmed by your participation in the research project, 
you are entitled to complain. (Further information is given in Part 2) 
 
Will my taking part in the study be kept confidential? 
Yes, all information that is collected about you during the course of the study will be 
kept strictly confidential. (Further information is given in Part 2) 
 
Contact Details: 
Researcher – Janine Winterbottom can be contacted both by phone and by email if you 
have any further questions or concerns at any stage in your participation. 
Telephone number – 0151 529 8424  
(Answer phone operating 24 hours, calls retrieved and returned during office hours, 
with limited weekend calls). 
Email- janine.winterbottom@thewaltoncentre.nhs.uk 
 
This completes Part 1 of the Information Sheet. 
 
If the information in Part 1 has interested you and you are considering participation, 
please continue to read the additional information in Part 2 before making any 
decision. 
 
Part 2. Additional Information            (14.07.08. Version 4)   
What will happen if I don’t want to carry on with the study? 
If you don’t want to carry on with the study, I will make no further contact.  
Any basic information collected before leaving the study, for example, your age and 
type of epilepsy may be used in the final report. However, direct quotes will not be 
used in the study report or any publication, and your rights to confidentiality and 
anonymity will be maintained. 
 
What if there is a problem or I want to complain? 
If you feel harmed by taking part in the study, there are no special compensation 
arrangements, and if you wish to pursue a claim, you may need to pay for it.  
Regardless of this, if you have a concern about any aspect of this study, I (Janine 
Winterbottom 0151 529 8424) will do my best to address your concerns.  If you 
remain unhappy and wish to complain formally, you can do this through the NHS 
Complaints Procedure.  Details can be obtained from your local hospital, which you 
attend for your epilepsy care. 
 
Will my taking part in this study be kept confidential? 
Any information about you collected during the course of the study will be kept strictly 
confidential. Your name and any other names mentioned within discussion will be 
removed, so that you cannot be recognised by anyone reading the final report. All 
procedures for handling, processing, storage and destruction of the data will be 
compliant with the Data Protection Act 1998. 
As the lead researcher, I am responsible for restricting access to this information; 
however, through the course of the research project the records may need to be 
accessed to check that the study is being carried out correctly. Anyone being granted 
access to the study data will have a duty of confidentiality to you and nothing that 
could reveal your identity will be disclosed outside the research team.  
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Involvement of your General Practitioner (GP)   
Your GP will be informed only of your recruitment into the study with your consent. 
No additional information will be passed to your GP without your written consent and 
agreement.  
Your GP is informed for the following reasons: - 
In case unanswered questions about your condition are revealed during the progress of 
the follow-up interview and you need to approach your doctor for assistance, treatment 
or referral.  
The need for additional contact with your epilepsy specialist or your GP might arise, if 
in the course of the interview, you mention something that I (as an epilepsy nurse 
specialist) feel might jeopardise your health. I have a duty of care, and would need to 
discuss this with you should the event arise. No contact would be made without your 
written agreement.   
 
What will happen to the results of the research study?   
The results will be written up as part of the examination of my PhD studies. It is my 
intention to publish the research results in medical journals with the goal of improving 
awareness of the needs of women with epilepsy. I would like to reassure you that every 
effort will be made to prevent your identity from revealed within any written report or 
presentation. 
On completion of the research, the findings will be shared with the national patient 
support groups e.g. Epilepsy Action; and, in two local public meetings, arranged in 
Liverpool and Manchester. You will receive an invite to attend these meetings along 
with local service providers. 
 
Funding of the research 
Funding has been secured through two research bursaries, from the HSA Charitable 
Trust and Epilepsy Action, and I have been awarded a fellowship grant from the 
Epilepsy Research Foundation to replace my clinical time as Epilepsy Nurse 
Specialist.  
 
Who has reviewed the study? 
My supervisors, Professor Gus Baker and Professor Ann Jacoby from Liverpool 
University, have reviewed the quality of the study, and will monitor its progress and 
any outputs.   
The study has received favourable review from Newcastle & North Tyneside Local 
Research Ethics Committee, where it was submitted for approval as the lead Multi 
Centre Research Ethics Committee; and from the departments of Research Governance 
in all participating Hospital Trust. 
 
Thank you for considering taking part and taking the time to read this information. I 
am happy to answer any remaining questions you might have by making contact by 
telephone or email. 
 
You may wish to keep this information sheet and the copy of your signed consent 
form. 
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       To be printed on hospital headed paper of the recruiting clinicians Trust. 
 
Participant Consent Form                (10.07.06 version 3) 
 
Title of Project: An in-depth analysis of women with epilepsy preparing for 
pregnancy. 
Name of Researcher: Janine B. Winterbottom 
 
1. I confirm that I have read and understand the information sheet dated 10
th
 July 2006 
for the above study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily.               Please initial box 
 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my medical care or legal rights being 
affected.         
           Please initial box 
 
3. I understand that relevant sections of any of my medical notes and data collected 
during part in this research may be reviewed by responsible members of the research 
team, from regulatory authorities or from the NHS Trust, where it is relevant to my 
taking part in this research.  I give permission for these individuals to have access to 
my records.                                                                                      Please initial box      
           Please initial box 
 
4. I understand that audiotapes will be used during all stages of the research, and that 
typed transcripts of the interviews, group discussion and clinic observation will be 
stored securely. I understand that every attempt will be made to shield personal 
identifying detail from written reports of the study findings. I give my permission for 
the use of audiotapes.   
           Please initial box    
  
 
5. I agree to my GP being informed of my participation in the study. 
           Please initial box   
          
 
6. I agree to take part in the above study.                      Please initial box 
             
 
     
________________________      ____________   ____________________ 
Name of Patient  Date Signature 
 
________________________ ____________   ____________________ 
Name of Person taking consent       Date  Signature 
(if different from researcher) 
_______________________ ____________   ____________________ 
Researcher  Date Signature 
When completed, 1 for patient; 1 for researcher site file; 1 (original) to be kept in medical notes.  
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      To be printed on hospital headed paper of the recruiting clinicians Trust. 
Clinician information sheet          (14.07.08. Version 4) 
 
STUDY TITLE:  Women with epilepsy preparing for pregnancy: A Qualitative 
analysis of the perception and communication of risk 
information.  
 
The overall aim is to provide an in-depth exploration of women with epilepsy’s 
perception of risk and the probability of adverse pregnancy outcomes, in the context of 
their involvement in shared decision-making. This will enable wider inference to be 
made regarding the role and potential outcomes from preconception counselling. 
 
The rationale for study design reflects the need to understand women with epilepsy’s 
experiences and feelings all of which might shape reproductive behaviour. Qualitative 
methods offer the opportunity to address the research objectives, which require 
explanation, and offer the opportunity to gain access into these areas of a woman’s 
private life, which are rarely accessed by quantitative research methods. 
 
The proposed study will be conducted in three phases (see table 1), with two stages of 
recruitment. 
 
Group 1- recruitment for Focus group 
Group 2- recruitment for observation of consultation & In-depth Interviews. 
 
Within each study group, stratified purposeful sampling will be used to identify female 
patients that meet the following criteria: 
 
 Women aged between 16 years and 45 years. 
 Have a confirmed diagnosis of epilepsy by a neurologist with a specialist 
interest in epilepsy. 
 History of epilepsy of at least 3 months. 
 Prescribed anti-epileptic medication for treatment of epilepsy. 
 Able to participate verbally in a group (phase 1 and 2 recruitment).  
 Able to converse in English. 
 Provide informed consent (copy filed in the patient case record). 
 
The women will also represent a stage during their reproductive career: 
  
 Teenager 16-19 years. 
 Women actively seeking preconception advice.  
 Pregnant women.  
 Women who have experienced pregnancy whilst taking AED’s. 
 Women with a recent diagnosis of epilepsy, or commencing treatment for 
the first time. 
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Stage  Expected work for participating 
Doctors and their patients. 
Expected time 
commitment.  
Phase 1 Focus Group 
discussion with women 
with epilepsy, to develop 
an understanding of their 
breadth of experience, 
views, beliefs and 
perceptions of being a 
woman with epilepsy. 
Patient selection using inclusion criteria.  
The researcher will be present during 
epilepsy clinics and will be available for 
patients to approach if they wish to discuss 
their involvement in the study.  
Pre-selected patients will only be 
approached as directed by the clinician, or 
if they request to speak the researcher at 
the end of their clinic appointment, or on 
return of the reply slip. 
It is expected that any 
extra time generated 
through patient selection, 
will be minimised by the 
researcher being available 
during referral triage, and 
ahead of the clinic start 
time.  
Patients will attend one 2-
hour focus group. 
Phase 2 Observation of 
clinic appointment – to 
develop an understanding 
of women’s experience of 
decision-making during 
clinic appointments in 
which reproductive issues 
are discussed, and risk 
information provided.  
Patient selection using inclusion criteria. 
Identification of potential participants will 
occur during routine referral triage and 
review of clinic lists. Recruitment will also 
occur during routine review of WWE, and 
will involve the selection of suitable 
patients who are likely to be presented 
with risk information at their next clinic 
review. Agreement and consent will be 
negotiated.      
The researcher will write to the patient 
ahead of their observed appointment, 
provide answers to any remaining 
questions, detail consent and plan to meet 
the patient at the time of their appointment.   
No extra time commitment 
is anticipated. The 
observation is of patient 
discussion and the clinican 
is asked to follow usual 
clinical practice. The 
researcher will not 
participate in the 
appointment, being present 
as an observer of the 
patients interaction with 
the clinician.  
The observation will 
include audiotape.   
Phase 3 Follow-up 
interview three months 
after the observed clinic 
appointment. The 
interview will be guided to 
enable woman to share 
their experience of 
decision-making and 
perceptions of pregnancy 
planning in light of 
information provided 
within their clinic visit.  
The patient will have contact with the 
researcher and will be advised of their 
ability to withdraw consent.  
A summary of themes discussed will be 
sent to the patient, and copied to the 
doctor; this will form part of the structure 
of the interview. The patient will meet for 
one interview lasting a maximum of 2 
hours.  
Interviews will take place 
in the patient’s own home; 
therefore, there is no time 
commitment for the 
clinician.  
Table 1 Study method 
 
Ethical Considerations 
The sensitive and emotional content of the study will be acknowledged in all 
communication between WWE and their clinician’s; providing detailed information 
about their role in the study, their ability to withdraw consent at any stage, the role of 
the interviewer in response to issues raised within interview, and setting ground rules 
for focus group participation.  
 
Tapes and transcripts will be securely stored within a locked filing cabinet within the 
investigators employing trust premises, and computer documents password protected. 
Data collection will conform to the Data Collection Guidelines and Clinical 
Governance. Confidentiality and anonymity will be guaranteed throughout the study, 
and within report writing and publication of findings. Audiotapes from observation and 
interview will remain the property of the investigator to enable further analysis and an 
ability to return to the raw data.  
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It is intended the data will be retained for eight years reflecting the maximum duration 
of study for part-time PhD including time for write up ‘pending submission’. The 
wishes of the participants for final disposal of tapes, whether to return to the individual 
or to destroy will be acknowledged.  
 
Newcastle & North Tyneside Local Research Ethics Committee has awarded ethical 
approval, whilst NHS Research Governance approval has been sought from the 
research and development departments of The Walton Centre for Neurology and 
Neurosurgery NHS Trust, The Liverpool Women’s Hospital NHS Trust and Salford 
Royal Hospitals NHS Trust. 
 
Project Management 
The research study has been developed to ensure compliance with standards for 
research governance, and has involved both patients and patient organisations in the 
development of the study aims and objectives, and agreement of acceptable methods of 
enquiry. The standard of work, scientific quality and timely submission of research 
reports will be maintained through academic supervision.  
The Epilepsy Research Foundation has awarded a fellowship grant, and two small 
research bursaries have been secured from Epilepsy Action and HSA Charitable Trust.       
 
Utilisation and dissemination 
It is expected the study findings will have immediate applicability to clinical practice, 
with short-term goals influencing patient care by publication within peer review 
journals and presentation at epilepsy meetings. The medium term objective would be 
to act as a source of evidence for the update of the NICE guideline review panel, whilst 
long-term goals are to influence further study into the information needs of WWE.  
Thank you for your considering taking part in the research, without your involvement 
the project would not be possible. Thank you for taking the time to read this 
information sheet, and please direct questions to the chief investigator Janine 
Winterbottom Tel- 0151 529 8424 (answer phone) or via Email – 
janine.winterbottom@thewaltoncentre.nhs.uk  
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(Form to be printed on hospital letter headed paper) 
Clinician Consent Form (14.07.08. Version 4)  
 
 
Title of Project: Women with epilepsy preparing for pregnancy: a qualitative 
analysis of the perception and communication of risk information 
 
Name of Researcher: Janine Winterbottom                        Please initial boxes 
 
1. I confirm that I have read and understand the information sheet              
 dated 14th July 2008 (version 4) for the above study. I have  
 had the opportunity to consider the information, ask questions  
 and have had these answered satisfactorily.           
 
2.   I understand that my participation is voluntary and that I am free  
 to withdraw at any time. 
 
 
3.  The use of supporting quotations in any report or publication will        
     not reveal the identity of either myself, my patient or hospital site.     
 
 
 
4.   I agree to take part in the above study.       
 
 
______________________   ______________________   _______________ 
Name of Clinician                   Signature                                Date 
 
______________________   ______________________   _______________ 
Researcher                            Signature                                 Date  
 
 
When completed, 1 copy for researcher’s file; 1 (original) to be retained by the 
participating clinician. 
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Appendix 2 Data collection tools 
Data collection tools include: 
1. Focus group sampling frame 
2. Participant questionnaire 
3. Focus group – introductory script 
4. Focus group – risk prompt cards 
5. Topic guides 
a. Focus Group topic guide 08-10-07 
b. Observation guide 
c. In-depth interview topic guide  
 
Topic guides were adapted during the process of focus group data collection to reflect 
the different group compositions (by age and reproductive experience). The topic 
guide illustrated here: a) was used for focus group 8 - participants who were pregnant 
at the time of attendance, b) Observation guides were used as additional reflective tool 
for recorded observation, c) example of interview guide used for interview 23. All 
topic guides met ethical approval, and followed a similar format of questions and 
prompts.  
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Focus Group sampling frame 
 
 
Age: Teenage 
group 
Planning 
group 
Pregnant 
group 
Mature  
group 
Target age distribution:  
Group size n= 6-8 
 16-19 year 
olds 
 19-45 year 
olds 
 19-45 year 
olds 
 35-45 year 
olds 
Reproductive experience across groups:  
Planning     
Pregnant     
History of pregnancy     
AED use across groups: 
Sodium valproate     
Lamotrigine     
Carbamazepine     
Phenytoin     
Levetiracetam      
Topiramate     
 Targeted recruitment – drug use applied as a guide to ensure women’s experience 
was similar to the wider population of reproductive age WWE. 
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Participant questionnaire 
 
Thank you for agreeing to take part in the research, which I hope you have found 
enjoyable and perhaps informative.  
 
To assist my analysis I would value some brief background information. This 
information is anonymous and your name does not appear on the questionnaire. 
Your answers will not be used in any way that could identify you personally. The 
information will be used by the researcher to demonstrate that a broad range of views 
and experience has been gathered, and will help support the final research conclusions 
and recommendations. 
 
Most of the questions require either a brief written answer or a tick in a box next to the 
answer that best applies to you.  
 
First some questions about your epileptic attacks. By epileptic attacks we mean any 
fits, seizures, convulsions or episodes of loss of consciousness. 
 
About your epilepsy –  
 
How old were you when you had your first epileptic attack?      
......………………years 
 
How old were you when you had your last epileptic attack?       
…………………..years  
 
Apart from your epilepsy, do you have any long-term problems with your health? 
 
Yes  
No  
  
If yes, please specify 
...…………………………………………………………………. 
…………………………………………………………………………………………
…… 
 
If yes, are you taking any drugs for the condition(s)? 
 
Yes  
No  
 
How many epileptic attacks have you had in the last six months? 
 
None  
Less than one per month   
One or more per month  
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Do your attacks happen? 
 
Only when you are asleep  
Usually within two hours of waking  
At any time of the day or night  
 
Sometimes people injure themselves during an epileptic attack. 
 
In the last six months have you suffered any type of injury as a result of having an 
epileptic seizure? 
 
Yes (please write in details)  
No  
………………………………………………… 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
In the last six months have you experienced an epileptic attack while bathing or 
swimming? 
 
Yes  
No  
 
Are you currently taking any drugs to control your epileptic attacks? 
 
Yes  
No  
 
If yes, please name the drugs you are currently taking?  ..……………………………. 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
How well do you think your attacks are controlled by the drugs you are taking? 
 
Very well controlled  
Fairly well controlled  
Not very well controlled  
Not at all well controlled  
 
 
Women’s issues 
 
Have you experienced a pregnancy? 
 
Yes  
No  
If yes, 
 
How many pregnancies?   .…………………………………………………  
How many children? ……………………………………………………….      
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Was your experience of pregnancy planned? 
 
Yes  
No  
 
In the last six months have you used contraception? 
 
Yes  
No  
 
If yes, 
 
What method do you rely on? ……………………………………………… 
 
Have you taken folic acid? 
 
Never  
Only during pregnancy  
During preparation for pregnancy and 
during pregnancy 
 
 
 
Finally, a few questions about you, yourself. Could you please tell us? 
 
Are you:    
  
 
           ………………………. …………………………………………… 
 
Who do you live with? 
 
With your husband / or steady partner  
With your children  
With your parents  
No-one – live alone  
Other (please write in)  
                               …………………………………………………………. 
 
Which of the following BEST describes your level of education? 
 
Left school at 16yrs, no qualifications  
Left school with GCSE’s  
Left school with A levels  
Vocational qualifications  
Professional qualifications  
University degree or above  
Other (please write in)  
                                 ……………………………………… 
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Single  
Married or living as married  
Divorced or separated  
Widowed   
Other (please write in)  
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Which of the following BEST describes your position about paid work?        
 
Employed full-time  
Employed part-time  
Unemployed  
Permanent sick leave  
Housewife  
Student   
Other (please write in)  
     ....…………………………………………………… 
 
What is your current job title or last main job title?   
…………………………………………….……...................................................…… 
………………………………………………………………………………………… 
 
Are you / were you  
 
An employee  
Self employed  
 
Are / were you a manager or supervisor of any kind? (Please tick all that apply) 
 
Yes, manager  
Yes supervisor  
No, neither  
   
If you have been working during the last six months, how many days have you 
been unable to work because of your epilepsy? 
 
None  
Number of days (please write in)  
                ………………………………….…………….. 
Are you currently receiving any allowances / benefits? 
 
Yes (please write in)  
No  
………………………………………………………… 
………………………………………………………………………………………… 
 
Do you hold a current driving licence? 
 
Yes  
No  
 
 
Thank you for completing of the questionnaire.         
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Focus Group introductory script 
 
Thank you for all attending today’s group discussion. I am Janine, I’m a student 
researcher and this research is part of my research education. I am employed as an 
Epilepsy Nurse Specialist by The Walton Centre for Neurology and Neurosurgery 
NHS Trust.  
This research is funded by the Epilepsy Research Foundation, a large charity 
responsible for supporting epilepsy research in the UK, with the aim of extending 
understanding about women’s experience of epilepsy during their child-bearing years 
and how they consider future pregnancy. We are holding several focus groups across 
the North West, with the aim of extending our awareness of the range of opinion and 
experience of women during this stage of their lives. The research aims to explore the 
views of women with epilepsy at different ages to determine the best methods of 
communicating information about pregnancy. 
I’ll start by asking a couple of questions just to get us started, and I really want to hear 
from everyone. There are no right or wrong answers, as I wish to explore as wide a 
range of opinions as possible. You can see the session is recorded, so if we can avoid 
all talking at the same time, this will help the quality of the recording, especially when 
I come to type it up. As we begin talking, if you feel something important needs to be 
said, you can write it on the flip chart, so we can come back to it. You can write 
anything onto the flip chart, and don’t worry about spelling. It’s just to help us, as a 
reminder; to highlight something you think is really important. I’ve put the pens on the 
table, so feel free. If we keep questions or subjects that are away from the main topic, 
for the break or at the end? I’m happy to answer any questions at those times. 
In a moment, I will switch on the recorders, and I’d like to reassure you that all your 
comments will be made anonymous, and your names will not be used in any written 
report. Your confidence will be maintained, and if you ask from each other that what is 
said in the session is not repeated outside.  
Finally a range of epilepsy literature is available for you to take with you today.  
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Focus group – Pregnancy risk prompt cards 
 
 
 
You have a 4% risk of 
having a child with major 
malformations. 
You have a 96% chance 
of having a healthy child 
unaffected by your 
treatment. 
We are uncertain of the 
risks from your treatment 
upon the outcome of your 
pregnancy. 
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Topic Guide – Focus Group (pregnant participant group 08-10-07) 
 
Introduction – I want to start by getting to know you, and would like you to introduce 
yourself to the group, saying something about your self, maybe your age, whether you 
live alone or with someone, and something about your experience of pregnancy? 
Prompt 
Brief about nature of epilepsy, type / frequency? 
Number of pregnancies / children? 
 
1. Focusing on your experience of being a woman with epilepsy (before we turn to 
your experience of pregnancy)- 
 
a. What has been your experience of having epilepsy at this time in your life?  
During child-bearing age? 
 
b. Has epilepsy changed any of your future plans at this stage in your life?  
Relationships / Family / Independence 
 
c. What are / have been your views about your need for treatment? 
What influence has this had? 
 
d. How did you see your future with epilepsy and pregnancy? 
Positive / negative 
What influenced these feelings? 
 
2. Focusing on your experience of making decisions about life with epilepsy-  
 
a. What experiences have you had about making decisions about your epilepsy? 
What factors influenced decision-making?  
During hospital / GP appointments? 
 
b. What was your experience of making decisions about contraception?  
What about interactions? 
What choices did you have? 
 
c. How did you make the decision to become pregnant / start family? 
What factors influenced your decisions? 
What were the pros and cons? 
What has been the role of information? Good, bad? 
  
3. Focusing on your experience of decisions about pregnancy?  
 I’d like to explore the meanings of planning a pregnancy for you as a group of 
women with epilepsy. 
 
a. Did you plan your current / recent (any) pregnancy? 
b. What did you do to plan? 
Delay conception?           1 
Commence folic acid? 
c. How have you experienced planning pregnancy? 
What influence has epilepsy had? 
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What influence has your AEDs had? 
What influence has your experience of information / uncertainty had? 
d. What do you think planning should involve / what would be your ideal plan for 
pregnancy with an epilepsy?  
e. What would you see as essential for any WWE to consider when planning? 
f. Who was the key decision maker in your plans for pregnancy? 
When in your appointments, who is key decision-maker / shared?  
 
4. How has your epilepsy influenced thinking about family? 
 
a. What has been your experience of pregnancy and what influence has epilepsy had? 
b. How do / did you feel when you discovered you were pregnant? 
Have those views changed on becoming/following pregnancy? 
c. Do you feel your experience is different from women who don’t have epilepsy? 
d. What experiences have had the greatest influence when thinking about pregnancy / 
motherhood?    
 
5. Focusing on epilepsy & pregnancy risks- 
 
a. What risks have been important to you?  
b. How did you understand the potential risk in epilepsy for WWE, relating to?  
 future pregnancy  
 planning of pregnancy, and  
 medications taken in pregnancy 
 
c. What factors were relevant / influenced you becoming pregnant when taking 
AED’s? 
d. What is your experience of getting information when planning pregnancy?  
 about the risks of treatment  
 about the benefits from treatment 
 What has/had the greatest influence?  
 
e. How would you describe the best methods of communicating risk information at this 
stage (before / during pregnancy)  
 views and experiences of the role health care professionals play 
 
f. How have you used risk information? 
 influence decision-making         2 
 what have you learnt from your experience about making decision 
 ideas/ solutions/ strategies  
 
g. Where do you go / have you got your information from? 
 Internet? What sites? 
 What are your views about the type of information provided / available 
sufficient/adequate/balanced? 
 Who do you trust? 
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Topic Guide – Observed clinic appointment   
 Before observation - Introduce the researcher, the study, and format of 
observation, role as an observer and my position as both a researcher and 
student at Liverpool University, and Epilepsy Nurse Specialist from The 
Walton Centre. 
 Confirm consent – patient and clinician 
 Introduce issues of confidentiality, and the use of a tape recorder. 
 
The following observations will be made, and documented during the course of 
the clinic appointment 
 
Room layout: position of patient and clinician e.g. desk in-between 
Accompanying persons: student observers, patient friends/relatives etc 
Interruptions: noise distractions, persons entering room, clinician leaving room etc 
 
Q.1 How involved was the patient within the consultation? 
 Evidence of questions and answering between women and their clinician 
 Evidence of clinician attempts to involve the woman in discussion about future 
pregnancy intentions 
Q.2 How was pregnancy risk information introduced into the consultation? 
 Was risk information individualised to the woman, her treatment and seizure type? 
 Response to the delivery of risk information 
 Risk information presentation style? 
Q.3 Was a risk benefit assessment made within the consultation? 
 Was a balanced approach to risk and benefit presented? 
 Were potential health promotion opportunities explained, and if so how? 
Q.4 Was a pregnancy plan discussed? 
 Were alternative treatment options explained (drug reduction, switch or 
withdrawal), and if so how? 
 Who raised the proposed pregnancy plan/time scale? 
 Were contraceptive measures discussed? 
 
Additional comments- 
 Emotions between patient and clinician, if event, how managed 
 Use of distinctive language e.g. medical terms or psuedo-medical terms or 
jargon 
 Use of structure in conversation 
 Questioning style 
 Turn taking 
 Dominance 
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Interview Topic Guide 23 
Confirm OK with study and interview, remind about confidentiality, duration of 
interview, & use of a tape recorder. Opening – being woman in reproductive years 
 
1. Having thought about your clinic visit (reading transcript and summary): 
 What had been your journey to this recent appointment? What had you hoped to get 
out of your recent appointments? What did you want to know/discuss? 
 Any issues arising from the consultation? Anything got you thinking? Specify 
 
2. What decisions have you made (considering) following this clinic visit?   
 Changes to medication? Withdrawal? Folic acid? Contraception? 
 Decisions about future family? Has anything changed? (what & why) 
 
3. What’s the most significant piece of information you recall from clinic?  
 Why? Specify  
 Risk of remaining on CBZ v risk of withdrawing CBZ? & % reduction? 
 How have you balanced these risks? “CBZ chemical attack unborn child” Harm 
 Switch over risk, risk of relapse, uncertainty on control/baby  
 What are your feelings about the risks mentioned? 2% risk of major 
malformations + long term developmental uncertainty? 
 What do you feel are your risks? Seizure relapse risk? Treatment risk? 
 What is your experience of preventing risks? CBZ preventing seizure? 
 What can you do to reduce these risks? Before / during pregnancy 
 
4. What were your feelings about the things discussed in clinic? 
 Focused on making the right decision? “Live normal life once made 
decision”  
 Anything not discussed? 
 
5. Looking ahead to a future pregnancy, any worries? Medication? Seizure? 
 Fear of seizure relapse, panic, fear leaving house 
 Coping with worry? What is greatest worry? 
 What are your decisions about future pregnancy? 
 When might the right time be? (Planned, informed, medication rationalized, best 
seizure control) (Intervention / support in place, or balanced) 
 What might be done to make sure you have a healthy pregnancy and baby in 
the future? Folic acid? Any preparations before / after conception 
 How might epilepsy influence decisions? Seizure relapse risk? Drug switch? 
 
6. What do you feel is or has influenced this stage in your life?  
 Significant others? Epilepsy control? Treatment? Past experience?  
 
7. What are your thoughts about becoming a mother? Having a family? 
 “Ultimate goal to try for baby” 
 Looking after the baby? Having seizure as mum? 
 Being able to cope?  
 Breastfeeding? 
 
8. What do you think should be done when preparing for pregnancy?  
 What’s your role? Who else might have responsibility? What does it include? 
 What’s important to you as you move into this stage of life?
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Appendix 3 Stages of analysis 
The aim here is provide a transparent account of my analysis. 
 
Stages 1 & 2 Line-by-line reading and initial noting 
Table A3.1 illustrates an extract of interview transcript for participant OI01. The 
extract highlights interesting sections of text (underlined within original transcript), 
and the left hand column represents the initial noting made as exploratory comments. 
Within NVivo 7 the process of noting text can be considered as building knowledge 
about the data through the development of codes as abstract representations of the 
participants experience of the phenomenon (Bazeley, 2007). The process of coding is 
analogous to developing a network of storage containers for related concepts or 
categories, known as nodes. ‘Node’ refers to a collection of references about a specific 
theme, and can be described as either ‘tree’ or ‘free’. Tree nodes refer to a theme of 
coded extracts of transcript which have been linked with a hierarchical structure (tree) 
representing shared meaning. Free nodes have no presumed relationship or connection 
to the thematic tree structure, representing ideas and comments about the transcript text 
that I wanted to highlight for further consideration. Each free node was given a title or 
name relating directly to the content of the participant’s speech. There were three 
levels of exploratory comments:  
1. Descriptive (normal text) 
2. Linguistic (italics) 
3. Conceptual (underlined) 
 
Descriptive comments involved describing the content of what the participant was 
saying and the subject matter of the participant’s speech. Prompted to describe what 
OI01 recalled from the consultation, she repeats the phrase as if describing a priority of 
concern to avoid having an accident, describing her choice of contraception specific 
for its mechanical obstruction of an accident, requiring removing of the coil before a 
pregnancy could occur.  OI01’s use of metaphor further highlights the importance of 
securing contraception to avoid an accidental pregnancy. OI01 implies through the use 
of the metaphors “fly by the seat of your pants sort of person” that this type of person 
was reckless, whereas she saw herself as ‘not that sort of person’, identifying herself as 
taking responsibility for controlling the timing of her future pregnancy. This text was 
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commented on further, as relating to identity, and how participant OI01 wished to 
present herself at interview. Within the context of the extract, OI01 defined planning as 
an activity that would result in being “better off” and “in control”; the term control was 
also seen to represent the importance she placed on controlling her epilepsy 
management before planning pregnancy. Conceptual comments relating to OI01’s 
account of contraception were reflected upon through my review of the literature, 
revealing empirical evidence of women using the oral contraceptive pill relaxing pill 
taking when ambivalent towards their experience of pregnancy (Barrett and Wellings, 
2002; Zabin, 1999).  
 
Exploratory comments 
(Annotations) 
Original interview transcript 
 Interviewer: In the consultation there was quite a bit of 
information given over, what are the things that jump to you 
mind?  
Priority of concern. 
Accident as term of reference for 
unplanned pregnancy.  
 
Meaning of planning. 
Control of epilepsy 
Better drug for pregnancy. 
Future baby 
Having a baby on medication. 
Size of potential disability 
Comparison of risk to anyone else. 
Don’t stop birth control. 
OI01: Hmm, the things that jump to my mind is hmm, don’t have 
an accident, that was one that came out, thinking don’t have an 
accident because [name of clinician] will kill you (laugh), but no, 
no it was don’t have an accident because you know, if you can 
plan things then you are better off aren’t you. Get it under control, 
hmm, I was on, I was on one of the better medications that I could 
be on if I was going to get pregnant, hmm, and you know if I do 
have a baby on the medication with my epilepsy doesn’t 
necessarily mean it’s going to come out with any massive 
disabilities or anything. You know, you’re only facing slight 
higher risk than anyone else getting pregnant so hmm, that was 
what I got from it really I think, but don’t have an accident 
(laugh). Don’t suddenly stop taking your birth control or anything. 
 Interviewer: Is that something you’d thought about before or 
 
Not who she is – identity  
Metaphor – reckless person 
Relying on coil rather than her 
remembering the pill. 
Contraception restricts her chance 
of an accident. 
 
The planned ‘unplanned’ 
pregnancy – a phrase for it in the 
literature? 
 
OI01: The don’t have an accident thing, I don’t think I would have 
an accident to be honest with you, I’m not really a kind of fly by 
the seat of your pants sort of person hmm but, which is why this 
contraception is so good for me, I mean you know, I don’t, there’s 
no chance of me missing anything so, and I’ve got to go and 
physically get the coil taken out in-order for it not to work. So 
hmm, that’s, that’s why this contraception is the best contraception 
for me, and I don’t think, I mean, I think erm, I think if I was to 
have an accident it wouldn’t be an accident I’d still be planning it 
somewhere so hmm, that would never happen I don’t think. 
Table A3.1 Example of Analytic Stages 1 & 2 (Participant OI01) 
 
I also linked comments to OI01’s reference to “having a baby on medication” and her 
focus on the positive likelihood of “facing only slightly higher risk than anyone else”. 
The potential for ‘massive disability’ led me to consider whether OI01 had anticipated 
being presented with higher risk during the consultation, reflecting her relief and 
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supporting her focus on priorities to avoid an accident until her epilepsy was better 
controlled.   
 
Stage 3 Developing emergent themes 
The task of looking for emergent themes involved reducing the volume of detail within 
the transcript text, whilst retaining the complexity within the exploratory nodes. These 
titles were descriptive and became progressively more conceptual as analysis 
progressed. Developing emergent themes involved working with ‘discrete chunks’ of 
transcript text with the associated with the labelled free node categories (Smith et al., 
2009) (table A3.2). Themes were developed out of the patterns that emerged, forming 
categories of codes (nodes) reflecting both description and interpretation. The task of 
developing emergent themes relied heavily upon the reorganisation of free nodes into 
tree nodes representing the hierarchical structures, and placed in order of their strength 
to describe the essence of the experience or concept that they were linked to. For 
example, the emerging free node theme “safer drug for baby” was defined by its use in 
the transcript discussing safety of one drug over another.  
 
Emergent themes Exploratory comments (Annotations) 
Priority of concern / Information and communication 
Influence on pregnancy plans 
 
Preparing for pregnancy 
Review of epilepsy management / Importance of 
seizure control 
Safer drug for baby 
Future pregnancy and motherhood 
Pregnant taking antiepileptic drugs (AEDs) 
Risks to unborn child 
Comparison of risk 
Pregnancy avoidance strategies 
Parenting role 
Fear of implications 
 
 
Pregnancy avoidance strategies 
 
 
Priority of concern. 
 
Accident as term of reference for unplanned 
pregnancy.  
Meaning of planning. 
Control of epilepsy 
 
Better drug for pregnancy. 
Future baby 
Having a baby on medication. 
Size of potential disability 
Comparison of risk to anyone else. 
Don’t stop birth control. 
Not who she is – identity  
Metaphor – reckless person 
Relying on coil rather than her remembering the pill. 
Contraception restricts her chance of an accident. 
The planned ‘unplanned’ pregnancy – a phrase for it 
in the literature? 
Table A3.2 Developing emerging themes (Participant OI01) 
 
Step 4 Searching for connections across emergent themes 
Several strategies are available to identifying patterns between free nodes supporting 
the development of a hierarchical structure of ‘tree’ nodes with the goal of representing 
                                                                                                                         Appendix 3 Stages of analysis 
 279 
the ‘super-ordinate’ or ‘substantive’ themes from the final theses results. The strategies 
I found helpful in my search for connections involved creating charts with the name of 
each node written onto post-it note. These were charted to link the relationships 
between the themes presenting a visual representation. The process of charting 
identified a cluster of free nodes relating to the fear of the implications of the decisions 
made in preparation for pregnancy; each individual free node represented a series of 
related participant references (table A3.3). 
 
S
u
b
-t
h
em
es
 
Theme: Fear of implications 
Cautious 
Dangerous drug 
Extra worry for women with epilepsy 
Fear of changes in seizure control 
Not worried for self 
Worst case scenario 
Scared of medication 
Scary not knowing 
Table A3.3 Development of theme ‘Fear of Implications’ 
 
Other strategies used for testing the development of the thematic structure included 
‘numeration’. Numeration takes account of the frequency with which a theme is 
supported within the participant accounts. It is a helpful way of identifying the 
importance of an emergent theme, as the frequency of terms used by the participant 
can be an indication the relevance of the theme.  
 
Figure A3.1 illustrates the coding coverage chart I prepared for my PhD upgrade report 
(26-09-08). It was the outcome of interim analysis for three focus group transcripts. Its 
value at this stage in analysis had been to highlight ‘preparing for pregnancy’ and its 
relative importance to the communication and provision of information. It also focused 
my attention to the importance of the emerging theme ‘fear of implications’, 
representing descriptions of emotional responses to the dilemmas faced by the focus 
group participants. The development of emergent themes involved making connections 
between participant accounts, representing similar and recurrent themes. Having 
established a thematic pattern using the techniques of numeration and charting I was 
also able to identify the highly emotive term ‘selfish’ applied by a sub-group of 
participant cases for further analysis and the development of alternate explanations 
(see Chapter 9, Section 9.2 The ‘selfish decision’). 
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Step 5 Moving to the next cases 
Repeating the analytic process for the next case involved balancing the demands of 
time required to recruit participants against the demands of time to focus on 
developing an understanding of their accounts. Although time consuming, transcribing 
helped stages 1 & 2 analysis as I became intimately engrossed in second by second 
accounts of the participant’s speech. My involvement as moderator assisted my 
familiarity of the group; individual mannerisms and behaviours towards each other 
supported my comments regarding group process (supporting a double analysis). 
Participants were observed to support each presenting their experience, questioning 
each other for further details before commenting on their own contrasting experience 
or as reinforcement for a particular experience. Table A3.4 illustrates the comments 
concerning group processes alongside the individual participant comments concerning 
experiential claims. The transcript illustrates group support and the use of humour. 
Additional comments were added by my supervisors (Professor Gus Baker (GB) and 
Professor Ann Jacoby (AJ)) who independently commented on the transcripts to 
ensure consistent coding and logical application of the emerging thematic code. Field 
notes reflected my observations during the focus group session. Reflexive field note 
comments highlighted a significant event, such as the strong sense of despair I felt in 
response to the group’s reaction, and FG71’s reply implying her coping with the 
situation she had faced.  
Figure A3.1 Focus Group Frequency of coded items
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Group comments Exploratory comments Original interview transcript 
Need to redirected 
discussion, moving off 
topic, wanted to get 
other comments 
 Facilitator: If I ask that we leave these issues 
until the end, I’m wondering if there was 
anything else about thinking about becoming 
pregnant. 
FG74 introduced her 
experience of 
accidental pregnancy 
on Epilim prompting 
earlier group 
discussion of drug 
risk. Group support of 
FG74’s focus on the 
harm of medication.  
Experience of pregnancy 
Having AED affected baby  
Worried about medication 
 
Why was she worried 
immediately about 
medication? Had she prior 
information? 
FG74: I think for me, knowing that I was 
pregnant. Was how the medication was going to 
affect, you know, the unborn baby initially? 
[Group: “Hmm”, agreement] 
FG73’s use of 
dramatic comment as 
over emphasis of 
potential harm 
Who are they? To blame? 
GB coded as Blame   
Sick humour  
FG73: They’re worried it’ll come out with two 
heads do you, or something like that 
[laugh][Group laughter] 
Need to re-direct Focus on earlier comment  Facilitator: Worried about the treatment 
 
Observation note: 
Group agreement 
 
Media 
Being given risk 
information 
Life on medication 
 
Baby’s drug exposure 
Biggest worry 
Link to Risk society & 
overload of risk 
information? 
Worst case scenario 
Uncertainty 
Luck 
FG74: Yes, you know, so really that because, 
you hear so much in the media, don’t drink 
coffee, don’t eat this, don’t… So then you’re 
taking in, you know, we can’t give blood, 
because the medication we’re on, you know. 
So, obviously you know that it’s going to be 
going directly in their, so that was the biggest 
worry for me. But, when I was given the 
appointment, urm, it was just the case that, well 
don’t take it, and you’re in a worse sort of area, 
really. Stop taking the medication and you don’t 
know what’s going to happen. And I was really 
genuinely lucky that my fits didn’t interfere 
with me at that point, 
 Seizures in pregnancy FG73: Or are they going to get worse basically 
because you’re pregnant? 
 
 
Observation note: 
empathic sense of 
guilt/despair 
Information  
Emphasis-size of problem  
Futility of planning 
AJ coded as planning-
effectiveness? 
Focus on health of unborn 
baby 
FG74: So in terms of planning then, you’re just 
seeking information. But, it is very much case, 
of that one large thing you can’t change. So as 
much planning as might want to do, you can’t 
change that, and it’s always about the health of 
the unborn baby isn’t it, so. 
Agrees with FG74 ‘it’s 
true’, absolving blame 
as she had not planned 
it. 
Managing accidental 
pregnancy 
Coping 
FG71: You can’t, you’re right. It’s true that, I 
feel exactly the same. You know, I mean, and I 
think, like, because, I mean, you accidentally 
got pregnant, so you had to deal with it,  
 
Table A3.4 Stage 5 – Focus Group Analysis 
 
Stage 6 Looking for patterns across cases  
Looking for patterns across cases was managed in a similar way to stage 4 analysis 
using NVivo summary reporting facilities. Table A3.5 illustrates the Code Summary 
report for the substantive theme ‘Pregnancy Planning’. The sub-themes are nested 
within the substantive theme, with the linked participant quote referenced to its 
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location within the transcript. These were printed to map-out the structure of the 
overall thematic analysis. This visual representation allowed me to look both within 
and across participant cases, and within and across themes. The process served to 
highlight ways in which participants represent unique idiosyncratic instances while 
sharing higher order qualities (Smith et al., 2009).  
 
Sub-theme-  
The experience of 
planning pregnancy  
Examples of participant coded references  Reference location 
What planning means to 
women with epilepsy 
FG106: they’re trying for a baby and stuff that’s 
what normally planning a pregnancy means 
FG102: it means to me that I should make sure 
I’m stable before I get pregnant, 
FG23: it was more sensible, and I had more. You 
know, more comfort in the fact that. Well at least, 
I’m being sensible here. Before I go ahead with 
this pregnancy… 
OI07: I do like to be in control, and I do like to be 
organised, yes definitely like that, anyone will tell 
you that 
OI08: I know what sort of sub headings I would 
need to have within that bit of my plan, you 
know, folic acid, possible lowering the 
medication you know 
FG10, line 1228. 
 
 
FG10, line 1440. 
 
FG2, line 614. 
 
 
 
Interview, line 793. 
 
 
Interview, line 874. 
Priorities in planning FG106: I don’t mean stable like in not having fits, 
I mean stable as in money and a stable partner. 
FG101: my medication is the big thing with this 
planning pregnancy that’s just the, it comes back 
to the medication all the time. 
FG82: That’s the biggest thing, is being properly 
counselled, beforehand. 
FG61: I think you’ve got to build up the support 
mechanisms first, and then everything else can 
fall into place 
FG10, line 1451. 
 
 
 
FG10, line 1507. 
 
FG8, line 1832. 
 
FG6, 632. 
Table A3.5 Code summary report for substantive theme – Pregnancy planning 
 
Stage 7 Taking it deeper: Levels of interpretation 
Interpretation is an integral component of an interpretative phenomenological analysis 
and has been incorporated into all stages of analysis. However, at this final stage 
‘taking it deeper’; the stage of interpretation requires making inferences, providing 
meaning and giving explanations for the experiences of women with epilepsy 
preparing for pregnancy.  
 
Working with my final study population (n=85), the importance of being able to make 
interpretive claims representing the group of participants from within the study 
population was made possible by group level themes being illustrated with particular 
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reference to the individual participant experience (Smith et al., 2009). The ability to 
support the claim of representativeness was established through charting the recurrence 
of emergent and substantive themes within the data. Figures A3.2 and A3.3 illustrates 
the representation of the sub-theme ‘Having an AED affected child’ within focus 
group and observation interview data. 
Figure A3.2 Recurrent themes Focus Group Data
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Figure A3.3 Recurrent themes Observation/Interview Data
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